Îñòàâüòå ññûëêó íà ýòó ñòðàíèöó â ñîöñåòÿõ:

Ïîèñê ïî áàçå äîêóìåíòîâ:

 

ÌÈÍÈÑÒÅÐÑÒÂÎ ÇÄÐÀÂÎÎÕÐÀÍÅÍÈß ÐÎÑÑÈÉÑÊÎÉ ÔÅÄÅÐÀÖÈÈ

 

ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÐÅÅÑÒÐ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ

 

ÎÔÈÖÈÀËÜÍÎÅ ÈÇÄÀÍÈÅ

(äàííûå ïî ñîñòîÿíèþ íà 1 íîÿáðÿ 1998 ã.)

 

×àñòü I, ãëàâà 1, ðàçäåëû 1, 2

 

×àñòü I, ãëàâà 1, ðàçäåëû 3-6, ãëàâû 2, 3, 4

 

×ÀÑÒÜ II.

 

ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÐÅÅÑÒÐ

ÇÀÐÓÁÅÆÍÛÕ ËÅÊÀÐÑÒÂÅÍÍÛÕ, ËÅ×ÅÁÍÎ-ÏÐÎÔÈËÀÊÒÈ×ÅÑÊÈÕ

È ÄÈÀÃÍÎÑÒÈ×ÅÑÊÈÕ ÑÐÅÄÑÒÂ, ÐÀÇÐÅØÅÍÍÛÕ

Ê ÌÅÄÈÖÈÍÑÊÎÌÓ ÏÐÈÌÅÍÅÍÈÞ È ÂÂÎÇÓ

 

Ãëàâà 1.

 

ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ, ÑÓÁÑÒÀÍÖÈÈ

È ÂÑÏÎÌÎÃÀÒÅËÜÍÛÅ ÂÅÙÅÑÒÂÀ

 

Ðàçäåë 1.

 

ÑÓÁÑÒÀÍÖÈÈ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ

È ÂÑÏÎÌÎÃÀÒÅËÜÍÛÅ ÂÅÙÅÑÒÂÀ

 

┌──────────────────────────────┬─────────────────────────┬──────────────────────────────┬──────────────────────────────┬────────────┐

     Òîðãîâîå íàçâàíèå             Ôàðì. ãðóïïà               Ôîðìà âûïóñêà                Ôèðìà (Ñòðàíà)            Íîìåð,   

     [ìåæä. íàçâàíèå]               [Êîä ÀÒÑ]                                                                         äàòà    

├──────────────────────────────┼─────────────────────────┼──────────────────────────────┼──────────────────────────────┼────────────┤

│Àçèòðîìèöèí                   │àíòèáèîòèê, ìàêðîëèä     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005835,    

                                                                                                                   │17.03.95   

                                                                                                                              

│Àêëåçèí {áîðöà áåëîóñòîãî     │àíòèàðèòìè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã  │Èíñòèòóò Õèìèè Ðàñòèòåëüíûõ   │95/370/2,  

│àëêàëîèäû}                                                                           │Âåùåñòâ ÀÍ Óçáåêèñòàíà        │27.12.95   

                                                                                     │(Óçáåêèñòàí)                             

                                                                                                                              

│Àêòîâåãèí êîíöåíòðàò          │ðåãåíåðàöèè ñòèìóëÿòîð   │ñóáñòàíöèÿ                    │Nycomed Austria Gmbh (Àâñòðèÿ)│010104,    

│{äåïðîòåèíèçèðîâàííûé                                                                                              │06.03.98   

│ãåìîäåðèâàò èç êðîâè òåëÿò}                                                                                                   

                                                                                                                              

│L-Àëàíèí                      │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00971,     

                              │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Àëåòðèñ ìó÷íèñòûé             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010244,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │10.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àëëàïèíèí {àêîíèòà áåëîóñòîãî │àíòèàðèòìè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã  │Èíñòèòóò Õèìèè Ðàñòèòåëüíûõ   │95/112/1,  

│àëêàëîèä (ëàïïàêîíèòèíà                                                              │Âåùåñòâ ÀÍ Óçáåêèñòàíà        │27.05.95   

│áðîìèä)}                                                                             │(Óçáåêèñòàí)                             

                                                                                                                              

│Àëëîïóðèíîë                   │êñàíòèíîêñèäàçû èíãèáèòîð│ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │006942,    

                                                                                     │(Ãîëëàíäèÿ)                   │25.12.95   

                                                                                                                             

│Àëîý                          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010324,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                            

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àëüáåíäàçîë                   │ïðîòèâîãåëüìèíòíîå       │ñóáñòàíöèÿ-ïîðîøîê (áàíêè)    │Èíñòèòóò Õèìèè Ðàñòèòåëüíûõ   │98/207/1   

                              │ñðåäñòâî                 │0.5, 1 êã                     │Âåùåñòâ ÀÍ Óçáåêèñòàíà                   

                                                                                     │(Óçáåêèñòàí)                             

                                                                                                                              

│DL-àëüôà-Òîêîôåðîë            │âèòàìèí                  │ñóáñòàíöèÿ ìàñëÿíàÿ (áàíêè    │Concern Basf (Ãåðìàíèÿ)       │009961,    

                                                       │àëþìèíèåâûå) 1, 5 êã;                                       │22.01.98   

                                                       │ñóáñòàíöèÿ ìàñëÿíàÿ (áî÷êè)                                            

                                                       │25, 30 êã                                                              

                                                                                                                              

│Àìáðà ãðèçåà                  │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010372,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àìèêàöèíà ñóëüôàò             │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005972,    

                                                                                                                   │18.04.95   

                                                                                                                              

│Àìèêñèí                       │èììóíîñòèìóëèðóþùåå      │ñóáñòàíöèÿ (áàíêè) 500 ã      │Îäåññêèé Ôèçèêîõèìè÷åñêèé     │96/252/1,  

                              │ñðåäñòâî                                               │Èíñòèòóò (Óêðàèíà)            │18.06.96   

                                                                                                                              

│Àìèíàëîí                      │íîîòðîïíîå ñðåäñòâî      │ñóáñòàíöèÿ (áàíêè îðàíæåâîãî  │Ôàðìàê ÀÎ (Óêðàèíà)           │74/552/1,  

                                                       │ñòåêëà ñ âèíòîâîé ãîðëîâèíîé) │                              │23.06.97   

                                                       │2 êã                                                                   

                                                                                                                              

│Àìèíîêàïðîíîâàÿ êèñëîòà       │ãåìîñòàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè ñòåêëÿííûå) │Õèìòåõíîëîãèÿ Ãîñíèïè         │69/110/1,  

                                                       │0.5, 1 êã; ñóáñòàíöèÿ (ïàêåòû │Õèìòåõíîëîãèé (Óêðàèíà)       │15.04.97   

                                                       │ïîëèýòèëåíîâûå äâóõñëîéíûå)                                            

                                                       │2, 15 êã                                                               

                                                                                                                              

│Àìèíîêàïðîíîâàÿ êèñëîòà       │ãåìîñòàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã  │Õèìôàðì ÀÎ (Êàçàõñòàí)        │69/110/1,  

                                                                                                                   │15.07.98   

                                                                                                                              

│Àìèòðèïòèëèíà ãèäðîõëîðèä     │àíòèäåïðåññàíò           │ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │007113,    

                                                                                     │(Ãîëëàíäèÿ)                   │29.02.96   

                                                                                                                              

│Àìîêñèöèëëèíà íàòðèåâàÿ ñîëü  │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Amypharma Sa (Èñïàíèÿ)        │006472,    

│ñòåðèëüíàÿ                                                                                                         │05.09.95   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò       │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Acopharma (Åãèïåò)            │007488,    

                                                                                                                   │12.05.96   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò       │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Kopran Ltd (Èíäèÿ)            │005714,    

                                                                                                                   │03.02.95   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò       │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Upeng Co Ltd (Êîðåÿ Þæíàÿ)    │005226,    

                                                                                                                   │15.08.94   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò       │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ (ìåøêè             │Fersinsa Gist-Brocades Sa de  │010000,    

                                                       │ïîëèýòèëåíîâûå) 10, 25 êã     │CV (Ìåêñèêà)                  │04.03.98   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò -     │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie (Èñïàíèÿ)           │009469,    

│êîìïàêò                                                                                                            │22.05.97   

                                                                                                                              

│Àìîêñèöèëëèíà òðèãèäðàò -     │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie (Èñïàíèÿ)           │009470,    

│ïîðîøîê                                                                                                            │22.05.97   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Chemifarma Sa (Èñïàíèÿ)       │006345,    

                                                                                                                   │02.08.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006060,    

                                                                                                                   │18.05.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Eupharma Laboratories (Èíäèÿ) │006040,    

                                                                                                                   │11.05.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │International Chemical        │006012,    

                                                                                     │Industry (Èòàëèÿ)             │03.05.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │J.B.F.Industries Ltd (Èíäèÿ)  │005837,    

                                                                                                                   │17.03.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Medochemie Ltd (Êèïð)         │005620,    

                                                                                                                   │04.01.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ ñòåðèëüíàÿ         │Ribbon S.R.L. (Èòàëèÿ)        │006691,    

                                                                                                                   │10.10.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ (êàíèñòðû          │Aurobindo Pharma Ltd (Èíäèÿ)  │010508,    

│(ñòåðèëüíàÿ)                                           │àëþìèíèåâûå) 5 êã                                           │20.10.98   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie Gmbh (Àâñòðèÿ)      │010431,    

│êðèñòàëëè÷åñêàÿ ñòåðèëüíàÿ                                                                                         │20.08.98   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Amypharma Sa (Èñïàíèÿ)        │006471,    

│ñòåðèëüíàÿ                                                                                                         │05.09.95   

                                                                                                                              

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Bristol-Myers Squibb (Èòàëèÿ) │009533,    

│ñòåðèëüíàÿ                                                                                                         │18.06.97   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Acopharma (Åãèïåò)            │007028,    

                                                                                                                   │31.01.96   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Agio Pharmaceuticals Ltd      │006845,    

                                                                                     │(Èíäèÿ)                       │17.11.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Aurobindo Pharma Ltd (Èíäèÿ)  │005634,    

                                                                                                                   │11.01.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie Gmbh (Àâñòðèÿ)      │009258,    

                                                                                                                   │19.02.97   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie (Èñïàíèÿ)           │009609,    

                                                                                                                   │18.07.97    

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Bristol-Myers Squibb (ÑØÀ)    │005046,    

                                                                                                                   │27.06.94   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006059,    

                                                                                                                   │18.05.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Eupharma Laboratories (Èíäèÿ) │006141,    

                                                                                                                   │06.06.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Gujarat Lyka Organics Ltd     │006344,    

                                                                                     │(Èíäèÿ)                       │02.08.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │J.B.F.Industries Ltd (Èíäèÿ)  │005836,    

                                                                                                                   │17.03.95   

                                                                                                                             

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Kopran Ltd (Èíäèÿ)            │003897,    

                                                                                                                   │06.05.94   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Medochemie Ltd (Êèïð)         │005843,    

                                                                                                                   │28.03.95    

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Oman Chemicals&               │010428,    

                                                                                     │Pharmaceuticals Llc (Îìàí)    │19.08.98   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Ranbaxy Laboratories Ltd      │009379,    

                                                                                     │(Èíäèÿ)                       │15.04.97   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Rupeung Co Ltd (Êîðåÿ Þæíàÿ)  │006020,    

                                                                                                                   │04.05.95   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Sol Pharmaceuticals Ltd       │003715,    

                                                                                    │(Èíäèÿ)                       │22.02.94   

                                                                                                                              

│Àìïèöèëëèíà òðèãèäðàò         │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ (ìåøêè             │Fersinsa Gist-Brocades Sa de  │009990,    

                                                       │ïîëèýòèëåíîâûå) 10, 25 êã     │CV (Ìåêñèêà)                  │18.02.98   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Chgune Nan Pharmacological    │006974,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                              │Factory (Êèòàé)               │11.01.96   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Pharmachim (ÍÐÁ)              │2389,      

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                                                            │22.01.75,  

                                                                                                                   │07.12.89   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Shandong Xinhua               │006401,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                              │Pharmaceutical Factory (Êèòàé)│14.08.95   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Shasun Chemicals&Drugs Ltd    │006442,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                              │(Èíäèÿ)                       │28.08.95   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Siris Ltd (Èíäèÿ)             │007524,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                                                            │21.05.96   

                                                                                                                              

│Àíàëüãèí                      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Wuhan Medicines & Health      │006722,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                              │Products Imp. & Exp.Corp      │18.10.95   

                                                                                     │(Êèòàé)                                  

                                                                                                                              

│Àíãóñòóðà íàñòîÿùàÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010280,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àðàëèÿ êèñòåíîñíàÿ            │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010285,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│L-Àðãèíèíà ìîíîãèäðîõëîðèä    │ãåïàòîïðîòåêòîðíîå       │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00960,     

                              │ñðåäñòâî                                               │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Àðèçåìà òðåõëèñòî÷êîâàÿ       │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010382,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àðèñòîëîõèÿ êëåìàòèòèñ        │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010275,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àðíèêà ãîðíàÿ                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010243,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │10.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Àñêîðáèíîâàÿ êèñëîòà          │âèòàìèí                  │ñóáñòàíöèÿ (ìåøêè             │Roche Products Ltd            │010492,    

                                                       │ïîëèýòèëåíîâûå) 25 êã         │(Âåëèêîáðèòàíèÿ)              │09.10.98   

                                                                                                                              

│Àñêîðáèíîâàÿ êèñëîòà          │âèòàìèí                  │ñóáñòàíöèÿ                    │Jiangsu Jiangshan             │010487,    

                                                                                     │Pharmaceutical Co Ltd (Êèòàé) │07.10.98   

                                                                                                                              

│Àñêîðáèíîâàÿ êèñëîòà (âèòàìèí │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Health & Nutrition A/S   │009826,    

│Ñ)                                                                                   │(Äàíèÿ)                       │12.11.97   

                                                                                                                              

│Àñïèðèí                       │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Chgune Nan Pharmacological    │005744,    

                                                                                     │Factory (Êèòàé)               │14.02.95   

                                                                                                                              

│Àñïèðèí                       │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Jiangsu Jiangshan             │006128,    

                                                                                     │Pharmaceutical Co Ltd (ÊÍÐ)   │31.05.95   

                                                                                                                              

│Àñïèðèí                       │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Nanjing Native Produce &      │006740,    

                                                                                     │Animal By-Products Ie Corp    │24.10.95   

                                                                                     │(Êèòàé)                                  

                                                                                                                              

│Àöåòèëñàëèöèëîâàÿ êèñëîòà     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Shandong Xinhua               │006399,    

                                                                                     │Pharmaceutical Factory (Êèòàé)│14.08.95   

                                                                                                                              

│Àöèêëîâèð                     │ïðîòèâîâèðóñíîå ñðåäñòâî │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006875,    

                                                                                                                   │06.12.95   

                                                                                                                              

│Àöèêëîâèð                     │ïðîòèâîâèðóñíîå ñðåäñòâî │ñóáñòàíöèÿ                    │Unibios (Èòàëèÿ)              │006838,    

                                                                                                                   │16.11.95   

                                                                                                                              

│Áàïòèçèÿ êðàñèëüíàÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010364,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áàðáàðèñ îáûêíîâåííûé         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010271,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áàøìà÷îê ïóøèñòûé             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010367,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                      │5, 10 ë                                                                

                                                                                                                              

│Áåçâðåìåííèê îñåííèé          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010369,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áåëëàäîííà                    │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010270,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áåíçèëáåíçîàò ìåäèöèíñêèé     │ñðåäñòâî óíè÷òîæåíèÿ     │ñóáñòàíöèÿ (áóòûëêè           │Ôàðìàê ÀÎ (Óêðàèíà)           │70/182/2,  

                              │ýêòîïàðàçèòîâ            │ïîëèýòèëåíîâûå ñ                                            │18.06.97   

                                                       │íàâèí÷èâàåìîé êðûøêîé) 10 êã                                           

                                                       │/â êîìïëåêòå ñ âêëàäûøåì                                               

                                                       │ïîëèýòèëåíîâûì/                                                        

                                                                                                                              

│Áåíçèëïåíèöèëëèíà íàòðèåâàÿ   │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Jiangxi Dongjeng              │009142,    

│ñîëü                                                                                 │Pharmaceutical Factory (Êèòàé)│17.02.97   

                                                                                                                              

│ÁåòàÂèò 10%                   │âèòàìèí                  │ñóáñòàíöèÿ (ìåøêè) 1, 5, 25 êã│Basf Health & Nutrition A/S   │010146,    

                                                                                     │(Äàíèÿ)                       │06.04.98   

                                                                                                                              

│ÁåòàÂèò 20%                   │âèòàìèí                  │ñóáñòàíöèÿ (ìåøêè) 1, 5, 25 êã│Basf Health & Nutrition A/S   │010147,    

                                                                                     │(Äàíèÿ)                       │06.04.98   

                                                                                                                              

│Áèôîíàçîë                     │ïðîòèâîãðèáêîâîå ñðåäñòâî│ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005480,    

                                                                                                                   │11.11.94   

                                                                                                                              

│Áîðùåâèê îáûêíîâåííûé         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010337,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áîÿðûøíèê, ïëîäû              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010410,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áîÿðûøíèê, öâåòóùèå âåðõóøêè  │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010321,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │15.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Áðîìãåêñèíà ãèäðîõëîðèä       │ìóêîëèòè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │Fdc Limited (Èíäèÿ)           │009392,    

                                                                                                                   │18.04.97   

                                                                                                                              

│Áóïðåíîðôèíà ãèäðîõëîðèä      │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ (ïàêåòû) 0.5, 1, 2 │Õàðüêîâñêèé Ãíöëñ (Óêðàèíà)   │95/43/2,   

                              │íàðêîòè÷åñêîå ñðåäñòâî   │êã                                                          │02.03.95   

                                                                                                                              

│Âàëèäîë {ìåíòîë,              │êîðîíàðîäèëàòèðóþùåå     │ñóáñòàíöèÿ (ôëàêîíû ñ         │Ôàðìàê ÀÎ (Óêðàèíà)           │64/228/42, 

│ìåíòèëèçîâàëåðèíàò}           │ñðåäñòâî                 │êîíóñíîé ãîðëîâèíîé è                                       │10.02.97   

                                                       │ïðèòåðòîé ïðîáêîé) 2 êã, 5                                             

                                                       │êã; ñóáñòàíöèÿ (ôëÿãè                                                  

                                                       │ìåòàëëè÷åñêèå) 25, 38, 40 êã                                           

                                                                                                                              

│Âàõòà òðåõëèñòíàÿ             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010422,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Âåðàïàìèëà ãèäðîõëîðèä        │ÁÌÊÊ                     │ñóáñòàíöèÿ                    │Recordati Spa (Èòàëèÿ)        │006930,    

                                                                                                                   │21.12.95   

                                                                                                                              

│Âåðàïàìèëà ãèäðîõëîðèä        │ÁÌÊÊ                     │ñóáñòàíöèÿ                    │Knoll Ag, Basf Pharma         │006892,    

                                                                                     │(Ãåðìàíèÿ)                    │14.12.95   

                                                                                                                              

│Âèíïîöåòèí                    │âàçîäèëàòèðóþùåå ñðåäñòâî│ñóáñòàíöèÿ                    │Nuova Linnea Sa (Øâåéöàðèÿ)   │010486,    

                                                                                                                   │07.10.98   

                                                                                                                              

│Âèíïîöåòèí {áàðâèíêà ìàëîãî   │âàçîäèëàòèðóþùåå ñðåäñòâî│ñóáñòàíöèÿ (ïàêåòû            │Omnichem Sa (Áåëüãèÿ)         │010406,    

│àëêàëîèä}                                              │ïîëèýòèëåíîâûå) 5, 10, 25 êã                                │14.08.98   

                                                                                                                              

│Âèòàìèí À àöåòàò 500          │âèòàìèí                  │ñóáñòàíöèÿ (ìåøêè             │Roche Vitamins Inc (ÑØÀ)      │010491,    

│ïîðîøêîîáðàçíûé                                        │ïîëèýòèëåíîâûå) 5, 25 êã                                    │09.10.98   

                                                                                                                              

│Âèòàìèí À-àöåòàò 500 ñóõîé    │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Health & Nutrition A/S   │009851,    

                                                                                     │(Äàíèÿ)                       │21.11.97   

                                                                                                                               

│Âèòàìèí À-àöåòàò ìàñëÿíàÿ     │âèòàìèí                  │ñóáñòàíöèÿ                    │Concern Basf (Ãåðìàíèÿ)       │009741,    

│ôîðìà                                                  │íåñòàáèëèçèðîâàííàÿ 1500000                                 │25.09.97   

                                                       │ÌÅ/ã - 1, 5, 25, 50 êã;                                                

                                                       │ñóáñòàíöèÿ                                                             

                                                       │íåñòàáèëèçèðîâàííàÿ 2800000                                            

                                                       │ÌÅ/ã - 1, 5, 25, 50 êã;                                                

                                                       │ñóáñòàíöèÿ ñòàáèëèçèðîâàííàÿ                                           

                                                       │ÁÃÒ 1500000 ÌÅ/ã - 1, 5, 25,                                           

                                                       │50 êã; ñóáñòàíöèÿ                                                      

                                                       │ñòàáèëèçèðîâàííàÿ òîêîôåðîëîì │                                         

                                                       │1500000 ÌÅ/ã - 1, 5, 25, 50 êã│                                         

                                                                                                                              

│Âèòàìèí À-ïàëüìèòàò 500 ñóõîé │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Health & Nutrition A/S   │009852,    

                                                                                     │(Äàíèÿ)                       │21.11.97   

                                                                                                                              

│Âèòàìèí À-ïàëüìèòàò ìàñëÿíàÿ  │âèòàìèí                  │ñóáñòàíöèÿ                    │Concern Basf (Ãåðìàíèÿ)       │009739,    

│ôîðìà                                                  │íåñòàáèëèçèðîâàííàÿ 1000000                                 │25.09.97   

                                                       │ÌÅ/ã - 1, 5, 25, 50 êã;                                                

                                                       │ñóáñòàíöèÿ                                                             

                                                       │íåñòàáèëèçèðîâàííàÿ 1700000                                            

                                                       │ÌÅ/ã - 1, 5, 25, 50 êã;                                                 

                                                       │ñóáñòàíöèÿ ñòàáèëèçèðîâàííàÿ                                           

                                                       │ÁÃÒ 1000000 ÌÅ/ã - 1, 5, 25,                                           

                                                       │50 êã; ñóáñòàíöèÿ                                                      

                                                       │ñòàáèëèçèðîâàííàÿ ÁÃÒ 1700000 │                                         

                                                       │ÌÅ/ã - 1, 5, 25, 50 êã;                                                

                                                       │ñóáñòàíöèÿ ñòàáèëèçèðîâàííàÿ                                           

                                                       │òîêîôåðîëîì 1700000 ÌÅ/ã - 1, │                                         

                                                       │5, 25, 50 êã                                                           

                                                                                                                              

│Âèòàìèí À-ïðîïèîíàò ìàñëÿíàÿ  │âèòàìèí                  │ñóáñòàíöèÿ ñòàáèëèçèðîâàííàÿ  │Concern Basf (Ãåðìàíèÿ)       │009740,    

│ôîðìà                                                  │ÁÃÒ 2500000 ÌÅ/ã - 1, 5, 25,                                │25.09.97   

                                                       │50 êã                                                                  

                                                                                                                              

│Âèòàìèí Â1                    │âèòàìèí                  │ñóáñòàíöèÿ                    │Huazhong State-Run            │007089,    

                                                                                     │Pharmaceutical Factory (Êèòàé)│15.02.96   

                                                                                                                             

│Âèòàìèí Â12 0.1% ÑÄ           │âèòàìèí                  │ñóáñòàíöèÿ (ïàêåòû            │Basf Health & Nutrition A/S   │010292,    

                                                       │ïîëèýòèëåíîâûå) 2.5, 12.5 êã  │(Äàíèÿ)                       │01.07.98   

                                                                                                                              

│Âèòàìèí Â12 1% ÑÄ             │âèòàìèí                  │ñóáñòàíöèÿ (ïàêåòû            │Basf Health & Nutrition A/S   │010293,    

                                                       │ïîëèýòèëåíîâûå) 2.5, 12.5 êã  │(Äàíèÿ)                       │01.07.98    

                                                                                                                              

│Âèòàìèí Â12 êðèñòàëëè÷åñêèé   │âèòàìèí                  │ñóáñòàíöèÿ (áàíêè æåñòÿíûå)   │Produits Roche Sa (Ôðàíöèÿ)   │010493,    

                                                       │10, 100 ã; ñóáñòàíöèÿ (áóòûëè │                              │09.10.98   

                                                       │àëþìèíèåâûå) 1 êã                                                      

                                                                                                                              

│Âèòàìèí Â6                    │âèòàìèí                  │ñóáñòàíöèÿ                    │Nanjing Native Produce &      │006400,    

                                                                                     │Animal By-Products Ie Corp    │14.08.95   

                                                                                     │(Êèòàé)                                  

                                                                                                                              

│Âèòàìèí Å-àöåòàò              │âèòàìèí                  │ñóáñòàíöèÿ (êîíöåíòðàò        │Basf Aktiengesellschaft       │007797,    

                                                       │ìàñëÿíûé)                     │(Ãåðìàíèÿ)                    │06.09.96   

                                                                                                                             

│Âèòàìèí Å-àöåòàò              │âèòàìèí                  │ñóáñòàíöèÿ (ïîðîøîê)          │Basf Health & Nutrition A/S   │007798,    

                                                                                     │(Äàíèÿ)                       │06.09.96   

                                                                                                                              

│Ãàëñàíà {öèòîñòåàðèë ñïèðò,   │ëå÷åáíî-ïðîôèëàêòè÷åñêîå │ñóáñòàíöèÿ-êðåì äëÿ           │ICN Yugoslavia (ÑÐ Þãîñëàâèÿ) │010177,    

│ïàðàôèí æèäêèé, âàçåëèí,      │êîñìåòè÷åñêîå ñðåäñòâî   │ïðèãîòîâëåíèÿ                                               │21.04.98   

│ãëèöåðîë, íàòðèÿ                                       │ëå÷åáíî-ïðîôèëàêòè÷åñêèõ                                               

│ëàóðèëñóëüôàò,                                         │êîñìåòè÷åñêèõ ñðåäñòâ (áàíêè) │                                         

│ìåòèëãèäðîêñèáåíçîàò, âîäà}                            │0.5, 1, 4.5, 20 êã                                                     

                                                                                                                              

│Ãàìàìåëèñ âèðãèíñêèé          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010281,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ãàììàëîí                      │íîîòðîïíîå ñðåäñòâî      │ñóáñòàíöèÿ                    │Northeast General             │007820,    

                                                                                     │Pharmaceutical Factory (Êèòàé)│16.09.96   

                                                                                                                              

│Ãàðïàãîôèòóì ðàñïðîñòåðòûé    │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010283,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ãâàÿêîâîå äåðåâî              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010416,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                 

                                                                                                                              

│Ãåëüçåìèé âå÷íîçåëåíûé        │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010288,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ãåìôèáðîçèë                   │ãèïîëèïèäåìè÷åñêîå       │ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │007114,    

                              │ñðåäñòâî                                               │(Ãîëëàíäèÿ)                   │29.02.96   

                                                                                                                              

│Ãåíòàìèöèíà ñóëüôàò           │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006117,    

                                                                                                                   │30.05.95   

                                                                                                                              

│Ãåíòàìèöèíà ñóëüôàò           │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │Fuzhou Antibiotic General     │006402,    

                                                                                     │Factory Imp&Exp Corporation   │14.08.95   

                                                                                     │(Êèòàé)                                  

                                                                                                                              

│Ãåíòàìèöèíà ñóëüôàò           │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │Lua Cheng Branch Factory Of   │006022,    

                                                                                     │Hua Bei Pharmaceutical        │04.05.95   

                                                                                     │Factory (ÊÍÐ)                             

                                                                                                                              

│Ãåïàðèíà íàòðèåâàÿ ñîëü       │àíòèêîàãóëÿíò ïðÿìîé     │ñóáñòàíöèÿ                    │Helm Ag (Ãåðìàíèÿ)            │005793,    

                                                                                                                   │27.02.95   

                                                                                                                              

│Ãåïàðèíà íàòðèåâàÿ ñîëü       │àíòèêîàãóëÿíò ïðÿìîé     │ñóáñòàíöèÿ                    │Kraeber Gmbh&Co (Ãåðìàíèÿ)    │007025,    

                                                                                                                   │30.01.96   

                                                                                                                              

│Ãåïàðèíà íàòðèåâàÿ ñîëü       │àíòèêîàãóëÿíò ïðÿìîé     │ñóáñòàíöèÿ                    │Shanghai                      │007029,    

                                                                                     │Biochemical&Pharmaceutical    │31.01.96   

                                                                                     │Laboratories (Êèòàé)                     

                                                                                                                              

│Ãèäðîêîðòèçîíà àöåòàò         │ãëþêîêîðòèêîñòåðîèä      │ñóáñòàíöèÿ                    │Tianjin Pharmaceuticals       │010395,    

                                                                                     │Corporation (Êèòàé)           │05.08.98   

                                                                                                                              

│Ãèäðîïåðèò                    │àíòèñåïòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (ïàêåòû            │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │67/554/28, 

                                                       │ïîëèýòèëåíîâûå äâîéíûå) îò 1                                │05.01.98   

                                                       │äî 3 êã                                                                

                                                                                                                              

│Ãèäðîõëîðòèàçèä               │äèóðåòè÷åñêîå ñðåäñòâî   │ñóáñòàíöèÿ                    │Pliva D.D. (Õîðâàòèÿ)         │007860,    

                                                                                                                   │30.09.96   

                                                                                                                               

│Ãèïîðàìèí {îáëåïèõè           │ïðîòèâîâèðóñíîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 0.5 êã     │Äàðíèöà Ôàðìàöåâòè÷åñêàÿ      │98/305/1,  

│êðóøèíîâèäíîé ëèñòüå ïðåïàðàò}│                                                       │Ôèðìà ÇÀÎ (Óêðàèíà)           │13.10.98   

                                                                                                                              

│L-Ãèñòèäèíà ìîíîãèäðîõëîðèä   │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00965,     

│ìîíîãèäðàò                    │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ãëèöèí                        │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00966,     

                              │ñðåäñòâî                                               │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ãëþêîçà                       │ñðåäñòâî óãëåâîäíîãî     │ñóáñòàíöèÿ (ìåøêè) 25, 45 êã  │Äíåïðîâñêèé                   │64/228/53, 

                              │ïèòàíèÿ                                                │Êðàõìàëîëîïàòî÷íûé Êîìáèíàò   │26.03.98   

                                                                                     │ÎÀÎ (Óêðàèíà)                            

                                                                                                                              

│Ãîíàäîòðîïèí õîðèîíè÷åñêèé    │ôîëëèêóëîñòèìóëèðóþùåå   │ñóáñòàíöèÿ                    │Akzo-Nobel/Diosynth           │009547,    

                              │ñðåäñòâî                                               │(Íèäåðëàíäû)                  │24.06.97   

                                                                                                                              

│Ãîðèöâåò âåñåííèé             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010327,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                        

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ãðå÷èõà ñúåäîáíàÿ             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010340,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ãóáêà ïðåñíîâîäíàÿ            │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010284,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                      │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ä-Ïàíòîòåíàò êàëüöèÿ          │âèòàìèí                  │ñóáñòàíöèÿ                    │Fuji Chemical Industries Ltd  │009261,    

                                                                                     │(ßïîíèÿ)                      │19.02.97   

                                                                                                                               

│Äå-Íîë                        │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ                    │Yamanouchi Europe B.V.        │006686,    

                              │ñðåäñòâî, ïðåïàðàò                                     │(Íèäåðëàíäû)                  │29.09.95   

                              │âèñìóòà                                                                                         

                                                                                                                              

│Äå-Íîë ãðàíóëÿò               │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ                    │Yamanouchi Europe B.V.        │006206,    

                              │ñðåäñòâî, ïðåïàðàò                                     │(Íèäåðëàíäû)                  │21.06.95   

                              │âèñìóòà                                                                                         

                                                                                                                              

│Äèàçîëèí                      │H1-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ (ïàêåòû            │Ôàðìàê ÀÎ (Óêðàèíà)           │67/554/32, 

                              │ðåöåïòîðîâ áëîêàòîð      │ïîëèýòèëåíîâûå äâóõñëîéíûå)                                 │11.06.97   

                                                       │1, 5, 10 êã                                                            

                                                                                                                             

│Äèêëîôåíàê                    │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Ningbo Smart Chemical &       │006721,    

                                                                                     │Pharmaceutical Co Ltd (Êèòàé) │18.10.95   

                                                                                                                              

│Äèêëîôåíàê                    │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │006943,    

                                                                                     │(Ãîëëàíäèÿ)                   │25.12.95   

                                                                                                                              

│Äèêëîôåíàê                    │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Unique Chemicals (Èíäèÿ)      │005803,    

                                                                                                                   │06.03.95   

                                                                                                                              

│Äèêëîôåíàê íàòðèÿ             │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Amoli Organix Pvt Ltd (Èíäèÿ) │006890,    

                                                                                                                   │07.12.95   

                                                                                                                              

│Äèêëîôåíàê íàòðèÿ             │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009780,    

                                                                                                                   │16.10.97   

                                                                                                                              

│Äèôôåíáàõèÿ êðîâàâàÿ          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010368,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Äîêñèöèêëèíà ãèäðîõëîðèä      │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009871,    

                                                                                                                   │02.12.97   

                                                                                                                              

│Äîêñèöèêëèíà ãèäðîõëîðèä      │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │International Pharmaceutical  │009507,    

                                                                                     │Factory (Êèòàé)               │04.06.97   

                                                                                                                              

│Äîêñèöèêëèíà ãèäðîõëîðèä      │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │Sujou Hiotat Medical Chemical │006037,    

                                                                                     │Co Ltd (ÊÍÐ)                  │10.05.95   

                                                                                                                              

│Äîêñèöèêëèíà ãèäðîõëîðèä      │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │Yanchen Suhai Pharmaceutical  │006038,    

                                                                                     │Co Ltd (ÊÍÐ)                  │11.05.95   

                                                                                                                              

│Äîêñèöèêëèíà õèêëàò           │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │Orsi International Sa         │007441,    

                                                                                     │(Áåëüãèÿ)                     │15.04.96   

                                                                                                                              

│Äîïàìèíà ãèäðîõëîðèä          │êàðäèîòîíè÷åñêîå         │ñóáñòàíöèÿ                    │Knoll Ag (Ãåðìàíèÿ)           │009706,    

                              │ñðåäñòâî,                                                                            │27.08.97   

                              │äîôàìèí-ñòèìóëÿòîð                                                                              

                                                                                                                              

│Äðîòàâåðèíà ãèäðîõëîðèä       │ñïàçìîëèòè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009591,    

                                                                                                                   │11.07.97   

                                                                                                                              

│Äÿãèëü ëåêàðñòâåííûé          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010331,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Åëü ÷åðíàÿ                    │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010370,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Çâåðîáîé ïðîäûðÿâëåííûé       │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010414,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Èáåðèéêà ãîðüêàÿ              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010418,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Èáóïðîôåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Agio Pharmaceuticals Ltd      │009888,    

                                                                                     │(Èíäèÿ)                       │05.12.97   

                                                                                                                              

│Èáóïðîôåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ (ïàêåòû            │Knoll Pharmaceuticals         │010227,    

                                                       │ïîëèýòèëåíîâûå) 20 êã         │(Âåëèêîáðèòàíèÿ)              │01.06.98   

                                                                                                                              

│Èáóïðîôåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Shandong Xinhua               │007875,    

                                                                                     │Pharmaceutical Factory (Êèòàé)│03.10.96   

                                                                                                                              

│Èáóïðîôåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Shasun Chemicals&Drugs Ltd    │006441,    

                                                                                     │(Èíäèÿ)                       │28.08.95   

                                                                                                                              

│Èáóïðîôåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Sumitra Pharmaceuticals &     │006958,    

                                                                                     │Chemicals Ltd (Èíäèÿ)         │04.01.96   

                                                                                                                              

│Èäåáåíîí                      │íîîòðîïíîå ñðåäñòâî      │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │010450,    

                                                                                                                   │03.09.98   

                                                                                                                              

│Èçîäèáóò                      │ñàõàðîñíèæàþùåå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 1, 2 êã    │Ôàðìàê ÀÎ (Óêðàèíà)           │91/112/1,  

                              │äëÿ ïåðîðàëüíîãî ïðèåìà                                                              │17.03.98   

                                                                                                                              

│L-Èçîëåéöèí                   │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00967,     

                              │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Èçîíèàçèä                     │ïðîòèâîòóáåðêóëåçíîå     │ñóáñòàíöèÿ                    │Beijing Medicines & Health    │007087,    

                              │ñðåäñòâî                                               │Products Import and Export    │15.02.96   

                                                                                     │Corporation (Êèòàé)                      

                                                                                                                              

│Èçîíèàçèä                     │ïðîòèâîòóáåðêóëåçíîå     │ñóáñòàíöèÿ                    │Beijing Second Pharmaceutical │009112,    

                              │ñðåäñòâî                                               │Factory (Êèòàé)               │03.02.97   

                                                                                                                              

│Èçîòóðîí                      │âàçîêîíñòðèêòîðíîå       │ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã  │Ãîñóíèâåðñèòåò Ìåäèöèíû è     │96/185/1,  

                              │ñðåäñòâî                                               │Ôàðìàöèè (Ìîëäîâà)            │07.05.96   

                                                                                                                              

│Èìèôîñ                        │ïðîòèâîîïóõîëåâîå        │ñóáñòàíöèÿ (áàíêè) 0.2, 0.3,  │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009199,    

                              │ñðåäñòâî                 │0.4, 0.7, 0.8 êã              │(Ëàòâèÿ)                      │20.11.97   

                                                                                                                              

│Èíäîìåòàöèí                   │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Chemo Iberica (Èñïàíèÿ)       │009317,    

                                                                                                                   │19.03.97   

                                                                                                                              

│Èíæèð                         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010320,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │15.07.98   

                                                       │60, 125, 250 ìë;                                                        

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Èíîçèí                        │ìåòàáîëè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │Ajinomoto Co Inc (ßïîíèÿ)     │005992,    

                                                                                                                   │24.04.95   

                                                                                                                              

│Èíîçèí                        │ìåòàáîëè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │Guangdong Zhaoqing Star Lake  │010448,    

                                                                                     │Biochemical Pharmaceutical    │01.09.98   

                                                                                     │Factory (Êèòàé)                          

                                                                                                                              

│Èíñóëèí ñâèíîé âûñîêîé        │èíñóëèí êîðîòêîãî        │ñóáñòàíöèÿ                    │Helm Ag (Ãåðìàíèÿ)            │009113,    

│î÷èñòêè {èíñóëèí ñâèíîé       │äåéñòâèÿ                                                                             │03.02.97   

│íåéòðàëüíûé}                                                                                                                  

                                                                                                                              

│Èðèñ ðàçíîöâåòíûé             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010328,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Éîäîïîâèäîí 30/06             │àíòèñåïòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ                    │Basf (Ãåðìàíèÿ)               │009939,    

                                                                                                                   │29.12.97   

                                                                                                                              

│Éîäîïîâèäîí 30/06 Ì10         │àíòèñåïòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ                    │Basf (Ãåðìàíèÿ)               │009939,    

                                                                                                                   │29.12.97   

                                                                                                                              

│Êàáàðãà                       │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010423,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êàëüìèÿ øèðîêîëèñòíàÿ         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010380,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êàëüöèÿ ãëþêîíàò              │ðåãóëÿòîð îáìåíà êàëüöèÿ │ñóáñòàíöèÿ                    │Wenzhou N2 Pharmaceutical     │007486,    

                              │è ôîñôîðà                                              │Factory (Êèòàé)               │12.05.96   

                                                                                                                              

│Êàëüöèÿ Ä-ïàíòîòåíàò          │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Aktiengesellschaft       │009321,    

                                                                                     │(Ãåðìàíèÿ)                    │19.03.97   

                                                                                                                              

│Êàíàìèöèíà êèñëîãî ñóëüôàò    │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │Lua Cheng Branch Factory of   │006021,    

                                                                                     │Hua Bei Pharmaceutical        │04.05.95   

                                                                                     │Factory (ÊÍÐ)                            

                                                                                                                              

│Êàïñóëû òâåðäûå æåëàòèíîâûå                            │âñïîìîãàòåëüíîå               │Associated Capsules Limited   │009593,    

                                                       │âåùåñòâî-êàïñóëû æåëàòèíîâûå  │(Èíäèÿ)                       │15.07.97   

                                                       │òâåðäûå N0, N00, N1, N2, N3,                                           

                                                       │N4                                                                     

                                                                                                                              

│Êàïòîïðèë                     │ÀÊÔ áëîêàòîð             │ñóáñòàíöèÿ                    │Bristol-Myers Squibb, a       │007055,    

                                                                                     │division of Squibb            │07.02.96   

                                                                                     │Manufacturing Inc                        

                                                                                     │(Ïóýðòî-Ðèêî)                            

                                                                                                                              

│Êàïòîïðèë                     │ÀÊÔ áëîêàòîð             │ñóáñòàíöèÿ                    │Swords Laboratories Ltd, a    │009348,    

                                                                                     │division of Bristol-Myers     │31.03.97   

                                                                                     │Squibb (Èðëàíäèÿ)                         

                                                                                                                              

│Êàðàêàòèöà àïòå÷íàÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010246,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │10.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êàðáàìàçåïèí                  │ïðîòèâîñóäîðîæíîå        │ñóáñòàíöèÿ                    │Chemo Iberica (Èñïàíèÿ)       │009319,    

                              │ñðåäñòâî                                                                             │19.03.97   

                                                                                                                              

│Êàðäóóñ ìàðèàíóñ              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010245,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │10.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│L-Êàðíèòèí                    │ìåòàáîëè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │Lonza Ltd (Øâåéöàðèÿ)         │007788,    

                                                                                                                   │05.09.96   

                                                                                                                               

│Êàñêàðà ñàãðàäà               │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010273,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êâàññèÿ öåäðîí                │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010272,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êåòàìèíà ãèäðîõëîðèä          │íàðêîçíîå                │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005640,    

                              │íåèíãàëÿöèîííîå ñðåäñòâî │                                                            │12.01.95   

                                                                                                                              

│Êåòîðîëàêà òðîìåòàìèí         │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │010355,    

                                                                                                                   │23.07.98   

                                                                                                                              

│Êåòîðîëàêà òðîìåòàìèí         │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Lupin Laboratories Ltd (Èíäèÿ)│006927,     

                                                                                                                   │20.12.95   

                                                                                                                              

│Êåòîòèôåíà ôóìàðàò            │ïðîòèâîàëëåðãè÷åñêîå     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005311,    

                              │ñðåäñòâî                                                                             │12.09.94   

                                                                                                                              

│Êèïàðèñ âå÷íîçåëåíûé          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010371,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êëîòðèìàçîë                   │ïðîòèâîãðèáêîâîå ñðåäñòâî│ñóáñòàíöèÿ (ìåøêè             │Chemo Iberica Sa (Èñïàíèÿ)    │010117,    

                                                       │ïîëèýòèëåíîâûå) 1, 5, 10, 25, │                              │12.03.98   

                                                       │50 êã                                                                  

                                                                                                                             

│Êîêàðáîêñèëàçû ãèäðîõëîðèä    │ìåòàáîëè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │E.Merck (Ãåðìàíèÿ)            │006498,    

                                                                                                                   │13.09.95   

                                                                                                                              

│Êîêîðûø                       │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010375,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98    

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êîëëèäîí 12 PF                │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ (ïàêåòû            │Basf Ag (Ãåðìàíèÿ)            │010148,    

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå) 50 êã                                       │06.04.98   

                                                                                                                              

│Êîëëèäîí 17 PF                │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ (ïàêåòû            │Basf Ag (Ãåðìàíèÿ)            │010149,    

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå) 50 êã                                       │06.04.98   

                                                                                                                              

│Êîëëèäîí 25, 30, 90F          │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ (ïàêåòû            │Basf Ag (Ãåðìàíèÿ)            │010167,    

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå) 50 êã                                       │27.04.98   

                                                                                                                              

│Êîëëèäîí CL, CL-M             │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ                    │Basf Aktiengesellschaft       │010443,    

                              │ñðåäñòâî                                               │(Ãåðìàíèÿ)                    │28.08.98   

                                                                                                                              

│Êîëëèäîí VA64                 │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ (ïàêåòû            │Basf Ag (Ãåðìàíèÿ)            │010342,    

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå) 35 êã                                       │16.07.98   

                                                                                                                              

│Êîëõèöèí {áåçâðåìåííèêà       │ïðîòèâîâîñïàëèòåëüíîå    │ñóáñòàíöèÿ (áàíêè) 0.25, 0.5  │Èíñòèòóò Ôàðìàêîõèìèè ÀÍ      │92/210/2,  

│âåëèêîëåïíîãî àëêàëîèä}       │ñðåäñòâî                 │êã                            │Ãðóçèè (Ãðóçèÿ)               │24.07.92   

                                                                                                                              

│Êîðèëóñ àâåëëàíà              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010365,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êîôåèí                        │ïñèõîñòèìóëèðóþùåå       │ñóáñòàíöèÿ                    │Agio Pharmaceuticals Ltd      │009623,    

                              │ñðåäñòâî                                               │(Èíäèÿ)                       │25.07.97   

                                                                                                                              

│Êîôåèí                        │ïñèõîñòèìóëèðóþùåå       │ñóáñòàíöèÿ                    │Knoll Ag (Ãåðìàíèÿ)           │009322,    

                              │ñðåäñòâî                                                                             │19.03.97   

                                                                                                                              

│Êîôåèí                        │ïñèõîñòèìóëèðóþùåå       │ñóáñòàíöèÿ                    │Shandong Xinhua               │006718,    

                              │ñðåäñòâî                                               │Pharmaceutical Factory (Êèòàé)│18.10.95   

                                                                                                                              

│Êîôåèí                        │ïñèõîñòèìóëèðóþùåå       │ñóáñòàíöèÿ                    │Shandong Xinhua               │006397,    

                              │ñðåäñòâî                                               │Pharmaceutical Factory (Êèòàé)│14.08.95   

                                                                                                                              

│Êîôåèí áåçâîäíûé              │ïñèõîñòèìóëèðóþùåå       │ñóáñòàíöèÿ (áàðàáàíû) 25 êã   │Tianjin Hebel Pharmaceu-tical │010159,    

                              │ñðåäñòâî                                               │Factory (First Branch) (Êèòàé)│13.04.98   

                                                                                                                              

│Êîõëåàðèÿ àðìîðàöèÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010378,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Êðèñòàëë ñâèíîãî Èíñóëèíà     │èíñóëèí êîðîòêîãî        │ñóáñòàíöèÿ                    │Biobras S/A (Áðàçèëèÿ)        │007539,    

                              │äåéñòâèÿ                                                                             │23.05.96   

                                                                                                                              

│Êðîñïîâèäîí Ì                 │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ (ïàêåòû            │Basf Ag (Ãåðìàíèÿ)            │010294,    

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå) 50 êã                                       │01.07.98   

                                                                                                                              

│Êñàíòèíîëà íèêîòèíàò          │àíòèàãðåãàíòíîå ñðåäñòâî │ñóáñòàíöèÿ                    │Farmak A.S. (×åøñêàÿ          │010511,    

                                                                                     │Ðåñïóáëèêà)                   │23.10.98   

                                                                                                                              

│Êñèëîìåòàçîëèíà ãèäðîõëîðèä   │àëüôà-àäðåíîñòèìóëÿòîð   │ñóáñòàíöèÿ (áàðàáàíû) 5, 10,  │Knoll Ag (Ãåðìàíèÿ)           │010207,    

                                                       │25, 50 êã                                                   │14.05.98   

                                                                                                                              

│Êóïèð                         │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ-ïîðîøîê (áàíêè) 1  │Òàøêåíòñêèé Ôàðìèíñòèòóò      │94/302/2,  

                              │ñðåäñòâî                 │êã                            │(Óçáåêèñòàí)                  │30.12.94   

                                                                                                                              

│Ë (+)Àñêîðáèíîâàÿ êèñëîòà     │âèòàìèí                  │ñóáñòàíöèÿ                    │Merck Kgaa (Ãåðìàíèÿ)         │007420,    

                                                                                                                   │05.04.96   

                                                                                                                              

│Ëàãîäåí                       │ãåìîñòàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 0.2, 1 êã  │Òàøêåíòñêèé Ãîñóíèâåðñèòåò    │92/221/1,  

                                                                                     │(Óçáåêèñòàí)                  │06.08.92   

                                                                                                                              

│Ëàíäûø ìàéñêèé                │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010407,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ëàíñîïðàçîë                   │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009592,    

                              │ñðåäñòâî, ïðîòîííîãî                                                                 │11.07.97   

                              │íàñîñà èíãèáèòîð                                                                                

                                                                                                                              

│L-Ëåéöèí                      │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00968,     

                              │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ëåñïåäåöà ãîëîâ÷àòàÿ          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010417,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│L-Ëèçèíà ìîíîãèäðîõëîðèä      │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00969,     

                              │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ëèêàäåêñ ÏÔ                   │ñðåäñòâî óãëåâîäíîãî     │ñóáñòàíöèÿ                    │Roquette Freres (Ôðàíöèÿ)     │006911,    

                              │ïèòàíèÿ                                                                              │19.12.95   

                                                                                                                              

│Ëèíêîìèöèíà ãèäðîõëîðèä       │àíòèáèîòèê, ëèíêîçàìèä   │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006083,    

                                                                                                                   │23.05.95   

                                                                                                                              

│Ëèíêîìèöèíà ãèäðîõëîðèä       │àíòèáèîòèê, ëèíêîçàìèä   │ñóáñòàíöèÿ                    │North China Pharmaceutical    │006511,    

                                                                                     │Corporation (Êèòàé)           │20.09.95    

                                                                                                                              

│Ëèíêîìèöèíà ãèäðîõëîðèä       │àíòèáèîòèê, ëèíêîçàìèä   │ñóáñòàíöèÿ                    │×îíõèíü Ðåéëèíü Ôàðì.Ôàáðèêà  │006039,    

                                                                                     │(ÊÍÐ)                         │11.05.95   

                                                                                                                              

│Ëîâàñòàòèí                    │ãèïîëèïèäåìè÷åñêîå       │ñóáñòàíöèÿ (áî÷êè             │Chemo Iberica Sa (Èñïàíèÿ)    │009948,    

                              │ñðåäñòâî                 │àëþìèíèåâûå) 1, 5, 10 êã                                    │13.01.98   

                                                                                                                              

│Ëîìîíîñ âèíîãðàäîëèñòíûé      │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010376,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ëîìîíîñ ïðÿìîé                │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010325,    

                                                      │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                               

│Ëîïåðàìèä                     │ïðîòèâîäèàðåéíîå ñðåäñòâî│ñóáñòàíöèÿ (êîíòåéíåðû        │Chemo Iberica Sa (Èñïàíèÿ)    │009957,    

                                                       │ïîëèýòèëåíîâûå) 1, 5, 10, 25                                │20.01.98   

                                                       │êã                                                                     

                                                                                                                              

│Ëîðàòàäèí                     │H1-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ (êîíòåéíåðû        │Chemo Iberica Sa (Èñïàíèÿ)    │009958,    

                              │ðåöåïòîðîâ áëîêàòîð      │ïîëèýòèëåíîâûå) 1, 5, 10, 25                                │20.01.98   

                                                       │êã                                                                     

                                                                                                                              

│Ëóäèïðåññ {ëàêòîçà 100%}                               │ñóáñòàíöèÿ-âñïîìîãàòåëüíîå    │Basf Aktiengesellschaft       │010393,    

                                                       │âåùåñòâî                      │(Ãåðìàíèÿ)                    │05.08.98   

                                                                                                                              

│Ëþöåðíà ïîñåâíàÿ              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010339,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ëÿäâåíåö ðîãàòûé              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010336,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ìàëüâà ëåñíàÿ                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010421,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│D (-) Ìàííèòîë                │äèóðåòè÷åñêîå ñðåäñòâî   │ñóáñòàíöèÿ                    │Merck Kgaa (Ãåðìàíèÿ)         │009555,    

                                                                                                                   │26.06.97   

                                                                                                                              

│Ìàðãàðèòêà ìíîãîëåòíÿÿ        │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010278,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ìàðñäåíèÿ êîíäóðàíãî          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010411,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ìàññóïîë 15                                            │ñóáñòàíöèÿ (îñíîâà äëÿ        │Loders Croklaan (Íèäåðëàíäû)  │007461,    

                                                       │ñóïïîçèòîðèåâ)                                              │23.04.96   

                                                                                                                              

│Ìåëèññà ëåêàðñòâåííàÿ         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010420,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ìåòàìèçîë íàòðèÿ              │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Medochemie Ltd (Êèïð)         │005609,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                                                            │28.12.94   

                                                                                                                              

│Ìåòàöèêëèíà ãèäðîõëîðèä       │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │Guilin Pharmaceutical Works   │006776,    

                                                                                     │(Êèòàé)                       │01.11.95   

                                                                                                                               

│N-Ìåòèëãëþêàìèí               │êîìïëåêñîîáðàçóþùåå      │ñóáñòàíöèÿ (ïàêåòû            │Ôàðìàê ÀÎ (Óêðàèíà)           │74/614/6,  

                              │ñðåäñòâî                 │ïîëèýòèëåíîâûå äâóõñëîéíûå)                                 │15.09.97   

                                                       │2, 10 êã                                                               

                                                                                                                              

│Ìåòèëóðàöèë                   │ðåãåíåðàöèè ñòèìóëÿòîð   │ñóáñòàíöèÿ (ïàêåòû) 0.5, 15 êã│Ôàðìàê ÀÎ (Óêðàèíà)           │71/273/38, 

                                                                                                                   │26.03.98   

                                                                                                                              

│L-Ìåòèîíèí                    │ìåòàáîëè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00970,     

                                                                                     │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ìåòîòðåêñàò                   │ïðîòèâîîïóõîëåâîå        │ñóáñòàíöèÿ                    │Orion Pharmaceutica           │006347,    

                              │ñðåäñòâî                                               │(Ôèíëÿíäèÿ)                   │04.08.95   

                                                                                                                              

│Ìåòðîíèäàçîë                  │ïðîòèâîìèêðîáíîå ñðåäñòâî│ñóáñòàíöèÿ                    │Aarti Drugs Ltd (Èíäèÿ)       │007617,    

                                                                                                                   │04.07.96   

                                                                                                                              

│Ìåòðîíèäàçîë                  │ïðîòèâîìèêðîáíîå ñðåäñòâî│ñóáñòàíöèÿ                    │Jinxin Pharmaceutical General │007641,    

                                                                                     │Factory (Êèòàé)               │11.07.96   

                                                                                                                              

│Ìåòðîíèäàçîë                  │ïðîòèâîìèêðîáíîå ñðåäñòâî│ñóáñòàíöèÿ                    │Unique Chemicals (Èíäèÿ)      │005801,    

                                                                                                                   │06.03.95   

                                                                                                                              

│Ìåòðîíèäàçîëà áåíçîàò         │ïðîòèâîìèêðîáíîå ñðåäñòâî│ñóáñòàíöèÿ                    │Unique Chemicals (Èíäèÿ)      │005802,    

                                                                                                                   │06.03.95   

                                                                                                                              

│Ìóðàâåé ðûæèé                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010323,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ìóõîìîð êðàñíûé               │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010287,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Íàäîëîë                       │áåòà-àäðåíîáëîêàòîð      │ñóáñòàíöèÿ                    │Bristol-Myers Squibb, a       │009002,    

                                                                                     │division of Squibb            │03.12.96    

                                                                                     │Manufacturing Inc                        

                                                                                     │(Ïóýðòî-Ðèêî)                            

                                                                                                                              

│Íàïåðñòÿíêà êðàñíàÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010335,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Íàïðîêñåí                     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Syntex Irlandia Ltd (Èðëàíäèÿ)│005509,    

                                                                                                                   │18.11.94   

                                                                                                                              

│Íàïðîêñåíà íàòðèåâàÿ ñîëü     │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Syntex Irlandia Ltd (Èðëàíäèÿ)│005510,    

                                                                                                                   │18.11.94   

                                                                                                                             

│Íàòðèÿ îêñèáóòèðàò            │íàðêîçíîå                │ñóáñòàíöèÿ (áàíêè) 0.7 êã     │Ôàðìàê ÀÎ (Óêðàèíà)           │69/737/8,  

                              │íåèíãàëÿöèîííîå ñðåäñòâî │                                                            │09.09.98   

                                                                                                                              

│Íàòðèÿ îêñèáóòèðàò            │íàðêîçíîå                │ñóáñòàíöèÿ (áàíêè) 0.5, 2 êã; │Õèìôàðì ÀÎ (Êàçàõñòàí)        │69/737/8,  

                              │íåèíãàëÿöèîííîå ñðåäñòâî │ñóáñòàíöèÿ (ìåøêè) 3, 15 êã                                 │26.03.98    

                                                                                                                              

│Íàôòèçèí                      │àëüôà-àäðåíîñòèìóëÿòîð   │ñóáñòàíöèÿ (ïàêåòû) 5, 10 êã  │Ôàðìàê ÀÎ (Óêðàèíà)           │71/380/9,  

                                                                                                                   │27.12.97   

                                                                                                                              

│Íåîìèöèíà ñóëüôàò             │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ (ïàêåòû            │Shanghai Corp.of Medicine &   │010155,    

                                                       │ïîëèýòèëåíîâûå) 25 êã         │Health, division of           │08.04.98   

                                                                                     │International Trade (Êèòàé)              

                                                                                                                              

│Íèàöèí ÞÑÏ                    │âèòàìèí                  │ñóáñòàíöèÿ                    │Lonza Ltd (Øâåéöàðèÿ)         │009584,    

                                                                                                                   │08.07.97   

                                                                                                                              

│Íèêîòèíàìèä ôàðìà             │âèòàìèí                  │ñóáñòàíöèÿ                    │Lonza Ltd (Øâåéöàðèÿ)         │006133,    

                                                                                                                   │01.06.95   

                                                                                                                              

│Íèïàãèí                       │Olainfarm Îëàéíñêèé ÕÔÇ  │009200, 20.11.97                                           

│(ìåòèë-ïàðà-îêñèáåíçîàò),     │ÀÎ (Ëàòâèÿ)                                                                         

│ñóáñòàíöèÿ (ïàêåòû) 1 êã                                                                                          

                                                                                                                              

│Íèòðåíäèïèí                   │ÁÌÊÊ                     │ñóáñòàíöèÿ (ïàêåòû            │Chemo Iberica Sa (Èñïàíèÿ)    │010297,    

                                                       │ïîëèýòèëåíîâûå) 1, 5, 10 êã                                 │02.07.98   

                                                                                                                              

│Íèôåäèïèí                     │ÁÌÊÊ                     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005641,    

                                                                                                                   │12.01.95   

                                                                                                                              

│Íèôåäèïèí                     │ÁÌÊÊ                     │ñóáñòàíöèÿ                    │Unique Chemicals (Èíäèÿ)      │005804,    

                                                                                                                   │06.03.95   

                                                                                                                              

│Íîãîòêè ëåêàðñòâåííûå         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010277,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Íîðôëîêñàöèí                  │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006710,    

                              │ñðåäñòâî, ôòîðõèíîëîí                                                                │11.10.95   

                                                                                                                              

│Îâåñ ïîñåâíîé                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010286,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Îâåñ ïðîðîùåííûé              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010412,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                 

                                                                                                                              

│Îêñàöèëëèí íàòðèåâàÿ ñîëü -   │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie (Èñïàíèÿ)           │009471,    

│êîìïàêò                                                                                                            │22.05.97   

                                                                                                                              

│Îêñàöèëëèí íàòðèåâàÿ ñîëü -   │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie (Èñïàíèÿ)           │009472,    

│ïîðîøîê                                                                                                           │22.05.97   

                                                                                                                              

│Îêñàöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Aurobindo Pharma Ltd (Èíäèÿ)  │006479,    

                                                                                                                   │06.09.95   

                                                                                                                              

│Îêñàöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Ribbon S.R.L. (Èòàëèÿ)        │006690,    

                                                                                                                   │10.10.95   

                                                                                                                              

│Îêñàöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Southwest Synthetic           │006782,    

                                                                                     │Pharmaceuticcal Factory       │01.11.95   

                                                                                     │(Êèòàé)                                  

                                                                                                                              

│Îêñàöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Sythesis Chimica Sa (Ïåðó)    │006510,    

                                                                                                                   │20.09.95   

                                                                                                                              

│Îêñàöèëëèíà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Bristol-Myers Squibb (Èòàëèÿ) │009534,     

│ñòåðèëüíàÿ                                                                                                         │18.06.97   

                                                                                                                              

│Îêñèòåòðàöèêëèíà ãèäðîõëîðèä  │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ (ïàêåòû            │Yangzhou Pharmaceutical       │010154,    

                                                       │ïîëèýòèëåíîâûå) 25 êã         │Factory (Êèòàé)               │08.04.98   

                                                                                                                              

│Îìåïðàçîë                     │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ (áî÷êè) 1, 5, 10,  │Chemo Iberica Sa (Èñïàíèÿ)    │009947,    

                              │ñðåäñòâî, ïðîòîííîãî     │25, 50 êã                                                   │13.01.98   

                              │íàñîñà èíãèáèòîð                                                                                

                                                                                                                              

│Îìåïðàçîë                     │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ                    │Hetero Drugs Pvt.Ltd. (Èíäèÿ) │009903,    

                              │ñðåäñòâî, ïðîòîííîãî                                                                 │17.12.97   

                              │íàñîñà èíãèáèòîð                                                                                

                                                                                                                              

│Îìåïðàçîë ïåëëåòû             │ïðîòèâîÿçâåííîå          │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │010356,    

                              │ñðåäñòâî, ïðîòîííîãî                                                                 │23.07.98   

                              │íàñîñà èíãèáèòîð                                                                                

                                                                                                                              

│Îðåõ ìóñêàòíûé                │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010419,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïàïàâåðèíà ãèäðîõëîðèä        │ñïàçìîëèòè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ (ïàêåòû            │Recordati Spa (Èòàëèÿ)        │010153,    

                                                       │ïîëèýòèëåíîâûå) 25, 50 êã                                   │08.04.98   

                                                                                                                              

│Ïàðàöåòàìîë                   │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ (ïàêåòû            │Huzhou Beigang Enterprises    │010291,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │ïîëèýòèëåíîâûå) 10 êã         │Group Corporation (Êèòàé)     │30.06.98   

                                                                                                                              

│Ïàðàöåòàìîë                   │àíàëüãåòè÷åñêîå          │ñóáñòàíöèÿ                    │Zhejiang Chemicals I/E Corp.  │009807,    

                              │íåíàðêîòè÷åñêîå ñðåäñòâî │                              │(Êèòàé)                       │28.10.97   

                                                                                                                              

│Ïåíèöèëëèí G íàòðèåâàÿ ñîëü   │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │North China Pharmaceutical    │009560,    

                                                                                     │Corporation (Êèòàé)           │30.06.97   

                                                                                                                              

│Ïåíèöèëëèí G íàòðèåâàÿ ñîëü   │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie Gmbh (Àâñòðèÿ)      │010394,    

│ñòåðèëüíàÿ                                                                                                         │05.08.98   

                                                                                                                              

│Ïåíòîêñèôèëëèí                │âàçîäèëàòèðóþùåå ñðåäñòâî│ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │006940,    

                                                                                     │(Ãîëëàíäèÿ)                   │25.12.95   

                                                                                                                              

│Ïåðåñòóïåíü                   │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010374,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïåôëîêñàöèí ìåòàí ñóëüôîíàò   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Wockhardt Ltd (Èíäèÿ)         │009014,    

│äèãèäðàò                      │ñðåäñòâî, ôòîðõèíîëîí                                                                │16.12.96   

                                                                                                                              

│Ïåôëîêñàöèíà ìåñèëàò          │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006537,    

                              │ñðåäñòâî, ôòîðõèíîëîí                                                                │21.09.95   

                                                                                                                              

│Ïèëîêàðïèíà ãèäðîõëîðèä       │ì-õîëèíîìèìåòèê          │ñóáñòàíöèÿ                    │Akzo-Nobel (Íèäåðëàíäû)       │005752,    

                                                                                                                   │15.02.95   

                                                                                                                              

│Ïèëîêàðïèíà ãèäðîõëîðèä       │ì-õîëèíîìèìåòèê          │ñóáñòàíöèÿ                    │E.Merck (Ãåðìàíèÿ)            │006496,    

                                                                                                                   │12.09.95   

                                                                                                                              

│Ïèëîêàðïèíà ãèäðîõëîðèä       │ì-õîëèíîìèìåòèê          │ñóáñòàíöèÿ                    │Pvp Socildade Anonima         │009701,    

                                                                                     │Farma-co-Quimicos (Áðàçèëèÿ)  │25.08.97   

                                                                                                                              

│Ïèðàöåòàì                     │íîîòðîïíîå ñðåäñòâî      │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │003731,    

                                                                                                                   │25.02.94   

                                                                                                                              

│Ïèðàöåòàì                     │íîîòðîïíîå ñðåäñòâî      │ñóáñòàíöèÿ                    │Northeast Pharmaceutical      │009651,    

                                                                                     │Corporation (Êèòàé)           │05.08.97   

                                                                                                                              

│Ïèðèäîêñèíà ãèäðîõëîðèä       │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Health & Nutrition a/S   │009801,    

                                                                                     │(Äàíèÿ)                       │23.10.97   

                                                                                                                              

│Ïèðîêñèêàì                    │ÍÏÂÑ                     │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005828,    

                                                                                                                   │16.03.95   

                                                                                                                              

│Ïëàñäîí Ñ-15                  │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ                    │International Special Product │009649,    

                              │ñðåäñòâî                                               │(ÑØÀ)                         │05.08.97   

                                                                                                                              

│Ïîâèäîí 8000                  │äåçèíòîêñèêàöèîííîå      │ñóáñòàíöèÿ                    │Basf Aktiengesellschaft       │010398,    

                              │ñðåäñòâî                                               │(Ãåðìàíèÿ)                    │05.08.98   

                                                                                                                              

│Ïîëûíü âûñîêàÿ                │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010409,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                      │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïîëûíü îáûêíîâåííàÿ           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010274,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïîðîõîâêà ãèãàíòñêàÿ          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010373,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïîñêîííèê ïðîíçåííîëèñòíûé    │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010282,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                          

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ïðîêàèí ãèäðîõëîðèä           │ìåñòíîàíåñòåçèðóþùåå     │ñóáñòàíöèÿ                    │Nanjing Pharmaceutical        │009405,    

                              │ñðåäñòâî                                               │Factory (Êèòàé)               │22.04.97   

                                                                                                                             

│L-Ïðîëèí                      │ñðåäñòâî ïàðåíòåðàëüíîãî │ñóáñòàíöèÿ                    │Kyowa Hakko Kogyo Co Ltd      │00973,     

                              │ïèòàíèÿ, àìèíîêèñëîòà                                  │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                   │21.07.94   

                                                                                                                              

│Ïðîïðàíîëîëà ãèäðîõëîðèä      │áåòà-àäðåíîáëîêàòîð      │ñóáñòàíöèÿ (ïàêåòû            │Jintan Pharmaceutical Factory │010157,    

                                                       │ïîëèýòèëåíîâûå) 25 êã         │(Êèòàé)                       │10.04.98   

                                                                                                                              

│Ïðîðîùåííîå çåðíî             │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010408,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ï÷åëà ìåäîíîñíàÿ              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010247,     

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │10.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ðàìîí                         │ïðîòèâîïñîðèàòè÷åñêîå    │ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã  │Êàçàõñêèé Ãîñóíèâåðñèòåò      │94/158/1,  

                              │ñðåäñòâî                                               │(Êàçàõñòàí)                   │29.07.94   

                                                                                                                              

│Ðàíèòèäèíà ãèäðîõëîðèä        │H2-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005310,    

                              │ðåöåïòîðîâ áëîêàòîð                                                                  │12.09.94   

                                                                                                                              

│Ðàíèòèäèíà ãèäðîõëîðèä        │H2-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ                    │Ranbaxy Laboratories Ltd      │009813,    

                              │ðåöåïòîðîâ áëîêàòîð                                    │(Èíäèÿ)                       │30.10.97   

                                                                                                                              

│Ðàíèòèäèíà ãèäðîõëîðèä        │H2-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ (áàðàáàíû) 50 êã   │Shasun Chemicals&Drugs Ltd    │010239,    

                              │ðåöåïòîðîâ áëîêàòîð                                    │(Èíäèÿ)                       │09.06.98   

                                                                                                                              

│Ðåìàíòàäèíà ãèäðîõëîðèä       │ïðîòèâîâèðóñíîå ñðåäñòâî │ñóáñòàíöèÿ (ìåøêè) 10, 15 êã  │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │010049,    

                                                                                     │(Ëàòâèÿ)                      │22.07.98   

                                                                                                                               

│Ðèôàìïèöèí                    │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Anhui Provincial Medicines &  │006866,    

                                                                                     │Health Products, Import &     │30.11.95   

                                                                                     │Export Corp (Êèòàé)                      

                                                                                                                              

│Ðèôàìïèöèí                    │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Polfa, Tarchomin              │006403,    

                                                                                     │Pharmaceutical Works Sa       │14.08.95   

                                                                                     │(Ïîëüøà)                                 

                                                                                                                              

│Ðèôàìïèöèí                    │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Syanghen Medicines            │005999,    

                                                                                     │Corporation (ÊÍÐ)             │26.04.95   

                                                                                                                              

│Ðîìàøêà àïòå÷íàÿ              │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010279,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ðóòèí                         │àíãèîïðîòåêòîðíîå        │ñóáñòàíöèÿ                    │E.Merck (Ãåðìàíèÿ)            │006497,    

                              │ñðåäñòâî                                                                             │13.09.95   

                                                                                                                              

│Ñàìøèò âå÷íîçåëåíûé           │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010330,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ñåëåíèöåðåóñ êðóïíîöâåòêîâûé  │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010326,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ñîòàëîëà ãèäðîõëîðèä          │áåòà-àäðåíîáëîêàòîð      │ñóáñòàíöèÿ                    │Bristol-Myers Barseloneta     │009440,    

                                                                                     │Inc, a division of            │13.05.97   

                                                                                     │Bristol-Myers Squibb (ÑØÀ)               

                                                                                                                              

│Ñòåáëåëèñò âàñèëèñíèêîâèäíûé  │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010276,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.06.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                            

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ñòðåïòîìèöèíà ñóëüôàò         │àíòèáèîòèê, àìèíîãëèêîçèä│ñóáñòàíöèÿ                    │North China Pharmaceutical    │006917,    

│ñòåðèëüíûé                                                                           │Corporation (Êèòàé)           │20.12.95   

                                                                                                                              

│Ñòðåïòîöèä                    │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Zhejiang Quzhou Chemical      │006719,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Industrial Corporation (Êèòàé)│18.10.95   

                                                                                                                              

│Ñóêðàëüôàò                    │ïðîòèâîÿçâåííîå ñðåäñòâî │ñóáñòàíöèÿ                    │Krka (Ñëîâåíèÿ)               │006314,    

                                                                                                                   │26.07.95   

                                                                                                                              

│Ñóêñàìåòîíèÿ õëîðèä           │ìèîðåëàêñèðóþùåå ñðåäñòâî│ñóáñòàíöèÿ                    │Nycomed Austria Gmbh (Àâñòðèÿ)│009276,    

                                                                                                                   │26.02.97   

                                                                                                                              

│Ñóëüôàãóàíèäèí                │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Nanhai Beisha Medical         │007966,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Material Factory (Êèòàé)      │21.11.96   

                                                                                                                              

│Ñóëüôàäèìåòîêñèí              │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (áàðàáàíû) 25, 50  │Ofichem B.V. (Íèäåðëàíäû)     │010490,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä  │êã                                                          │08.10.98   

                                                                                                                             

│Ñóëüôàäèìèäèí                 │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Beijing Medicines & Health    │007086,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Products Import and Export    │15.02.96   

                                                                                     │Corporation (Êèòàé)                      

                                                                                                                              

│Ñóëüôàäèìèäèí                 │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Guangdong Pharmaceutical      │007474,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Factory (Êèòàé)               │25.04.96   

                                                                                                                              

│Ñóëüôàìåòîêñàçîë              │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (áàðàáàíû) 50 êã   │Siris Ltd (Èíäèÿ)             │009959,    

                              │êîìáèíèðîâàííîå ñðåäñòâî │                                                            │22.01.98   

                                                                                                                              

│Ñóëüôàìåòîêñàçîë              │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (áàðàáàíû) 25, 50  │Virchow Laboratories Ltd      │009960,    

                              │êîìáèíèðîâàííîå ñðåäñòâî │êã                            │(Èíäèÿ)                       │22.01.98   

                                                                                                                              

│Ñóëüôàòèàçîë                  │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Shanghai Sunve Pharmaceutical │007088,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Corporation (Êèòàé)           │15.02.96   

                                                                                                                              

│Ñóëüôàòèàçîë íàòðèÿ           │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Ofichem B.V. (Íèäåðëàíäû)     │007487,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                                              │12.05.96   

                                                                                                                              

│Ñóëüôàöåòàìèä íàòðèÿ          │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Katwijk Chemie B.V.           │006508,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │(Ãîëëàíäèÿ)                   │19.09.95   

                                                                                                                               

│Ñóëüôàöèë íàòðèÿ              │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Jiangning Country Organic     │005942,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Chemical Plant (Êèòàé)        │11.04.95   

                                                                                                                              

│Òàìîêñèôåíà öèòðàò            │àíòèýñòðîãåí             │ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │007064,    

                                                                                     │(Ãîëëàíäèÿ)                   │08.02.96   

                                                                                                                             

│Òâåðäûé æèð, ñóáñòàíöèÿ       │Loders Croklaan          │010506, 19.10.98                                           

│(êîðîáêè) 25 êã               │(Íèäåðëàíäû)                                                                         

                                                                                                                              

│Òåîôèëëèí                     │áðîíõîäèëàòèðóþùåå       │ñóáñòàíöèÿ                    │Shandong Xinhua               │006398,    

                              │ñðåäñòâî                                               │Pharmaceutical Factory (Êèòàé)│14.08.95   

                                                                                                                              

│Òåîôèëëèí áåçâîäíûé           │áðîíõîäèëàòèðóþùåå       │ñóáñòàíöèÿ                    │Knoll Ag (Ãåðìàíèÿ)           │009323,    

                              │ñðåäñòâî                                                                             │19.03.97   

                                                                                                                              

│Òåîôèëëèí áåçâîäíûé           │áðîíõîäèëàòèðóþùåå       │ñóáñòàíöèÿ                    │Shandong Xinhua               │006938,    

                              │ñðåäñòâî                                               │Pharmaceutical Factory (Êèòàé)│21.12.95   

                                                                                                                              

│Òåîôèëëèí ãðàíóëÿò Í          │áðîíõîäèëàòèðóþùåå       │ñóáñòàíöèÿ                    │Boehringer Ingelheim Kg       │007909,    

                              │ñðåäñòâî                                               │(Ãåðìàíèÿ)                    │23.10.96   

                                                                                                                              

│Òåðìîïñèñà ýêñòðàêò ñóõîé     │ðàñòèòåëüíîãî            │ñóáñòàíöèÿ (áàíêè) 50, 70 ã;  │Õèìôàðì ÀÎ (Êàçàõñòàí)        │72/334/16, 

                              │ïðîèñõîæäåíèÿ ñðåäñòâî   │ñóáñòàíöèÿ (áàíêè) 1.2, 1.5 êã│                              │20.04.98   

                                                                                                                              

│Òåòðàöèêëèíà ãèäðîõëîðèä      │àíòèáèîòèê, òåòðàöèêëèí  │ñóáñòàíöèÿ                    │First Pharmaceutical Factory  │006512,     

                                                                                     │of Chengde (Êèòàé)            │20.09.95   

                                                                                                                              

│Òèàìèíà ãèäðîõëîðèä {òèàìèíà  │âèòàìèí                  │ñóáñòàíöèÿ                    │Basf Health & Nutrition A/S   │009928,    

│õëîðèä}                                                                              │(Äàíèÿ)                       │26.12.97   

                                                                                                                              

│Òèîïåíòàë íàòðèÿ ñòåðèëüíûé   │íàðêîçíîå                │ñóáñòàíöèÿ                    │Biochemie Gmbh (Àâñòðèÿ)      │006981,    

                              │íåèíãàëÿöèîííîå ñðåäñòâî │                                                            │15.01.96   

                                                                                                                              

│Òèîôîñôàìèä                   │ïðîòèâîîïóõîëåâîå        │ñóáñòàíöèÿ (áàíêè) 0.25, 0.5  │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009215,    

                              │ñðåäñòâî                 │êã                            │(Ëàòâèÿ)                      │03.12.97   

                                                                                                                              

│Òðàìàäîëà ãèäðîõëîðèä         │àíàëüãåòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ                    │Chemo Iberica (Èñïàíèÿ)       │009318,    

                              │öåíòðàëüíîãî äåéñòâèÿ                                                                │19.03.97   

                                                                                                                              

│Òðàìàäîëà ãèäðîõëîðèä         │àíàëüãåòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ                    │Grunenthal Gmbh (Ãåðìàíèÿ)    │006154,    

                              │öåíòðàëüíîãî äåéñòâèÿ                                                                │06.06.95   

                                                                                                                              

│Òðèìåòîïðèì                   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Dong Wha Pharmaceutical       │009811,    

                              │ñðåäñòâî, ôîëèåâîé                                     │Ind.Co, Ltd (Êîðåÿ Þæíàÿ)     │29.10.97   

                              │êèñëîòû àíòàãîíèñò                                                                              

                                                                                                                              

│Óíèòèîë                       │êîìïëåêñîîáðàçóþùåå      │ñóáñòàíöèÿ (áàíêè) 1 êã       │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │010056,    

                              │ñðåäñòâî                                               │(Ëàòâèÿ)                      │01.09.98   

                                                                                                                              

│Ôàìîòèäèí                     │H2-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ (áî÷êè) 1, 5, 10,  │Chemo Iberica Sa (Èñïàíèÿ)    │010108,    

                              │ðåöåïòîðîâ áëîêàòîð      │25 êã                                                       │10.03.98   

                                                                                                                              

│Ôåíêàðîë {õèôåíàäèíà          │H1-ãèñòàìèíîâûõ          │ñóáñòàíöèÿ (ìåøêè) 15 êã      │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009198,    

│ãèäðîõëîðèä}                  │ðåöåïòîðîâ áëîêàòîð                                    │(Ëàòâèÿ)                      │20.11.97   

                                                                                                                              

│Ôåíîáàðáèòàë                  │ñíîòâîðíîå ñðåäñòâî      │ñóáñòàíöèÿ (ïàêåòû            │Nantong General               │010158,    

                                                       │ïîëèýòèëåíîâûå) 25 êã         │Pharmaceutical Factory (Êèòàé)│10.04.98   

                                                                                                                              

│Ôëóîêñåòèíà ãèäðîõëîðèä       │àíòèäåïðåññàíò           │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009735,    

                                                                                                                   │23.09.97   

                                                                                                                              

│Ôëóîöèíîëîí àöåòîíèä          │ãëþêîêîðòèêîñòåðîèä äëÿ  │ñóáñòàíöèÿ                    │Farmabios S.R.L (Èòàëèÿ)      │007430,    

│{ôëóîöèíîëîíà àöåòîíèä}       │ìåñòíîãî ïðèìåíåíèÿ                                                                  │10.04.96   

                                                                                                                              

│Ôëþîòàí                       │íàðêîçíîå èíãàëÿöèîííîå  │ñóáñòàíöèÿ                    │Zeneca Limited                │005868,    

                              │ñðåäñòâî                                               │(Âåëèêîáðèòàíèÿ)              │27.03.95   

                                                                                                                              

│Ôòàëèëñóëüôàòèàçîë            │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Ofichem B.V. (Íèäåðëàíäû)     │007874,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                                              │03.10.96   

                                                                                                                              

│Ôòàëèëñóëüôàòèàçîë            │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Shanghai Sunve Pharmaceutical │010498,    

                              │ñðåäñòâî, ñóëüôàíèëàìèä                                │Ltd. Corp (Êèòàé)             │13.10.98   

                                                                                                                              

│Ôóðàãèí                       │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (ìåøêè) 10, 15 êã; │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009192,    

                              │ñðåäñòâî, íèòðîôóðàí     │ñóáñòàíöèÿ (áàðàáàíû) 10, 15  │(Ëàòâèÿ)                      │31.10.97   

                                                       │êã                                                                     

                                                                                                                              

│Ôóðàäîíèí                     │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (ïàêåòû) 0.1, 5    │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009191,    

                              │ñðåäñòâî, íèòðîôóðàí     │êã; ñóáñòàíöèÿ (ìåøêè) 10, 15 │(Ëàòâèÿ)                      │31.10.97   

                                                       │êã                                                                     

                                                                                                                              

│Ôóðàçîëèäîí                   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Jinan Jinda Pharmaceutical    │007693,    

                              │ñðåäñòâî, íèòðîôóðàí                                   │Chemistry Co Ltd (Êèòàé)      │26.07.96   

                                                                                                                              

│Ôóðàçîëèäîí                   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ (ìåøêè) 10, 15 êã; │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009193,    

                              │ñðåäñòâî, íèòðîôóðàí     │ñóáñòàíöèÿ (áàðàáàíû) 10, 15  │(Ëàòâèÿ)                      │31.10.97   

                                                       │êã; ñóáñòàíöèÿ (ïàêåòû) 1 êã                                           

                                                                                                                              

│Ôóðàöèëèí                     │àíòèñåïòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 100 ã;     │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009216,    

                                                       │ñóáñòàíöèÿ (ïàêåòû) 0.5, 5    │(Ëàòâèÿ)                      │03.12.97   

                                                       │êã; ñóáñòàíöèÿ (ìåøêè) 10, 15 │                                         

                                                       │êã                                                                     

                                                                                                                              

│Ôóðîñåìèä                     │äèóðåòè÷åñêîå ñðåäñòâî   │ñóáñòàíöèÿ                    │Plantex Chemicals B.V.        │006941,    

                                                                                     │(Ãîëëàíäèÿ)                   │25.12.95   

                                                                                                                              

│Õâîù çèìóþùèé                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010329,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Õëîðàìôåíèêîë                 │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006118,    

                                                                                                                   │30.05.95   

                                                                                                                              

│Õëîðàìôåíèêîë                 │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Northeast General             │006720,    

                                                                                     │Pharmaceutical Factory Ie     │18.10.95   

                                                                                     │Corporation (Êèòàé)                      

                                                                                                                              

│Õëîðàìôåíèêîë                 │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Southwest Synthetic           │007133,    

                                                                                     │Pharmaceutical Corporation    │12.03.96   

                                                                                     │Ltd (Êèòàé)                              

                                                                                                                              

│Õëîðàìôåíèêîë Ëåâî            │àíòèáèîòèê               │ñóáñòàíöèÿ                    │Shanghai Corp.of Medicine &   │006773,    

                                                                                     │Health, division of           │31.10.95   

                                                                                     │International Trade (Êèòàé)              

                                                                                                                              

│Õëîðàìôåíèêîëà íàòðèÿ ñóêöèíàò│àíòèáèîòèê               │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006082,    

                                                                                                                   │23.05.95   

                                                                                                                              

│Õëîðãåêñèäèíà ãëþêîíàò 20%    │äåçèíôèöèðóþùåå ñðåäñòâî │ñóáñòàíöèÿ                    │Zeneca Limited                │005869,    

│ðàñòâîð                                                                              │(Âåëèêîáðèòàíèÿ)              │27.03.95   

                                                                                                                              

│Õìåëü îáûêíîâåííûé            │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010379,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Õðèçàíòåëëóì àìåðèêàíñêèé     │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010377,     

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Öåíòåëëà àçèàòñêàÿ            │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010413,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Antibioticos (Èòàëèÿ)         │006013,    

                                                                                                                   │03.05.95   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Cheil Foods&Chemicals Inc     │005832,    

                                                                                     │(Êîðåÿ Þæíàÿ)                 │16.03.95   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ ñòåðèëüíàÿ         │Ribbon S.R.L. (Èòàëèÿ)        │006466,    

                                                                                                                   │04.09.95    

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Upeng Co Ltd (Êîðåÿ Þæíàÿ)    │003905,    

                                                                                                                   │12.05.94   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, ïåíèöèëëèí   │ñóáñòàíöèÿ                    │Biochemie Gmbh (Àâñòðèÿ)      │010432,    

│êðèñòàëëè÷åñêàÿ ñòåðèëüíàÿ                                                                                         │20.08.98   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ (ìåøêè             │Acs Dobfar (Èòàëèÿ)           │010348,    

│ñòåðèëüíàÿ                                             │ïîëèýòèëåíîâûå) 10 êã                                       │21.07.98   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Amifarma Sa (Èñïàíèÿ)         │009430,    

│ñòåðèëüíàÿ                                                                                                         │05.05.97   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Chemferm Industrial           │009435,    

│ñòåðèëüíàÿ                                                                           │Pharmaceuticals Sa (Èñïàíèÿ)  │06.05.97   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Chemifarma Sa (Èñïàíèÿ)       │009945,    

│ñòåðèëüíàÿ                                                                                                         │09.01.98   

                                                                                                                              

│Öåôàçîëèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │007489,    

│ñòåðèëüíàÿ                                                                                                         │12.05.96   

                                                                                                                              

│Öåôàëåêñèí                    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Chemferm Industrial           │009004,    

                                                                                     │Pharmaceuticals Sa (Èñïàíèÿ)  │03.12.96   

                                                                                                                              

│Öåôàëåêñèí                    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Lupin Laboratories Ltd (Èíäèÿ)│007016,    

                                                                                                                   │26.01.96   

                                                                                                                              

│Öåôàëåêñèí                    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Orchid Chemicals &            │006887,    

                                                                                     │Pharmaceuticals Ltd (Èíäèÿ)   │13.12.95   

                                                                                                                              

│Öåôàëåêñèí                    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Ranbaxy Laboratories Ltd      │009922,    

                                                                                     │(Èíäèÿ)                       │24.12.97   

                                                                                                                              

│Öåôàëîòèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Biochimica Opos Spa (Èòàëèÿ)  │006014,    

                                                                                                                   │03.05.95   

                                                                                                                              

│Öåôàëîòèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │006058,    

                                                                                                                   │18.05.95   

                                                                                                                              

│Öåôàëîòèíà íàòðèåâàÿ ñîëü     │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Acs Dobfar (Èòàëèÿ)           │010392,    

│ñòåðèëüíàÿ                                                                                                         │05.08.98   

                                                                                                                              

│Öåôàìàíäîëà íàôàò ñòåðèëüíûé  │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ (ìåøêè             │Acs Dobfar S.P.a. (Èòàëèÿ)    │010354,    

                                                       │ïîëèýòèëåíîâûå) 5 êã                                        │23.07.98   

                                                                                                                              

│Öåôîòàêñèì íàòðèÿ ñòåðèëüíûé  │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ (êîíòåéíåðû        │Orchid Chemicals &            │009954,    

│{öåôîòàêñèì íàòðèÿ}                                    │àëþìèíèåâûå) 5 êã             │Pharmaceuticals Ltd (Èíäèÿ)   │19.01.98   

                                                                                                                              

│Öåôîòàêñèìà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Cheil Foods&Chemicals Inc     │005829,    

│{öåôîòàêñèì íàòðèÿ}                                                                  │(Êîðåÿ Þæíàÿ)                 │16.03.95   

                                                                                                                              

│Öåôîòàêñèìà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Han Mi Fine Chemical Co Ltd   │005347,    

│{öåôîòàêñèì íàòðèÿ}                                                                  │(Êîðåÿ Þæíàÿ)                 │21.09.94   

                                                                                                                              

│Öåôîòàêñèìà íàòðèåâàÿ ñîëü    │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Lucky Ltd (Êîðåÿ Þæíàÿ)       │006716,    

│ñòåðèëüíàÿ {öåôîòàêñèì íàòðèÿ}│                                                                                     │18.10.95   

                                                                                                                              

│Öåôòðèàêñîíà íàòðèåâàÿ ñîëü   │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Cheil Foods&Chemicals Inc     │005830,    

                                                                                     │(Êîðåÿ Þæíàÿ)                 │16.03.95   

                                                                                                                              

│Öåôòðèàêñîíà íàòðèåâàÿ ñîëü   │àíòèáèîòèê, öåôàëîñïîðèí │ñóáñòàíöèÿ                    │Lupin Laboratories Ltd (Èíäèÿ)│006926,    

│ñòåðèëüíàÿ                                                                                                         │20.12.95   

                                                                                                                             

│Öèêëàìåí åâðîïåéñêèé          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010332,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Öèííàðèçèí                    │ÁÌÊÊ                     │ñóáñòàíöèÿ (ïàêåòû            │Chemo Iberica Sa (Èñïàíèÿ)    │010298,    

                                                       │ïîëèýòèëåíîâûå) 1, 5, 10, 25                                │02.07.98   

                                                       │êã                                                                     

                                                                                                                              

│Öèííàðèçèí                    │ÁÌÊÊ                     │ñóáñòàíöèÿ                    │Pharmacia-AD (Áîëãàðèÿ)       │009516,    

                                                                                                                   │06.06.97   

                                                                                                                              

│Öèíõîíà êðàñíîñîêîâàÿ         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010366,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Öèïðîôëîêñàöèíà ãèäðîõëîðèä   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │005481,    

                              │ñðåäñòâî, ôòîðõèíîëîí                                                                │11.11.94   

                                                                                                                              

│Öèïðîôëîêñàöèíà ãèäðîõëîðèä   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Kopran Ltd (Èíäèÿ)            │005713,    

                              │ñðåäñòâî, ôòîðõèíîëîí                                                                │03.02.95   

                                                                                                                              

│Öèïðîôëîêñàöèíà ãèäðîõëîðèä   │ïðîòèâîìèêðîáíîå         │ñóáñòàíöèÿ                    │Ranbaxy Laboratories Ltd      │009029,    

                              │ñðåäñòâî, ôòîðõèíîëîí                                  │(Èíäèÿ)                       │18.12.96   

                                                                                                                              

│Ýíàëàïðèëà ìàëåàò {ýíàëàïðèëà │ÀÊÔ áëîêàòîð             │ñóáñòàíöèÿ                    │Neuland Laboratories Limited  │010488,    

│ìàëåàò}                                                                              │(Èíäèÿ)                       │08.10.98   

                                                                                                                              

│Ýðèòðîìèöèí                   │àíòèáèîòèê, ìàêðîëèä     │ñóáñòàíöèÿ                    │Polfa, Tarchomin              │006404,    

                                                                                     │Pharmaceutical Works Sa       │14.08.95   

                                                                                     │(Ïîëüøà)                                 

                                                                                                                              

│Ýòàìáóòîëà ãèäðîõëîðèä        │ïðîòèâîòóáåðêóëåçíîå     │ñóáñòàíöèÿ (ïàêåòû            │Lupin Laboratories Ltd (Èíäèÿ)│010471,    

                              │ñðåäñòâî                 │ïëàñòèêîâûå) 25 êã                                          │24.09.98   

                                                                                                                              

│Ýòàìçèëàò                     │ãåìîñòàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ                    │Chemo Iberica Sa (Èñïàíèÿ)    │009089,    

                                                                                                                   │22.01.97   

                                                                                                                               

│Ýòàöèçèí                      │àíòèàðèòìè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ (áàíêè) 0.4 êã;    │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │010050,    

                                                       │ñóáñòàíöèÿ (ïàêåòû) 4 êã;     │(Ëàòâèÿ)                      │22.07.98   

                                                       │ñóáñòàíöèÿ (ìåøêè) 10 êã                                               

                                                                                                                              

│Ýòèëîâûé ýôèð                 │ñåäàòèâíîå ñðåäñòâî      │ñóáñòàíöèÿ                    │Laborchemie Apolda Gmbh       │009313,    

│àëüôà-áðîìèçîâàëåðèàíîâîé                                                            │(Ãåðìàíèÿ)                    │18.03.97   

│êèñëîòû                                                                                                                       

                                                                                                                              

│Ýòèìèçîë                      │àíàëåïòè÷åñêîå ñðåäñòâî  │ñóáñòàíöèÿ (ïàêåòû            │Ôàðìàê ÀÎ (Óêðàèíà)           │72/334/24, 

                                                       │ïîëèýòèëåíîâûå äâóõñëîéíûå)                                 │11.06.97   

                                                       │5, 10 êã                                                               

                                                                                                                              

│Ýòìîçèí                       │àíòèàðèòìè÷åñêîå ñðåäñòâî│ñóáñòàíöèÿ (áàíêè) 0.5, 1 êã; │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009213,    

                                                       │ñóáñòàíöèÿ (ïàêåòû) 4 êã;     │(Ëàòâèÿ)                      │03.03.98   

                                                       │ñóáñòàíöèÿ (ìåøêè) 10 êã                                               

                                                                                                                              

│Ýòîíèé                        │àíòèñåïòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ (áàíêè) 1 êã;      │Ôàðìàê ÀÎ (Óêðàèíà)           │70/765/17, 

                                                       │ñóáñòàíöèÿ (ïàêåòû                                          │10.02.97   

                                                       │ïîëèýòèëåíîâûå äâóõñëîéíûå)                                            

                                                       │0.5, 1.5, 10 êã                                                        

                                                                                                                               

│Ýóôèëëèí {òåîôèëëèí 80%,      │áðîíõîäèëàòèðóþùåå       │ñóáñòàíöèÿ (áàíêè) 0.8, 1.5 êã│Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009214,    

│ýòèëåíäèàìèí 20%}             │ñðåäñòâî                                               │(Ëàòâèÿ)                      │03.03.98   

                                                                                                                              

│Ýôåäðèíà ãèäðîõëîðèä          │àëüôà- è                 │ñóáñòàíöèÿ                    │Knoll Ag (Ãåðìàíèÿ)           │009410,    

                              │áåòà-àäðåíîñòèìóëÿòîð                                                                │23.04.97   

                                                                                                                              

│Ýõèíàöåÿ óçêîëèñòíàÿ          │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010334,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│Ýøøîëüöèÿ êàëèôîðíèéñêàÿ      │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010322,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│ßñåíü àìåðèêàíñêèé            │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010338,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│ßñåíü âûñîêèé                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010415,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │17.08.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│ßñíîòêà áåëàÿ                 │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010381,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │29.07.98   

                                                       │60, 125, 250 ìë;                                                       

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

                                                                                                                              

│ßñòðåáèíêà âîëîñèñòàÿ         │ãîìåîïàòè÷åñêîå ñðåäñòâî │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │Laboratories Dolisos (Áåëüãèÿ)│010333,    

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 30, │                              │16.07.98   

                                                       │60, 125, 250 ìë;                                                        

                                                       │ñóáñòàíöèÿ-íàñòîéêà ìàòðè÷íàÿ │                                         

                                                       │ãîìåîïàòè÷åñêàÿ (ôëàêîíû) 1,                                           

                                                       │5, 10 ë                                                                

└──────────────────────────────┴─────────────────────────┴──────────────────────────────┴──────────────────────────────┴────────────┘

 

Ðàçäåë 2.

 

ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ

 

┌───────────────────────────────────┬──────────────────────────────┬──────────────────────────────┬──────────────────────────────┬────────────┐

       Òîðãîâîå íàçâàíèå                   Ôàðì. ãðóïïà                 Ôîðìà âûïóñêà                 Ôèðìà (Ñòðàíà)            Íîìåð,  

        [ìåæä. íàçâàíèå]                    [Êîä ÀÒÑ]                                                                            äàòà   

           [ñîñòàâ]                                                                                                                     

├───────────────────────────────────┼──────────────────────────────┼──────────────────────────────┼──────────────────────────────┼────────────┤

│4-Âýé [Îêñèìåòàçîëèí]              │àëüôà-àäðåíîñòèìóëÿòîð        │ñïðåé íàçàëüíûé (ôëàêîíû)     │Bristol-Myers Squibb (Êàíàäà) │007523,    

                                   │[R01AA05]                     │0.05% - 14.2 ìë                                             │21.05.96   

                                                                                                                                        

│5-ÀÑÀ [Ìåñàëàçèí]                  │ïðîòèâîìèêðîáíîå è            │ñâå÷è 250 ìã; äðàæå 250, 500  │Slaviamed (Þãîñëàâèÿ)         │009146,    

                                   │ïðîòèâîâîñïàëèòåëüíîå         │ìã                                                          │18.02.97   

                                   │ñðåäñòâî [A07EC02]                                                                                   

                                                                                                                                         

│5-íèòðîêñ [Íèòðîêñîëèí]            │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Pharmachim (Áîëãàðèÿ)         │2500,      

                                   │îêñèõèíîëèí [G04AG06]         │îáîëî÷êîé 50 ìã                                             │22.07.76,  

                                                                                                                             │25.03.87   

                                                                                                                                        

│5-ÍÎÊ [Íèòðîêñîëèí]                │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │006580,    

                                   │îêñèõèíîëèí [G04AG06]         │50 ìã                                                       │13.10.95   

                                                                                                                                        

│5-Ôòîðóðàöèë-Ýáåâå [Ôòîðóðàöèë]    │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êîíöåíòðàò äëÿ èíôóçèé        │Ebewe Arzneimittel Gmbh       │009661,    

                                   │[L01BC02]                     │(àìïóëû) 250 ìã/5 ìë;         │(Àâñòðèÿ)                     │08.08.97   

                                                                 │êîíöåíòðàò äëÿ èíôóçèé                                                 

                                                                 │(ôëàêîíû) 250 ìã/5 ìë, 500                                             

                                                                 │ìã/10 ìë, 1000 ìã/20 ìë, 5000 │                                         

                                                                 │ìã/100 ìë                                                              

                                                                                                                                        

│6 Õ.Å.Ñ. [Îêñèýòèëêðàõìàë]         │ïëàçìîçàìåùàþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Morishita Pharmaceutical Co,  │01241,     

                                   │[B05AA07]                     │500 ìë                        │Ltd (ßïîíèÿ)                  │15.02.86   

                                                                                                                                        

│HL-Êîëä {õëîðôåíàìèí 2 ìã,         │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè øèïó÷èå              │Sagmel Inc (ÑØÀ)              │009026,    

│ôåíèëïðîïàíîëàìèí 15 ìã,           │ÎÐÇ è ïðîñòóäû [R01BA51]                                                                  │18.12.96   

│àöåòèëñàëèöèëîâàÿ êèñëîòà 325 ìã}                                                                                                       

                                                                                                                                        

│L-Àëàíèí [Àëàíèí]                  │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00827,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Àðãèíèí [Àðãèíèí]                │ãåïàòîïðîòåêòîðíîå ñðåäñòâî   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00813,     

                                   │[B05XB01]                     │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Àñïàðàãèí [Àñïàðàãèí]            │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00820,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,  

                                                                                                                             │20.10.80   

                                                                                                                                        

│L-àñïàðàãèíàçà [Àñïàðàãèíàçà]      │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Grindex Ëàòâ.Ãîñôèðìà Ïî      │009226,    

                                   │[L01XX02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Èññëåä.È Ïðîèçâ.Ìåäïðåïàðàòîâ │09.12.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 3000,      │(Ëàòâèÿ)                                 

                                                                 │10000 ÌÅ                                                               

                                                                                                                                        

│L-Àñïàðàãèíîâàÿ êèñëîòà            │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00818,     

│[Àñïàðàãèíîâàÿ êèñëîòà]            │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│L-Âàëèí [Âàëèí]                    │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00826,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Ãèñòåãèí [Ãèñòèäèí]              │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00823,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│L-Ãëóòàìèíîâàÿ êèñëîòà             │íîîòðîïíîå ñðåäñòâî [A09AB01] │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00817,     

│[Ãëóòàìèíîâàÿ êèñëîòà]                                           │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Èçîëåéöèí [Èçîëåéöèí]            │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00822,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Ëåéöèí [Ëåéöèí]                  │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00819,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│L-Ëèçèí [Ëèçèí]                    │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00810,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà         │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                   │[B05XB03]                                                                                 │08.12.93   

                                                                                                                                        

│L-Ìåòèîíèí [Ìåòèîíèí]              │ìåòàáîëè÷åñêîå ñðåäñòâî       │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00824,     

                                   │[B05XB]                       │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│L-Ïðîëèí [Ïðîëèí]                  │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00814,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Ñåðèí [Ñåðèí]                    │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00808,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│L-Òèðîçèí [Òèðîçèí]                │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00821,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Òèðîçèí [Òèðîçèí]                │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00977,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                      │23.12.82   

                                                                                                                                        

│L-òèðîêñèí 25 Áåðëèí-Õåìè          │òèðåîèäíîå ñðåäñòâî [H03AA01] │òàáëåòêè 25 ìêã               │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005511,    

│[Ëåâîòèðîêñèí]                                                                                                               │18.11.94   

                                                                                                                                        

│L-òèðîêñèí 50 Áåðëèí Õåìè          │òèðåîèäíîå ñðåäñòâî [H03AA01] │òàáëåòêè 50 ìêã               │Berlin-Chemie Ag (Ãåðìàíèÿ)   │003226,    

│[Ëåâîòèðîêñèí]                                                                                                               │11.08.93   

                                                                                                                                        

│L-òèðîêñèí-100 Áåðëèí Õåìè         │òèðåîèäíîå ñðåäñòâî [H03AA01] │òàáëåòêè 100 ìêã              │Berlin-Chemie Ag (Ãåðìàíèÿ)   │003226,    

│[Ëåâîòèðîêñèí]                                                                                                               │11.08.93   

                                                                                                                                        

│L-Òðåîíèí [Òðåîíèí]                │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00812,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Òðåîíèí [Òðåîíèí]                │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00975,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                      │23.12.82   

                                                                                                                                        

│L-Òðèïòîôàí [Òðèïòîôàí]            │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00815,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Òðèïòîôàí [Òðèïòîôàí]            │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │01009,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                      │22.06.83   

                                                                                                                                        

│L-Ôåíèëàëàíèí [Ôåíèëàëàíèí]        │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00811,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                         

│L-Ôåíèëàëàíèí [Ôåíèëàëàíèí]        │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00972,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                      │23.12.82,  

                                                                                                                             │21.07.94   

                                                                                                                                        

│L-Öèñòåèí [Öèñòåèí]                │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00816,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │08.12.93   

                                                                                                                                        

│L-Öèñòèí [Öèñòèí]                  │ñðåäñòâî ïàðåíòåðàëüíîãî      │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00809,     

                                   │ïèòàíèÿ, àìèíîêèñëîòà [B05XB] │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│V-Ïåíèöèëëèí Ñëîâàêîôàðìà          │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 250, 500 ìã          │Slovakofarma Sa (Ñëîâàêèÿ)    │009073,    

│[Ôåíîêñèìåòèëïåíèöèëëèí]           │[J01CE02]                                                                                 │14.01.97   

                                                                                                                                        

│À.Ò.10 [Äèãèäðîòàõèñòåðîë]         │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │ðàñòâîð (ôëàêîíû) 1 ìã/ìë -   │Merck (Ãåðìàíèÿ)              │003551,    

                                   │ôîñôîðà [A11CC02]             │15 ìë                                                       │07.12.93   

                                                                                                                                        

│Àêëåçèíà òàáëåòêè ïîêðûòûå         │àíòèàðèòìè÷åñêîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Èíñòèòóò õèìèè ðàñòèòåëüíûõ   │95/370/7,  

│îáîëî÷êîé 0.025 ã {áîðöà           │[C01BG]                       │25 ìã                         │âåùåñòâ ÀÍ Óçáåêèñòàíà        │27.12.95   

│áåëîóñòîãî àëêàëîèäû}                                                                          │(Óçáåêèñòàí)                             

                                                                                                                                        

│Àáàêòàë [Ïåôëîêñàöèí]              │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Lek (ÑÔÐÞ)                    │01845,     

                                   │ôòîðõèíîëîí [J01MA03]         │èíúåêöèé (àìïóëû) 400 ìã - 5                                │30.05.90   

                                                                 │ìë                                                                     

                                                                                                                                        

│ÀÁÔ ïëåíêà [Íîíîêñèíîë]            │êîíòðàöåïòèâíîå ìåñòíîå       │ïëåíêà èíòðàâàãèíàëüíàÿ 70 ìã │ICN Galenika (Þãîñëàâèÿ)      │003475,    

                                   │ñðåäñòâî [G02BB]                                                                          │01.11.93   

                                                                                                                                        

│Àâåëèçèí [Ñòðåïòîêèíàçà]           │ôèáðèíîëèòè÷åñêîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Arzneimittelwerk Dresden Gmbh │005685,    

                                   │[B01AD01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ãåðìàíèÿ)                    │24.01.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 750000,                                              

                                                                 │1500000 ÅÄ                                                             

                                                                                                                                        

│Àâåëèçèí Áðàóí [Ñòðåïòîêèíàçà]     │ôèáðèíîëèòè÷åñêîå ñðåäñòâî    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │B.Braun Melsungen Ag          │007950,    

                                   │[B01AD01]                     │èíúåêöèîííîãî ðàñòâîðà        │(Ãåðìàíèÿ)                    │13.11.96   

                                                                 │(ôëàêîíû) 100000, 250000,                                              

                                                                 │750000, 1500000 ÌÅ                                                     

                                                                                                                                        

│Àâèñàíà òàáëåòêè ïîêðûòûå          │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Áèîñòèìóëÿòîð îäåññêîå ÏÕÔΠ  │70/151/7,  

│îáîëî÷êîé 0.05 ã {àììè çóáíîé      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │50 ìã                         │(Óêðàèíà)                     │12.05.98   

│ýêñòðàêò}                          │[A03]                                                                                                

                                                                                                                                        

│Àãàïóðèí [Ïåíòîêñèôèëëèí]          │âàçîäèëàòèðóþùåå ñðåäñòâî     │äðàæå 100 ìã                  │Slovakofarma Sa (Ñëîâàêèÿ)    │2817,      

                                   │[C04AD03]                                                                                 │06.02.86,  

                                                                                                                             │23.06.94   

                                                                                                                                        

│Àãàïóðèí [Ïåíòîêñèôèëëèí]          │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Slovakofarma Sa (Ñëîâàêèÿ)    │008205,    

                                   │[C04AD03]                     │20 ìã/ìë - 5 ìë                                             │05.03.97   

                                                                                                                                        

│Àãàïóðèí 600 ðåòàðä                │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè ðåòàðä 600 ìã        │Slovakofarma Sa (Ñëîâàêèÿ)    │005866,    

│[Ïåíòîêñèôèëëèí]                   │[C04AD03]                                                                                 │27.03.95   

                                                                                                                                        

│Àãàïóðèí ðåòàðä [Ïåíòîêñèôèëëèí]   │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 400 ìã               │Slovakofarma Sa (Ñëîâàêèÿ)    │2908,      

                                   │[C04AD03]                                                                                 │22.09.88,  

                                                                                                                             │23.06.94   

                                                                                                                                        

│Àãèîëàêñ {ïîäîðîæíèêà ñåìåíà 2.6   │ñëàáèòåëüíîå ñðåäñòâî         │ãðàíóëû                       │Madaus Ag (Ãåðìàíèÿ)          │00741,     

│ã, ïîäîðîæíèêà ñåìåííàÿ êîæóðà     │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │10.03.80,  

│0.11 ã, ñåííû ïëîäû 0.62 ã,        │[A06AB]                                                                                   │12.04.95   

│ñàõàðîçà 0.9 ã - 5 ã}                                                                                                                   

                                                                                                                                        

│Àäàëàò [Íèôåäèïèí]                 │ÁÌÊÊ [C08CA05]                │êàïñóëû 10 ìã; ðàñòâîð äëÿ    │Bayer Ag (Ãåðìàíèÿ)           │007318,    

                                                                 │èíúåêöèé (øïðèö îäíîðàçîâûé)                                │26.09.96   

                                                                 │0.01% - 2 ìë; ðàñòâîð äëÿ                                              

                                                                 │èíúåêöèé (ôëàêîíû) 0.01% - 50 │                                         

                                                                 │ìë /â êîìïëåêòå ñ øïðèöåì                                              

                                                                 │îäíîðàçîâûì è èíôóçèîííîé                                              

                                                                 │òðóáêîé/                                                               

                                                                                                                                        

│Àäàëàò ÑË [Íèôåäèïèí]              │ÁÌÊÊ [C08CA05]                │òàáëåòêè ðåòàðä 20 ìã         │Bayer Ag (Ãåðìàíèÿ)           │003752,    

                                                                                                                             │11.03.94   

                                                                                                                                        

│Àäâàíòàí [Ìåòèëïðåäíèçîëîíà        │ãëþêîêîðòèêîñòåðîèä [D07AA01] │ìàçü (òóáû)                   │Schering Ag (Ãåðìàíèÿ)        │005135,    

│àöåïîíàò]                                                                                                                    │15.07.94   

                                                                                                                                        

│Àäâåðçóòåí 1 [Ïðàçîçèí]            │àëüôà-àäðåíîáëîêàòîð [C02CA01]│òàáëåòêè 1 ìã                 │Arzneimittelwerk Dresden Gmbh │008294,    

                                                                                               │(Ãåðìàíèÿ)                    │19.06.97   

                                                                                                                                        

│Àäâåðçóòåí 5 [Ïðàçîçèí]            │àëüôà-àäðåíîáëîêàòîð [C02CA01]│òàáëåòêè 5 ìã                 │Arzneimittelwerk Dresden Gmbh │008295,    

                                                                                               │(Ãåðìàíèÿ)                    │19.06.97   

                                                                                                                                        

│Àäâèë [Èáóïðîôåí]                  │ÍÏÂÑ [M02AA13]                │äðàæå 200 ìã                  │Wyeth Spa Aprilia For         │009994,    

                                                                                               │Whitehall (Èòàëèÿ)            │23.02.98   

                                                                                                                                        

│Àääèòèâà âèòàìèí Ñ øèïó÷èå         │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå 1 ã          │Np Pharma (Ïîëüøà)            │009725,    

│òàáëåòêè ñ ëèìîííûì âêóñîì                                                                                                   │15.09.97   

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                                                                  

                                                                                                                                        

│Àääèòèâà êàëüöèé [Êàëüöèÿ êàðáîíàò]│àíòàöèäíîå ñðåäñòâî [A02AC01] │òàáëåòêè øèïó÷èå 4.2 ã        │Np Pharma (Ïîëüøà)            │010311,    

                                                                                                                             │09.07.98   

                                                                                                                                        

│Àäåáèò [Áóôîðìèí]                  │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 50 ìã                │Chinoin (Âåíãðèÿ)             │2016,      

                                   │ïåðîðàëüíîãî ïðèåìà [A10BA03] │                                                            │01.07.70,  

                                                                                                                             │09.11.83,  

                                                                                                                             │30.01.95   

                                                                                                                                        

│Àäåëüôàí {äèãèäðàëàçèí 10 ìã,      │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè                      │Ciba-Geigy Hindustan Ltd      │005551,    

│ðåçåðïèí 0.1 ìã}                   │ñðåäñòâî [C02AA52]                                          │(Èíäèÿ)                       │07.12.94   

                                                                                                                                        

│Àäåëüôàí-ýçèäðåêñ {äèãèäðàëàçèí 10 │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè                      │Ciba-Geigy Hindustan (Èíäèÿ)  │008106,    

│ìã, ðåçåðïèí 0.1 ìã,               │ñðåäñòâî [C02LA51]                                                                        │24.12.96   

│ãèäðîõëîðîòèàçèä 10 ìã}                                                                                                                 

                                                                                                                                        

│Àäåíîêîð [Àäåíîçèíà ôîñôàò]        │ìåòàáîëè÷åñêîå ñðåäñòâî       │ðàñòâîð äëÿ èíúåêöèé          │Sanofi-Winthrop (Ôðàíöèÿ)     │006225,    

                                   │[C01EB10]                     │(ôëàêîíû) 6 ìã - 2 ìë                                       │27.06.95   

                                                                                                                                        

│Àäåíîñòîï {äóðíèøíèêà òðàâû        │ñðåäñòâî ëå÷åíèÿ àäåíîìû      │ðàñòâîð äëÿ âíóòðåííåãî       │Biofarm Sa, Medchim (Ðóìûíèÿ) │007454,    

│ýêñòðàêò 66 ã, äóðíèøíèêà êîëþ÷åãî │ïðîñòàòû ðàñòèòåëüíîãî        │ïðèìåíåíèÿ (ôëàêîíû)                                        │18.04.96   

│òðàâà 34 ã, ãëèöåðîë 10 ã, ýòàíîë  │ïðîèñõîæäåíè [G04BX]                                                                                 

│70% äî 100 ã}                                                                                                                           

                                                                                                                                         

│Àäèóðåòèí ÑÄ [Äåñìîïðåññèí]        │àíòèäèóðåòè÷åñêîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ferring-Lechiva Sa (×åõèÿ)    │008138,    

                                   │[H01BA02]                     │4 ìêã/ìë                                                    │27.01.97   

                                                                                                                                        

│Àäèóðåòèí-ÑÄ [Äåñìîïðåññèí]        │àíòèäèóðåòè÷åñêîå ñðåäñòâî    │êàïëè íàçàëüíûå (ôëàêîíû) 0.1 │Ferring-Lechiva Sa (×åõèÿ)    │006648,    

                                   │[H01BA02]                     │ìã/ìë                                                       │19.02.96   

                                                                                                                                        

│Àäîëîðèí {êîôåèí 50 ìã,            │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │F.Joh.Kwizda Gmbh (Àâñòðèÿ)   │005939,    

│ïàðàöåòàìîë 300 ìã, ïðîïèôåíàçîí   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │10.04.95   

│250 ìã}                            │[N02BE71]                                                                                            

                                                                                                                                        

│Àäðåíàëèí [Ýïèíåôðèí]              │àëüôà- è                      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sanavita Gesundcheitsmittel & │006848,    

                                   │áåòà-àäðåíîñòèìóëÿòîð         │1 ìã/ìë                       │Co Kg (Ãåðìàíèÿ)              │22.11.95   

                                   │[C01CA24]                                                                                            

                                                                                                                                        

│Àäðèàìèöèí [Äîêñîðóáèöèí]          │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Carlo Erba Farmitalia         │006216,    

                                   │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │International (Èíäîíåçèÿ)     │23.06.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã                                               

                                                                                                                                        

│Àäðèàíîë {ôåíèëýôðèí 1 ìã,         │ïðîòèâîêîíãåñòèâíîå ñðåäñòâî  │êàïëè íàçàëüíûå äëÿ âçðîñëûõ  │Zdravle (Þãîñëàâèÿ)           │007478,    

│òðàìàçîëèí 1.5 ìã - 1 ìë äëÿ       │[R01AB01]                     │(ôëàêîíû) 10 ìë; êàïëè                                      │29.04.96   

│âçðîñëûõ; ôåíèëýôðèí 0.5 ìã,                                     │íàçàëüíûå äëÿ äåòåé (ôëàêîíû) │                                         

│òðàìàçîëèí 0.5 ìã - 1 ìë äëÿ äåòåé}│                              │10 ìë                                                                  

                                                                                                                                        

│Àäðèáëàñòèí áûñòðîðàñòâîðèìûé      │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmacia (Èòàëèÿ)            │008177,    

│[Äîêñîðóáèöèí]                     │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │05.03.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã /â                                            

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │âîäà äëÿ èíúåêöèé/;                                                    

                                                                 │ëèîôèëèç.ïîðîøîê äëÿ                                                   

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                            

                                                                 │ðàñòâîðà (ôëàêîíû) 50 ìã                                               

                                                                                                                                         

│Àçàêòàì [Àçòðåîíàì]                │àíòèáèîòèê [J01DF01]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Bristol-Myers Squibb (Èòàëèÿ) │008391,    

                                                                 │ðàñòâîðà äëÿ èíúåêöèé                                       │09.02.98   

                                                                 │(ôëàêîíû) 0.5, 1 ã                                                     

                                                                                                                                        

│Àçåêòîë [Àòåíîëîë]                 │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã               │Help (Ãðåöèÿ)                 │003746,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │04.03.94   

                                                                                                                                        

│Àçèâîê [Àçèòðîìèöèí]               │àíòèáèîòèê, ìàêðîëèä [J01FA10]│êàïñóëû 250 ìã                │Wockhardt Ltd (Èíäèÿ)         │009018,    

                                                                                                                             │16.12.96   

                                                                                                                                        

│Àçëîöèëëèí [Àçëîöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmachim (Áîëãàðèÿ)         │2905,      

                                   │[J01CA09]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │13.09.88   

                                                                 │ðàñòâîðà (ôëàêîíû) 1, 2, 5 ã                                           

                                                                                                                                        

│Àçìàêîðò [Òðèàìöèíîëîí]            │ãëþêîêîðòèêîñòåðîèä [R03BA]   │àýðîçîëü äîçèðîâàííûé 100     │Rhone-Poulenc Rorer (ÑØÀ)     │006241,    

                                                                 │ìêã/äîçà (ôëàêîíû) 240 äîç                                  │03.07.95   

                                                                                                                                        

│Àçîíà [Òðàçîäîí]                   │àíòèäåïðåññàíò [N06AX05]      │êàïñóëû 25, 50, 100 ìã        │Orion Corporation (Ôèíëÿíäèÿ) │008431,    

                                                                                                                             │08.09.97   

                                                                                                                                        

│Àçîòà çàêèñü [Äèíèòðîãåí îêñèä]    │íàðêîçíîå èíãàëÿöèîííîå       │ãàç ñæàòûé (áàëëîíû           │Êîíöåðí Ñòèðîë ÎÀÎ (Óêðàèíà)  │010054,    

                                   │ñðåäñòâî [N01AX13]            │ìåòàëëè÷åñêèå) 6.2 êã - 10 ë                                │26.08.98   

                                                                                                                                        

│Àçóëàí {ðîìàøêè ýêñòðàêò, ýòàíîë}  │àíòèñåïòè÷åñêîå ñðåäñòâî      │ýêñòðàêò äëÿ âíóòðåííåãî      │Herbapol, Warszawskie Zaklady │007872,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïðèìåíåíèÿ (ôëàêîíû) 90 ã     │Zielarskie (Ïîëüøà)           │02.10.96   

                                   │[A01AB11]                                                                                            

                                                                                                                                        

│Àçóïðîñòàò Ì [Áåòà-ñèòîñòåðîë]     │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │êàïñóëû 65 ìã                 │Azupharma Gmbh (Ãåðìàíèÿ)     │007949,    

                                   │[C10AX]                                                                                   │12.11.96   

                                                                                                                                        

│Àèìàôèêñ Ä.È. [Ôàêòîð ñâåðòûâàíèÿ  │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │Instituto Sierovaccinogeno    │009753,    

│êðîâè IX]                          │[B02BD04]                     │ïðèãîòîâëåíèÿ èíúåêöèé        │Italiano Isi Spa (Èòàëèÿ)     │02.10.97   

                                                                 │(ôëàêîíû - â êîìïëåêòå ñ                                               

                                                                 │ðàñòâîðèòåëåì) 200 ÌÅ/5 ìë,                                            

                                                                 │500 ÌÅ/10 ìë, 800 ÌÅ/10 ìë                                             

                                                                                                                                        

│Àéðèôåí [Êåòîòèôåí]                │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │òàáëåòêè 1 ìã; ñèðîï          │Panacea Biotec Ltd (Èíäèÿ)    │005081,    

                                   │[R06AX17]                     │(ôëàêîíû) 1 ìã|5 ìë                                         │04.07.94   

                                                                                                                                        

│Àéðîë [Òðåòèíîèí]                  │ðåãåíåðàöèè ñòèìóëÿòîð        │êðåì (òóáû) 0.05% - 20 ã;     │F.Hoffmann La Roche Ltd       │008253,    

                                   │[D10AD01]                     │ëîñüîí (ôëàêîíû) 0.05% - 50 ìë│(Øâåéöàðèÿ)                   │08.04.97   

                                                                                                                                        

│Àéðòàë [Àöåêëîôåíàê]               │ÍÏÂÑ [M01AB16]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Prodesfarma Sa (Èñïàíèÿ)      │007019,    

                                                                 │100 ìã                                                      │28.01.96   

                                                                                                                                        

│Àêàìîë-Òåâà [Ïàðàöåòàìîë]          │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã; ñèðîï        │Teva Pharmaceutical           │003531,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │(ôëàêîíû) 125 ìã|5 ìë - 100   │Industries Ltd (Èçðàèëü)      │30.11.93   

                                   │[N02BE01]                     │ìë; ñâå÷è 150 ìã                                                        

                                                                                                                                        

│Àêàòèíîë Ìåìàíòèí [Ìåìàíòèíà       │ìèîðåëàêñèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Merz Co Gmbh & Co (Ãåðìàíèÿ)  │009141,    

│ãèäðîõëîðèä]                       │[M03BX]                       │10 ìã; êàïëè äëÿ ïðèåìà                                     │17.02.97   

                                                                 │âíóòðü 10 ìã/ìë                                                        

                                                                                                                                        

│Àêâàìàã {ìàãàëäðàò 400 ìã,         │àíòàöèäíîå ñðåäñòâî [A02AF01] │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Hemage Ltd (Èíäèÿ)            │005728,    

│ñèìåòèêîí 40 ìã - 5 ìë}                                          │180 ìë                                                      │10.02.95   

                                                                                                                                        

│Àêâàôîð [Êñèïàìèä]                 │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 10, 40 ìã            │Eli Lilly (Ãåðìàíèÿ)          │006360,    

                                   │[C03BA10]                                                                                 │07.08.95   

                                                                                                                                        

│Àêèíåòîí [Áèïåðèäåí]               │í-õîëèíîáëîêàòîð öåíòðàëüíûé  │òàáëåòêè 2 ìã; ðàñòâîð äëÿ    │Knoll Ag (Ãåðìàíèÿ)           │008268,    

                                   │[N04AA02]                     │èíúåêöèé (àìïóëû) 5 ìã/ìë                                   │22.04.97   

                                                                                                                                        

│Àêèíåòîí ÑÐ [Áèïåðèäåí]            │í-õîëèíîáëîêàòîð öåíòðàëüíûé  │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Knoll Ag (Ãåðìàíèÿ)           │010482,    

                                   │[N04AA02]                     │îáîëî÷êîé çàìåäëåííîãî                                      │01.10.98   

                                                                 │âûñâîáîæäåíèÿ 4 ìã                                                     

                                                                                                                                        

│Àêêóïðî [Õèíàïðèë]                 │ÀÊÔ áëîêàòîð [C09AA06]        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Godecke/Parke-Davis (Ãåðìàíèÿ)│005842,    

                                                                 │5, 10, 20 ìã                                                │28.03.95   

                                                                                                                                        

│Àêíå êðåì äîêòîðà Òàéñà {ýòàíîë    │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │êðåì                          │Naturwaren Ohg (Ãåðìàíèÿ)     │006182,    

│12%, Áåíòîíèò 3%, Áèîñóëüôóð 1%,   │[D10AX30]                                                                                 │14.06.95   

│Òðèêëîçàí 0.1%}                                                                                                                         

                                                                                                                                        

│Àêíå êðåì ôîðòå äîêòîðà Òàéññà     │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │êðåì (òóáû) 10 ã              │Naturwaren, Dr.P.Theiss       │007445,    

│{öèíêà îêñèä 5.870 ìã, ñåðà 2 ã,   │[D10AX30]                                                   │(Ãåðìàíèÿ)                    │17.04.96   

│êàëàìèí 6 ã}                                                                                                                            

                                                                                                                                        

│Àêíå ëîñüîí äîêòîðà Òàéñà          │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │ãåëü                          │Naturwaren Ohg (Ãåðìàíèÿ)     │006183,    

│{ôåíîêñèïðîïàíîë 2%}               │[D10AX]                                                                                   │14.06.95   

                                                                                                                                         

│Àêîëàò [Çàôèðëóêàñò]               │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Zeneca Limited                │009451,    

                                   │[R03DC01]                     │20, 40 ìã                     │(Âåëèêîáðèòàíèÿ)              │15.05.97   

                                                                                                                                        

│Àêîðòèí [Ãèäðîêîðòèçîí]            │ãëþêîêîðòèêîñòåðîèä [D07AA02] │êðåì (òóáû) 1%                │American Drug Company (ÑØÀ)   │006185,    

                                                                                                                             │14.06.95   

                                                                                                                                        

│Àêñåòèí [Öåôóðîêñèì]               │àíòèáèîòèê, öåôàëîñïîðèí      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Medochemie Ltd (Êèïð)         │005121,    

                                   │[J01DA06]                     │èíúåêöèîííîãî ðàñòâîðà                                      │13.07.94   

                                                                 │(ôëàêîíû) 250, 750 ìã                                                  

                                                                                                                                        

│Àêñèä [Íèçàòèäèí]                  │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │êàïñóëû 150, 300 ìã           │Eli Lilly (Èñïàíèÿ)           │008643,    

                                   │áëîêàòîð [A02BA04]                                                                        │01.07.98   

                                                                                                                                        

│Àêñèä [Íèçàòèäèí]                  │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Eli Lilly (Èòàëèÿ)            │008642,    

                                   │áëîêàòîð [A02BA04]            │25 ìã/ìë - 4 ìë                                             │01.07.98   

                                                                                                                                         

│Àêñèäîêñî [Äîêñîðóáèöèí]           │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Bharat Serums & Vaccines Pvt  │009981,    

                                   │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Ltd (Èíäèÿ)                   │10.02.98   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã /â                                            

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │âîäà äëÿ èíúåêöèé/                                                     

                                                                                                                                        

│Àêñèïëàò [Öèñïëàòèí]               │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Bharat Serums & Vac-cines Pvt │009967,    

                                   │[L01XA01]                     │(ôëàêîíû) 0.5 ìã/ìë - 20, 100 │Ltd (Èíäèÿ)                   │29.01.98   

                                                                 │ìë                                                                     

                                                                                                                                        

│Àêòàë [Àëåêñèòîë íàòðèÿ]           │àíòàöèäíîå ñðåäñòâî [A02AB]   │òàáëåòêè 360 ìã               │Sterling Health               │003623,    

                                                                                               │(Âåëèêîáðèòàíèÿ)              │11.01.94   

                                                                                                                                        

│Àêòè-5 {ãëóòàìèí                   │îáùåòîíèçèðóþùåå ñðåäñòâî     │ñèðîï (ôëàêîíû) 1.25 ã - 125  │Pierre Fabre (Ôðàíöèÿ)        │003828,    

│äèìåòèëàìèíîýòàíîë 1 ã, ëèçèíà     │[A13A]                        │ìë                                                          │05.04.94   

│ãèäðîõëîðèä 4 ã, êàëüöèÿ                                                                                                                 

│ãëþêîíîãëþêîãåïòîíàò 3 ã,                                                                                                               

│ôîñôîðíàÿ êèñëîòà 0.5 ã, ñîðáèòîë                                                                                                       

│15 ã - 100 ìë}                                                                                                                          

                                                                                                                                        

│Àêòèâàíàä-N {òèàìèíà íèòðàò 1 ìã,  │îáùåòîíèçèðóþùåå ñðåäñòâî     │äðàæå                         │Knoll Ag (Ãåðìàíèÿ)           │009349,    

│ðèáîôëàâèí 0.5 ìã, íèêîòèíàìèä 5   │[A13A]                                                                                    │31.03.97   

│ìã, àñêîðáèíîâàÿ êèñëîòà 50 ìã,                                                                                                         

│êîôåèí 25 ìã}                                                                                                                           

                                                                                                                                        

│Àêòèâàíàä-N {ýêñòðàêò ïå÷åíè 253   │îáùåòîíèçèðóþùåå ñðåäñòâî     │ñîê (ôëàêîíû) 200, 500, 1000  │Knoll Ag (Ãåðìàíèÿ)           │009295,    

│ìã, äðîææåé ýêñòðàêò 112.5 ìã,     │[A13A]                        │ìë                                                          │12.03.97   

│êîôåèí 53.3 ìã, øèïîâíèêà ïëîäîâ                                                                                                        

│ýêñòðàêò 150 ìã, ýòàíîë 11%,                                                                                                            

│íàòðèÿ ìåòèëïàðàãèäðîêñèáåíçîàò,                                                                                                        

│íàòðèÿ ïðîïèëïàðàãèäðîêñèáåíçîàò - │                                                                                                     

│15 ìë}                                                                                                                                   

                                                                                                                                        

│Àêòèëèçå [Àëòåïëàçà]               │ôèáðèíîëèòè÷åñêîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Boehringer Ingelheim          │008257,    

                                   │[B01AD02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │International Gmbh (Ãåðìàíèÿ) │10.04.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 50 ìã /â                                            

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │âîäà äëÿ èíúåêöèé (ôëàêîíû)                                            

                                                                 │50 ìë/                                                                 

                                                                                                                                        

│Àêòèôåððèí {æåëåçà ñóëüôàò 171 ìã  │ãåìîïîýçà ñòèìóëÿòîð,         │ñèðîï (ôëàêîíû) 100 ìë;       │Merckle Gmbh (Ãåðìàíèÿ)       │008560,    

│(æåëåçî++ 34.5 ìã), ñåðèí 2.58 ìã  │ïðåïàðàò æåëåçà [B03AE10]     │ðàñòâîð-êàïëè (ôëàêîíû) 30                                  │06.07.98   

│- ñèðîï 5 ìë; æåëåçà ñóëüôàò 47, 2 │                              │ìë; êàïñóëû                                                            

│ìã (æåëåçî++ 9.8 ìã), ñåðèí -                                                                                                           

│êàïëè 1 ìë = 18 êàïåëü; æåëåçà                                                                                                          

│ñóëüôàò 113.85 ìã (æåëåçî++ 34.5                                                                                                        

│ìã), ñåðèí 129 ìã - êàïñóëà}                                                                                                            

                                                                                                                                         

│Àêòèôåððèí-êîìïîçèòóì {ôîëèåâàÿ    │ãåìîïîýçà ñòèìóëÿòîð,         │êàïñóëû                       │Merckle Gmbh (Ãåðìàíèÿ)       │009900,    

│êèñëîòà 0.575 ìã, öèàíîêîáàëàìèí   │ïðåïàðàò æåëåçà [B03AE10]                                                                 │17.12.97   

│0.39 ìã, ñåðèí 129 ìã, æåëåçî                                                                                                           

│113.85 ìã, âîñê 10.33 ìã, ñîåâîå                                                                                                        

│ìàñëî ãèäðèðîâàííîå 10.3 ìã,                                                                                                            

│ñîåâîå ìàñëî ÷àñòè÷íî                                                                                                                   

│ãèäðèðîâàííîå 41.32 ìã, ëåöèòèí                                                                                                         

│ñîåâûé 11.735 ìã, êàëüöèÿ ôîñôàò                                                                                                        

│3.51 ìã}                                                                                                                                

                                                                                                                                        

│Àêòîâåãèí {äåïðîòåèíèçèðîâàííûé    │ðåãåíåðàöèè ñòèìóëÿòîð        │äðàæå ôîðòå; ãåëü ãëàçíîé 20% │Hafslund Nycomed Pharma Ag    │002554,    

│ãåìîäåðèâàò èç êðîâè òåëÿò}        │[B06AB] [S01XA]                                             │(Àâñòðèÿ)                     │14.07.92   

                                                                                                                                        

│Àêòîâåãèí {äåïðîòåèíèçèðîâàííûé    │ðåãåíåðàöèè ñòèìóëÿòîð [D11AX]│êðåì 5%; ìàçü 5%; ãåëü 20%    │Hafslund Nycomed Pharma Ag    │002553,    

│ãåìîäåðèâàò èç êðîâè òåëÿò}                                                                    │(Àâñòðèÿ)                     │14.07.92   

                                                                                                                                         

│Àêòîâåãèí {äåïðîòåèíèçèðîâàííûé    │ðåãåíåðàöèè ñòèìóëÿòîð [B06AB]│ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hafslund Nycomed Pharma Ag    │006050,    

│ãåìîäåðèâàò èç êðîâè òåëÿò}                                      │2, 5, 10 ìë                   │(Àâñòðèÿ)                     │17.05.95   

                                                                                                                                        

│Àêòîâåãèí {äåïðîòåèíèçèðîâàííûé    │ðåãåíåðàöèè ñòèìóëÿòîð [B06AB]│ðàñòâîð äëÿ èíôóçèé ñ         │Nycomed Austria Gmbh (Àâñòðèÿ)│008194,    

│ãåìîäåðèâàò èç êðîâè òåëÿò}                                      │ãëþêîçîé (ôëàêîíû) 10% - 250                                │21.05.97   

                                                                 │ìë; ðàñòâîð äëÿ èíôóçèé ñ                                              

                                                                 │íàòðèÿ õëîðèäîì (ôëàêîíû)                                              

                                                                 │10%, 20% - 250 ìë                                                      

                                                                                                                                        

│Àêòîâåãèí {äåïðîòåèíèçèðîâàííûé    │ðåãåíåðàöèè ñòèìóëÿòîð        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │008465,    

│ãåìîäåðèâàò èç êðîâè òåëÿò}        │[B06AB] [D11AX]               │40 ìã/ìë - 2, 5, 10 ìë; ìàçü  │Laboratories (Èíäèÿ)          │10.11.97   

                                                                 │(òóáû) 5% - 20 ã; æåëå (òóáû) │                                         

                                                                 │20% - 20 ã                                                             

                                                                                                                                        

│Àêòðàïèä ÌÑ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk a/S (Äàíèÿ)      │008450,    

                                   │[A10AB]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │15.10.97   

                                                                                                                                        

│Àêòðàïèä ÌÑ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk a/S (Äàíèÿ)      │010359,    

                                   │[A10AB]                       │(ôëàêîíû) 100 ÌÅ/ìë - 10 ìë                                 │27.07.98   

                                                                                                                                        

│Àêòðàïèä ÌÑ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Torrent Pharmaceuticals Ltd   │008613,    

                                   │[A10AB]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë    │(Èíäèÿ)                       │28.04.98   

                                                                                                                                        

│Àêòðàïèä ÍÌ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk a/S (Äàíèÿ)      │008517,    

                                   │[A10AB]                       │(ôëàêîíû) 100 ÌÅ/ìë - 10 ìë                                 │10.02.98   

                                                                                                                                        

│Àêòðàïèä ÍÌ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk a/S (Äàíèÿ)      │008449,    

                                   │[A10AB]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │15.10.97   

                                                                                                                                        

│Àêòðàïèä ÍÌ [Èíñóëèí-ÁÄ]           │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Torrent Pharmaceuticals Ltd   │008490,    

                                   │[A10AB]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë    │(Èíäèÿ)                       │09.01.98   

                                                                                                                                         

│Àêòðàïèä ÍÌ ïåíôèëë [Èíñóëèí-ÁÄ]   │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé (ãèëüçû  │Novo Nordisk (Äàíèÿ)          │003268,    

                                   │[A10AB]                       │ñòåêëÿííûå äëÿ øïðèöðó÷êè)                                  │26.08.93   

                                                                 │100 ÌÅ/ìë - 3 ìë                                                       

                                                                                                                                        

│Àêòðàïèä ÍÌ ïåíôèëë [Èíñóëèí-ÁÄ]   │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Novo Nordisk a/S (Äàíèÿ)      │008451,    

                                   │[A10AB]                       │(êàðòðèäæè) 100 ÅÄ/ìë - 1.5 ìë│                              │15.10.97   

                                                                                                                                        

│Àêòðîí [Êåòîïðîôåí]                │ÍÏÂÑ [M01AE03]                │êàïëè îðàëüíûå (ôëàêîíû) 5% - │Bayer Ag (Ãåðìàíèÿ)           │007642,    

                                                                 │10 ìë                                                       │11.07.96   

                                                                                                                                        

│Àëãîìèí {àöåòèëñàëèöèëîâàÿ êèñëîòà │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Pennex Labs (ÑØÀ)             │005200,    

│250 ìã, êîôåèí 65 ìã, ïàðàöåòàìîë  │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │01.08.94   

│250 ìã}                            │[N02BA71]                                                                                            

                                                                                                                                        

│Àëãîí {àöåòèëñàëèöèëîâàÿ êèñëîòà   │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Minerva Pharmaceutical Sa     │009058,    

│400 ìã, êîôåèí 50 ìã, ïàðàöåòàìîë  │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Ãðåöèÿ)                      │05.01.97   

│200 ìã}                            │[N02BA71]                                                                                            

                                                                                                                                        

│Àëäèçåì [Äèëòèàçåì]                │ÁÌÊÊ [C08DB01]                │òàáëåòêè 90 ìã                │Alkaloid (Ðåñïóáëèêà          │008626,    

                                                                                               │Ìàêåäîíèÿ)                    │18.05.98   

                                                                                                                                        

│Àëåêñàí [Öèòàðàáèí]                │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Heinrich Mack Nachf.          │008448,    

                                   │[L01BC01]                     │(ôëàêîíû) 40 ìã/2 ìë, 100     │(Ãåðìàíèÿ)                    │15.10.97   

                                                                 │ìã/5 ìë, 500 ìã/10 ìë, 1000                                            

                                                                 │ìã/20 ìë                                                               

                                                                                                                                        

│Àëåìîêñàí [Êëîçàïèí]               │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 50 ìã                │Arzneimittelwerk Dresden Feb  │01671,     

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                 │(ÃÄÐ)                         │30.08.89   

                                   │[N05AH02]                                                                                            

                                                                                                                                        

│Àëçîëàì [Àëïðàçîëàì]               │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 0.25, 0.5, 1 ìã      │Sun Pharmaceutical Industries │002757,    

                                   │[N05BA12]                                                   │Ltd (Èíäèÿ)                   │16.12.92   

                                                                                                                                        

│Àëèâ [Íàïðîêñåí]                   │ÍÏÂÑ [M01AE02]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Roche-Nicholas   │007759,    

                                                                 │220 ìã                        │Sa (Ôðàíöèÿ)                  │27.08.96   

                                                                                                                                        

│Àëèíàäåðì                          │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Alina (Àâñòðèÿ)               │0019-11,   

                                   │ñðåäñòâî [D08AX]                                                                          │11.07.94   

                                                                                                                                        

│Àëèíàìàí                           │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Alina (Àâñòðèÿ)               │0019-12,   

                                   │ñðåäñòâî [D08AX]                                                                          │11.07.94   

                                                                                                                                        

│Àëêàäèë [Êàïòîïðèë]                │ÀÊÔ áëîêàòîð [C09AA01]        │òàáëåòêè 25 ìã                │Alkaloid (Ìàêåäîíèÿ)          │003482,    

                                                                                                                             │02.11.93   

                                                                                                                                        

│Àëêà-Çåëüòöåð {àöåòèëñàëèöèëîâàÿ   │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå              │Miles Ltd, Company Bayer'S    │008320,    

│êèñëîòà 324 ìã, ëèìîííàÿ êèñëîòà   │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Groop (Âåëèêîáðèòàíèÿ)        │25.08.97   

│965 ìã, íàòðèÿ ãèäðîêàðáîíàò 1.625 │[N02BA51]                                                                                             

│ã}                                                                                                                                      

                                                                                                                                        

│Àëêà-Çåëüòöåð ïëþñ àýðîçîëü        │àëüôà-àäðåíîñòèìóëÿòîð        │ðàñòâîð (ôëàêîíû ñ äîçàòîðîì) │Bayer Ag (Ãåðìàíèÿ)           │007844,    

│íàçàëüíûé [Îêñèìåòàçîëèí]          │[R01AA05]                     │0.05% - 10 ìë                                               │26.09.96   

                                                                                                                                        

│Àëêà-Çåëüòöåð ïëþñ áîëåóòîëÿþùåå è │àíàëüãåòè÷åñêîå               │ãðàíóëû ðàñòâîðèìûå (ñàøå)    │Bayer Ag (Ãåðìàíèÿ)           │007845,    

│æàðîïîíèæàþùåå ñðåäñòâî            │íåíàðêîòè÷åñêîå ñðåäñòâî      │500 ìã                                                      │26.09.96   

│[Ïàðàöåòàìîë]                      │[N02BE01]                                                                                            

                                                                                                                                        

│Àëêàëèò {ëèìîííàÿ êèñëîòà, êàëèÿ   │ñðåäñòâî ëå÷åíèÿ íåôðîëèòèàçà │ãðàíóëÿò                      │Lechiva (×åõèÿ)               │2538,      

│öèòðàò, íàòðèÿ öèòðàò}             │[G04BC]                                                                                   │17.01.78,  

                                                                                                                             │16.12.93   

                                                                                                                                        

│Àëêåðàí [Ìåëôàëàí]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Wellcome Foundation Ltd       │005671,    

                                   │[L01AA03]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Âåëèêîáðèòàíèÿ)              │23.01.95   

                                                                 │ðàñòâîðà (àìïóëû) 50 ìã                                                 

                                                                                                                                        

│Àëêåðàí [Ìåëôàëàí]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │òàáëåòêè 2 ìã, 5 ìã; ïîðîøîê  │Wellcome Foundation Ltd       │002579,    

                                   │[L01AA03]                     │äëÿ ïðèãîòîâëåíèÿ             │(Âåëèêîáðèòàíèÿ)              │28.07.92   

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                                 

                                                                 │(ôëàêîíû) 100 ìã /â êîìïëåêòå │                                         

                                                                 │ñ ðàñòâîðèòåëåì/                                                       

                                                                                                                                        

│Àëëàïèíèíà òàáëåòêè 0.025 ã        │àíòèàðèòìè÷åñêîå ñðåäñòâî     │òàáëåòêè (áàíêè) 25 ìã;       │Èíñòèòóò õèìèè ðàñòèòåëüíûõ   │95/112/5,  

│[Àëëàïèíèí]                        │[C01BG]                       │òàáëåòêè (óïàêîâêè ÿ÷åéêîâûå  │âåùåñòâ ÀÍ Óçáåêèñòàíà        │27.05.95   

                                                                 │êîíòóðíûå) 25 ìã              │(Óçáåêèñòàí)                             

                                                                                                                                        

│Àëëåðãèí [Äèôåíãèäðàìèí]           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Four Ventures Enterprises     │009439,    

                                   │áëîêàòîð [R06AA02]            │25 ìã                         │(ÑØÀ)                         │12.05.97   

                                                                                                                                        

│Àëëåðãîäèë [Àöåëàñòèí]             │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé 2 │Asta Medica Ag (Ãåðìàíèÿ)     │006144,    

                                   │áëîêàòîð [R01AC03] [R06AX19]  │ìã; ñïðåé íàçàëüíûé                                         │06.06.95   

                                                                 │äîçèðîâàííûé (ôëàêîíû) 0.14                                            

                                                                 │ìã|0.14 ìë                                                             

                                                                                                                                        

│Àëëåðãîäèë [Àöåëàñòèí]             │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð-êàïëè ãëàçíûå         │Asta Medica Ltd               │010211,    

                                   │áëîêàòîð [S01GX]              │(ôëàêîíû) 0.05% - 6, 10 ìë    │(Âåëèêîáðèòàíèÿ)              │19.05.98   

                                                                                                                                        

│Àëëèòåðà {ïåðâîöâåòà ñåìÿí ìàñëî,  │îáùåòîíèçèðóþùåå ñðåäñòâî     │êàïñóëû 500 ìã                │Biogal Pharmaceutical Works   │009362,    

│÷åñíî÷íîå ìàñëî}                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Sa (Âåíãðèÿ)                  │08.04.97   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Àëëî [Àëëîïóðèíîë]                 │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100, 300 ìã          │Ct-Arzneimittel Chemishe      │006771,    

                                   │[M04AA01]                                                   │Tempelchof Gmbh (Ãåðìàíèÿ)    │31.10.95   

                                                                                                                                        

│Àëëîìàðîí {àëëîïóðèíîë 100 ìã,     │ïðîòèâîïîäàãðè÷åñêîå ñðåäñòâî │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002976,    

│áåíçáðîìàðîí 20 ìã}                │[M04AA51]                     │îáîëî÷êîé 100 ìã/20 ìã                                      │23.04.93   

                                                                                                                                         

│Àëëîïèí [Àëëîïóðèíîë]              │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100 ìã               │General Drug House (Òàéëàíä)  │005587,    

                                   │[M04AA01]                                                                                 │20.12.94   

                                                                                                                                        

│Àëëîïóðèíîë Íèêîìåä [Àëëîïóðèíîë]  │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100, 300 ìã          │Nycomed Dak (Äàíèÿ)           │006396,    

                                   │[M04AA01]                                                                                 │14.08.95   

                                                                                                                                        

│Àëëîïóðèíîë-Òåâà [Àëëîïóðèíîë]     │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100, 300 ìã          │Teva Pharmaceutical           │006734,    

                                   │[M04AA01]                                                   │Industries Ltd (Èçðàèëü)      │19.10.95   

                                                                                                                                        

│Àëëîôåðèí [Àëêóðîíèÿ õëîðèä]       │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │F.Hoffmann La Roche Ltd       │008252,    

                                   │[M03AA01]                     │10 ìã - 2 ìë                  │(Øâåéöàðèÿ)                   │08.04.97   

                                                                                                                                        

│Àëëîõîë {æåë÷ü, ÷åñíîêà ýêñòðàêò,  │æåë÷åãîííîå ñðåäñòâî          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │67/554/3,  

│êðàïèâû ýêñòðàêò, óãîëü            │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │12.10.98   

│àêòèâèðîâàííûé}                    │[A05AX]                                                                                              

                                                                                                                                         

│Àëëîõîë òàáëåòêè ïîêðûòûå          │æåë÷åãîííîå ñðåäñòâî          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Áîðùàãîâñêèé ÕÔÇ (Óêðàèíà)    │67/554/3,  

│îáîëî÷êîé {æåë÷ü, ÷åñíîêà          │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │14.04.98   

│ýêñòðàêò, êðàïèâû ýêñòðàêò, óãîëü  │[A05AX]                                                                                              

│àêòèâèðîâàííûé}                                                                                                                         

                                                                                                                                        

│Àëëóïîë [Àëëîïóðèíîë]              │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100 ìã               │Polfa, Grodziskie             │009292,    

                                   │[M04AA01]                                                   │Pharmaceutical Works (Ïîëüøà) │12.03.97   

                                                                                                                                        

│Àëìàãåëü {àëãåëäðàò 0.3 ã, ìàãíèÿ  │àíòàöèäíîå ñðåäñòâî [A02AX]   │ãåëü                          │Pharmachim (Áîëãàðèÿ)         │2317,      

│ãèäðîêñèä 0.1 ã, ñîðáèòîë 0.8 ã -                                                                                            │07.05.73,  

│5 ìë}                                                                                                                        │28.04.84   

                                                                                                                                        

│Àëìàãåëü À {àëãåëäðàò 0.3 ã,       │àíòàöèäíîå ñðåäñòâî [A02AX]   │ãåëü                          │Pharmachim (Áîëãàðèÿ)         │2318,      

│ìàãíèÿ ãèäðîêñèä 0.1 ã, ñîðáèòîë                                                                                             │07.05.73,  

│0.8 ã, áåíçîêàèí 0.1 ã - 5 ìë}                                                                                               │28.04.84   

                                                                                                                                         

│Àëìàêîí {àëãåëäðàò 200 ìã, ìàãíèÿ  │àíòàöèäíîå ñðåäñòâî [A02AF02] │òàáëåòêè æåâàòåëüíûå 200      │Rugby (ÑØÀ)                   │005007,    

│ãèäðîêñèä 200 ìã, ñèìåòèêîí 20 ìã                                │ìã/200 ìã/20 ìã; ñóñïåíçèÿ                                  │15.06.94   

│- òàáëåòêè; àëãåëäðàò 200 ìã/400                                 │îðàëüíàÿ 200 ìã/200 ìã/20 ìã, │                                         

│ìã, ìàãíèÿ ãèäðîêñèä 200 ìã/400                                  │400 ìã/400 ìã/40 ìã                                                    

│ìã, ñèìåòèêîí 20 ìã /40 ìã - 5 ìë} │                                                                                                     

                                                                                                                                        

│Àëìàôèë {àëãåëäðàò 200 ìã, ìàãíèÿ  │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè 400 ìã               │Philopharm Gmbh Quedlinburg   │003657,    

│ãèäðîêñèä 200 ìã}                                                                              │(Ãåðìàíèÿ)                    │01.02.94   

                                                                                                                                        

│Àëìèíîêñ {ìàãíèÿ ãèäðîêñèä 144.7   │àíòàöèäíîå ñðåäñòâî [A02AD01] │òàáëåòêè æåâàòåëüíûå;         │Nycomed Dak (Äàíèÿ)           │007836,    

│ìã, àëþìèíèÿ àìèíîàöåòàò 500 ìã,                                 │ñóñïåíçèÿ äëÿ âíóòðåííåãî                                   │20.09.96   

│ìàííèòîë 185 ìã, ñàõàðèí 0.5 ìã -                                │ïðèìåíåíèÿ (ôëàêîíû) 250 ìë                                            

│òàáëåòêè; ìàãíèÿ îêñèä 17.6 ìã,                                                                                                         

│àëþìèíèÿ àìèíîàöåòàò 88 ìã - 1 ìë} │                                                                                                     

                                                                                                                                        

│Àëìèðàë [Äèêëîôåíàê]               │ÍÏÂÑ [M01AB05] [M02AA15]      │òàáëåòêè 50 ìã; ðàñòâîð äëÿ   │Medochemie Ltd (Êèïð)         │003130,    

                                                                 │èíúåêöèé (àìïóëû) 75 ìã - 3                                 │01.07.93   

                                                                 │ìë; ãåëü 1%                                                            

                                                                                                                                        

│Àëìîë {àëãåëäðàò 225 ìã, ìàãíèÿ    │àíòàöèäíîå ñðåäñòâî [A02AX]   │ñóñïåíçèÿ äëÿ âíóòðåííåãî     │Sagmel Inc (ÑØÀ)              │009456,    

│ãèäðîêñèä 200 ìã - 5 ìë}                                         │ïðèìåíåíèÿ (ôëàêîíû) 355 ìë                                 │19.05.97   

                                                                                                                                        

│Àëîìèä [Ëîäîêñàìèä]                │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │êàïëè ãëàçíûå (ôëàêîíû) 0.1%  │Alcon-Couvreur Sa (Áåëüãèÿ)   │007515,    

                                   │[S01GX05]                     │- 5, 10, 15 ìë                                              │15.05.96   

                                                                                                                                        

│Àëîïåêñè [Ìèíîêñèäèë]              │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ íàðóæíîãî         │Pierre Fabre (Ôðàíöèÿ)        │007854,    

                                   │[D11AX01]                     │ïðèìåíåíèÿ (ôëàêîíû) 2% - 15, │                              │30.09.96   

                                                                 │60 ìë                                                                  

                                                                                                                                        

│Àëîïðîë [Ñàëüáóòàìîë]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 2 ìã                 │Hemofarm D.D. (Þãîñëàâèÿ)     │003804,    

                                   │ñåëåêòèâíûé [R03CC02]                                                                     │29.03.94   

                                                                                                                                         

│Àëîïðîí [Àëëîïóðèíîë]              │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100, 300 ìã          │Remedica Ltd - Minnex (Êèïð)  │006808,    

                                   │[M04AA01]                                                                                 │09.11.95   

                                                                                                                                        

│Àëîý ýêñòðàêò æèäêèé äëÿ èíúåêöèé  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Åðåâàíñêàÿ                    │72/334/4,  

│â àìïóëàõ ïî 1 ìë                  │ñðåäñòâî                      │1 ìë                          │õèìèêî-ôàðìàöåâòè÷åñêàÿ ôèðìà │27.10.97   

                                                                                               │ÎÀÎ (Ðåñïóáëèêà Àðìåíèÿ)                 

                                                                                                                                        

│Àëïðîêñ [Àëïðàçîëàì]               │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 0.25, 0.5, 1 ìã      │Orion Corporation (Ôèíëÿíäèÿ) │010208,    

                                   │[N05BA12]                                                                                 │15.05.98   

                                                                                                                                        

│Àëñóêðàë [Ñóêðàëüôàò]              │ïðîòèâîÿçâåííîå ñðåäñòâî      │òàáëåòêè 0.5, 1 ã             │Orion Corporation (Ôèíëÿíäèÿ) │008430,    

                                   │[A02BX02]                                                                                 │08.09.97   

                                                                                                                                        

│Àëòàëåêñ {ìÿòû ëèìîííîé ìàñëî,     │ñåäàòèâíîå ñðåäñòâî           │êàïëè äëÿ âíóòðåííåãî è       │Lek Ljubljana (Ñëîâåíèÿ)      │005041,    

│ìÿòû ïåðå÷íîé ìàñëî, ôåíõåëÿ       │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │íàðóæíîãî ïðèìåíåíèÿ (ôëàêîíû)│                              │24.06.94   

│ìàñëî, ìóñêàòíîå ìàñëî, ãâîçäè÷íîå │[N05CM]                                                                                               

│ìàñëî, ÷àáðåöà ìàñëî, ñîñíû õâîè                                                                                                        

│ìàñëî, àíèñîâîå ìàñëî, øàëôåÿ                                                                                                           

│ìàñëî, êîðèöû ìàñëî, ëàâàíäîâîå                                                                                                         

│ìàñëî, ýòàíîë - ðàñòâîð ñïèðòîâîé                                                                                                       

│2.5%}                                                                                                                                   

                                                                                                                                        

│Àëòåéíîãî êîðíÿ ýêñòðàêò ñóõîé     │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïîðîøîê (áàíêè) 150, 350 ã    │Ãàëè÷ôàðì ÀÎ (Óêðàèíà)        │72/334/5,  

                                   │ñðåäñòâî                                                                                  │18.02.98   

                                                                                                                                        

│Àëòèàçåì ÐÐ [Äèëòèàçåì]            │ÁÌÊÊ [C08DB01]                │êàïñóëû 180 ìã                │Instituto Lusofarmaco (Èòàëèÿ)│007448,    

                                                                                                                             │17.04.96   

                                                                                                                                        

│Àëóïåíò [Îðöèïðåíàëèí]             │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 20 ìã; ðàñòâîð äëÿ   │Boehringer Ingelheim          │00169,     

                                   │ñåëåêòèâíûé [R03AB03]         │èíúåêöèé (àìïóëû) 0.5 ìã - 1  │International Gmbh (Ãåðìàíèÿ) │12.09.71,  

                                   │[R03CB03]                     │ìë; àýðîçîëü äîçèðîâàííûé                                   │24.10.83,  

                                                                 │0.75 ìã/äîçà (èíãàëÿòîð 400                                 │04.05.95   

                                                                 │äîç) 20 ìë                                                             

                                                                                                                                        

│Àëôëóòîï {ýêñòðàêò ìîðñêèõ         │ïðîòèâîâîñïàëèòåëüíîå         │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Biotechnos Sa (Ðóìûíèÿ)       │007588,    

│æèâîòíûõ}                          │ñðåäñòâî [C05CX]              │10 ìã/ìë                                                    │18.06.96   

                                                                                                                                        

│Àëüáåíäàçîëà òàáëåòêè 0.2 ã        │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè (óïàêîâêè ÿ÷åéêîâûå  │Èíñòèòóò õèìèè ðàñòèòåëüíûõ   │98/207/3   

│[Àëáåíäàçîë]                       │[P02CA03]                     │êîíòóðíûå) 0.2 ã              │âåùåñòâ ÀÍ Óçáåêèñòàíà                   

                                                                                               │(Óçáåêèñòàí)                             

                                                                                                                                        

│Àëüáóìèí ÷åëîâå÷åñêèé [Àëüáóìèí]   │ïëàçìîçàìåùàþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Octapharma Ag (Øâåéöàðèÿ)     │005151,    

                                   │[B05AA01]                     │5%, 20%                                                     │20.07.94   

                                                                                                                                        

│Àëüáóìèí ÷åëîâå÷åñêèé 20% Èììóíî   │ïëàçìîçàìåùàþùåå ñðåäñòâî     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Immuno Ag (Àâñòðèÿ)           │009394,    

│[Àëüáóìèí]                         │[B05AA01]                     │ââåäåíèÿ (ôëàêîíû) 20% - 10,                                │21.04.97   

                                                                 │50, 100 ìë                                                             

                                                                                                                                         

│Àëüáóìèí ÷åëîâå÷åñêèé Äåññàó       │ïëàçìîçàìåùàþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Pharma Dessau Gmbh (Ãåðìàíèÿ) │007893,    

│[Àëüáóìèí]                         │[B05AA01]                     │5% - 50, 100, 250 ìë; ðàñòâîð │                              │14.10.96   

                                                                 │äëÿ èíôóçèé (ôëàêîíû) 20% -                                            

                                                                 │50, 100, 250 ìë                                                        

                                                                                                                                        

│Àëüäàêòîí [Ñïèðîíîëàêòîí]          │äèóðåòè÷åñêîå                 │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Boehringer Mannheim Gmbh      │002801,    

                                   │êàëèéñáåðåãàþùåå ñðåäñòâî     │50 ìã; êàïñóëû 100 ìã;        │(Àâñòðèÿ)                     │12.01.93   

                                   │[C03DA01]                     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                         

                                                                 │200 ìã - 10 ìë                                                         

                                                                                                                                        

│Àëüäàêòîí [Ñïèðîíîëàêòîí]          │äèóðåòè÷åñêîå                 │òàáëåòêè 25, 100 ìã           │ICN Galenika (Þãîñëàâèÿ)      │003918,    

                                   │êàëèéñáåðåãàþùåå ñðåäñòâî                                                                 │18.05.94   

                                   │[C03DA01]                                                                                            

                                                                                                                                        

│Àëüäàêòîí Ñàëüòóöèí {ñïèðîíîëàêòîí │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │äðàæå 50 ìã/5 ìã; êàïñóëû     │Boehringer Mannheim Gmbh      │003898,    

│50 ìã, áóòèçèä 5 ìã - äðàæå;       │ñðåäñòâî [C03EA14]            │ôîðòå 100 ìã/10 ìã            │(Àâñòðèÿ)                     │10.05.94   

│ñïèðîíîëàêòîí 0.1 ã, áóòèçèä 10 ìã │                                                                                                     

│- êàïñóëà}                                                                                                                              

                                                                                                                                        

│Àëüäàðîí [Àìèîäàðîí]               │àíòèàðèòìè÷åñêîå ñðåäñòâî     │òàáëåòêè 200 ìã               │Cadila Exports Ltd (Èíäèÿ)    │003643,    

                                   │[C01BD01]                                                                                 │26.01.94   

                                                                                                                                        

│Àëüäåöèí [Áåêëîìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé         │Schering-Plough (Áåëüãèÿ)     │009105,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │(áàëëîíû) 50 ìêã/äîçà - 200                                 │03.02.97   

                                                                 │äîç /â êîìïëåêòå ñ íîñîâûì è                                           

                                                                 │ðîòîâûì àïïëèêàòîðàìè/                                                 

                                                                                                                                        

│Àëüäåöèí [Áåêëîìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé 50      │Schering-Plough (ÑØÀ)         │003842,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │ìêã/äîçà                                                    │08.04.94   

                                                                                                                                        

│Àëüäîëîð [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå               │êàïëåòû 500 ìã; ñèðîï áåç     │Cts Chemical Industries Ltd   │006513,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │ñàõàðà (ôëàêîíû) 120 ìã|5 ìë; │(Èçðàèëü)                     │20.09.95   

                                   │[N02BE01]                     │êàïëè îðàëüíûå (ôëàêîíû) 100                                           

                                                                 │ìã/ìë                                                                  

                                                                                                                                        

│Àëüäîìåò [Ìåòèëäîïà]               │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè 250, 500 ìã          │Merck Sharp & Dohme (ÑØÀ)     │002676,    

                                   │öåíòðàëüíûé [C02AB02]                                                                     │02.11.92   

                                                                                                                                        

│Àëüäîïóð [Ñïèðîíîëàêòîí]           │äèóðåòè÷åñêîå                 │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │F.Joh.Kwizda Gmbh (Àâñòðèÿ)   │007014,    

                                   │êàëèéñáåðåãàþùåå ñðåäñòâî     │100 ìã                                                      │26.01.96   

                                   │[C03DA01]                                                                                            

                                                                                                                                        

│Àëüêà-ïðèì {àöåòèëñàëèöèëîâàÿ      │ÍÏÂÑ [N02BA51]                │òàáëåòêè øèïó÷èå              │Polpharma Pharmaceutical      │007083,    

│êèñëîòà 330 ìã, ëèìîííàÿ êèñëîòà                                                               │Works Sa (Ïîëüøà)             │14.02.96   

│685 ìã, íàòðèÿ ãèäðîêàðáîíàò 1.685 │                                                                                                     

│ã, ãëèöèí 100 ìã}                                                                                                                       

                                                                                                                                        

│Àëüìàã {àëãåëäðàò 0.2 ã, ìàãíèÿ    │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè                      │Ct-Arzneimittel Chemishe      │007595,    

│ãèäðîêñèä 0.2 ã}                                                                               │Tempelchof Gmbh (Ãåðìàíèÿ)    │20.06.96   

                                                                                                                                        

│Àëüìàã {àëãåëäðàò 0.35 ã, ìàãíèÿ   │àíòàöèäíîå ñðåäñòâî [A02AF02] │ñóñïåíçèÿ îðàëüíàÿ (ïàêåòèêè) │Ct-Arzneimittel Chemishe      │007595,    

│òðèñèëèêàò 0.35 ã, äèìåòèêîí 40 ìã │                              │10 ìë                         │Tempelchof Gmbh (Ãåðìàíèÿ)    │20.06.96   

│- 10 ìë}                                                                                                                                

                                                                                                                                        

│Àëüïðîãåëü {àëãåëäðàò 0.3 ã,       │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè; ñóñïåíçèÿ îðàëüíàÿ  │Promed Exports Pvt Ltd (Èíäèÿ)│006191,    

│ìàãíèÿ ãèäðîêñèä 0.1 ã}                                          │(ôëàêîíû) 170 ìë; ñóñïåíçèÿ                                 │15.06.95   

                                                                 │îðàëüíàÿ (ïàêåòèêè) 10 ìë                                              

                                                                                                                                        

│Àëüòðàìåò [Öèìåòèäèí]              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Arzneimittelwerk Dresden Gmbh │005359,    

                                   │áëîêàòîð [A02BA01]            │200, 400, 800 ìã              │(Ãåðìàíèÿ)                    │23.09.94   

                                                                                                                                        

│Àëüôà Ä3-Òåâà [Àëüôàêàëüöèäîë]     │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │êàïñóëû 0.25, 1 ìêã           │Teva Pharmaceutical           │005116,    

                                   │ôîñôîðà [A11CC03]                                           │Industries Ltd (Èçðàèëü)      │11.07.94   

                                                                                                                                         

│Àëüôàäîïà [Ìåòèëäîïà]              │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Merind Ltd (Èíäèÿ)            │005285,    

                                   │öåíòðàëüíûé [C02AB02]         │250 ìã                                                      │01.09.94   

                                                                                                                                        

│Àëüôàêàèí Í {àðòèêàèí 40 ìã,       │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ðàñòâîð äëÿ èíúåêöèé          │Laboratoire Spad (Ôðàíöèÿ)    │009006,    

│ýïèíåôðèí 1:200000}                │[N01BB58]                     │(êàðòðèäæè) 1.8 ìë                                          │04.12.96   

                                                                                                                                        

│Àëüôàêàèí ÑÏ {àðòèêàèí 40 ìã,      │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ðàñòâîð äëÿ èíúåêöèé          │Laboratoire Spad (Ôðàíöèÿ)    │009007,    

│ýïèíåôðèí 1:100000}                │[N01BB58]                     │(êàðòðèäæè) 1.8 ìë                                          │04.12.96   

                                                                                                                                        

│àëüôà-Òîêîôåðîëà àöåòàòà (âèòàìèí  │âèòàìèí [A11HA03]             │êàïñóëû 0.2 ã                 │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │009247,    

│Å) ðàñòâîð â ìàñëå 50% â êàïñóëàõ                                                                                            │17.12.97   

│[Âèòàìèí Å]                                                                                                                             

                                                                                                                                        

│Àëüôàöåò [Öåôàêëîð]                │àíòèáèîòèê, öåôàëîñïîðèí      │êàïñóëû 250, 500 ìã; ïîðîøîê  │ICN Galenika (ÑÐ Þãîñëàâèÿ)   │008385,    

                                   │[J01DA08]                     │äëÿ ïðèãîòîâëåíèÿ ñóñïåíçèè                                 │08.01.98   

                                                                 │(ôëàêîíû) 125 ìã|5 ìë, 250                                              

                                                                 │ìã|5 ìë - 60 ìë                                                        

                                                                                                                                        

│Àëüôîãåëü [Àëþìèíèÿ ôîñôàò]        │àíòàöèäíîå ñðåäñòâî [A02AB03] │ãåëü (ïàêåòèêè) 55% - 16 ã    │ICN Galenika (Þãîñëàâèÿ)      │008039,    

                                                                                                                             │30.10.96   

                                                                                                                                        

│Àëþãàñòðèí [Êàðáàëäðàò]            │àíòàöèäíîå ñðåäñòâî [A02AB04] │âçâåñü äëÿ ïðèåìà âíóòðü      │Polfa, Lodzkie Pharmaceutical │008420,    

                                                                 │(ôëàêîíû) 250 ìë              │Works (Ïîëüøà)                │13.08.97   

                                                                                                                                        

│Àëþãàñòðèí [Êàðáàëäðàò]            │àíòàöèäíîå ñðåäñòâî [A02AB04] │òàáëåòêè äëÿ ðàññàñûâàíèÿ     │Polfa, Lodzkie Pharmaceutical │007085,    

                                                                                               │Works (Ïîëüøà)                │15.02.96   

                                                                                                                                        

│Àëþãåëü ôîðòå {àëãåëäðàò 0.4 ã,    │àíòàöèäíîå ñðåäñòâî [A02AF02] │òàáëåòêè æåâàòåëüíûå          │Deva Holding As (Òóðöèÿ)      │007606,    

│ìàãíèÿ ãèäðîêñèä 0.4 ã, ñèìåòèêîí                                                                                            │24.06.96   

│20 ìã}                                                                                                                                  

                                                                                                                                        

│Àëþìàã {àëãåëäðàò 200 ìã, ìàãíèÿ   │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè                      │Polfa (Ïîëüøà)                │003012,    

│ãèäðîêñèä 200 ìã}                                                                                                            │28.05.93   

                                                                                                                                        

│Àëþìàã-Òåâà {àëãåëäðàò 470 ìã,     │àíòàöèäíîå ñðåäñòâî [A02AX]   │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Teva Pharmaceutical           │006232,    

│ìàãíèÿ ãèäðîêñèä 410 ìã - 5 ìë}                                                                │Industries Ltd (Èçðàèëü)      │29.06.95   

                                                                                                                                        

│Àëþìèíèÿ ãèäðîîêèñü-Ðèâîôàðì       │àíòàöèäíîå ñðåäñòâî [A02AB02] │òàáëåòêè 500 ìã               │Rivopharm Sa (Øâåéöàðèÿ)      │003856,    

│[Àëãåëäðàò]                                                                                                                  │18.04.94   

                                                                                                                                        

│Àìàðèë [Ãëèìåïèðèä]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 1, 2, 3, 4, 6 ìã     │Hoechst Ag (Ãåðìàíèÿ)         │009966,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB12] │                                                            │28.01.98   

                                                                                                                                        

│Àìáåíå {ôåíèëáóòàçîí 0.4 ã, íàòðèÿ │ïðîòèâîâîñïàëèòåëüíîå         │àìïóëû äâîéíûå; øïðèöû ãîòîâûå│Ludwig Merckle Gmbh (Àâñòðèÿ) │005343,    

│ñàëèöèëàìèä 0.15 ã, äåêñàìåòàçîí   │ñðåäñòâî [M01BA01]                                                                        │21.09.94   

│3.32 ìã, ëèäîêàèí 4 ìã - àìïóëà;                                                                                                        

│öèàíîêîáàëàìèí 2.5 ìã, ëèäîêàèí 2                                                                                                       

│ìã - àìïóëà}                                                                                                                             

                                                                                                                                        

│Àìáèçîì [Àìôîòåðèöèí Â]            │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ëèîôèëèç.ïîðîøîê äëÿ èíúåêöèé │Nexstar Pharmaceuticals       │008703,    

                                   │[A01AB04]                     │(ôëàêîíû) 50 ìã               │International Ltd             │26.08.98   

                                                                                               │(Âåëèêîáðèòàíèÿ)                         

                                                                                                                                        

│Àìáðîáåíå [Àìáðîêñîë]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │Merckle Gmbh (Ãåðìàíèÿ)       │008368,    

                                   │[R05CB06]                     │èíúåêöèé (àìïóëû) 15 ìã - 2                                 │05.12.97   

                                                                 │ìë; êàïñóëû ðåòàðä 75 ìã;                                              

                                                                 │ñèðîï (ôëàêîíû) 15 ìã|5 ìë -                                           

                                                                 │100 ìë; ðàñòâîð äëÿ ïðèåìà                                             

                                                                 │âíóòðü (ôëàêîíû) 7.5 ìã/ìë -                                           

                                                                 │40, 100 ìë; ñóïïîçèòîðèè 15,                                           

                                                                 │30 ìã                                                                  

                                                                                                                                        

│Àìáðîãåêñàë [Àìáðîêñîë]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã; ðàñòâîð       │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │005841,    

                                   │[R05CB06]                     │îðàëüíûé (ôëàêîíû) 7.5 ìã/ìë; │                              │28.03.95   

                                                                 │ñèðîï îðàëüíûé (ôëàêîíû) 3                                             

                                                                 │ìã/ìë                                                                  

                                                                                                                                        

│Àìáðîãåêñàë [Àìáðîêñîë]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè øèïó÷èå 30, 60 ìã    │Hexal Ag (Ãåðìàíèÿ)           │009686,    

                                   │[R05CB06]                                                                                 │18.08.97   

                                                                                                                                        

│Àìáðîêñîë [Àìáðîêñîë]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ct-Arzneimittel Chemishe      │007435,    

                                   │[R05CB06]                     │15 ìã - 2 ìë; ðàñòâîð äëÿ     │Tempelchof Gmbh (Ãåðìàíèÿ)    │15.04.96   

                                                                 │âíóòðèâåííîãî ââåäåíèÿ                                                 

                                                                 │(ôëàêîíû) 7.5 ìã/ìë; ñèðîï                                             

                                                                 │(ôëàêîíû) 15 ìã|5 ìë                                                   

                                                                                                                                        

│Àìáðîêñîë [Àìáðîêñîë]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè øèïó÷èå 30 ìã        │Ct-Arzneimittel Chemishe      │005778,    

                                   │[R05CB06]                                                   │Tempelchof Gmbh (Ãåðìàíèÿ)    │24.02.95   

                                                                                                                                        

│Àìáðîêñîë [Àìáðîêñîë]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã                │Sanavita Gesundcheits- mittel │008005,    

                                   │[R05CB06]                                                   │Gmbh & Co Kg (Ãåðìàíèÿ)       │15.11.96   

                                                                                                                                        

│Àìáðîëàí [Àìáðîêñîë]               │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã; êàïñóëû       │Lannacher Heilmittel Gmbh     │007999,    

                                   │[R05CB06]                     │ðåòàðä 75 ìã; ñèðîï (ôëàêîíû) │(Àâñòðèÿ)                     │03.12.96   

                                                                 │15 ìã|5 ìë - 100 ìë; ðàñòâîð                                           

                                                                 │äëÿ ïðèåìà âíóòðü è èíãàëÿöèé │                                         

                                                                 │(ôëàêîíû) 7.5 ìã/ìë - 40, 100 │                                         

                                                                 │ìë                                                                     

                                                                                                                                        

│Àìáðîñàí [Àìáðîêñîë]               │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã                │Pro.Med.Cs Praha As (×åõèÿ)   │008582,    

                                   │[R05CB06]                                                                                 │17.07.98   

                                                                                                                                        

│Àìãåíò [Ãåíòàìèöèí]                │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │M.J.Pharmaceuticals Ltd       │007043,    

                                   │[J01GB03]                     │40 ìã/ìë - 2 ìë               │(Èíäèÿ)                       │02.02.96   

                                                                                                                                        

│Àìæåöåôò [Öåôòàçèäèì]              │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │M.J.Pharmaceuticals Ltd       │007044,    

                                   │[J01DA11]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Èíäèÿ)                       │02.02.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.25, 0.5, │                                         

                                                                 │1, 2 ã                                                                 

                                                                                                                                        

│Àìèãëóðàöèë {ìåòèëóðàöèë 1 ã,      │ðåãåíåðàöèè ñòèìóëÿòîð [V03A] │ëèîôèëèç.ïîðîøîê äëÿ èíúåêöèé │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │009175,    

│ìåòèëãëóêàìèí 3 ã}                                               │(ôëàêîíû) 0.1 ã                                             │06.10.97   

                                                                                                                                        

│Àìèçîë [Àìèòðèïòèëèí]              │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 10, 25 ìã; ðàñòâîð   │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │003525,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 20 ìã - │                              │25.11.93   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Àìèêàöèí [Àìèêàöèí]                │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │ICN Galenika (Þãîñëàâèÿ)      │008266,    

                                   │[J01GB06]                     │100 ìã/2 ìë, 500 ìã/2 ìë                                    │22.04.97   

                                                                                                                                        

│Àìèêàöèí [Àìèêàöèí]                │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (ÍÐÁ)              │2977,      

                                   │[J01GB06]                     │12.5% - 2 ìë; ðàñòâîð äëÿ                                   │19.06.90   

                                                                 │èíúåêöèé (àìïóëû) 25% - 2, 4                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Àìèêèí [Àìèêàöèí]                  │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé          │Bristol-Myers Squibb (Èòàëèÿ) │009372,    

                                   │[B05BA04] [J01GB06]           │(ôëàêîíû) 100 ìã/2 ìë, 250                                  │11.04.97   

                                                                 │ìã/2 ìë, 500 ìã/2 ìë, 1000                                             

                                                                 │ìã/4 ìë                                                                

                                                                                                                                        

│Àìèêèí [Àìèêàöèí]                  │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bristol-Myers Squibb (ÑØÀ)    │002089,    

                                   │[B05BA04] [J01GB06]           │100, 500 ìã - 2 ìë                                          │26.03.91   

                                                                                                                                        

│Àìèêîçèò [Àìèêàöèí]                │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Eczacibasi (Òóðöèÿ)           │002992,    

                                   │[J01GB06]                     │100, 500 ìã - 2 ìë                                          │28.04.93   

                                                                                                                                        

│Àìèêñèä {àìèòðèïòèëèí 25 ìã,       │àíòèäåïðåññàíò [N06CA01]      │òàáëåòêè òåìíî - ñèíèå 25 ìã/ │Sun Pharmaceutical Industries │003054,    

│õëîðäèàçåïîêñèä 10 ìã}                                           │10 ìã                         │Ltd (Èíäèÿ)                   │08.06.93   

                                                                                                                                        

│Àìèêñèä-5 {àìèòðèïòèëèí 25 ìã,     │àíòèäåïðåññàíò [N06CA01]      │òàáëåòêè çåëåíûå 25 ìã/5 ìã   │Sun Pharmaceutical Industries │003053,    

│õëîðäèàçåïîêñèä 5 ìã}                                                                          │Ltd (Èíäèÿ)                   │08.06.93   

                                                                                                                                        

│Àìèêñèä-Í {àìèòðèïòèëèí 12.5 ìã,   │àíòèäåïðåññàíò [N06CA01]      │òàáëåòêè ïåðñèêîâîãî öâåòà    │Sun Pharmaceutical Industries │003052,    

│õëîðäèàçåïîêñèä 5 ìã}                                            │12.5 ìã/5 ìã                  │Ltd (Èíäèÿ)                   │08.06.93   

                                                                                                                                        

│Àìèêñèíà òàáëåòêè 0.125 ã          │èììóíîñòèìóëèðóþùåå ñðåäñòâî  │òàáëåòêè (óïàêîâêè ÿ÷åéêîâûå  │Îäåññêèé Ôèçèêîõèìè÷åñêèé     │96/252/3,  

                                   │[J05AX]                       │êîíòóðíûå) 125 ìã             │èíñòèòóò (Óêðàèíà)            │18.06.96   

                                                                                                                                        

│Àìèëîçèä {àìèëîðèä 5 ìã,           │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │òàáëåòêè                      │Ct-Arzneimittel Chemishe      │007594,    

│ãèäðîõëîðîòèàçèä 50 ìã}            │ñðåäñòâî [C03EA01]                                          │Tempelchof Gmbh (Ãåðìàíèÿ)    │20.06.96   

                                                                                                                                        

│Àìèëîðåòèê {àìèëîðèä 5 ìã,         │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │òàáëåòêè 5 ìã/50 ìã, 2.5      │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │006127,    

│ãèäðîõëîðîòèàçèä 50 ìã}            │ñðåäñòâî [C03EA01]            │ìã/25 ìã                                                    │30.05.95   

                                                                                                                                         

│Àìèí [Àìîêñèöèëëèí]                │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã           │Kopran Ltd (Èíäèÿ)            │005625,    

                                   │[J01CA04]                                                                                 │10.01.95   

                                                                                                                                        

│Àìèíàäîë [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå               │òàáëåòêè æåâàòåëüíûå äëÿ      │Myevska Pharmaceuticals Inc   │007555,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │äåòåé 80 ìã; ýëèêñèð äëÿ      │(ÑØÀ)                         │30.05.96   

                                   │[N02BE01]                     │äåòåé (ôëàêîíû) 80 ìã|2.5 ìë                                           

                                                                 │- 30, 118 ìë                                                           

                                                                                                                                        

│Àìèíàäîë [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå               │òàáëåòêè æåâàòåëüíûå äëÿ      │Pennex Labs (ÑØÀ)             │005295,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │äåòåé 80 ìã; ýëèêñèð äëÿ                                    │05.09.94   

                                   │[N02BE01]                     │äåòåé (ôëàêîíû) 160 ìã|5 ìë;                                           

                                                                 │êàïëè îðàëüíûå äëÿ äåòåé                                               

                                                                 │(ôëàêîíû) 100 ìã/ìë                                                    

                                                                                                                                        

│Àìèíàçèíà ðàñòâîð äëÿ èíúåêöèé     │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Êàëüöåêñ Ãï (Ëàòâèÿ)          │010006,    

│2.5% [Õëîðïðîìàçèí]                │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │2.5% - 2 ìë                                                 │23.01.98   

                                   │[N05AA01]                                                                                            

                                                                                                                                        

│Àìèíåóðèí [Àìèòðèïòèëèí]           │àíòèäåïðåññàíò [N06AA09]      │ôèëìòàáëåòêè 10, 25, 50 ìã    │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │005216,    

                                                                                                                             │09.08.94   

                                                                                                                                        

│Àìèíîâåíîç ïåä 6% {àìèíîêèñëîòû}   │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ âíóòðèâåííîãî     │Fresenius Ag (ÔÐÃ)            │01288,     

                                   │ïèòàíèÿ [B05BA01]             │ââåäåíèÿ (ôëàêîíû) 6% - 100 ìë│                              │23.05.86,  

                                                                                                                             │22.06.94   

                                                                                                                                        

│Àìèíîãëóòåòèìèä [Àìèíîãëóòåòèìèä]  │ñòåðîèäîâ ñèíòåçà èíãèáèòîð   │òàáëåòêè 250 ìã               │Instytut Farmaceutyczny       │003845,    

                                   │[L02BG01]                                                   │Warszawa (Ïîëüøà)             │12.04.94   

                                                                                                                                        

│Àìèíîïåä {àìèíîêèñëîòû}            │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé 5%, 10%   │Kabi Pharmacia (Øâåöèÿ)       │003000,    

                                   │ïèòàíèÿ [B05BA01]                                                                         │26.05.93   

                                                                                                                                        

│Àìèíîïëàçìàëü 10% Å                │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │B.Braun Melsungen Ag          │010217,    

                                   │ïèòàíèÿ [B05BA01]             │10% - 500, 1000 ìë            │(Ãåðìàíèÿ)                    │21.05.98   

                                                                                                                                        

│Àìèíîïëàçìàëü Ãåïà-10%             │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │B.Braun Melsungen Ag          │010112,    

                                   │ïèòàíèÿ [B05BA01]             │500, 1000 ìë                  │(Ãåðìàíèÿ)                    │11.03.98   

                                                                                                                                        

│Àìèíîïëàñìàëü-10% (ÑÅ)             │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │B.Braun Melsungen Ag          │008049,    

│{àìèíîêèñëîòû}                     │ïèòàíèÿ [B05BA01]             │500, 1000 ìë                  │(Ãåðìàíèÿ)                    │06.11.96   

                                                                                                                                        

│Àìèíîñîë {àìèíîêèñëîòû, âèòàìèíû,  │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Hemofarm D.D. (Þãîñëàâèÿ)     │009578,    

│ýíåðãåòè÷åñêàÿ öåííîñòü 600 êêàë,  │ïèòàíèÿ [B05BA10]             │600, 800 êêàë - 500 ìë                                      │07.07.97   

│800 êêàë}                                                                                                                               

                                                                                                                                        

│Àìèíîñîë ÊÅ {àìèíîêèñëîòû,         │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Hemofarm D.D. (Þãîñëàâèÿ)     │009577,    

│âèòàìèíû}                          │ïèòàíèÿ [B05BA10]             │500 ìë                                                      │07.07.97   

                                                                                                                                        

│Àìèíîñòåðèë II íîâóì               │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Orion Corporation (Ôèíëÿíäèÿ) │008203,    

│{L-àìèíîêèñëîòû 94.4% (íåçàìåíèìûå │ïèòàíèÿ [B05BA01]             │100, 500, 1000 ìë                                           │03.03.97   

│42%), ýíåðãåòè÷åñêàÿ öåííîñòü 370                                                                                                       

│êêàë/ë, îáùèé àçîò 14.2 ã/ë,                                                                                                            

│õëîðèäû 39.7 ììîëü/ë}                                                                                                                   

                                                                                                                                        

│Àìèíîñòåðèë III íîâóì              │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Orion Corporation (Ôèíëÿíäèÿ) │008204,    

│{àìèíîêèñëîòû, ýíåðãåòè÷åñêàÿ      │ïèòàíèÿ [B05BA01]             │500, 1000 ìë                                                │03.03.97   

│öåííîñòü 125 êêàë/ë}                                                                                                                    

                                                                                                                                        

│Àìèíîñòåðèë N-Ãåïà {àìèíîêèñëîòû}  │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Fresenius Ag (Ãåðìàíèÿ)       │008121,    

                                   │ïèòàíèÿ [B05BA01]             │5% - 100, 250, 500, 1000 ìë;                                │20.01.97   

                                                                 │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │                                         

                                                                 │8% - 100, 250, 500, 1000 ìë                                            

                                                                                                                                        

│Àìèíîñòåðèë ÊÅ 10% áåçóãëåâîäíûé   │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Fresenius Ag (Ãåðìàíèÿ)       │008119,    

│{àìèíîêèñëîòû}                     │ïèòàíèÿ [B05BA01]             │10% - 100, 250, 500, 1000 ìë                                │20.01.97   

                                                                                                                                        

│Àìèíîñòåðèë ÊÅ Íåôðî áåçóãëåâîäíûé │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Fresenius Ag (Ãåðìàíèÿ)       │008120,    

│{àìèíîêèñëîòû}                     │ïèòàíèÿ [B05BA01]             │100, 250, 500, 1000 ìë                                      │20.01.97   

                                                                                                                                        

│Àìèíîôèëëèí [Àìèíîôèëëèí]          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè ðåòàðä 350 ìã        │Lek (Ñëîâåíèÿ)                │002365,    

                                   │[R03DA05]                                                                                 │27.01.92   

                                                                                                                                        

│Àìèíîôèëëèí [Àìèíîôèëëèí]          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lek (Ñëîâåíèÿ)                │002301,    

                                   │[R03DA05]                     │250 ìã - 10 ìë                                              │10.12.91   

                                                                                                                                        

│Àìèíîôèëëèí [Àìèíîôèëëèí]          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Krakowskie             │008403,    

                                   │[R03DA05]                     │2.4% - 10 ìë                  │Pharmaceutical Works (Ïîëüøà) │26.06.97   

                                                                                                                                        

│Àìèíîôèëëèí [Àìèíîôèëëèí]          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè ðåòàðä 350 ìã        │Polfa, Krakowskie             │005403,    

                                   │[R03DA05]                                                   │Pharmaceutical Works (Ïîëüøà) │17.10.94   

                                                                                                                                         

│Àìèíîôèëëèí [Àìèíîôèëëèí]          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │ñâå÷è 360 ìã                  │Remedica Ltd - Minnex (Êèïð)  │006812,    

                                   │[R03DA05]                                                                                 │09.11.95   

                                                                                                                                        

│Àìèîäàðîí [Àìèîäàðîí]              │àíòèàðèòìè÷åñêîå ñðåäñòâî     │òàáëåòêè 200 ìã               │Rivopharm Sa (Øâåéöàðèÿ)      │009564,    

                                   │[C01BD01]                                                                                 │02.07.97   

                                                                                                                                        

│Àìèðîë [Àìèòðèïòèëèí]              │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè ïîêðûòûå ñàõàðíîé    │Remedica Ltd - Minnex (Êèïð)  │009758,    

                                                                 │îáîëî÷êîé 10, 25 ìã                                         │06.10.97   

                                                                                                                                        

│Àìèòîí [Àìèòðèïòèëèí]              │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 25 ìã                │Intas                         │005583,    

                                                                                               │International-Pharmaceuticals │19.12.94   

                                                                                               │(Èíäèÿ)                                  

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 25 ìã                │Indopharma (Èíäîíåçèÿ)        │003857,    

                                                                                                                             │18.04.94   

                                                                                                                                         

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │êàïñóëû ðåòàðä 25, 50 ìã      │Laboratoires Ethypharma       │007022,    

                                                                                               │(Ôðàíöèÿ)                     │28.01.96   

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lechiva (×åõèÿ)               │2701,      

                                                                 │2 ìë                                                        │10.09.82,  

                                                                                                                             │16.03.94   

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 25, 75 ìã            │Ct-Arzneimittel Chemishe      │007438,    

                                                                                               │Tempelchof Gmbh (Ãåðìàíèÿ)    │15.04.96   

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │äðàæå 25 ìã                   │Polfa, Rzeszowskie            │008061,    

                                                                                               │Pharmaceutical Works Sa       │19.11.96   

                                                                                               │(Ïîëüøà)                                 

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │äðàæå 25 ìã                   │Slovakofarma Sa (Ñëîâàêèÿ)    │2242,      

                                                                                                                             │01.06.72,  

                                                                                                                             │07.09.83,  

                                                                                                                             │10.03.94   

                                                                                                                                        

│Àìèòðèïòèëèí [Àìèòðèïòèëèí]        │àíòèäåïðåññàíò [N06AA09]      │äðàæå 25 ìã                   │Weimer Pharma Gmbh (ÔÐÃ)      │002823,    

                                                                                                                             │01.02.93   

                                                                                                                                        

│Àìèòðèïòèëèí Íèêîìåä [Àìèòðèïòèëèí]│àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 10, 25, 50 ìã        │Nycomed Dak As (Äàíèÿ)        │005348,    

                                                                                                                             │21.09.94   

                                                                                                                                        

│Àìèöèí [Àìèêàöèí]                  │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé          │Biochem Pharmaceutical        │007906,    

                                   │[J01GB06]                     │(ôëàêîíû) 100, 250, 500 ìã -  │Industries (Èíäèÿ)            │22.10.96   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Àìëîâàñ [Àìëîäèïèí]                │ÁÌÊÊ [C08CA01]                │òàáëåòêè 5, 10 ìã             │Unique Pharmaceutical         │007103,    

                                                                                               │Laboratories (Èíäèÿ)          │26.02.96   

                                                                                                                                         

│Àììèàêà ðàñòâîð 10% â àìïóëàõ      │àíàëåïòè÷åñêîå ñðåäñòâî       │ðàñòâîð (àìïóëû) 10% - 1 ìë   │Áîðèñîâñêèé çàâîä             │73/461/33, 

│[Àììèàê]                           │[R07AB]                                                     │ìåäïðåïàðàòîâ (Áåëàðóñü)      │16.07.97   

                                                                                                                                        

│Àìîêëàâèí {àìîêñèöèëëèí 500 ìã,    │àíòèáèîòèê,                   │ôèëìòàáëåòêè 625 ìã; ïîðîøîê  │Deva Holding As (Òóðöèÿ)      │006560,    

│êëàâóëàíîâàÿ êèñëîòà 125 ìã;       │ïåíèöèëëèí+áåòà-ëàêòàìàç      │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │27.09.95   

│àìîêñèöèëëèí 250 ìã, êëàâóëàíîâàÿ  │èíãèáèòîð [J01CR02]           │ñóñïåíçèè ôîðòå (ôëàêîíû)                                              

│êèñëîòà 60.5 ìã; àìîêñèöèëëèí 125                                │312.5 ìã|5 ìë; ïîðîøîê äëÿ                                             

│ìã, êëàâóëàíîâàÿ êèñëîòà 30.25 ìã} │                              │ïðèãîòîâëåíèÿ îðàëüíîé                                                 

                                                                 │ñóñïåíçèè äëÿ äåòåé (ôëàêîíû) │                                         

                                                                 │156 ìã|5 ìë                                                            

                                                                                                                                        

│Àìîêñèêàð [Àìîêñèöèëëèí]           │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ãðàíóëû  │Pharmacar Ltd (Èçðàèëü)       │006685,    

                                   │[J01CA04]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │29.09.95   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                           

                                                                 │ìë, 250 ìã|5 ìë                                                        

                                                                                                                                         

│Àìîêñèêëàâ {àìîêñèöèëëèí,          │àíòèáèîòèê,                   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │008706,    

│êëàâóëàíîâàÿ êèñëîòà}              │ïåíèöèëëèí+áåòà-ëàêòàìàç      │625 ìã; ïîðîøîê äëÿ                                         │01.09.98   

                                   │èíãèáèòîð [J01CR02]           │ïðèãîòîâëåíèÿ ñóñïåíçèè ôîðòå │                                         

                                                                 │(ôëàêîíû) 312 ìã|5 ìë - 100                                            

                                                                 │ìë /â êîìïëåêòå ñ                                                      

                                                                 │äîçèðîâî÷íîé ëîæêîé/; ïîðîøîê │                                         

                                                                 │äëÿ ïðèãîòîâëåíèÿ êàïåëü                                               

                                                                 │(ôëàêîíû) 62.5 ìã|1 ìë - 20                                            

                                                                 │ìë /â êîìïëåêòå ñ                                                      

                                                                 │äîçèðîâî÷íîé ïèïåòêîé/                                                 

                                                                                                                                        

│Àìîêñèêëàâ {àìîêñèöèëëèí,          │àíòèáèîòèê,                   │ëèîôèëèç.ïîðîøîê (ôëàêîíû)    │Lek (Ñëîâåíèÿ)                │003495,    

│êëàâóëàíîâàÿ êèñëîòà}              │ïåíèöèëëèí+áåòà-ëàêòàìàç      │600, 1200 ìã; ñóñïåíçèÿ 156                                 │09.11.93   

                                   │èíãèáèòîð [J01CR02]           │ìã|5 ìë; òàáëåòêè 375 ìã                                               

                                                                                                                                        

│Àìîêñèëëàò [Àìîêñèöèëëèí]          │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Azupharma Gmbh (Ãåðìàíèÿ)     │005437,    

                                   │[J01CA04]                     │750, 1000 ìã                                                │28.10.94   

                                                                                                                                        

│Àìîêñèëëàò-250 [Àìîêñèöèëëèí]      │àíòèáèîòèê, ïåíèöèëëèí        │ãðàíóëÿò                      │Azupharma Gmbh (Ãåðìàíèÿ)     │003605,    

                                   │[J01CA04]                                                                                 │20.12.93   

                                                                                                                                        

│Àìîêñèöèëëèí [Àìîêñèöèëëèí]        │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ïîðîøîê  │Hemofarm D.D. (Þãîñëàâèÿ)     │005523,    

                                   │[J01CA04]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │25.11.94   

                                                                 │ñóñïåíçèè (ôëàêîíû) 250 ìã|5                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Àìîêñèöèëëèí [Àìîêñèöèëëèí]        │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 500 ìã; ãðàíóëû äëÿ  │Sanavita Gesundcheitsmittel & │006781,    

                                   │[J01CA04]                     │ïðèãîòîâëåíèÿ îðàëüíîé        │Co Kg (Ãåðìàíèÿ)              │01.11.95   

                                                                 │ñóñïåíçèè (ôëàêîíû) 250 ìã|5                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Àìîêñèöèëëèí 1000 Ñòàäà            │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Stada Arzneimittel Ag         │009490,    

│ìåæäóíàðîäíûé [Àìîêñèöèëëèí]       │[J01CA04]                     │1000 ìã                       │(Ãåðìàíèÿ)                    │29.05.97   

                                                                                                                                        

│Àìîêñèöèëëèí 250 Ñòàäà             │àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Stada Arzneimittel Ag         │009491,    

│ìåæäóíàðîäíûé [Àìîêñèöèëëèí]       │[J01CA04]                     │îðàëüíîé ñóñïåíçèè (ôëàêîíû)  │(Ãåðìàíèÿ)                    │29.05.97   

                                                                 │41.6 ã                                                                 

                                                                                                                                        

│Àìîêñèöèëëèí-Ðàòèîôàðì             │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 500, 750 ìã          │Ratiopharm Gmbh & Co          │005603,    

│[Àìîêñèöèëëèí]                     │[J01CA04]                                                   │(Ãåðìàíèÿ)                    │26.12.94   

                                                                                                                                        

│Àìîêñèöèëëèí-Ðàòèîôàðì 250 ÒÑ      │àíòèáèîòèê, ïåíèöèëëèí        │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Ratiopharm Gmbh & Co          │005816,    

│[Àìîêñèöèëëèí]                     │[J01CA04]                     │îðàëüíîé ñóñïåíçèè 250 ìã|5 ìë│(Ãåðìàíèÿ)                    │10.03.95   

                                                                                                                                        

│Àìîêñèöèëëèí-Òåâà [Àìîêñèöèëëèí]   │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; êàïñóëû ôîðòå │Teva Pharmaceutical           │003171,    

                                   │[J01CA04]                     │500 ìã; ñóñïåíçèÿ 125 ìã|5    │Industries Ltd (Èçðàèëü)      │02.08.93   

                                                                 │ìë; ñóñïåíçèÿ 250 ìã|5 ìë                                              

                                                                                                                                         

│Àìîêñîí [Àìîêñèöèëëèí]             │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; ïîðîøîê äëÿ   │Jeyson Pharmaceuticals Ltd    │009914,    

                                   │[J01CA04]                     │ïðèãîòîâëåíèÿ ñèðîïà          │(Áàíãëàäåø)                   │23.12.97   

                                                                 │(ôëàêîíû) 125 ìã|5 ìë - 100 ìë│                                         

                                                                                                                                        

│Àìîë {ìåíòîë 10 ìã, àñêîðáèíîâàÿ   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè                      │Roland Arzneimittel Gmbh      │009272,    

│êèñëîòà 30 ìã, öèòðîíåëëû ìàñëî    │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │25.02.97   

│1.342 ìã, ãâîçäè÷íîå ìàñëî 1.342   │[A01AB11]                                                                                            

│ìã, êîðèöû ìàñëî 3.222 ìã, ìÿòû                                                                                                         

│ïåðå÷íîé ìàñëî 3.222 ìã,                                                                                                                

│ëàâàíäîâîå ìàñëî 3.222 ìã,                                                                                                              

│ëèìîííîå ìàñëî 7.65 ìã}                                                                                                                 

                                                                                                                                        

│Àìîë {ìÿòû ïåðå÷íîé ìàñëî 2.4 ã,   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð ýôèðíûõ ìàñåë         │Roland (Ãåðìàíèÿ)             │003912,    

│ìÿòû ëèìîííîé ìàñëî 1 ã,           │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ñïèðòîâîé 70% (ôëàêîíû)                                     │16.05.94   

│ãâîçäè÷íîå ìàñëî 1 ã, êàìôîðíîå    │[A01AB11]                                                                                            

│ìàñëî 2.4 ã, ëàâàíäîâîå ìàñëî 2.4                                                                                                        

│ã, ëèìîííîå ìàñëî 5.7 ã, îðåõà                                                                                                          

│ìóñêàòíîãî ìàñëî 2.9 ã, ìåíòîë                                                                                                          

│17.23 ã, ýòàíîë}                                                                                                                        

                                                                                                                                        

│Àìîòèä [Àìîêñèöèëëèí]              │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã           │Dolphin Laboratories Ltd      │007053,    

                                   │[J01CA04]                                                   │(Èíäèÿ)                       │06.02.96   

                                                                                                                                        

│Àìïèê [Àìïèöèëëèí]                 │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã;          │Kopran Ltd (Èíäèÿ)            │005624,    

                                   │[J01CA01]                     │ñóñïåíçèÿ îðàëüíàÿ 125 ìã|5 ìë│                              │10.01.95   

                                                                                                                                        

│Àìïèðåêñ [Àìïèöèëëèí]              │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; ïîðîøîê äëÿ   │Jeyson Pharmaceuticals Ltd    │009915,    

                                   │[J01CA01]                     │ïðèãîòîâëåíèÿ ñèðîïà          │(Áàíãëàäåø)                   │23.12.97   

                                                                 │(ôëàêîíû) 125 ìã|5 ìë - 100 ìë│                                         

                                                                                                                                        

│Àìïèñèä [Ñóëüòàìèöèëëèí]           │àíòèáèîòèê,                   │òàáëåòêè 375 ìã;              │Mustafa Nevzat Ilac Sanayi As │005856,    

                                   │ïåíèöèëëèí+áåòà-ëàêòàìàç      │ëèîôèëèç.ïîðîøîê äëÿ          │(Òóðöèÿ)                      │23.03.95   

                                   │èíãèáèòîð [J01CR04]           │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                            

                                                                 │ðàñòâîðà (ôëàêîíû) 250, 500,                                           

                                                                 │1000 ìã /â êîìïëåêòå ñ                                                 

                                                                 │ðàñòâîðèòåëåì/                                                         

                                                                                                                                        

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │ãðàíóëÿò äëÿ ïðèãîòîâëåíèÿ    │Berlin-Chemie Ag (ÔÐÃ)        │002242,    

                                   │[J01CA01]                     │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                │18.09.91   

                                                                 │125 ìã|5 ìë, 250 ìã|5 ìë                                               

                                                                                                                                       

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ïîðîøîê  │Belupo (Õîðâàòèÿ)             │007557,    

                                   │[J01CA01]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │03.06.96   

                                                                 │ñóñïåíçèè (ôëàêîíû) 250 ìã/5                                           

                                                                 │ìë - 70 ã                                                              

                                                                                                                                        

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ñèðîï    │Hemofarm D.D. (Þãîñëàâèÿ)     │003793,    

                                   │[J01CA01]                     │250 ìã|5 ìë                                                 │29.03.94   

                                                                                                                                        

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (Áîëãàðèÿ)         │2311,      

                                   │[J01CA01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │10.07.73,  

                                                                 │(ôëàêîíû) 250, 500 ìã                                       │10.11.85   

                                                                                                                                        

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; ãðàíóëû äëÿ   │Sanavita Gesundcheitsmittel & │006784,    

                                   │[J01CA01]                     │ïðèãîòîâëåíèÿ îðàëüíîé        │Co Kg (Ãåðìàíèÿ)              │02.11.95   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                           

                                                                 │ìë                                                                    

                                                                                                                                        

│Àìïèöèëëèí [Àìïèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; òàáëåòêè │Sol Pharmaceuticals Ltd       │005325,    

                                   │[J01CA01]                     │125, 250 ìã                   │(Èíäèÿ)                       │15.09.94   

                                                                                                                                        

│Àìïèöèëëèí Èííîòåê [Àìïèöèëëèí]    │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 500 ìã                │Innotech International        │005236,    

                                   │[J01CA01]                                                   │(Ôðàíöèÿ)                     │19.08.94   

                                                                                                                                        

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü         │àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │73/272/1,  

│[Àìïèöèëëèí]                       │[J01CA01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │12.11.97   

                                                                 │(ôëàêîíû) 0.25, 0.5 ã                                                  

                                                                                                                                        

│Àìïèöèëëèíà íàòðèåâàÿ ñîëü         │àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Áîðèñîâñêèé çàâîä             │73/272/1,  

│[Àìïèöèëëèí]                       │[J01CA01]                     │èíúåêöèîííîãî ðàñòâîðà        │ìåäïðåïàðàòîâ (Áåëàðóñü)      │07.10.98   

                                                                 │(ôëàêîíû) 250, 500 ìã;                                                  

                                                                 │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                              

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                                

                                                                 │(ôëàêîíû) 250, 500 ìã /â                                               

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │âîäà äëÿ èíúåêöèé (àìïóëû) 2                                           

                                                                 │ìë/                                                                    

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàò â êàïñóëàõ   │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã                │Áîðèñîâñêèé çàâîä             │73/159/3,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                   │ìåäïðåïàðàòîâ (Áåëàðóñü)      │07.10.98   

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàò â êàïñóëàõ   │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã                │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │73/159/3,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                                                 │15.09.98   

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàò òàáëåòêè     │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 0.25 ã               │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │69/612/7,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                                                 │12.11.97   

                                                                                                                                         

│Àìïèöèëëèíà òðèãèäðàòà òàáëåòêè    │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 250 ìã               │Ôàðìàêî ÀÎ (Ìîëäîâà)          │69/612/7,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                                                │17.09.98   

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàòà òàáëåòêè    │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 250 ìã               │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │69/612/7,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                   │ôèðìà ÎÀÎ (Óêðàèíà)           │07.07.98   

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàòà òàáëåòêè    │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 250 ìã               │Áîðèñîâñêèé çàâîä             │69/612/7,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                   │ìåäïðåïàðàòîâ (Áåëàðóñü)      │07.10.98   

                                                                                                                                        

│Àìïèöèëëèíà òðèãèäðàòà òàáëåòêè    │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 250 ìã               │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │69/612/7,  

│0.25 ã [Àìïèöèëëèí]                │[J01CA01]                                                                                 │15.09.98   

                                                                                                                                        

│Àìïèöèëëèí-Òåâà [Àìïèöèëëèí]       │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; êàïñóëû ôîðòå │Teva Pharmaceutical           │003172,    

                                   │[J01CA01]                     │500 ìã; ñóñïåíçèÿ 125 ìã|5    │Industries Ltd (Èçðàèëü)      │02.08.93   

                                                                 │ìë; ñóñïåíçèÿ ôîðòå 250 ìã|5                                           

                                                                 │ìë; ïîðîøîê äëÿ ïðèãîòîâëåíèÿ │                                          

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                                 

                                                                 │(ôëàêîíû) 250, 500, 1000 ìã                                           

                                                                                                                                        

│Àìïëèòàë [Àìïèöèëëèí]              │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 500 ìã                │Farmitalia Carlo Erba (Èòàëèÿ)│003498,    

                                   │[J01CA01]                                                                                 │10.11.93   

                                                                                                                                        

│Àìôîöèë [Àìôîòåðèöèí Â]            │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ëèîôèëèç.ïîðîøîê äëÿ          │Zeneca Limited                │006267,    

                                   │[A01AB04]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Âåëèêîáðèòàíèÿ)              │11.07.95   

                                                                 │ðàñòâîðà 50, 100 ìã                                                    

                                                                                                                                        

│Àíàâåíîë {äèãèäðîýðãîêðèñòèí 0.5   │âåíîòîíèçèðóþùåå ñðåäñòâî     │êàïëè                         │Galena (×åõèÿ)                │006657,    

│ìã, ýñêóëèí 1.5 ìã, ðóòîçèä 30 ìã} │[C05CX]                                                                                   │29.02.96   

                                                                                                                                        

│Àíàâåíîë {äèãèäðîýðãîêðèñòèí 0.5   │âåíîòîíèçèðóþùåå ñðåäñòâî     │äðàæå                         │Lechiva (×åõèÿ)               │007195,    

│ìã, ýñêóëèí 1.5 ìã, ðóòîçèä 30 ìã} │[C05CX]                                                                                   │23.05.96   

                                                                                                                                         

│Àíàêîëä {ôåíèëýôðèí 5 ìã,          │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè                      │Darou Paksh Pharmaceutical    │006728,    

│ïàðàöåòàìîë 325 ìã, õëîðôåíàìèí 2  │ÎÐÇ è ïðîñòóäû [N02BE51]                                    │Company (Èðàí)                │19.10.95   

│ìã}                                                                                                                                     

                                                                                                                                        

│Àíàëãîñ {êàïñàèöèí 50 ìã,          │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû) 2% - 50 ã         │Leipziger Arzneimittelwerk    │008064,    

│ïðîïèëíèêîòèíàò 2 ã,               │[M02AB]                                                     │Gmbh (Ãåðìàíèÿ)               │20.11.96   

│ìåòèëñàëèöèëàò 0.2 ã, ìåòèëïàðàáåí │                                                                                                     

│140 ìã, íàòðèÿ ïðîïèëîêñèáåíçîàò                                                                                                        

│60 ìã}                                                                                                                                  

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Alkaloid (Ìàêåäîíèÿ)          │003521,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │1 ã/2 ìë, 2.5 ã/5 ìë                                        │25.11.93   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Hemofarm D.D. (Þãîñëàâèÿ)     │003798,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │29.03.94   

                                   │[N02BB02]                                                                                            

                                                                                                                                       

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Natur Produkt (Ôðàíöèÿ)       │007127,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │05.03.96   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Pharmachim (Áîëãàðèÿ)         │2168,      

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │03.06.70,  

                                   │[N02BB02]                                                                                 │28.04.84   

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Pharmachim Holding Ead,       │008589,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Medica Ead (Áîëãàðèÿ)         │21.07.98   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ñàíèòàñ ÀÎ (Ëèòâà)            │010032,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │25%, 50% - 1 ìë; ðàñòâîð äëÿ                                │14.05.98   

                                   │[N02BB02]                     │èíúåêöèé (àìïóëû) 25%, 50% -                                           

                                                                 │2 ìë                                                                  

                                                                                                                                        

│Àíàëüãèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009251,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │25%, 50% - 1 ìë               │çàâîä ÀÎ (Ýñòîíèÿ)            │29.12.97   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèí èíúåêò ÁÕ [Ìåòàìèçîë      │àíàëüãåòè÷åñêîå               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006863,    

│íàòðèÿ]                            │íåíàðêîòè÷åñêîå ñðåäñòâî      │1 ã - 2 ìë                                                  │28.11.95   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèíà òàáëåòêè 0.5 ã           │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009252,    

│[Ìåòàìèçîë íàòðèÿ]                 │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │çàâîä ÀÎ (Ýñòîíèÿ)            │29.12.97   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèíà òàáëåòêè 0.5 ã           │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Ôàðìàêî ÀÎ (Ìîëäîâà)          │70/151/50, 

│[Ìåòàìèçîë íàòðèÿ]                 │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │12.10.98   

                                   │[N02BB02]                                                                                           

                                                                                                                                        

│Àíàëüãèíà òàáëåòêè 0.5 ã           │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Ãàëè÷ôàðì ÀÎ (Óêðàèíà)        │70/151/50, 

│[Ìåòàìèçîë íàòðèÿ]                 │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │12.05.98   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèíà òàáëåòêè 0.5 ã           │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Áîðèñîâñêèé çàâîä             │70/151/50, 

│[Ìåòàìèçîë íàòðèÿ]                 │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │ìåäïðåïàðàòîâ (Áåëàðóñü)      │20.10.97   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèíà òàáëåòêè 0.5 ã           │àíàëüãåòè÷åñêîå               │òàáëåòêè 0.5 ã                │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/151/50, 

│[Ìåòàìèçîë íàòðèÿ]                 │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │18.11.97   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Àíàëüãèí-õèíèí {ìåòàìèçîë 0.2 ã,   │àíàëüãåòè÷åñêîå               │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Pharmachim (ÍÐÁ)              │2399,      

│õèíèí 50 ìã}                       │íåíàðêîòè÷åñêîå ñðåäñòâî      │îáîëî÷êîé                                                   │17.03.75,  

                                   │[N02B]                                                                                   │06.12.89   

                                                                                                                                        

│Àíàíäðîí [Íèëóòàìèä]               │àíòèàíäðîãåí [L02BB02]        │òàáëåòêè 50 ìã                │Roussel Uclaf (Ôðàíöèÿ)       │002372,    

                                                                                                                             │27.01.92   

                                                                                                                                        

│Àíàïðèëèíà ðàñòâîð 1% (ãëàçíûå     │áåòà-àäðåíîáëîêàòîð [C07AA05] │êàïëè ãëàçíûå (ôëàêîíû) 1% -  │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │009184,    

│êàïëè) [Ïðîïðàíîëîë]                                             │5 ìë                                                        │29.10.97   

                                                                                                                                        

│Àíàïðèëèíà òàáëåòêè [Ïðîïðàíîëîë]  │áåòà-àäðåíîáëîêàòîð [C07AA05] │òàáëåòêè 10, 40 ìã            │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009160,    

                                                                                               │(Ëàòâèÿ)                      │11.06.97   

                                                                                                                                        

│Àíàïðèëèíà òàáëåòêè 0.01 ã         │áåòà-àäðåíîáëîêàòîð [C07AA05] │òàáëåòêè 10 ìã                │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │71/211/2,  

│[Ïðîïðàíîëîë]                                                                                  │ôèðìà ÎÀÎ (Óêðàèíà)           │07.10.98   

                                                                                                                                        

│Àíàïðèëèíà òàáëåòêè 0.04 ã         │áåòà-àäðåíîáëîêàòîð [C07AA05] │òàáëåòêè 40 ìã                │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │71/211/2,  

│[Ïðîïðàíîëîë]                                                                                  │ôèðìà ÎÀÎ (Óêðàèíà)           │07.10.98   

                                                                                                                                       

│Àíàóðàí {ïîëèìèêñèí B 1000000 ÌÅ,  │àíòèáèîòèê êîìáèíèðîâàííûé    │êàïëè óøíûå 25 ìë             │Zambon Group Spa (Èòàëèÿ)     │005512,    

│íåîìèöèí 0.5 ã, ëèäîêàèí 4 ã}      │[S02AA30]                                                                                 │18.11.94   

                                                                                                                                        

│Àíàôðàíèë [Êëîìèïðàìèí]            │àíòèäåïðåññàíò [N06AA04]      │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Ciba-Geigy (Øâåéöàðèÿ)        │007482,    

                                                                 │10, 25 ìã; òàáëåòêè ïîêðûòûå                                │05.05.96   

                                                                 │îáîëî÷êîé ïðîëîíãèðîâàííîãî                                            

                                                                 │äåéñòâèÿ 75 ìã; ðàñòâîð äëÿ                                            

                                                                 │èíúåêöèé (àìïóëû) 25 ìã - 2 ìë│                                         

                                                                                                                                        

│Àíàöèä {àëãåëäðàò 50 ìã, ìàãíèÿ    │àíòàöèäíîå ñðåäñòâî [A02AX]   │ñóñïåíçèÿ äëÿ ïðèåìà âíóòðü   │Galena a/S (×åøñêàÿ           │008365,    

│ãèäðîêñèä 50 ìã - 1 ìë}                                          │(ïàêåòèêè) 5 ìë               │Ðåñïóáëèêà)                   │03.12.97   

                                                                                                                                        

│Àíãè Ñåïò äîêòîðà Òàéññà {ìåíòîë   │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè; òàáëåòêè ñ ëèìîíîì  │Naturwaren Ohg, Dr.P.Theiss   │010429,    

│5.4 ìã, ìÿòû ïåðå÷íîé ìàñëî 0.6    │[A01AB11]                                                   │(Ãåðìàíèÿ)                    │20.08.98   

│ìã, àíåòîë 2.4 ìã,                                                                                                                      

│äèõëîðáåíçèëîâûé ñïèðò 1.2 ìã}                                                                                                         

                                                                                                                                        

│Àíãèçåì [Äèëòèàçåì]                │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Sun Pharmaceutical Industries │002758,    

                                                                                               │Ltd (Èíäèÿ)                   │16.12.92   

                                                                                                                                        

│Àíãèíèí [Ïèðèêàðáàò]               │àíãèîïðîòåêòîðíîå ñðåäñòâî    │òàáëåòêè                      │Banyu Pharmaceutical Co Ltd   │00213,     

                                   │[C10AX]                                                     │(ßïîíèÿ)                      │06.10.72,  

                                                                                                                             │17.03.83   

                                                                                                                                        

│Àíãèîïðèë-25 [Êàïòîïðèë]           │ÀÊÔ áëîêàòîð [C09AA01]        │òàáëåòêè 25 ìã                │Torrent Pharmaceuticals Ltd   │007265,    

                                                                                               │(Èíäèÿ)                       │26.07.96   

                                                                                                                                        

│Àíãèðîë [Öèíàðèí]                  │æåë÷åãîííîå ñðåäñòâî [A05AX]  │äðàæå                         │Biofarm-Romferchim (Ðóìûíèÿ)  │2580,      

                                                                                                                             │25.10.78,  

                                                                                                                             │12.09.94   

                                                                                                                                        

│Àíäðèîë [Òåñòîñòåðîí]              │àíäðîãåí [G03BA03]            │êàïñóëû 40 ìã                 │N.V.Organon (Íèäåðëàíäû)      │005201,    

                                                                                                                             │02.08.94   

                                                                                                                                        

│Àíäðîêóð [Öèïðîòåðîí]              │àíòèàíäðîãåí [G03HA01]        │òàáëåòêè 50 ìã                │Schering Ag (ÔÐÃ)             │00733,     

                                                                                                                             │21.01.80,  

                                                                                                                             │25.01.93   

                                                                                                                                        

│Àíäðîêóð [Öèïðîòåðîí]              │àíòèàíäðîãåí [G03HA01]        │òàáëåòêè 10 ìã                │Schering Ag (ÔÐÃ)             │002910,    

                                                                                                                             │17.03.93   

                                                                                                                                        

│Àíäðîêóð-äåïî [Öèïðîòåðîí]         │àíòèàíäðîãåí [G03HA01]        │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │Schering Ag (Ãåðìàíèÿ)        │005514,    

                                                                 │(àìïóëû) 100 ìã/ìë                                          │21.11.94   

                                                                                                                                        

│Àíåêàèí [Áóïèâàêàèí]               │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ðàñòâîð äëÿ èíúåêöèé          │Pliva Sa (Õîðâàòèÿ)           │007803,    

                                   │[N01BB01]                     │(ôëàêîíû) 0.5% - 20 ìë                                      │09.09.96   

                                                                                                                                        

│Àíåêñàò [Ôëóìàçåíèë]               │áåíçîäèàçåïèíîâ àíòàãîíèñò    │ðàñòâîð äëÿ èíúåêöèé 0.5 ìã/5 │F.Hoffmann La Roche Ltd       │009812,    

                                   │[V03AB25]                     │ìë, 1 ìã/10 ìë                │(Øâåéöàðèÿ)                   │29.10.97   

                                                                                                                                        

│Àíèôåä [Íèôåäèïèí]                 │ÁÌÊÊ [C08CA05]                │êàïñóëû æåëàòèíîâûå 10 ìã;    │Laboratorio Giorgio Zoja      │003819,    

                                                                 │òàáëåòêè ðåòàðä 20 ìã         │Chimico-Farmaceutica (Èòàëèÿ) │04.04.94   

                                                                                                                                        

│Àíêâèí [Íîðôëîêñàöèí]              │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 400, 800 ìã          │Lyka Labs Ltd (Èíäèÿ)         │003107,    

                                   │ôòîðõèíîëîí [J01MA06]                                                                     │29.06.93   

                                                                                                                                        

│Àíêðóñàë [Ñóêðàëüôàò]              │ïðîòèâîÿçâåííîå ñðåäñòâî      │òàáëåòêè 500 ìã               │Polfa, Kutnowskie             │006203,    

                                   │[A02BX02]                                                   │Pharmaceutical Works Sa       │21.06.95   

                                                                                               │(Ïîëüøà)                                 

                                                                                                                                        

│Àíîïèðèí [Àöåòèëñàëèöèëîâàÿ        │ÍÏÂÑ [N02BA01]                │òàáëåòêè 400 ìã               │Slovakofarma Sa (Ñëîâàêèÿ)    │003600,    

│êèñëîòà]                                                                                                                     │17.12.93   

                                                                                                                                        

│Àíòàêñîí [Íàëòðåêñîí]              │îïèîèäíûõ ðåöåïòîðîâ          │êàïñóëû 50 ìã                 │Zambon Group Spa (Èòàëèÿ)     │010204,    

                                   │àãîíèñò-àíòàãîíèñò [V03AB30]                                                              │08.05.98   

                                                                                                                                        

│Àíòàðåñ 120 {êàâà-êàâà ýêñòðàêò}   │ñåäàòèâíîå ñðåäñòâî           │òàáëåòêè 120 ìã               │Krewel Meuselbach Gmbh        │010101,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │04.03.98   

                                   │[N05CX]                                                                                              

                                                                                                                                        

│Àíòåëåïñèí 0.25 [Êëîíàçåïàì]       │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè 0.25 ìã              │Arzneimittelwerk Dresden Gmbh │008189,    

                                   │[N03AE01]                                                   │(Ãåðìàíèÿ)                    │23.04.97   

                                                                                                                                        

│Àíòåëåïñèí 1 [Êëîíàçåïàì]          │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè 1 ìã                 │Arzneimittelwerk Dresden Gmbh │008188,    

                                   │[N03AE01]                                                   │(Ãåðìàíèÿ)                    │23.04.97   

                                                                                                                                        

│Àíòåîâèí {ýòèíèëýñòðàäèîë 0.05 ìã, │êîíòðàöåïòèâíîå ñðåäñòâî      │òàáëåòêè                      │Gedeon Richter (Âåíãðèÿ)      │008258,    

│ëåâîíîðãåñòðåë 0.05 ìã}            │[G03AA07]                                                                                 │10.04.97   

                                                                                                                                        

│Àíòè-Àíãèí {òåòðàêàèí 0.2 ìã,      │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè                      │Somaco (Ôðàíöèÿ)              │005820,    

│õëîðãåêñèäèí 2 ìã, àñêîðáèíîâàÿ    │[R02AA05]                                                                                 │15.03.95   

│êèñëîòà 50 ìã, ìåíòîë 3.8 ìã}                                                                                                           

                                                                                                                                        

│Àíòè-Àíãèí {òåòðàêàèí 0.2 ìã,      │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè                      │Naturwaren, Dr.P.Theiss       │005800,    

│õëîðãåêñèäèí 2 ìã, àñêîðáèíîâàÿ    │[R02AA05]                                                   │(Ãåðìàíèÿ)                    │02.03.95   

│êèñëîòà 50 ìã, ìåíòîë 3.8 ìã}                                                                                                           

                                                                                                                                        

│Àíòèáåò [Ãëèáåíêëàìèä]             │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 2.5, 5 ìã            │Rusan Pharma (Èíäèÿ)          │009260,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │19.02.97   

                                                                                                                                        

│Àíòèãåìîôèëüíûé ôàêòîð ÷åëîâåêà-Ì  │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │American Red Cross Baxter     │009857,    

│(AHF-M) [Ôàêòîð ñâåðòûâàíèÿ êðîâè  │[B02BD02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(ÑØÀ)                         │24.11.97   

│VIII]                                                            │ðàñòâîðà (ôëàêîíû - â                                                  

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                             

                                                                 │âîäà äëÿ èíúåêöèé,                                                     

                                                                 │äâóñòîðîííåé èãëîé è èãëîé ñ                                          

                                                                 │ôèëüòðîì) 200-300 ÌÅ/10 ìë,                                            

                                                                 │400-600 ÌÅ/10 ìë, 800-1200                                             

                                                                 │ÌÅ/10 ìë                                                               

                                                                                                                                        

│Àíòèãèïåðòîíèí {äèãèäðàëàçèí 10    │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè                      │Natur Produkt (Ôðàíöèÿ)       │009882,    

│ìã, ãèäðîõëîðîòèàçèä 10 ìã,        │ñðåäñòâî [C02LA51]                                                                        │03.12.97   

│ðåçåðïèí 0.1 ìã}                                                                                                                        

                                                                                                                                        

│Àíòèãðèïïèí {ïàðàöåòàìîë 0.5 ã,    │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè øèïó÷èå              │Natur Produkt (Ôðàíöèÿ)       │007124,    

│àñêîðáèíîâàÿ êèñëîòà 200 ìã,       │ÎÐÇ è ïðîñòóäû [R05X]                                                                     │04.03.96   

│õëîðôåíàìèí 10 ìã}                                                                                                                      

                                                                                                                                        

│Àíòèãðèïïîêàïñ {àöåòèëñàëèöèëîâàÿ  │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │êàïñóëû                       │Ìèíñêèíòåðêàïñ Ñï             │010025,    

│êèñëîòà 180 ìã, àñêîðáèíîâàÿ       │ÎÐÇ è ïðîñòóäû [N02BA51]                                    │Áåëàðóññêî-Àìåðèêàíñêîå       │17.04.98   

│êèñëîòà 50 ìã, êàëüöèÿ ëàêòàò 100                                                              │(Áåëàðóñü)                               

│ìã, ðóòèí 10 ìã, äèôåíãèäðàìèí 10                                                                                                      

│ìã}                                                                                                                                     

                                                                                                                                        

│Àíòèäèàá [Ãëèïèçèä]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Krka (Ñëîâåíèÿ)               │006156,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB07] │                                                            │06.06.95   

                                                                                                                                        

│Àíòèêîàãóëÿíò Öèòðàò äåêñòðîçà     │ãåìîêîíñåðâàíò,               │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │006904,    

│{ëèìîííàÿ êèñëîòà 750 ìã/440 ìã,   │âñïîìîãàòåëüíîå âåùåñòâî      │ïëàñòèêîâûå) 500, 1000 ìë                                   │19.12.95   

│äåêñòðîçà 2.45 ã/1.47 ã, íàòðèÿ    │[V07AC]                                                                                              

│öèòðàò 2.2 ã/1.32 ã - 100 ìë}                                                                                                           

                                                                                                                                        

│Àíòèñåïòè÷åñêèå ïàñòèëêè [Äîìèôåíà │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè ñ ïðèâêóñîì ìåäà;    │Confab (Êàíàäà)               │003904,    

│áðîìèä]                            │[A01AB06]                     │ïàñòèëêè ñ ïðèâêóñîì                                        │11.05.94   

                                                                 │ýâêàëèïòà; ïàñòèëêè ñ                                                  

                                                                 │ïðèâêóñîì âèøíè; ïàñòèëêè ñ                                             

                                                                 │ïðèâêóñîì àïåëüñèíà; ïàñòèëêè │                                         

                                                                 │ñ ïðèâêóñîì ëèìîíà; ïàñòèëêè                                          

                                                                 │ñ ïðèâêóñîì ìÿòû                                                       

                                                                                                                                        

│Àíòèñòðóìèí-Äàðíèöà [Êàëèÿ éîäèä]  │ïðåïàðàò éîäà, ðåãóëÿòîð      │òàáëåòêè 1 ìã                 │Äàðíèöà Ôàðìàöåâòè÷åñêàÿ      │010076,    

                                   │ñèíòåçà òèðîêñèíà [R05CA02]                                 │Ôèðìà ÇÀÎ (Óêðàèíà)           │20.10.98   

                                                                                                                                        

│ÀíòèÔëó {ïàðàöåòàìîë 650 ìã,       │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │ïîðîøîê äîçèðîâàííûé äëÿ      │Sagmel Inc (ÑØÀ)              │009596,    

│ïñåâäîýôåäðèí 60 ìã, õëîðôåíèðàìèí │ÎÐÇ è ïðîñòóäû [R01BA52]      │ïðèãîòîâëåíèÿ ðàñòâîðà äëÿ                                  │15.07.97   

│4 ìã}                                                            │âíóòðåííåãî ïðèìåíåíèÿ                                                 

                                                                 │(ïàêåòèêè)                                                             

                                                                                                                                        

│Àíòèôóíãîë [Êëîòðèìàçîë]           │ïðîòèâîãðèáêîâîå ñðåäñòâî     │òàáëåòêè âàãèíàëüíûå 500 ìã;  │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │006071,    

                                   │[D01AC01] [G01AF02]           │êðåì 1%; êðåì âàãèíàëüíûé 2%                                │19.05.95   

                                                                                                                                        

│Àíòîäèí [Ôàìîòèäèí]                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 20, 40 ìã            │Amoun Pharmaceutical          │006919,    

                                   │áëîêàòîð [A02BA03]                                          │Industries Co, Apic (Åãèïåò)  │20.12.95   

                                                                                                                                       

│Àíòðèìà {ñóëüôàäèàçèí 400 ìã,      │ïðîòèâîìèêðîáíîå              │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Doms Adrian      │005990,    

│òðèìåòîïðèì 80 ìã - òàáëåòêà;      │êîìáèíèðîâàííîå ñðåäñòâî      │400 ìã/80 ìã; ñóñïåíçèÿ       │(Ôðàíöèÿ)                     │24.04.95   

│ñóëüôàäèàçèí 100 ìã, òðèìåòîïðèì   │[J01EE02]                     │îðàëüíàÿ äëÿ äåòåé (ôëàêîíû)                                           

│20 ìã - 2.5 ìë}                                                  │100 ìã/20 ìã|2.5 ìë                                                    

                                                                                                                                        

│Àíöåô [Öåôàçîëèí]                  │àíòèáèîòèê, öåôàëîñïîðèí      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Smithkline Beecham            │006561,    

                                   │[J01DA04]                     │èíúåêöèîííîãî ðàñòâîðà        │Pharmaceuticals (ÑØÀ)         │28.09.95   

                                                                 │(ôëàêîíû) 0.5, 1 ã                                                     

                                                                                                                                        

│Àïàóðèí [Äèàçåïàì]                 │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé 2 │Krka (Ñëîâåíèÿ)               │00097,     

                                   │[N05BA01]                     │ìã, 5 ìã                                                    │11.02.71,  

                                                                                                                             │13.02.84,  

                                                                                                                             │14.12.94   

                                                                                                                                         

│Àïàóðèí [Äèàçåïàì]                 │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Krka (Ñëîâåíèÿ)               │008317,    

                                   │[N05BA01]                     │10 ìã - 2 ìë                                               │29.07.97   

                                                                                                                                        

│Àïáóòîë [Ýòàìáóòîë]                │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî │òàáëåòêè 200, 400, 600, 800,  │Unique Pharmaceutical         │007558,    

                                   │[J04AK02]                     │1000 ìã                       │Laboratories (Èíäèÿ)          │03.06.96   

                                                                                                                                        

│Àïèçàðòðîí {ÿä ï÷åëèíûé 3 ã,       │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü (òóáû) [20, 30, 50, 100  │Esparma (Ãåðìàíèÿ)            │00121,     

│ìåòèëñàëèöèëàò 10 ã,               │ñðåäñòâî äëÿ ìåñòíîãî         │ã]                                                          │15.03.71,  

│àëèëèçîòèîöèàíàò 1 ã - 100 ã}      │ïðèìåíåíèÿ [M02AC]                                                                        │18.05.84,  

                                                                                                                             │11.05.95   

                                                                                                                                        

│Àïèê ìåëàòîíèí {ìåëàòîíèí 3 ìã,    │àäàïòîãåííîå ñðåäñòâî [A13A]  │òàáëåòêè                      │Apic Usa Inc (ÑØÀ)            │010140,    

│ïèðèäîêñèí 10 ìã}                                                                                                            │03.04.98   

                                                                                                                                        

│Àïèëàê [Àïèëàê]                    │áèîñòèìóëèðóþùåå ñðåäñòâî     │òàáëåòêè 10 ìã                │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009227,    

                                   │[A13A]                                                      │çàâîä ÀÎ (Ýñòîíèÿ)            │09.12.97   

                                                                                                                                        

│Àïèëàê ìàçü 3% [Àïèëàê]            │áèîñòèìóëèðóþùåå ñðåäñòâî     │ìàçü (òóáû) 3% - 50 ã         │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009223,    

                                   │[D11AX]                                                     │çàâîä ÀÎ (Ýñòîíèÿ)            │08.12.97   

                                                                                                                                        

│Àïèëåïñèí [Âàëüïðîåâàÿ êèñëîòà]    │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │äðàæå 150, 300 ìã; êàïëè      │Krka (Ñëîâåíèÿ)               │008044,    

                                   │[N03AG01]                     │(ôëàêîíû) 300 ìã/ìë - 60 ìë                                 │01.11.96   

                                                                                                                                        

│Àïî-Àëëîïóðèíîë [Àëëîïóðèíîë]      │êñàíòèíîêñèäàçû èíãèáèòîð     │òàáëåòêè 100, 200, 300 ìã     │Apotex Inc (Êàíàäà)           │009473,    

                                   │[M04AA01]                                                                                 │22.05.97   

                                                                                                                                        

│Àïî-Àìèòðèïòèëèí [Àìèòðèïòèëèí]    │àíòèäåïðåññàíò [N06AA09]      │òàáëåòêè 10, 25, 50 ìã        │Apotex Inc (Êàíàäà)           │003883,    

                                                                                                                             │27.04.94   

                                                                                                                                        

│Àïî-Àìîêñè [Àìîêñèöèëëèí]          │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ïîðîøîê  │Apotex Inc (Êàíàäà)           │003884,    

                                   │[J01CA04]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │27.04.94   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                            

                                                                 │ìë, 250 ìã|5 ìë                                                        

                                                                                                                                       

│Àïî-Àìïè [Àìïèöèëëèí]              │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã; ïîðîøîê  │Apotex Inc (Êàíàäà)           │003812,    

                                   │[J01CA01]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │31.03.94   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                           

                                                                 │ìë, 250 ìã|5 ìë                                                        

                                                                                                                                        

│Àïî-Àñà [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │Apotex Inc (Êàíàäà)           │002754,    

                                                                                                                             │15.12.92   

                                                                                                                                        

│Àïî-Àòåíîë [Àòåíîëîë]              │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Apotex Inc (Êàíàäà)           │002935,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │30.03.93   

                                                                                                                                        

│Àïî-Áèñàêîäèë [Áèñàêîäèë]          │ñëàáèòåëüíîå ñðåäñòâî         │ñâå÷è 10 ìã; òàáëåòêè ñ       │Apotex Inc (Êàíàäà)           │009652,    

                                   │[A06AB02]                     │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │05.08.97   

                                                                 │5 ìã                                                                    

                                                                                                                                        

│Àïî-Áðîìîêðèïòèí [Áðîìîêðèïòèí]    │äîôàìèí-ñòèìóëÿòîð [N04BC01]  │òàáëåòêè 2.5 ìã               │Apotex Inc (Êàíàäà)           │007423,    

                                                                                                                             │09.04.96   

                                                                                                                                        

│Àïî-Ãàëîïåðèäîë [Ãàëîïåðèäîë]      │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 0.5, 1, 2, 5 ìã      │Apotex Inc (Êàíàäà)           │003710,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │18.02.94   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Àïî-Ãëèáóðèä [Ãëèáåíêëàìèä]        │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 2.5, 5 ìã            │Apotex Inc (Êàíàäà)           │003684,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │09.02.94   

                                                                                                                                        

│Àïî-Äèàçåïàì [Äèàçåïàì]            │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2, 5, 10 ìã          │Apotex Inc (Êàíàäà)           │002917,    

                                   │[N05BA01]                                                                                 │29.03.93   

                                                                                                                                        

│Àïî-Äèêëî [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Apotex Inc (Êàíàäà)           │003815,    

                                                                 │îáîëî÷êîé 25, 50 ìã                                         │31.03.94   

                                                                                                                                        

│Àïî-Äèëòèàç [Äèëòèàçåì]            │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Apotex Inc (Êàíàäà)           │002711,    

                                                                                                                             │25.11.92   

                                                                                                                                        

│Àïî-Äèïèðèäàìîë [Äèïèðèäàìîë]      │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 25, 50, 75 ìã        │Apotex Inc (Êàíàäà)           │002712,    

                                   │[B01AC07]                                                                                 │25.11.92   

                                                                                                                                        

│Àïî-Äîêñè [Äîêñèöèêëèí]            │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Apotex Inc (Êàíàäà)           │005232,    

                                   │[J01AA02]                                                                                 │18.08.94   

                                                                                                                                        

│Àïî-Èáóïðîôåí ÔÑ [Èáóïðîôåí]       │ÍÏÂÑ [M02AA13]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Apotex Inc (Êàíàäà)           │008633,    

                                                                 │200, 300, 400 ìã                                            │01.06.98   

                                                                                                                                        

│Àïî-Èìèïðàìèí [Èìèïðàìèí]          │àíòèäåïðåññàíò [N06AA02]      │òàáëåòêè 10, 25, 50, 75 ìã    │Apotex Inc (Êàíàäà)           │005758,    

                                                                                                                             │17.02.95   

                                                                                                                                         

│Àïî-Èíäîìåòàöèí [Èíäîìåòàöèí]      │ÍÏÂÑ [M01AB01]                │òàáëåòêè 25, 50 ìã            │Apotex Inc (Êàíàäà)           │003042,    

                                                                                                                            │08.06.93   

                                                                                                                                        

│Àïî-Êàïòî [Êàïòîïðèë]              │ÀÊÔ áëîêàòîð [C09AA01]        │òàáëåòêè 12.5, 25, 50, 100 ìã │Apotex Inc (Êàíàäà)           │008389,    

                                                                                                                             │26.01.98   

                                                                                                                                        

│Àïî-Êàðáàìàçåïèí [Êàðáàìàçåïèí]    │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè 200 ìã               │Apotex Inc (Êàíàäà)           │005275,    

                                   │[N03AF01]                                                                                 │30.08.94   

                                                                                                                                        

│Àïî-Êëîíèäèí [Êëîíèäèí]            │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè 0.1, 0.2 ìã          │Apotex Inc (Êàíàäà)           │005394,    

                                   │öåíòðàëüíûé [S01EA04]                                                                     │13.10.94   

                                                                                                                                        

│Àïî-Êëîðàçåïàò [Êëîðàçåïàò äèêàëèÿ]│àíêñèîëèòè÷åñêîå ñðåäñòâî     │êàïñóëû 3.75, 7.5, 15 ìã      │Apotex Inc (Êàíàäà)           │009097,    

                                   │[N05BA05]                                                                                 │28.01.97   

                                                                                                                                        

│Àïî-Ëîðàçåïàì [Ëîðàçåïàì]          │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 0.5, 1, 2 ìã         │Apotex Inc (Êàíàäà)           │002918,    

                                   │[N05BA06]                                                                                 │29.03.93   

                                                                                                                                       

│Àïî-Ìåïðîáàìàò [Ìåïðîáàìàò]        │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 400 ìã               │Apotex Inc (Êàíàäà)           │006736,    

                                   │[N05BC01]                                                                                 │20.10.95   

                                                                                                                                        

│Àïî-Ìåòîêëîï [Ìåòîêëîïðàìèä]       │ïðîòèâîðâîòíîå ñðåäñòâî,      │òàáëåòêè 5, 10 ìã             │Apotex Inc (Êàíàäà)           │003543,    

                                   │äîôàìèí áëîêàòîð öåíòðàëüíûé                                                              │06.12.93   

                                   │[A03FA01]                                                                                            

                                                                                                                                        

│Àïî-Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]    │ïðîòèâîìèêðîáíîå ñðåäñòâî     │òàáëåòêè 200, 250, 400 ìã     │Apotex Inc (Êàíàäà)           │003881,    

                                   │[J01XD01]                                                                                 │27.04.94   

                                                                                                                                        

│Àïî-Íàïðîêñåí [Íàïðîêñåí]          │ÍÏÂÑ [M01AE02]                │òàáëåòêè 125, 250, 375, 500 ìã│Apotex Inc (Êàíàäà)           │008632,    

                                                                                                                             │01.06.98   

                                                                                                                                        

│Àïî-Íèòðîôóðàíòîèí [Íèòðîôóðàíòîèí]│ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 50, 100 ìã           │Apotex Inc (Êàíàäà)           │005757,    

                                   │íèòðîôóðàí [G04AC01]                                                                      │17.02.95   

                                                                                                                                       

│Àïî-Íèôåä [Íèôåäèïèí]              │ÁÌÊÊ [C08CA05]                │êàïñóëû 5 ìã, 10 ìã           │Apotex Inc (Êàíàäà)           │006454,    

                                                                                                                             │30.08.95   

                                                                                                                                        

│Àïî-Îêñàçåïàì [Îêñàçåïàì]          │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 10, 15, 30 ìã        │Apotex Inc (Êàíàäà)           │003685,    

                                   │[N05BA04]                                                                                 │09.02.94   

                                                                                                                                        

│Àïî-Îêñòðèôèëëèí [Õîëèíà           │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè 100, 200, 300 ìã     │Apotex Inc (Êàíàäà)           │005119,    

│òåîôèëëèíàò]                       │[R03DA02]                                                                                 │12.07.94   

                                                                                                                                        

│Àïî-Ïèðîêñèêàì [Ïèðîêñèêàì]        │ÍÏÂÑ [M02AA07]                │êàïñóëû òâåðäûå 10, 20 ìã     │Apotex Inc (Êàíàäà)           │005044,    

                                                                                                                             │24.06.94   

                                                                                                                                        

│Àïî-Ïðåäíèçîí [Ïðåäíèçîí]          │ãëþêîêîðòèêîñòåðîèä [H02AB07] │òàáëåòêè 5, 50 ìã             │Apotex Inc (Êàíàäà)           │005813,    

                                                                                                                             │09.03.95   

                                                                                                                                        

│Àïî-Ïðîïðàíîëîë [Ïðîïðàíîëîë]      │áåòà-àäðåíîáëîêàòîð [C07AA05] │òàáëåòêè 10, 20, 40, 80 ìã    │Apotex Inc (Êàíàäà)           │003703,    

                                                                                                                             │16.02.94   

                                                                                                                                        

│Àïî-Ðàíèòèäèí [Ðàíèòèäèí]          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150, 300 ìã          │Apotex Inc (Êàíàäà)           │003683,    

                                   │áëîêàòîð [A02BA02]                                                                        │09.02.94   

                                                                                                                                        

│Àïî-Ñóëüôàòðèì [Êî-òðèìîêñàçîë]    │ïðîòèâîìèêðîáíîå              │òàáëåòêè 400 ìã/80 ìã, 800    │Apotex Inc (Êàíàäà)           │003709,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │ìã/160 ìã                                                   │18.02.94   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Àïî-Ñóëüôàòðèì [Êî-òðèìîêñàçîë]    │ïðîòèâîìèêðîáíîå              │òàáëåòêè                      │Apotex Inc (Êàíàäà)           │009431,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │05.05.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Àïî-Ñóëüôèíïèðàçîí [Ñóëüôèíïèðàçîí]│ïðîòèâîïîäàãðè÷åñêîå ñðåäñòâî │òàáëåòêè 100, 200 ìã          │Apotex Inc (Êàíàäà)           │009429,    

                                   │[M04AB02]                                                                                 │05.05.97   

                                                                                                                                       

│Àïî-Òèîðèäàçèí [Òèîðèäàçèí]        │àíòèïñèõîòè÷åñêîå             │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Apotex Inc (Êàíàäà)           │007644,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │10, 25, 50, 100 ìã                                          │15.07.96   

                                   │[N05AC02]                                                                                            

                                                                                                                                        

│Àïî-Òðàéãåêñ [Òðèãåêñèôåíèäèë]     │í-õîëèíîáëîêàòîð öåíòðàëüíûé  │òàáëåòêè 2 ìã, 5 ìã           │Apotex Inc (Êàíàäà)           │006453,    

                                   │[N04AA01]                                                                                 │30.08.95   

                                                                                                                                        

│Àïî-Òðèàçèä {ãèäðîõëîðîòèàçèä 25   │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │òàáëåòêè 50 ìã/25 ìã          │Apotex Inc (Êàíàäà)           │003813,    

│ìã, òðèàìòåðåí 50 ìã}              │ñðåäñòâî [C03EA01]                                                                        │31.03.94   

                                                                                                                                        

│Àïî-Òðèôëóîïåðàçèí [Òðèôëóîïåðàçèí]│àíòèïñèõîòè÷åñêîå             │òàáëåòêè 1, 2, 5, 10, 20 ìã   │Apotex Inc (Êàíàäà)           │003941,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │25.05.94   

                                   │[N05AB06]                                                                                            

                                                                                                                                         

│Àïî-Ôàìîòèäèí [Ôàìîòèäèí]          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 20, 40 ìã            │Apotex Inc (Êàíàäà)           │003882,    

                                   │áëîêàòîð [A02BA03]                                                                       │27.04.94   

                                                                                                                                        

│Àïî-Ôåððîãëþêîíàò [Æåëåçà ãëþêîíàò]│ãåìîïîýçà ñòèìóëÿòîð,         │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Apotex Inc (Êàíàäà)           │007725,    

                                   │ïðåïàðàò æåëåçà [B03AA03]     │300 ìã                                                      │14.08.96   

                                                                                                                                        

│Àïî-Ôëóîêñåòèí [Ôëóîêñåòèí]        │àíòèäåïðåññàíò [N06AB03]      │êàïñóëû 10, 20 ìã             │Apotex Inc (Êàíàäà)           │010238,    

                                                                                                                             │09.06.98   

                                                                                                                                        

│Àïî-Ôëóðàçåïàì [Ôëóðàçåïàì]        │àíêñèîëèòè÷åñêîå ñðåäñòâî     │êàïñóëû 15, 30 ìã             │Apotex Inc (Êàíàäà)           │009669,    

                                   │[N05CD01]                                                                                 │12.08.97   

                                                                                                                                        

│Àïî-Ôóðîñåìèä [Ôóðîñåìèä]          │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 20, 40 ìã            │Apotex Inc (Êàíàäà)           │008398,    

                                   │[C03CA01]                                                                                 │23.03.98   

                                                                                                                                        

│Àïî-Õëîðäèàçåïîêñèä                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │êàïñóëû 5, 10, 25 ìã          │Apotex Inc (Êàíàäà)           │006735,    

│[Õëîðäèàçåïîêñèä]                  │[N05BA02]                                                                                 │20.10.95   

                                                                                                                                       

│Àïî-Õëîðïðîïàìèä [Õëîðïðîïàìèä]    │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 100, 250 ìã          │Apotex Inc (Êàíàäà)           │005120,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB02] │                                                            │12.07.94   

                                                                                                                                        

│Àïî-Õëîðòàëèäîí [Õëîðòàëèäîí]      │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 50, 100 ìã           │Apotex Inc (Êàíàäà)           │007743,    

                                   │[C03BA04]                                                                                 │16.08.96   

                                                                                                                                        

│Àïî-Öeôàëåêñ [Öåôàëåêñèí]          │àíòèáèîòèê, öåôàëîñïîðèí      │òàáëåòêè 250, 500 ìã          │Apotex Inc (Êàíàäà)           │003814,    

                                   │[J01DA01]                                                                                 │31.03.94   

                                                                                                                                        

│Àïî-Öèìåòèäèí [Öèìåòèäèí]          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 200, 300, 400, 600,  │Apotex Inc (Êàíàäà)           │003542,    

                                   │áëîêàòîð [A02BA01]            │800 ìã                                                      │06.12.93   

                                                                                                                                        

│Àïî-Ýíàëàïðèë [Ýíàëàïðèë]          │ÀÊÔ áëîêàòîð [C09AA02]        │òàáëåòêè 2.5, 5, 10, 20 ìã    │Apotex Inc (Êàíàäà)           │005606,    

                                                                                                                             │26.12.94   

                                                                                                                                        

│Àïðàíàêñ [Íàïðîêñåí]               │ÍÏÂÑ [M01AE02]                │òàáëåòêè 550 ìã               │Syntex Pharma Ag (Øâåéöàðèÿ)  │005148,    

                                                                                                                             │19.07.94   

                                                                                                                                        

│Àïðîâåëü [Èðáåñàðòàí]              │àíãèîòåíçèíà II ðåöåïòîðîâ    │òàáëåòêè 75, 150, 300 ìã      │Sanofi-Winthrop Industrie     │009671,    

                                   │àíòàãîíèñò [C09CA04]                                        │(Ôðàíöèÿ)                     │12.08.97   

                                                                                                                                        

│Àïóëåèí [Áóäåñîíèä]                │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì                          │Gedeon Richter (Âåíãðèÿ)      │002332,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC09] │                                                            │14.01.92   

                                                                                                                                        

│Àïóëåèí [Áóäåñîíèä]                │ãëþêîêîðòèêîñòåðîèä äëÿ       │ìàçü (òóáû) 15 ã              │Gedeon Richter (Âåíãðèÿ)      │008036,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC09] │                                                            │30.10.96   

                                                                                                                                        

│Àðáèôëåêñ [Ïåíòîêñèôèëëèí]         │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Torrent Exports Ltd (Èíäèÿ)   │002822,    

                                   │[C04AD03]                     │îáîëî÷êîé 100 ìã; òàáëåòêè â                                │27.01.93   

                                                                 │îáîëî÷êå èç ñàõàðà 400 ìã                                               

                                                                                                                                        

│Àðãîñóëüôàí [Ñóëüôàòèàçîë ñåðåáðà] │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │êðåì (òóáû) 2% - 40 ã         │Polfa, Jelfa Sa (Ïîëüøà)      │005580,    

                                   │ñóëüôàíèëàìèä [D06BA02]                                                                   │16.12.94   

                                                                                                                                        

│Àðäóàí [Ïèïåêóðîíèÿ áðîìèä]        │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Gedeon Richter (Âåíãðèÿ)      │2653,      

                                   │[M03AC06]                     │èíúåêöèîííîãî ðàñòâîðà                                      │09.12.80,  

                                                                 │(ôëàêîíû) 4 ìã /â êîìïëåêòå ñ │                              │25.01.93   

                                                                 │ðàñòâîðèòåëåì/                                                         

                                                                                                                                        

│Àðåäèà [Ïàìèäðîíîâàÿ êèñëîòà]      │êîñòíîé ðåçîðáöèè èíãèáèòîð,  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ciba-Geigy (Øâåéöàðèÿ)        │003500,    

                                   │áèôîñôîíàò [M05BA03]          │15 ìã - 5 ìë; ïîðîøîê äëÿ                                   │15.11.93   

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                            

                                                                 │ðàñòâîðà (ôëàêîíû) 15, 30 ìã                                           

                                                                 │/â êîìïëåêòå ñ ðàñòâîðèòåëåì/ │                                         

                                                                                                                                        

│Àðåëèêñ [Ïèðåòàíèä]                │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè ìèòå 3 ìã, 6 ìã;     │Hoechst Ag (Ãåðìàíèÿ)         │002337,    

                                   │[C03CA03]                     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │15.01.92   

                                                                 │6 ìã/2 ìë, 12 ìã/5 ìë                                                 

                                                                                                                                        

│Àðåëèêñ ÐÐ [Ïèðåòàíèä]             │äèóðåòè÷åñêîå ñðåäñòâî        │êàïñóëû ñ ìîäèôèöèðîâàííûì    │Hoechst Ag (Ãåðìàíèÿ)         │002338,    

                                   │[C03CA03]                     │âûäåëåíèåì äåéñòâóþùåãî                                     │15.01.92   

                                                                 │âåùåñòâà 6 ìã                                                          

                                                                                                                                        

│Àðèëèí [Ìåòðîíèäàçîë]              │ïðîòèâîìèêðîáíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Dr.August Wolff Gmbh          │006783,    

                                   │[G01AF01] [J01XD01]           │250, 500 ìã; ñâå÷è            │Arzneimittel (Ãåðìàíèÿ)       │02.11.95   

                                                                 │âàãèíàëüíûå 100 ìã                                                     

                                                                                                                                        

│Àðèìèäåêñ [Àíàñòðîçîë]             │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé 1 │Zeneca Limited                │007911,    

                                   │[L02BG03]                     │ìã                            │(Âåëèêîáðèòàíèÿ)              │23.10.96   

                                                                                                                                        

│Àðèñåïò [Äîíåïåçèë]                │àíòèõîëèíýñòåðàçíîå ñðåäñòâî  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pfizer (Ôðàíöèÿ)              │010451,    

                                   │[N07AA05]                     │5, 10 ìã                                                    │03.09.98   

                                                                                                                                        

│Àðèôîí [Èíäàïàìèä]                 │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Servier (Ôðàíöèÿ)│008426,    

                                   │[C03BA11]                     │2.5 ìã                                                      │28.08.97   

                                                                                                                                        

│Àðèôîí [Èíäàïàìèä]                 │äèóðåòè÷åñêîå ñðåäñòâî        │äðàæå 2.5 ìã                  │Zorka Pharma (Þãîñëàâèÿ)      │008270,    

                                   │[C03BA11]                                                                                 │24.04.97   

                                                                                                                                        

│Àðòàìèí [Ïåíèöèëëàìèí]             │ïðîòèâîâîñïàëèòåëüíîå         │êàïñóëû 150, 250 ìã           │Biochemie Gmbh (Àâñòðèÿ)      │008167,    

                                   │ñðåäñòâî [M01CC01]                                                                        │18.02.97   

                                                                                                                                        

│Àðòðåêñ [Äèêëîôåíàê]               │ÍÏÂÑ [M02AA15]                │ãåëü (òóáû) 1% - 50, 100 ã    │Knoll Ag (Ãåðìàíèÿ)           │010385,    

                                                                                                                             │29.07.98   

                                                                                                                                        

│Àðòðîòåê {ìèçîïðîñòîë 200 ìã,      │ÍÏÂÑ [M01AB55]                │òàáëåòêè                      │Searle (ÑØÀ)                  │003440,    

│äèêëîôåíàê íàòðèÿ 50 ìã}                                                                                                     │20.10.93   

                                                                                                                                         

│Àðóìåò [Áåêëîìåòàçîí]              │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé         │Ankerpharm Gmbh (Ãåðìàíèÿ)    │003713,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │                                                           │21.02.94   

                                                                                                                                        

│Àðóòåðîë [Ôåíîòåðîë]               │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé         │Ankerpharm Gmbh (Ãåðìàíèÿ)    │003712,    

                                   │ñåëåêòèâíûé [R03AC04]                                                                     │21.02.94   

                                                                                                                                        

│Àðóòèìîë [Òèìîëîë]                 │áåòà-àäðåíîáëîêàòîð [S01ED01] │êàïëè ãëàçíûå                 │Ankerwerk Groupe Chauvin      │008410,    

                                                                 │(ôëàêîí-êàïåëüíèöû) 0.25%,    │(Ãåðìàíèÿ)                    │05.08.97   

                                                                 │0.5% - 5 ìë                                                            

                                                                                                                                        

│Àðóòðîïèä [Èïðàòðîïèÿ áðîìèä]      │ì-õîëèíîáëîêàòîð [R03BB01]    │àýðîçîëü äîçèðîâàííûé         │Ankerpharm Gmbh (Ãåðìàíèÿ)    │003711,    

                                                                                                                             │21.02.94   

                                                                                                                                        

│Àðôëîêñ [Öèïðîôëîêñàöèí]           │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 250, 500 ìã          │Armour Chemicals Ltd (Èíäèÿ)  │002881,    

                                   │ôòîðõèíîëîí [J01MA02]                                                                     │26.02.93   

                                                                                                                                         

│ÀÑ ìÿãêèé [Âîäîðîäà ïåðåêèñü]      │àíòèñåïòè÷åñêîå ñðåäñòâî      │æèäêîñòü                      │Procter & Gamble (Èòàëèÿ)     │0036-9,    

                                   │[D08AX01]                                                                                │02.03.98   

                                                                                                                                        

│Àñåïòèíîë Ñ                        │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Pettens France Chemie         │0020-4,    

                                   │ñðåäñòâî [D08AX]                                            │(Ôðàíöèÿ)                     │09.11.94   

                                                                                                                                        

│Àñåïòèíîë ñïðåé                    │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Pettens France Chemie         │0020-5,    

                                   │ñðåäñòâî [D08AX]                                            │(Ôðàíöèÿ)                     │09.11.94   

                                                                                                                                        

│Àñêàëüöèí {êàëüöèÿ ëàêòîãëþêîíàò   │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå              │Polfa, Lodzkie Pharmaceutical │007084,    

│775 ìã, àöåòèëñàëèöèëîâàÿ êèñëîòà  │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Works (Ïîëüøà)                │15.02.96   

│300 ìã, íàòðèÿ ãèäðîêàðáîíàò 875   │[A11GB01]                                                                                            

│ìã}                                                                                                                                     

                                                                                                                                        

│Àñêàôô {àöåòèëñàëèöèëîâàÿ êèñëîòà  │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Sagmel Inc (ÑØÀ)              │009025,    

│400 ìã, êîôåèí 32 ìã}              │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │18.12.96   

                                   │[N02BA71]                                                                                            

                                                                                                                                       

│Àñêîðáèíîâàÿ êèñëîòà [Àñêîðáèíîâàÿ │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå 25, 50, 250  │Natur Produkt (Ôðàíöèÿ)       │010434,    

│êèñëîòà]                                                         │ìã; òàáëåòêè øèïó÷èå 500 ìã                                 │24.08.98   

                                                                                                                                        

│Àñêîðáèíîâîé êèñëîòû 0.1 ã ñ       │âèòàìèí [A11GA01]             │òàáëåòêè                      │Áîðèñîâñêèé çàâîä             │70/626/45, 

│ãëþêîçîé òàáëåòêè [Àñêîðáèíîâàÿ                                                                │ìåäïðåïàðàòîâ (Áåëàðóñü)      │14.04.98   

│êèñëîòà]                                                                                                                                

                                                                                                                                        

│Àñêîðáèíîâîé êèñëîòû 0.1 ã ñ       │âèòàìèí [A11GA01]             │òàáëåòêè                      │Áîðùàãîâñêèé ÕÔÇ (Óêðàèíà)    │70/626/45, 

│ãëþêîçîé òàáëåòêè [Àñêîðáèíîâàÿ                                                                                              │14.04.98   

│êèñëîòà]                                                                                                                                

                                                                                                                                        

│Àñêîðáèíîâîé êèñëîòû ðàñòâîð äëÿ   │âèòàìèí [A11GA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ñàíèòàñ ÀÎ (Ëèòâà)            │009210,    

│èíúåêöèé 5% (âèòàìèí Ñ)                                          │5% - 2 ìë                                                   │02.12.97   

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                                                                   

                                                                                                                                        

│Àñêîðáèíîâîé êèñëîòû ðàñòâîð äëÿ   │âèòàìèí [A11GA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ýíäîêðèíèíÿé Ïðåïàðàòàé ÀΠ   │009232,    

│èíúåêöèé 5% (âèòàìèí Ñ)                                          │5% - 2 ìë                     │(Ëèòâà)                       │11.12.97   

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                                                                  

                                                                                                                                        

│Àñêîðáèíîâîé êèñëîòû ðàñòâîð äëÿ   │âèòàìèí [A11GA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Åðåâàíñêàÿ                    │73/941/12, 

│èíúåêöèé 5% [Àñêîðáèíîâàÿ êèñëîòà] │                              │5% - 1 ìë                     │õèìèêî-ôàðìàöåâòè÷åñêàÿ ôèðìà │18.11.97   

                                                                                               │ÎÀÎ (Ðåñïóáëèêà Àðìåíèÿ)                 

                                                                                                                                        

│Àñêîðèë ýêñïåêòîðàíò {ñàëüáóòàìîë  │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 100 ìë        │Glenmark Pharmaceuticals Ltd  │010230,    

│2 ìã, áðîìãåêñèí 4 ìã, ãâàéôåíåçèí │[R05CB10]                                                   │(Èíäèÿ)                       │02.06.98   

│100 ìã, ìåíòîë 1 ìã - 10 ìë}                                                                                                            

                                                                                                                                        

│Àñêîôåí ïëþñ {àöåòèëñàëèöèëîâàÿ    │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Natur Produkt (Ôðàíöèÿ)       │009264,    

│êèñëîòà 200 ìã, êîôåèí 40 ìã,      │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │19.02.97   

│ïàðàöåòàìîë 200 ìã}                │[N02BA71]                                                                                             

                                                                                                                                        

│Àñìàäèë [Ñàëüáóòàìîë]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 2 ìã, 4 ìã           │Arab Pharmaceutical           │003667,    

                                   │ñåëåêòèâíûé [R03CC02]                                       │Manufacturing Co Ltd          │03.02.94   

                                                                                               │(Èîðäàíèÿ)                               

                                                                                                                                        

│Àñìîâàë 10 [Àñòåìèçîë]             │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Remedica Ltd - Minnex (Êèïð)  │009766,    

                                   │áëîêàòîð [R06AX11]                                                                        │06.10.97   

                                                                                                                                        

│Àñïàðêàì òàáëåòêè [Êàëèÿ è ìàãíèÿ  │ïðåïàðàò êàëèÿ è ìàãíèÿ       │òàáëåòêè                      │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │75/244/14, 

│àñïàðàãèíàò]                       │[A12BA51]                                                                                 │29.10.97   

                                                                                                                                        

│Àñïàðêàì [Êàëèÿ è ìàãíèÿ           │ïðåïàðàò êàëèÿ è ìàãíèÿ       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Äíåïðîôàðì ÎÀÎ (Óêðàèíà)      │90/260/1,  

│àñïàðàãèíàò]                       │[A12BA51]                     │5 ìë                                                        │14.10.98   

                                                                                                                                        

│Àñïàðêàì òàáëåòêè [Êàëèÿ è ìàãíèÿ  │ïðåïàðàò êàëèÿ è ìàãíèÿ       │òàáëåòêè                      │Êðàñíàÿ Çâåçäà ÕÔÇ ÎÀΠ       │75/244/14, 

│àñïàðàãèíàò]                       │[A12BA51]                                                   │(Óêðàèíà)                     │02.03.98   

                                                                                                                                        

│Àñïàðêàì òàáëåòêè [Êàëèÿ è ìàãíèÿ  │ïðåïàðàò êàëèÿ è ìàãíèÿ       │òàáëåòêè                      │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │75/244/14, 

│àñïàðàãèíàò]                       │[A12BA51]                                                   │ôèðìà ÎÀÎ (Óêðàèíà)           │07.10.98   

                                                                                                                                        

│Àñïàðêàì òàáëåòî÷íàÿ ìàññà [Êàëèÿ  │ïðåïàðàò êàëèÿ è ìàãíèÿ       │òàáëåòî÷íàÿ ìàññà (ìåøêè      │Êðàñíàÿ Çâåçäà ÕÔÇ ÎÀΠ       │91/146/8,  

│è ìàãíèÿ àñïàðàãèíàò]              │[A12BA51]                     │ïîëèýòèëåíîâûå) 15 êã         │(Óêðàèíà)                     │02.03.98   

                                                                                                                                        

│Àñïèçîë [Àöåòèëñàëèöèëàò ëèçèíà]   │ÍÏÂÑ [N02BA13]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Bayer Ag (Ãåðìàíèÿ)           │007317,    

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                      │26.09.96   

                                                                 │(ôëàêîíû) 1 ã /â êîìïëåêòå ñ                                           

                                                                 │ðàñòâîðèòåëåì - âîäà äëÿ                                               

                                                                 │èíúåêöèé (àìïóëû) 5 ìë/                                                

                                                                                                                                        

│Àñïèëàéò [Àöåòèëñàëèöèëîâàÿ        │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Myevska Pharmaceuticals Inc   │009608,    

│êèñëîòà]                                                         │325 ìã                        │(ÑØÀ)                         │18.07.97   

                                                                                                                                         

│Àñïèëàéò [Àöåòèëñàëèöèëîâàÿ        │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pennex Labs (ÑØÀ)             │005293,    

│êèñëîòà]                                                         │325 ìã                                                     │05.09.94   

                                                                                                                                        

│Àñïèðèí Éîðê [Àöåòèëñàëèöèëîâàÿ    │ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │York Pharmaceuticals Inc (ÑØÀ)│008662,    

│êèñëîòà]                                                                                                                     │24.07.98   

                                                                                                                                        

│Àñïèðèí Êâîëèòè [Àöåòèëñàëèöèëîâàÿ │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Hadson Corp (ÑØÀ)             │005089,    

│êèñëîòà]                                                         │325 ìã                                                      │06.07.94   

                                                                                                                                        

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 100, 500 ìã          │Bayer Ag (Ãåðìàíèÿ)           │007341,    

                                                                                                                             │07.10.96   

                                                                                                                                        

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè øèïó÷èå 500 ìã       │Bayer Ag (Ãåðìàíèÿ)           │007507,    

                                                                                                                             │15.05.96   

                                                                                                                                        

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 100, 500 ìã          │Bifa, Bayer (Òóðöèÿ)          │002746,    

                                                                                                                             │11.12.92   

                                                                                                                                       

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │Lnk Internationl Inc (ÑØÀ)    │006109,    

                                                                                                                             │25.05.95   

                                                                                                                                        

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã               │Natur Produkt (Ôðàíöèÿ)       │007128,    

                                                                                                                             │05.03.96   

                                                                                                                                        

│Àñïèðèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]│ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │Sagmel Inc (ÑØÀ)              │009854,    

                                                                                                                             │21.11.97   

                                                                                                                                        

│Àñïèðèí {àöåòèëñàëèöèëîâàÿ êèñëîòà │ÍÏÂÑ [N02BA51]                │òàáëåòêè äèñïåðãèðóåìûå 350,  │Natco Pharma Ltd (Èíäèÿ)      │007297,    

│350 ìã, êàëüöèÿ êàðáîíàò 105 ìã,                                 │500 ìã                                                      │22.08.96   

│ëèìîííàÿ êèñëîòà 35 ìã}                                                                                                                 

                                                                                                                                        

│Àñïèðèí 325 ìã [Àöåòèëñàëèöèëîâàÿ  │ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │Êîíöåðí Ñòèðîë ÎÀÎ (Óêðàèíà)  │009176,    

│êèñëîòà]                                                                                                                     │17.10.97   

                                                                                                                                       

│Àñïèðèí äëÿ äåòåé                  │ÍÏÂÑ [N02BA01]                │òàáëåòêè æåâàòåëüíûå 81 ìã    │Sagmel Inc (ÑØÀ)              │009862,    

│[Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                                                                  │25.11.97   

                                                                                                                                        

│Àñïèðèí êàðäèî [Àöåòèëñàëèöèëîâàÿ  │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Bayer Ag (Ãåðìàíèÿ)           │009130,    

│êèñëîòà]                                                         │100, 300 ìã                                                 │10.02.97   

                                                                                                                                        

│Àñïèðèí ïëþñ Ñ {àöåòèëñàëèöèëîâàÿ  │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå 400 ìã/240 ìã│Bifa, Bayer (Òóðöèÿ)          │002747,    

│êèñëîòà 0.4 ã, àñêîðáèíîâàÿ        │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │11.12.92   

│êèñëîòà 0.24 ã}                    │[N02BA51]                                                                                            

                                                                                                                                        

│Àñïèðèí ÓÏÑÀ [Àöåòèëñàëèöèëîâàÿ    │ÍÏÂÑ [N02BA01]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratoires Upsa (Ôðàíöèÿ)   │005407,    

│êèñëîòà]                                                         │îðàëüíîãî ðàñòâîðà (ñàøå) 100 │                              │19.10.94   

                                                                 │ìã                                                                     

                                                                                                                                         

│Àñïèðèí ÓÏÑÀ [Àöåòèëñàëèöèëîâàÿ    │ÍÏÂÑ [N02BA01]                │òàáëåòêè øèïó÷èå 325, 500 ìã  │Laboratoires Upsa (Ôðàíöèÿ)   │005852,    

│êèñëîòà]                                                                                                                    │13.03.95   

                                                                                                                                        

│Àñïèðèí ÓÏÑÀ ñ âèòàìèíîì C         │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå              │Upsa Laboratoires, a division │008326,    

│{àöåòèëñàëèöèëîâàÿ êèñëîòà 0.33 ã, │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │of Bristol-Myers Squibb       │17.09.97   

│àñêîðáèíîâàÿ êèñëîòà 0.2 ã}        │[N02BA51]                                                   │(Ôðàíöèÿ)                                

                                                                                                                                        

│Àñïèðèí+Ñ {àöåòèëñàëèöèëîâàÿ       │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå              │Natur Produkt (Ôðàíöèÿ)       │007116,    

│êèñëîòà 0.35 ã, àñêîðáèíîâàÿ       │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │01.03.96   

│êèñëîòà 0.2 ã}                     │[N02BA51]                                                                                            

                                                                                                                                        

│Àñïèðèí-Äèðåêò [Àöåòèëñàëèöèëîâàÿ  │ÍÏÂÑ [N02BA01]                │òàáëåòêè æåâàòåëüíûå 500 ìã   │Bayer Ag (Ãåðìàíèÿ)           │006778,    

│êèñëîòà]                                                                                                                     │01.11.95   

                                                                                                                                        

│Àñïèðèí-Ìèëòîì [Àöåòèëñàëèöèëîâàÿ  │ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã; òàáëåòêè     │A&Z Pharmaceutical Inc (ÑØÀ)  │009708,    

│êèñëîòà]                                                         │æåâàòåëüíûå äåòñêèå 81 ìã                                   │01.09.97   

                                                                                                                                        

│Àñïèðèí-Ñ {àöåòèëñàëèöèëîâàÿ       │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå              │Bayer Ag (Ãåðìàíèÿ)           │007340,    

│êèñëîòà 0.4 ã, àñêîðáèíîâàÿ        │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │07.10.96   

│êèñëîòà 0.24 ã}                    │[N02BA51]                                                                                            

                                                                                                                                        

│Àñïðî Âèòàìèí Ñ {àöåòèëñàëèöèëîâàÿ │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå 300 ìã/500   │Laboratoires Roche-Nicholas   │006924,    

│êèñëîòà 300 ìã, àñêîðáèíîâàÿ       │íåíàðêîòè÷åñêîå ñðåäñòâî      │ìã, 200 ìã/320 ìã             │Sa (Ôðàíöèÿ)                  │20.12.95   

│êèñëîòà 500 ìã; àöåòèëñàëèöèëîâàÿ  │[N02BA51]                                                                                            

│êèñëîòà 200 ìã, àñêîðáèíîâàÿ                                                                                                            

│êèñëîòà 320 ìã}                                                                                                                         

                                                                                                                                        

│Àñïðî ñ Âèòàìèíîì C                │àíàëüãåòè÷åñêîå               │ãðàíóëÿò øèïó÷èé (ñàøå) 500   │Laboratoires Roche-Nicholas   │007023,    

│{àöåòèëñàëèöèëîâàÿ êèñëîòà 0.5 ã,  │íåíàðêîòè÷åñêîå ñðåäñòâî      │ìã/300 ìã                     │Sa (Ôðàíöèÿ)                  │28.01.96   

│àñêîðáèíîâàÿ êèñëîòà 0.3 ã}        │[N02BA51]                                                                                            

                                                                                                                                        

│ÀÑÑ+Ö-Ðàòèîôàðì {àöåòèëñàëèöèëîâàÿ │àíàëüãåòè÷åñêîå               │òàáëåòêè øèïó÷èå 600 ìã/200 ìã│Ratiopharm Gmbh & Co          │003508,    

│êèñëîòà 0.6 ã, àñêîðáèíîâàÿ        │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Ãåðìàíèÿ)                    │17.11.93   

│êèñëîòà 0.2 ã}                     │[N02BA51]                                                                                           

                                                                                                                                        

│ÀÑÑ-Ðàòèîôàðì [Àöåòèëñàëèöèëîâàÿ   │ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã               │Ratiopharm Gmbh & Co          │005755,    

│êèñëîòà]                                                                                       │(Ãåðìàíèÿ)                    │16.02.95   

                                                                                                                                        

│Àñòàëèí [Ñàëüáóòàìîë]              │áåòà2-àäðåíîñòèìóëÿòîð        │ðàñòâîð äëÿ èíãàëÿöèé         │Cipla Ltd (Èíäèÿ)             │007880,    

                                   │ñåëåêòèâíûé [R03AC02]         │(àìïóëû) 1 ìã/ìë - 2.5 ìë;                                  │07.10.96   

                                   │[R03CC02]                     │ðàñòâîð äëÿ èíãàëÿöèé                                                  

                                                                 │(ôëàêîíû) 5 ìã/ìë - 15 ìë;                                             

                                                                 │ñèðîï (ôëàêîíû) 2 ìã|5 ìë -                                            

                                                                 │100 ìë; ñèðîï îòõàðêèâàþùèé                                            

                                                                 │(ôëàêîíû) 100 ìë                                                       

                                                                                                                                        

│Àñòàôåí [Êåòîòèôåí]                │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │òàáëåòêè 1 ìã; ñèðîï 1 ìã|5 ìë│Ilsan Iltash As (Òóðöèÿ)      │003892,    

                                   │[R06AX17]                                                                                 │04.05.94   

                                                                                                                                        

│Àñòàôåí [Êåòîòèôåí]                │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │òàáëåòêè 1 ìã                 │Torrent Exports Ltd (Èíäèÿ)   │002672,    

                                   │[R06AX17]                                                                                 │27.10.92   

                                                                                                                                        

│Àñòåëîíã [Àñòåìèçîë]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Torrent Exports Ltd (Èíäèÿ)   │005050,    

                                   │áëîêàòîð [R06AX11]                                                                        │28.06.94   

                                                                                                                                        

│Àñòåìèçîë [Àñòåìèçîë]              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Jaka-80 (Ìàêåäîíèÿ)           │009069,    

                                   │áëîêàòîð [R06AX11]                                                                        │13.01.97   

                                                                                                                                        

│Àñòåìèñàí [Àñòåìèçîë]              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Zdravle (Þãîñëàâèÿ)           │002793,    

                                   │áëîêàòîð [R06AX11]                                                                        │12.01.93   

                                                                                                                                        

│Àñòìîïåíò [Îðöèïðåíàëèí]           │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé         │Polfa, Poznanskie             │006052,    

                                   │ñåëåêòèâíûé [R03AB03]         │(áàëëîíû 400 äîç) 0.75        │Pharmaceutical Works (Ïîëüøà) │17.05.95   

                                                                 │ìã/äîçà - 20 ìë                                                         

                                                                                                                                        

│Àñòìîïåíò [Îðöèïðåíàëèí]           │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 20 ìã; ðàñòâîð äëÿ   │Polfa, Warszawskie            │008409,    

                                   │ñåëåêòèâíûé [R03CB03]         │èíúåêöèé (àìïóëû) 0.5 ìã/ìë   │Pharmaceutical Works (Ïîëüøà) │31.07.97   

                                                                                                                                        

│Àñòðàñåïò {àìèëìåòàêðåçîë 0.6 ìã,  │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè îáû÷íûå; ïàñòèëêè ñ  │Fermentapharma Biodil Ltd     │009135,    

│äèõëîðáåíçèëîâûé ñïèðò 1.2 ìã}     │[R02AA20]                     │çàïàõîì ëèìîíà; ïàñòèëêè ñ    │(Èíäèÿ)                       │11.02.97   

                                                                 │çàïàõîì àïåëüñèíà; ïàñòèëêè ñ │                                         

                                                                 │çàïàõîì èìáèðÿ è ëèìîíà                                                

                                                                                                                                        

│Àòàðàêñ [Ãèäðîêñèçèí]              │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 10, 25 ìã; ðàñòâîð   │Ucb Sa (Áåëüãèÿ)              │003690,    

                                   │[N05BB01]                     │äëÿ èíúåêöèé (àìïóëû) 100 ìã                                │10.02.94   

                                                                 │- 2 ìë                                                                 

                                                                                                                                        

│Àòåãåêñàë êîìïîçèòóì {àòåíîëîë 50  │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │007684,    

│ìã, õëîðòàëèäîí 12.5 ìã; àòåíîëîë  │ñðåäñòâî [C07BB03]                                                                        │24.07.96   

│100 ìã, õëîðòàëèäîí 25 ìã}                                                                                                               

                                                                                                                                        

│Àòåí [Àòåíîëîë]                    │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 25, 50, 100 ìã       │Kopran Ltd (Èíäèÿ)            │005205,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │03.08.94   

                                                                                                                                        

│Àòåíèë [Àòåíîëîë]                  │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ecosol Ag Pharmaceu-tical     │006092,    

                                   │ñåëåêòèâíûé [C07AB03]         │50, 100 ìã                    │Production (Øâåéöàðèÿ)        │23.02.95   

                                                                                                                                        

│Àòåíîáåíå [Àòåíîëîë]               │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Merckle Gmbh (Àâñòðèÿ)        │008477,    

                                   │ñåëåêòèâíûé [C07AB03]         │îáîëî÷êîé 50, 100 ìã                                        │24.12.97   

                                                                                                                                        

│Àòåíîâà [Àòåíîëîë]                 │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Lupin Laboratories Limited    │008688,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Èíäèÿ)                       │19.10.98   

                                                                                                                                        

│Àòåíîë [Àòåíîëîë]                  │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã               │Laboratorio Farmaceutico C.T. │006703,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Èòàëèÿ)                      │11.10.95   

                                                                                                                                         

│Àòåíîëàí [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lannacher Heilmittel Gmbh     │007969,    

                                   │ñåëåêòèâíûé [C07AB03]         │50, 100 ìã                    │(Àâñòðèÿ)                     │21.11.96   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã               │Clonmel Healthcare (Èðëàíäèÿ) │007147,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │18.03.96   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Cox Pharmaceuticals           │005300,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Âåëèêîáðèòàíèÿ)              │06.09.94   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ipca Laboratories Limited     │010300,    

                                   │ñåëåêòèâíûé [C07AB03]         │25, 50 ìã                     │(Èíäèÿ)                       │03.07.98   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Norton Healthcare Ltd         │003249,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Âåëèêîáðèòàíèÿ)              │18.08.93   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Pliva Sa (Õîðâàòèÿ)           │006073,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │22.05.95   

                                                                                                                                       

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Biocom Pharmaceutical Works   │005964,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Ïîëüøà)                      │13.04.95   

                                                                                                                                        

│Àòåíîëîë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Tamilnadu Dadha               │003940,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │Pharmaceuticals Ltd (Èíäèÿ)   │25.05.94   

                                                                                                                                        

│Àòåíîëîë êîìï. {àòåíîëîë 100 ìã,   │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè ïîêðûòûå îáîëî÷êîé;  │Ct-Arzneimittel Chemishe      │007439,    

│õëîðòàëèäîí 25 ìã; àòåíîëîë 50 ìã, │ñðåäñòâî [C07BB03]            │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Tempelchof Gmbh (Ãåðìàíèÿ)    │15.04.96   

│õëîðòàëèäîí 12.5 ìã}                                             │ìèòå                                                                   

                                                                                                                                        

│Àòåíîëîë-Ðàòèîôàðì 100 [Àòåíîëîë]  │áåòà1-àäðåíîáëîêàòîð          │ôèëìòàáëåòêè 100 ìã           │Ratiopharm Gmbh & Co          │005815,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Ãåðìàíèÿ)                    │10.03.95   

                                                                                                                                        

│Àòåíîëîë-Ðàòèîôàðì 25 [Àòåíîëîë]   │áåòà1-àäðåíîáëîêàòîð          │ôèëìòàáëåòêè 25 ìã            │Ratiopharm Gmbh & Co          │005815,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Ãåðìàíèÿ)                    │10.03.95   

                                                                                                                                       

│Àòåíîëîë-Ðàòèîôàðì 50 [Àòåíîëîë]   │áåòà1-àäðåíîáëîêàòîð          │ôèëìòàáëåòêè 50 ìã            │Ratiopharm Gmbh & Co          │005815,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │(Ãåðìàíèÿ)                    │10.03.95   

                                                                                                                                        

│Àòåíîëîë-Òåâà [Àòåíîëîë]           │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Teva Pharmaceutical           │005111,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │Industries Ltd (Èçðàèëü)      │11.07.94   

                                                                                                                                        

│Àòåíîñàí [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sanofi-Winthrop               │006222,    

                                   │ñåëåêòèâíûé [C07AB03]         │50, 100 ìã                    │(Âåëèêîáðèòàíèÿ)              │27.06.95   

                                                                                                                                        

│Àòåðîìèêñîë [Ïîëèêîñàíîë]          │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │òàáëåòêè ïîêðûòûå îáîëî÷êîé 5 │Dalmer (Êóáà)                 │007720,    

                                   │[C10AX]                       │ìã                                                          │14.08.96   

                                                                                                                                        

│Àòêàðäèë [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Sun Pharmaceutical Industries │002958,    

                                   │ñåëåêòèâíûé [C07AB03]                                       │Ltd (Èíäèÿ)                   │12.04.93   

                                                                                                                                        

│Àòîêñèëèí [Àìîêñèöèëëèí]           │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè 500 ìã; ïîðîøîê äëÿ  │Atabay Ilac Fabrikasi As      │009657,    

                                   │[J01CA04]                     │ïðèãîòîâëåíèÿ ñóñïåíçèè äëÿ   │(Òóðöèÿ)                      │06.08.97   

                                                                 │âíóòðåííåãî ïðèìåíåíèÿ                                                 

                                                                 │(ôëàêîíû) 250 ìã|5 ìë - 100 ìë│                                         

                                                                                                                                        

│Àòðàëêñèòèí [Öåôîêñèòèí]           │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratories Atral Sa         │002702,    

                                   │[J01DA05]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ïîðòóãàëèÿ)                  │23.11.92   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ã                                                 

                                                                                                                                        

│Àòðàëöåô [Öåôàçîëèí]               │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratories Atral Sa         │002703,    

                                   │[J01DA04]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ïîðòóãàëèÿ)                  │23.11.92   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ã /â                                              

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Àòðèêàí 250 [Òåíîíèòðîçîë]         │ïðîòèâîïðîòîçîéíîå ñðåäñòâî   │êàïñóëû 250 ìã                │Innothera/Innotech            │003831,    

                                   │[J01XD]                                                     │International (Ôðàíöèÿ)       │06.04.94   

                                                                                                                                       

│Àòðîâåíò [Èïðàòðîïèÿ áðîìèä]       │ì-õîëèíîáëîêàòîð [R03BB01]    │àýðîçîëü äîçèðîâàííûé         │Boehringer Ingelheim (ÔÐÃ)    │008557,    

                                                                 │(áàëëîíû 15 ìë) 20 ìêã/äîçà - │                              │23.06.98   

                                                                 │300 äîç                                                                

                                                                                                                                        

│Àòðîâåíò [Èïðàòðîïèÿ áðîìèä]       │ì-õîëèíîáëîêàòîð [R03BB01]    │ïîðîøîê äëÿ èíãàëÿöèé â       │Boehringer Ingelheim          │007175,    

                                                                 │êàïñóëàõ 0.2 ìã/äîçà - 5 ìã   │International Gmbh (Ãåðìàíèÿ) │04.04.96   

                                                                                                                                        

│Àòðîâåíò [Èïðàòðîïèÿ áðîìèä]       │ì-õîëèíîáëîêàòîð [R03BB01]    │ðàñòâîð äëÿ èíãàëÿöèé         │Boehringer Ingelheim          │009127,    

                                                                 │(ôëàêîíû ñ êàïåëüíèöåé)       │International Gmbh (Ãåðìàíèÿ) │05.02.97   

                                                                 │0.025% - 20, 40, 100 ìë                                                

                                                                                                                                        

│Àòðîâåíò [Èïðàòðîïèÿ áðîìèä]       │ì-õîëèíîáëîêàòîð [R03BB01]    │ðàñòâîð äëÿ èíãàëÿöèé         │Boehringer Ingelheim Italy    │008713,    

                                                                 │(ôëàêîíû ñ êàïåëüíèöåé)       │Spa, a division of Boehringer │22.10.98   

                                                                 │0.025% - 20 ìë                │Ingelheim International Gmbh              

                                                                                               │(Èòàëèÿ)                                 

                                                                                                                                       

│Àòðîâåíò [Èïðàòðîïèÿ áðîìèä]       │ì-õîëèíîáëîêàòîð [R01AX03]    │àýðîçîëü íàçàëüíûé (ôëàêîíû)  │Boehringer Ingelheim Inc (ÑØÀ)│007655,    

                                                                 │0.03% - 10, 15, 20, 30 ìë                                   │22.07.96   

                                                                                                                                        

│Àòðîìåä [Àòðîïèí]                  │ì-õîëèíîáëîêàòîð [S01FA01]    │êàïëè ãëàçíûå (ôëàêîíû) 1% -  │Promed Exports Pvt Ltd (Èíäèÿ)│006850,    

                                                                 │5 ìë                                                        │22.11.95   

                                                                                                                                        

│Àóãìåíòèí {àìîêñèöèëëèí 0.5 ã,     │àíòèáèîòèê,                   │òàáëåòêè 625 ìã               │Smithkline Beecham            │005238,    

│êëàâóëàíîâàÿ êèñëîòà 0.125 ìã}     │ïåíèöèëëèí+áåòà-ëàêòàìàç                                    │Pharmaceuticals               │19.08.94   

                                   │èíãèáèòîð [J01CR02]                                         │(Âåëèêîáðèòàíèÿ)                         

                                                                                                                                        

│Àóãìåíòèí {àìîêñèöèëëèí 250 ìã,    │àíòèáèîòèê,                   │òàáëåòêè 375 ìã; ïîðîøîê äëÿ  │Smithkline Beecham Ltd        │008128,    

│êëàâóëàíîâàÿ êèñëîòà 125 ìã}       │ïåíèöèëëèí+áåòà-ëàêòàìàç      │ïðèãîòîâëåíèÿ ñèðîïà          │(Âåëèêîáðèòàíèÿ)              │22.01.97   

                                   │èíãèáèòîð [J01CR02]           │(ôëàêîíû) 156 ìã|5 ìë                                                  

                                                                                                                                         

│Àóãìåíòèí {àìîêñèöèëëèí 250 ìã,    │àíòèáèîòèê,                   │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Smithkline Beecham Ltd        │008127,    

│êëàâóëàíîâàÿ êèñëîòà 125 ìã}       │ïåíèöèëëèí+áåòà-ëàêòàìàç      │èíúåêöèîííîãî ðàñòâîðà        │(Âåëèêîáðèòàíèÿ)              │22.01.97   

                                   │èíãèáèòîð [J01CR02]           │(ôëàêîíû) 0.6, 1.2 ã                                                   

                                                                                                                                        

│Àóãìåíòèí {àìîêñèöèëëèí 875 ìã,    │àíòèáèîòèê,                   │òàáëåòêè 1 ã                  │Beecham Pharmaceuticals       │007912,    

│êëàâóëàíîâàÿ êèñëîòà 125 ìã}       │ïåíèöèëëèí+áåòà-ëàêòàìàç                                    │(Âåëèêîáðèòàíèÿ)              │25.10.96   

                                   │èíãèáèòîð [J01CR02]                                                                                  

                                                                                                                                        

│Àóðîáèí {ïðåäíèçîëîí 2 ìã,         │ãëþêîêîðòèêîñòåðîèä           │ìàçü (òóáû) 20 ã              │Gedeon Richter (Âåíãðèÿ)      │008075,    

│ëèäîêàèí 20 ìã, äåêñïàíòåíîë 20    │+ïðîòèâîìèêðîáíîå ñðåäñòâî                                                                │28.11.96   

│ìã, òðèêëîçàí 1 ìã - 1 ã}          │[D07BA01]                                                                                            

                                                                                                                                        

│Àóðîïàí [Àóðàíîôèí]                │ïðîòèâîâîñïàëèòåëüíîå         │òàáëåòêè 3 ìã                 │Krka (Ñëîâåíèÿ)               │007322,    

                                   │ñðåäñòâî, ïðåïàðàò çîëîòà                                                                 │26.09.96   

                                   │[M01CB03]                                                                                            

                                                                                                                                         

│Àóðîðèêñ [Ìîêëîáåìèä]              │àíòèäåïðåññàíò [N06AG02]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │F.Hoffmann La Roche Ltd       │010107,    

                                                                 │150, 300 ìã                   │(Øâåéöàðèÿ)                   │08.07.98   

                                                                                                                                        

│Àôåíîêñèí [Öèïðîôëîêñàöèí]         │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 250, 500 ìã          │Faran Laboratories Sa (Ãðåöèÿ)│003661,    

                                   │ôòîðõèíîëîí [J01MA02]                                                                     │01.02.94   

                                                                                                                                        

│Àôîíèëóì ÑÐ [Òåîôèëëèí]            │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │êàïñóëû ñ çàìåäëåííûì         │Knoll Ag (Ãåðìàíèÿ)           │009867,    

                                   │[R03DA04]                     │âûñâîáîæäåíèåì 125, 500 ìã                                  │28.11.97   

                                                                                                                                        

│Àôîíèëóì ÑÐ [Òåîôèëëèí]            │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │êàïñóëû 250, 375 ìã           │Knoll Ag, Basf Pharma         │006499,    

                                   │[R03DA04]                                                   │(Ãåðìàíèÿ)                    │13.09.95   

                                                                                                                                        

│Àôðèí [Îêñèìåòàçîëèí]              │àëüôà-àäðåíîñòèìóëÿòîð        │ñïðåé íàçàëüíûé (ôëàêîíû) 0.5 │Schering-Plough (Áåëüãèÿ)     │007578,    

                                   │[R01AA05]                     │ìã/ìë - 20 ìë                                               │10.06.96   

                                                                                                                                        

│Àôðèí [Îêñèìåòàçîëèí]              │àëüôà-àäðåíîñòèìóëÿòîð        │êàïëè ãëàçíûå (ôëàêîíû)       │Schering-Plough (Áåëüãèÿ)     │009008,    

                                   │[S01GA04]                     │0.025% - 10 ìë                                              │04.12.96   

                                                                                                                                       

│Àôðîäîð 2000 {àöåêàðáîìàë 100 ìã,  │ïîòåíöèè ñòèìóëÿòîð           │äðàæå                         │Farco-Pharma Gmbh (Ãåðìàíèÿ)  │007964,    

│êâåáðàõî êîðû ýêñòðàêò 30 ìã,      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │19.11.96   

│òîêîôåðîë 33 ìã}                   │[G04BX]                                                                                              

                                                                                                                                        

│ÀÕÄ-2000-Ñïåöèàëü                  │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Lysoform Desinfection Ag      │0025-1,    

                                   │ñðåäñòâî [D08AC52]                                          │(Øâåéöàðèÿ)                   │25.07.95   

                                                                                                                                        

│Àöåáóòîëîë [Àöåáóòîëîëà            │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ct-Arzneimittel Chemishe      │003971,    

│ãèäðîõëîðèä]                       │ñåëåêòèâíûé ñ ÑÌÀ [C07AB04]   │200, 400 ìã                   │Tempelchof Gmbh (Ãåðìàíèÿ)    │01.06.94   

                                                                                                                                        

│Àöåêîð [Àöåáóòîëîëà ãèäðîõëîðèä]   │áåòà1-àäðåíîáëîêàòîð          │ôèëìòàáëåòêè 200, 400 ìã      │Spa (Èòàëèÿ)                  │006245,    

                                   │ñåëåêòèâíûé ñ ÑÌÀ [C07AB04]                                                               │04.07.95   

                                                                                                                                        

│Àöåëèçèí 0.2 ã (äëÿ ïèòüÿ)         │ÍÏÂÑ [N02BA13]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Õàðüêîâñêèé ÃÍÖËÑ (Óêðàèíà)   │92/327/9,  

│[Àöåòèëñàëèöèëàò ëèçèíà]                                         │îðàëüíîãî ðàñòâîðà (ïàêåòû)                                 │15.12.92   

                                                                 │200 ìã                                                                

                                                                                                                                        

│Àöåëèçèí äëÿ èíúåêöèé 1 ã          │ÍÏÂÑ [N02BA13]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │90/248/6,  

│[Àöåòèëñàëèöèëàò ëèçèíà]                                         │èíúåêöèîííîãî ðàñòâîðà                                      │12.11.97   

                                                                 │(ôëàêîíû) 1 ã                                                          

                                                                                                                                        

│Àöåëèçèí äëÿ èíúåêöèé 2 ã          │ÍÏÂÑ [N02BA13]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Õàðüêîâñêèé ÃÍÖËÑ (Óêðàèíà)   │94/229/9,  

│[Àöåòèëñàëèöèëàò ëèçèíà]                                         │èíúåêöèîííîãî ðàñòâîðà                                      │26.10.94   

                                                                 │(ôëàêîíû) 2 ã                                                          

                                                                                                                                        

│Àöåëèçèí äëÿ ïèòüÿ 0.6 ã           │ÍÏÂÑ [N02BA13]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Õàðüêîâñêèé ÃÍÖËÑ (Óêðàèíà)   │94/229/8,  

│[Àöåòèëñàëèöèëàò ëèçèíà]                                         │îðàëüíîãî ðàñòâîðà (ïàêåòû)                                 │26.10.94   

                                                                 │600 ìã - 2.6 ã                                                         

                                                                                                                                        

│Àöåíîçèí {äèãèäðîýðãîêðèñòèí 0.5   │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │äðàæå                         │Hemofarm D.D. (Þãîñëàâèÿ)     │007739,    

│ìã, ðåçåðïèí 0.1 ìã, êëîïàìèä 5 ìã}│ñðåäñòâî [C02LA51]                                                                        │15.08.96   

                                                                                                                                       

│Àöåíîêóìàðîë [Àöåíîêóìàðîë]        │àíòèêîàãóëÿíò, âèòàìèíà Ê     │òàáëåòêè 4 ìã                 │Polfa, Warszawskie            │005269,    

                                   │àíòàãîíèñò [B01AA07]                                        │Pharmaceutical Works (Ïîëüøà) │26.08.94   

                                                                                                                                        

│Àöåíòåðèí [Àöåòèëñàëèöèëîâàÿ       │ÍÏÂÑ [N02BA01]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Nycomed Christians (Áåëüãèÿ)  │005631,    

│êèñëîòà]                                                         │îáîëî÷êîé 500 ìã                                            │11.01.95   

                                                                                                                                        

│Àöåðáèí {ÿáëî÷íàÿ êèñëîòà 1.37 ã,  │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Montavit Gmbh (Àâñòðèÿ)       │006682,    

│áåíçîéíàÿ êèñëîòà 0.14 ã,          │[D08A]                        │ïðèìåíåíèÿ                                                  │29.09.95   

│ñàëèöèëîâàÿ êèñëîòà 40 ìã}                                                                                                              

                                                                                                                                        

│Àöåñîëü ðàñòâîð äëÿ èíúåêöèé       │ðåãèäðàòèðóþùåå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Íåñâèæñêèé çàâîä              │72/590/1,  

│{íàòðèÿ àöåòàò 2 ã, íàòðèÿ õëîðèä  │[B05BB]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë  │ìåäïðåïàðàòîâ (Áåëàðóñü)      │26.01.98   

│5 ã, êàëèÿ õëîðèä 1 ã - 1 ë}                                                                                                            

                                                                                                                                         

│Àöåñîëü ðàñòâîð äëÿ èíúåêöèé       │ðåãèäðàòèðóþùåå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Êîíîòîïìÿñî ÀÎ (Óêðàèíà)      │72/590/1,  

│{íàòðèÿ àöåòàò 2 ã, íàòðèÿ õëîðèä  │[B05BB]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë                               │15.07.98   

│5 ã, êàëèÿ õëîðèä 1 ã - 1 ë}                                                                                                            

                                                                                                                                        

│Àöåñîëü ðàñòâîð äëÿ èíúåêöèé       │ðåãèäðàòèðóþùåå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │72/590/1,  

│{íàòðèÿ àöåòàò 2 ã, íàòðèÿ õëîðèä  │[B05BB]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë                                │17.12.97   

│5 ã, êàëèÿ õëîðèä 1 ã - 1 ë}                                                                                                            

                                                                                                                                        

│Àöåòàò êàëüöèÿ 500 ìã Ñàëüìîí Ôàðìà│ðåãóëÿòîð îáìåíà êàëüöèÿ è    │òàáëåòêè 500 ìã               │Salmon Pharma (Øâåéöàðèÿ)     │009443,    

                                   │ôîñôîðà [A12AA12]                                                                         │13.05.97   

                                                                                                                                        

│Àöåòåí [Êàïòîïðèë]                 │ÀÊÔ áëîêàòîð [C09AA01]        │òàáëåòêè 25 ìã                │Wockhardt Ltd (Èíäèÿ)         │007269,    

                                                                                                                             │30.07.96   

                                                                                                                                        

│Àöåòèëñàëèöèëáåíå                  │ÍÏÂÑ [N02BA01]                │òàáëåòêè øèïó÷èå              │Ludwig Merckle Gmbh (Àâñòðèÿ) │005339,    

│[Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                                                                  │21.09.94   

                                                                                                                                        

│Àöåòèëñàëèöèëîâàÿ êèñëîòà          │ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã               │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009179,    

│[Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                                    │çàâîä ÀÎ (Ýñòîíñêàÿ           │21.10.97   

                                                                                               │Ðåñïóáëèêà)                              

                                                                                                                                        

│Àöåòèëñàëèöèëîâîé êèñëîòû òàáëåòêè │ÍÏÂÑ [N02BA01]                │òàáëåòêè 250 ìã               │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/626/47, 

│0.25 ã [Àöåòèëñàëèöèëîâàÿ êèñëîòà] │                                                                                          │05.01.98   

                                                                                                                                        

│Àöåòèëñàëèöèëîâîé êèñëîòû òàáëåòêè │ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã               │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/626/47, 

│0.5 ã [Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                                                            │05.01.98   

                                                                                                                                        

│Àöåòèëñàëèöèëîâîé êèñëîòû òàáëåòêè │ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã               │Áîðèñîâñêèé çàâîä             │70/626/47, 

│0.5 ã [Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                              │ìåäïðåïàðàòîâ (Áåëàðóñü)      │20.10.97   

                                                                                                                                        

│Àöåòèëöèñòåèí [Àöåòèëöèñòåèí]      │ìóêîëèòè÷åñêîå ñðåäñòâî       │ãðàíóëÿò îðàëüíûé (ïàêåòû)    │Ct-Arzneimittel Chemishe      │003970,    

                                   │[R05CB01]                     │100, 200 ìã                   │Tempelchof Gmbh (Ãåðìàíèÿ)    │01.06.94   

                                                                                                                                        

│Àöåòèëöèñòåèí [Àöåòèëöèñòåèí]      │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 100, 200, 600 ìã     │Stada Arzneimittel Ag         │010295,    

                                   │[R05CB01]                                                   │(Ãåðìàíèÿ)                    │02.07.98   

                                                                                                                                        

│Àöèäåêñ [Ðàíèòèäèí]                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150, 300 ìã          │Sun Pharmaceutical Industries │005149,    

                                   │áëîêàòîð [A02BA02]                                          │Ltd (Èíäèÿ)                   │20.07.94   

                                                                                                                                        

│Àöèä-Õ {ïàðàöåòàìîë 500 ìã,        │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Bdi Pharmaceuticals (ÑØÀ)     │006310,    

│êàëüöèÿ êàðáîíàò 250 ìã}           │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │21.07.95   

                                   │[N02B]                                                                                               

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 400, 800 ìã          │Lek D.D. (Ñëîâåíèÿ)           │007954,    

                                   │[J05AB01]                                                                                 │15.11.96   

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │êàïñóëû 200 ìã                │Pharmimpex (Ãðóçèÿ)           │009196,    

                                   │[J05AB01]                                                                                 │17.11.97   

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │êðåì (òóáû) 5%                │Remedica Ltd - Minnex (Êèïð)  │006801,    

                                   │[D06BB03]                                                                                 │09.11.95   

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200, 400, 800 ìã     │Searle, Produced By Heumann   │010520,    

                                   │[J05AB01]                                                   │Pharma Gmbh (Ãåðìàíèÿ)        │02.11.98   

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │010179,    

                                   │[J05AB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │21.04.98   

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã                                              

                                                                                                                                        

│Àöèêëîâèð [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200 ìã; êðåì (òóáû)  │Zdravle (Þãîñëàâèÿ)           │005879,    

                                   │[D06BB03] [J05AB01]           │5%                                                          │31.03.95   

                                                                                                                                        

│Àöèêëîâèð Ãåêñàë [Àöèêëîâèð]       │ïðîòèâîâèðóñíîå ñðåäñòâî      │êðåì (òóáû) 5% - 2 ã, 5 ã, 20 │Hexal Ag (Ãåðìàíèÿ)           │009275,    

                                   │[D06BB03]                     │ã                                                           │26.02.97   

                                                                                                                                        

│Àöèêëîâèð-ÁÌÑ [Àöèêëîâèð]          │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200, 400, 800 ìã;    │Gea Farmaceutik Fabrik As, a  │009748,    

                                   │[J05AB01] [S01AD03]           │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │division of Bristol-Myers     │30.09.97   

                                                                 │èíúåêöèîííîãî ðàñòâîðà        │Squibb (Äàíèÿ)                           

                                                                 │(ôëàêîíû) 125, 250, 500 ìã;                                            

                                                                 │ìàçü ãëàçíàÿ (òóáû) 3% - 4.5 ã│                                         

                                                                                                                                        

│Àöèê-îôòàëü [Àöèêëîâèð]            │ïðîòèâîâèðóñíîå ñðåäñòâî      │ìàçü ãëàçíàÿ (òóáû) 3% - 4.5 ã│Dr.Robert Winzer Pharma Gmbh  │009617,    

                                   │[S01AD03]                                                   │(Ãåðìàíèÿ)                    │24.07.97   

                                                                                                                                        

│Àöèëîê-Å [Ðàíèòèäèí]               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150, 300 ìã; ðàñòâîð │Cadila Laboratories Ltd       │02013,     

                                   │áëîêàòîð [A02BA02]            │äëÿ èíúåêöèé (àìïóëû) 2 ìë    │(Èíäèÿ)                       │27.11.90   

                                                                                                                                        

│Àöèëïèðèí [Àöåòèëñàëèöèëîâàÿ       │ÍÏÂÑ [N02BA01]                │òàáëåòêè 500 ìã; òàáëåòêè     │Slovakofarma Sa (Ñëîâàêèÿ)    │003832,    

│êèñëîòà]                                                         │ðàñòâîðèìûå 500 ìã                                          │07.04.94   

                                                                                                                                         

│Àöèïåï [Ôàìîòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 20, 40 ìã            │Kopran Ltd (Èíäèÿ)            │005206,    

                                   │áëîêàòîð [A02BA03]                                                                       │03.08.94   

                                                                                                                                        

│Àöèôåèí {àöåòèëñàëèöèëîâàÿ êèñëîòà │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Slovakofarma Sa (Ñëîâàêèÿ)    │003601,    

│250 ìã, êîôåèí 200 ìã, ïàðàöåòàìîë │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │17.12.93   

│200 ìã}                            │[N02BA71]                                                                                            

                                                                                                                                        

│Àöóïàìèë [Âåðàïàìèë]               │ÁÌÊÊ [C08DA01]                │äðàæå 40, 80, 120 ìã          │Azupharma Gmbh (Ãåðìàíèÿ)     │005234,    

                                                                                                                             │18.08.94   

                                                                                                                                        

│Àöóïåíòàò-400 [Ïåíòîêñèôèëëèí]     │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè                      │Azuchemie Gmbh (Ãåðìàíèÿ)     │003558,    

                                   │[C04AD03]                                                                                 │07.12.93   

                                                                                                                                        

│ÀÖÖ [Àöåòèëöèñòåèí]                │ìóêîëèòè÷åñêîå ñðåäñòâî       │ãðàíóëÿò äëÿ ïðèãîòîâëåíèÿ    │Hexal Ag (Ãåðìàíèÿ)           │010257,    

                                   │[R05CB01]                     │ðàñòâîðà äëÿ ïðèåìà âíóòðü                                  │19.06.98   

                                                                 │(ôëàêîíû) 20 ìã/ìë - 75, 150                                            

                                                                 │ìë                                                                     

                                                                                                                                       

│ÀÖÖ [Àöåòèëöèñòåèí]                │ìóêîëèòè÷åñêîå ñðåäñòâî       │ãðàíóëÿò äëÿ ïðèãîòîâëåíèÿ    │Hexal Ag (Ãåðìàíèÿ)           │009704,    

                                   │[R05CB01]                     │ãîðÿ÷åãî íàïèòêà (ïàêåòèêè)                                 │27.08.97   

                                                                 │200, 600 ìã                                                            

                                                                                                                                        

│ÀÖÖ 100 [Àöåòèëöèñòåèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè øèïó÷èå 100 ìã       │Hexal Ag (Ãåðìàíèÿ)           │009464,    

                                   │[R05CB01]                                                                                 │20.05.97   

                                                                                                                                        

│ÀÖÖ 200 [Àöåòèëöèñòåèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè øèïó÷èå 200 ìã       │Hexal Ag (Ãåðìàíèÿ)           │009465,    

                                   │[R05CB01]                                                                                 │20.05.97   

                                                                                                                                        

│ÀÖÖ èíúåêò. [Àöåòèëöèñòåèí]        │ìóêîëèòè÷åñêîå ñðåäñòâî       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │007514,    

                                   │[R05CB01]                     │300 ìã - 3 ìë                                               │15.05.96   

                                                                                                                                        

│ÀÖÖ-100 [Àöåòèëöèñòåèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │ãðàíóëÿò (ïàêåòèêè) 100 ìã    │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │003409,    

                                   │[R05CB01]                                                                                 │12.10.93   

                                                                                                                                       

│ÀÖÖ-200 [Àöåòèëöèñòåèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │ãðàíóëÿò (ïàêåòèêè) 200 ìã    │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │003409,    

                                   │[R05CB01]                                                                                 │12.10.93   

                                                                                                                                        

│ÀÖÖ-ëîíã [Àöåòèëöèñòåèí]           │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè øèïó÷èå 600 ìã       │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │003408,    

                                   │[R05CB01]                                                                                 │12.10.93   

                                                                                                                                        

│Àýðîñîíèò [Èçîñîðáèä äèíèòðàò]     │âàçîäèëàòèðóþùåå ñðåäñòâî     │àýðîçîëü (ôëàêîíû) 1.25       │Polfa, Poznanskie             │007074,    

                                   │[C01DA08]                     │ìã/äîçà - 300 äîç             │Pharmaceutical Works (Ïîëüøà) │13.02.96   

                                                                                                                                        

│Àýñöèí [Ýñöèí]                     │âåíîòîíèçèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Kutnowskie             │006523,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Pharmaceutical Works (Ïîëüøà) │20.09.95   

                                   │[C05CX]                                                                                              

                                                                                                                                        

│Àÿòèí [Áåíçîäîäåöèíèÿ ãèäðîáðîìèä] │àíòèñåïòè÷åñêîå ñðåäñòâî      │íàñòîéêà                      │Slovakofarma Sa (Ñëîâàêèÿ)    │2578,      

                                   │[D09AA05]                                                                                 │25.10.78,  

                                                                                                                            │10.03.94   

                                                                                                                                        

│Áàéîòàêñ [Öåôîòàêñèì]              │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │Biochem Pharmaceutical        │007839,    

                                   │[J01DA10]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries (Èíäèÿ)            │24.09.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.25, 1 ã                                           

                                                                                                                                        

│Áàêëîôåí [Áàêëîôåí]                │ìèîðåëàêñèðóþùåå ñðåäñòâî     │òàáëåòêè 10, 25 ìã            │Polpharma Pharmaceutical      │008480,    

                                   │[M03BX01]                                                   │Works Sa (Ïîëüøà)             │29.12.97   

                                                                                                                                        

│Áàêòåðîë {ïîëèìèêñèí B 5000 ÅÄ,    │àíòèáèîòèê êîìáèíèðîâàííûé    │ìàçü (òóáû) 14.18, 28.4 ã     │Four Ventures Enterprises     │010142,    

│áàöèòðàöèí 400 ÅÄ, íåîìèöèí 5 ìã - │[D06AX]                                                     │(ÑØÀ)                         │03.04.98   

│1 ã}                                                                                                                                    

                                                                                                                                        

│Áàêòèíîð [Íîðôëîêñàöèí]            │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 400 ìã               │Sun Pharmaceutical Industries │007804,    

                                   │ôòîðõèíîëîí [J01MA06]                                       │Ltd (Èíäèÿ)                   │10.09.96   

                                                                                                                                        

│Áàêòîðåäóêò [Êî-òðèìîêñàçîë]       │ïðîòèâîìèêðîáíîå              │òàáëåòêè 400 ìã/80 ìã, 800    │Azupharma Gmbh (Ãåðìàíèÿ)     │005061,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │ìã/160 ìã; ñèðîï äëÿ äåòåé                                  │30.06.94   

                                   │[J01EE01]                     │200 ìã/40 ìã|5 ìë                                                      

                                                                                                                                        

│Áàêòðèì [Êî-òðèìîêñàçîë]           │ïðîòèâîìèêðîáíîå              │òàáëåòêè 400 ìã/80 ìã; ñèðîï  │F.Hoffmann La Roche Ltd       │006998,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │(ôëàêîíû) 240 ìã|5 ìë         │(Øâåéöàðèÿ)                   │19.01.96   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áàêòðèì [Êî-òðèìîêñàçîë]           │ïðîòèâîìèêðîáíîå              │òàáëåòêè; òàáëåòêè äëÿ äåòåé  │Galenika (Þãîñëàâèÿ)          │00270,     

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │14.01.74,  

                                   │[J01EE01]                                                                                 │22.02.85   

                                                                                                                                        

│Áàêòðèì [Êî-òðèìîêñàçîë]           │ïðîòèâîìèêðîáíîå              │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Galenika (Þãîñëàâèÿ)          │01437,     

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │100 ìë                                                      │27.04.88   

                                   │[J01EE01]                                                                                             

                                                                                                                                        

│Áàêòðèì ñèðîï [Êî-òðèìîêñàçîë]     │ïðîòèâîìèêðîáíîå              │ñèðîï (ôëàêîíû) 240 ìã|5 ìë - │F.Hoffmann La Roche Ltd/Roche │009525,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │50, 100 ìë                    │Fontenay (Ôðàíöèÿ) (Øâåéöàðèÿ)│13.06.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áàêòðèì ôîðòå [Êî-òðèìîêñàçîë]     │ïðîòèâîìèêðîáíîå              │òàáëåòêè 800 ìã/160 ìã        │F.Hoffmann La Roche Ltd       │008261,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                    │(Øâåéöàðèÿ)                   │21.04.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áàêòðîáàí [Ìóïèðîöèí]              │àíòèáèîòèê [D06AX09]          │ìàçü (òóáû) 2% - 15 ã         │Smithkline Beecham            │008219,    

                                                                                               │Pharmaceuticals               │13.03.97   

                                                                                               │(Âåëèêîáðèòàíèÿ)                         

                                                                                                                                        

│Áàêòðîáàí [Ìóïèðîöèí]              │àíòèáèîòèê [R01AX06]          │ìàçü íàçàëüíàÿ                │Smithkline Beecham            │005082,    

                                                                                               │Pharmaceuticals               │05.07.94   

                                                                                               │(Âåëèêîáðèòàíèÿ)                          

                                                                                                                                        

│Áàëüçàì Çäîðîâüå {ìåíòîë 100 ã,    │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü                          │Biopharmtech (ÑÐÂ)            │007107,    

│êàìôîðà 200 ã, ìÿòû ïåðå÷íîé ìàñëî │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │27.02.96   

│130 ã, ýâêàëèïòîâîå ìàñëî 60 ã,    │[M02AX]                                                                                              

│ãâîçäè÷íîå ìàñëî 60 ã, êîðèöû                                                                                                           

│ìàñëî 7.5 ã, ìåòèëñàëèöèëàò 32.5 ã │                                                                                                     

│- 1000 ã}                                                                                                                               

                                                                                                                                        

│Áàëüçàì Çîëîòàÿ çâåçäà {ìåíòîë 455 │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü                          │Biopharmtech (ÑÐÂ)            │007106,    

│ìã, êàìôîðà 910 ìã, ìÿòû ïåðå÷íîé  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │27.02.96   

│ìàñëî 0.59 ìë, ýâêàëèïòîâîå ìàñëî  │[M02AX]                                                                                              

│0.14 ìë, ãâîçäè÷íîå ìàñëî 0.228                                                                                                         

│ìë, êîðèöû ìàñëî 0.053 ìë - 4 ã}                                                                                                        

                                                                                                                                        

│Áàëüçàì Çîëîòîé äðàêîí {æåíüøåíÿ   │àäàïòîãåííîå ñðåäñòâî         │áàëüçàì îðàëüíûé (ôëàêîíû)    │Biopharmtech (ÑÐÂ)            │005888,    

│êîðíÿ ýêñòðàêò 2.5 ã, ðåìàíèè êîðû │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │03.04.95   

│ýêñòðàêò æèäêèé 10 ã, ýâêîìèè êîðû │[A13A]                                                                                               

│ýêñòðàêò æèäêèé 3 ã, äóäíèêà                                                                                                           

│äàóðñêîãî êîðíåé ýêñòðàêò æèäêèé 5 │                                                                                                     

│ã, ãîðöà ìíîãîöâåòêîâîãî êîðíåé                                                                                                         

│ýêñòðàêò æèäêèé 5 ã, ëèãóñòèêóìà                                                                                                        

│óîëëè÷à êîðíåâèùà ýêñòðàêò æèäêèé                                                                                                       

│0.75 ã, ìåä 5 ã, êîðèöû ìàñëî 50                                                                                                        

│ìã, ãâîçäè÷íîå ìàñëî 6.25 ìã,                                                                                                           

│ñàõàð 20 ã, ýòàíîë 95% - 105 ìë}                                                                                                        

                                                                                                                                        

│Áàëüçàì Ìàóðåðà îðèãèíàëüíûé       │àäàïòîãåííîå ñðåäñòâî         │íàñòîéêà (ôëàêîíû) 50, 250,   │Sebastian Stroh Gmbh (Àâñòðèÿ)│007421,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │500 ìë                                                      │08.04.96   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Áàìèïèí-Ðàòèîôàðì [Áàìèïèí]        │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ìàçü (òóáû) 2%                │Ratiopharm Gmbh & Co          │006078,    

                                   │áëîêàòîð [R06AX01]                                          │(Ãåðìàíèÿ)                    │22.05.95   

                                                                                                                                        

│Áàíåîöèí {íåîìèöèí 250 ÅÄ,         │àíòèáèîòèê êîìáèíèðîâàííûé    │ìàçü; ïîðîøîê äëÿ íàðóæíîãî   │Biochemie Gmbh (Àâñòðèÿ)      │003707,    

│áàöèòðàöèí 5000 ÅÄ}                │[D06AX]                       │ïðèìåíåíèÿ                                                  │18.02.94   

                                                                                                                                        

│Áàðàëãèí {ìåòàìèçîë 0.5 ã,         │àíàëüãåòè÷åñêîå è             │òàáëåòêè; ðàñòâîð äëÿ èíúåêöèé│Hoechst Pharmaceutical Ltd    │00899,     

│ôåíïèâåðèíèÿ áðîìèä 100 ìêã,       │ñïàçìîëèòè÷åñêîå ñðåäñòâî                                   │(Èíäèÿ)                       │25.02.82   

│ïèòîôåíîí 5 ìã - òàáëåòêè;         │[N02BB52]                                                                                            

│ìåòàìèçîë 500 ìã, ôåíïèâåðèíèÿ                                                                                                          

│áðîìèä 20 ìêã, ïèòîôåíîí 2 ìã - 1                                                                                                       

│ìë}                                                                                                                                     

                                                                                                                                        

│Áàðàëãèí {ìåòàìèçîë 500 ìã,        │àíàëüãåòè÷åñêîå è             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Jugoremedia (Þãîñëàâèÿ)       │006669,    

│ôåíïèâåðèíèÿ áðîìèä 100 ìêã,       │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │5 ìë; òàáëåòêè                                              │22.03.96   

│ïèòîôåíîí 5 ìã - òàáëåòêè;         │[N02BB52]                                                                                            

│ìåòàìèçîë 500 ìã, ôåíïèâåðèíèÿ                                                                                                          

│áðîìèä 20 ìêã, ïèòîôåíîí 2 ìã - 1                                                                                                        

│ìë}                                                                                                                                     

                                                                                                                                       

│Áàðàëãèí Ì [Ìåòàìèçîë íàòðèÿ]      │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Hoechst Ag (Ãåðìàíèÿ)         │003677,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │èíúåêöèé (àìïóëû) 500 ìã/ìë - │                              │09.02.94   

                                   │[N02BB02]                     │5 ìë; ñâå÷è 300, 1000 ìã                                               

                                                                                                                                        

│Áàðàëãèí Ì [Ìåòàìèçîë íàòðèÿ]      │àíàëüãåòè÷åñêîå               │êàïëè îðàëüíûå (ôëàêîíû)      │Hoechst Ag (Ãåðìàíèÿ)         │005307,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │12.09.94   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Áàðáîâàë {ýòèëáðîìèçîâàëåðèàíàò 18 │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │ðàñòâîð-êàïëè äëÿ âíóòðåííåãî │Ôàðìàê ÀÎ (Óêðàèíà)           │010029,    

│ã, âàëèäîë 80.1 ã, áàðáèòàë 17 ã,  │[C01EX]                       │ïðèìåíåíèÿ                                                  │05.05.98   

│íàòðèÿ ãèäðîêñèä 3.1 ã, ýòàíîë 730 │                              │(ôëàêîí-êàïåëüíèöû) 25 ìë                                              

│ìë, âîäà - 1 ë}                                                                                                                         

                                                                                                                                        

│Áàðíåòèë [Ñóëüòîïðèä]              │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Delagrange (Ôðàíöèÿ)          │01100,     

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │èíúåêöèé (àìïóëû) 200 ìã - 2                                │18.09.84   

                                   │[N05AL02]                     │ìë                                                                    

                                                                                                                                        

│Áàðîôàí Çèäðåêñ {äèãèäðàëàçèí 10   │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè                      │Ipca Laboratories Ltd (Èíäèÿ) │009855,    

│ìã, ðåçåðïèí 0.1 ìã,               │ñðåäñòâî [C02LA51]                                                                        │24.11.97   

│ãèäðîõëîðîòèàçèä 10 ìã}                                                                                                                 

                                                                                                                                        

│Áàðòåë äðàãç À.Ñ.Ê.                │ÍÏÂÑ [N02BA01]                │òàáëåòêè 325 ìã               │Vitech America Corporation    │006240,    

│[Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                                    │(ÑØÀ)                         │03.07.95   

                                                                                                                                        

│Áàðòåë äðàãç Àëàìàã {àëãåëäðàò 225 │àíòàöèäíîå ñðåäñòâî [A02AX]   │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │K.C.Pharmaceuticals Inc (ÑØÀ) │006103,    

│ìã, ìàãíèÿ ãèäðîêñèä 200 ìã - 5 ìë}│                                                                                          │24.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Àíòàöèäíûå òàáëåòêè   │àíòàöèäíîå ñðåäñòâî [A02AC01] │òàáëåòêè 500 ìã               │Vitech America Corporation    │006101,    

│[Êàëüöèÿ êàðáîíàò]                                                                             │(ÑØÀ)                         │24.05.95   

                                                                                                                                         

│Áàðòåë äðàãç Áàöèòðàöèíîâàÿ ìàçü   │àíòèáèîòèê [D06AX05]          │ìàçü (òóáû)                   │Segol Distributing (ÑØÀ)      │006380,    

│[Áàöèòðàöèí]                                                                                                                │09.08.95   

                                                                                                                                        

│Áàðòåë äðàãç Áèçìàò [Âèñìóòà       │àíòèñåïòè÷åñêîå êèøå÷íîå      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │K.C.Pharmaceuticals Inc (ÑØÀ) │006100,    

│ñóáñàëèöèëàò]                      │ñðåäñòâî [A02BX05]                                                                        │24.05.95   

                                                                                                                                        

│Áàðòåë Äðàãç Âèòàìèí À [Ðåòèíîë]   │âèòàìèí [A11CA01]             │êàïñóëû 10000 ÌÅ              │Vitech America Corporation    │007767,    

                                                                                               │(ÑØÀ)                         │28.08.96   

                                                                                                                                        

│Áàðòåë äðàãç Âèòàìèí Â12           │âèòàìèí [B03BA01]             │òàáëåòêè 100 ìêã              │Vitech America Corporation    │006062,    

│[Öèàíîêîáàëàìèí]                                                                               │(ÑØÀ)                         │18.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Âèòàìèí Â6            │âèòàìèí [A11HA02]             │òàáëåòêè 100 ìã               │Vitech America Corporation    │006063,    

│[Ïèðèäîêñèí]                                                                                   │(ÑØÀ)                         │18.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Âèòàìèí Å [Âèòàìèí Å] │âèòàìèí [A11HA03]             │êàïñóëû 400 ÌÅ                │Vitech America Corporation    │006098,    

                                                                                               │(ÑØÀ)                         │24.05.95   

                                                                                                                                       

│Áàðòåë äðàãç Âèòàìèí Ñ             │âèòàìèí [A11GA01]             │òàáëåòêè 500 ìã               │Vitech America Corporation    │005984,    

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                         │(ÑØÀ)                         │20.04.95   

                                                                                                                                        

│Áàðòåë äðàãç Âèòàìèí Ñ æåâàòåëüíûé │âèòàìèí [A11GA01]             │òàáëåòêè 250 ìã               │Vitech America Corporation    │005983,    

│ñ àïåëüñèíîâûì âêóñîì                                                                          │(ÑØÀ)                         │20.04.95   

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                                                                  

                                                                                                                                        

│Áàðòåë äðàãç Ãèäðîêîðòèçîíîâàÿ 1%  │ãëþêîêîðòèêîñòåðîèä [D07AA02] │ìàçü (òóáû) 1% - 28.35 ã      │Clay-Park Labs Inc (ÑØÀ)      │007490,    

│ìàçü [Ãèäðîêîðòèçîí]                                                                                                         │12.05.96   

                                                                                                                                        

│Áàðòåë äðàãç Äåòñêàÿ çàùèòíàÿ è    │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │ìàçü (òóáû)                   │Clay-Park Labs Inc (ÑØÀ)      │006102,    

│ëå÷åáíàÿ ìàçü {öèíêà îêñèä, òàëüê, │[D02AB]                                                                                   │24.05.95   

│ëàíîëèí, òðåñêè ïå÷åíè æèð}                                                                                                             

                                                                                                                                         

│Áàðòåë äðàãç Èáóïðîôåí [Èáóïðîôåí] │ÍÏÂÑ [M02AA13]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Vitech America Corporation    │006104,    

                                                                 │200 ìã                        │(ÑØÀ)                         │24.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Ìàçü äëÿ ìûøö         │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû)                   │Clay-Park Labs Inc (ÑØÀ)      │006081,    

│{ìåíòîë, ìåòèëñàëèöèëàò, ëàíîëèí}  │[M02AC]                                                                                   │22.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Ìàçü ñ âèòàìèíàìè À è │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │ìàçü (òóáû) 56.7 ã            │Clay-Park Labs Inc (ÑØÀ)      │007491,    

│Ä {ðåòèíîë, ýðãîêàëüöèôåðîë}       │[D10AD]                                                                                   │12.05.96   

                                                                                                                                        

│Áàðòåë äðàãç Îáåçáîëåâàþùåå        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã; êàïëè äëÿ    │Vitech America Corporation    │006096,    

│ñðåäñòâî àïàï [Ïàðàöåòàìîë]        │íåíàðêîòè÷åñêîå ñðåäñòâî      │äåòåé (ôëàêîíû); òàáëåòêè äëÿ │(ÑØÀ)                         │24.05.95   

                                   │[N02BE01]                     │äåòåé 80 ìã; ýëèêñèð äëÿ                                               

                                                                 │äåòåé (ôëàêîíû)                                                        

                                                                                                                                        

│Áàðòåë äðàãç Îáåçáîëèâàþùèé ãåëü   │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ãåëü (òóáû)                   │Clay-Park Labs Inc (ÑØÀ)      │006080,    

│äëÿ ãóá è ñëèçèñòîé ðòà [Áåíçîêàèí]│[D04AB04]                                                                                 │22.05.95   

                                                                                                                                        

│Áàðòåë äðàãç Ïðîëàíòà {àëãåëäðàò   │àíòàöèäíîå ñðåäñòâî [A02AX]   │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │K.C.Pharmaceuticals Inc (ÑØÀ) │006099,    

│90 ìã, ìàãíèÿ ãèäðîêñèä 60 ìã - 1                                                                                            │24.05.95   

│ìë}                                                                                                                                     

                                                                                                                                        

│Áàðòåë äðàãç Ïðîòèâîîòå÷íûå è      │ïðîòèâîêîíãåñòèâíîå ñðåäñòâî  │êàïñóëû                       │Segol Distributing (ÑØÀ)      │006379,    

│Àíòèãèñòàìèííûå êàïñóëû            │[R01BA51]                                                                                 │09.08.95   

│{ôåíèëïðîïàíîëàìèí 75 ìã,                                                                                                               

│õëîðôåíàìèí 4 ìã}                                                                                                                       

                                                                                                                                        

│Áàðòåë Äðàãç Ïðîòèâîîòå÷íûé ñïðåé  │àëüôà-àäðåíîñòèìóëÿòîð        │ñïðåé (ôëàêîíû) 0.5 ìã - 29.6 │Clay-Park Labs Inc (ÑØÀ)      │006672,    

│äëÿ íîñà 12-òè ÷àñîâîãî äåéñòâèÿ   │[R01AA05]                     │ìë                                                          │29.09.95   

│[Îêñèìåòàçîëèí]                                                                                                                         

                                                                                                                                        

│Áàðòåë äðàãç Òîëíàôòàò 1% ìàçü     │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ìàçü (òóáû) 1% - 14.2 ã       │Clay-Park Labs Inc (ÑØÀ)      │007492,    

│[Òîëíàôòàò]                        │[D01AE18]                                                                                 │12.05.96   

                                                                                                                                        

│Áàðòåë äðàãç Òðîéíàÿ               │àíòèáèîòèê êîìáèíèðîâàííûé    │ìàçü (òóáû)                   │Segol Distributing (ÑØÀ)      │006381,    

│àíòèáèîòèêîâàÿ ìàçü {ïîëèìèêñèí B  │[D06AX]                                                                                   │09.08.95   

│5000 ÌÅ, áàöèòðàöèí 400 ÌÅ,                                                                                                             

│íåîìèöèí 3.5 ìã - 1 ã}                                                                                                                  

                                                                                                                                        

│Áàññàäî [Äîêñèöèêëèí]              │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Poli (Èòàëèÿ)                 │006853,    

                                   │[J01AA02]                                                                                 │24.11.95   

                                                                                                                                        

│Áàòðàôåí [Öèêëîïèðîêñ]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì (òóáû) 1% - 20, 50 ã;    │Hoechst Ag (Ãåðìàíèÿ)         │008217,    

                                   │[D01AE14]                     │ïóäðà (ôëàêîíû) 10 ìã/ã - 30                                │13.03.97   

                                                                 │ã; ðàñòâîð äëÿ íàðóæíîãî                                               

                                                                 │ïðèìåíåíèÿ (ôëàêîíû) 1% - 20, │                                         

                                                                 │50 ìë                                                                  

                                                                                                                                        

│Áàòðàôåí [Öèêëîïèðîêñ]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì âàãèíàëüíûé (òóáû) 10    │Hoechst Ag (Ãåðìàíèÿ)         │009663,    

                                   │[G01AX12]                     │ìã|1 ã - 40 ã                                               │08.08.97   

                                                                                                                                       

│Áàòðàôåí [Öèêëîïèðîêñ]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ëàê äëÿ íîãòåé (ôëàêîíû) 8%   │Hoechst Ag (Ãåðìàíèÿ)         │010396,    

                                   │[D01AE14]                                                                                 │05.08.98   

                                                                                                                                        

│Áàòðàôåí [Öèêëîïèðîêñ]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ðàñòâîð äëÿ íàðóæíîãî         │Roussel (India) Limited       │009588,    

                                   │[D01AE14]                     │ïðèìåíåíèÿ (ôëàêîíû) 1% - 20  │(Èíäèÿ)                       │10.07.97   

                                                                 │ìë; êðåì (òóáû) 1% - 15 ã                                              

                                                                                                                                        

│Áàòðàôåí [Öèêëîïèðîêñ]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì; ïóäðà äëÿ íàðóæíîãî     │Jugoremedia (Þãîñëàâèÿ)       │005075,    

                                   │[D01AE14]                     │ïðèìåíåíèÿ; ðàñòâîð                                         │01.07.94   

                                                                                                                                        

│Áåáèíîñ {ðîìàøêè öâåòêè 0.2 ã,     │âåòðîãîííîå ñðåäñòâî          │êàïëè îðàëüíûå äëÿ äåòåé      │Dentinox (Ãåðìàíèÿ)           │005545,    

│ôåíõåëÿ ïëîäîâ ýêñòðàêò 0.32 ã,    │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │06.12.94   

│êîðèàíäðà öâåòêè 0.2 ã}            │[A02DA]                                                                                              

                                                                                                                                         

│Áåáóëèí ÒÈÌ 4 (Ôàêòîð IX ÷åëîâåêà  │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │Immuno Ag (Àâñòðèÿ)           │005808,    

│êîíöåíòðèðîâàííûé) [Ôàêòîð         │[B02BD04]                     │ïðèãîòîâëåíèÿ âíóòðèâåííîãî                                │07.03.95   

│ñâåðòûâàíèÿ êðîâè IX]                                            │ðàñòâîðà (ôëàêîíû) 600, 1200                                           

                                                                 │ÌÅ /â êîìïëåêòå ñ                                                      

                                                                 │ðàñòâîðèòåëåì/                                                         

                                                                                                                                        

│Áåçàëèï [Áåçàôèáðàò]               │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Boehringer Mannheim Gmbh      │008200,    

                                   │[C10AB02]                     │200 ìã                        │(Ãåðìàíèÿ)                    │05.06.97   

                                                                                                                                        

│Áåçàìèäèí [Áåçàôèáðàò]             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Krka (Ñëîâåíèÿ)               │007305,    

                                   │[C10AB02]                     │200 ìã                                                      │10.09.96   

                                                                                                                                        

│Áåêëîäæåò 250 [Áåêëîìåòàçîí]       │ãëþêîêîðòèêîñòåðîèä äëÿ       │ñóñïåíçèÿ äëÿ èíãàëÿöèé       │Promedica (Ôðàíöèÿ)           │010519,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │(ôëàêîíû) 250 ìêã/äîçà - 200                                │30.10.98   

                                                                 │äîç /â êîìïëåêòå ñ                                                     

                                                                 │èíãàëÿöèîííîé êàìåðîé - ÄÆÅÒ                                            

                                                                 │ñèñòåìà/                                                               

                                                                                                                                       

│Áåêëîêîðò [Áåêëîìåòàçîí]           │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü ìèòå; àýðîçîëü ôîðòå │Polfa (Ïîëüøà)                │2973,      

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │                                                            │06.06.90   

                                                                                                                                        

│Áåêëîìåò-èçèõåéëåð [Áåêëîìåòàçîí]  │ãëþêîêîðòèêîñòåðîèä äëÿ       │ïîðîøîê äëÿ èíãàëÿöèé         │Orion Corporation (Ôèíëÿíäèÿ) │009563,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │(äîçèðóþùåå óñòðîéñòâî -                                    │01.07.97   

                                                                 │èçèõåéëåð) 200 ìêã/äîçà - 200 │                                         

                                                                 │äîç; ïîðîøîê äëÿ èíãàëÿöèé                                             

                                                                 │(äîçèðóþùåå óñòðîéñòâî -                                               

                                                                 │èçèõåéëåð ñ çàùèòíûì                                                   

                                                                 │ôóòëÿðîì) 200 ìêã/äîçà - 200                                           

                                                                 │äîç                                                                    

                                                                                                                                        

│Áåêëîôîðòå [Áåêëîìåòàçîí]          │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé         │Glaxo-Wellcome Operations Ltd │009154,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │(áàëëîíû) 250 ìêã/äîçà - 80,  │(Âåëèêîáðèòàíèÿ)              │18.02.97   

                                                                 │200 äîç                                                                

                                                                                                                                       

│Áåêîäèñê [Áåêëîìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │ïîðîøîê (êàïñóëû) 100, 200    │Glaxo (Âåëèêîáðèòàíèÿ)        │002874,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │ìêã /â êîìïëåêòå ñ                                          │25.02.93   

                                                                 │äèñêõàëåðîì/                                                           

                                                                                                                                        

│Áåêîíàçà [Áåêëîìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │ñïðåé íàçàëüíûé               │Glaxo (Âåëèêîáðèòàíèÿ)        │00911,     

                                   │ìåñòíîãî ïðèìåíåíèÿ [R01AD01] │                                                            │28.04.82,  

                                                                                                                             │28.06.94   

                                                                                                                                        

│Áåêîíàçå [Áåêëîìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │ñïðåé íàçàëüíûé âîäíûé 50     │Glaxo-Wellcome (Èñïàíèÿ)      │007747,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R01AD01] │ìêã/äîçà - 200 äîç                                          │19.08.96   

                                                                                                                                        

│Áåêîòèä [Áåêëîìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü (èíãàëÿòîð ñ         │Norton Healthcare For         │008598,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │îïòèìèçàòîðîì äîçû) 100, 250  │Glaxo-Wellcome                │14.08.98   

                                                                 │ìêã/äîçà - 200 äîç; àýðîçîëü  │(Âåëèêîáðèòàíèÿ)                          

                                                                 │(áàëëîí÷èêè) 50, 100, 250                                              

                                                                 │ìêã/äîçà - 200 äîç                                                    

                                                                                                                                        

│Áåêóíèñ {ñåííû ýêñòðàêò 150-220 ìã}│ñëàáèòåëüíîå ñðåäñòâî         │äðàæå                         │Roha Arzneimittel Gmbh        │006032,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │05.05.95   

                                   │[A06AB06]                                                                                            

                                                                                                                                        

│Áåêóíèñ ëåãêèé {ïîäîðîæíèêà        │ñëàáèòåëüíîå ñðåäñòâî         │ãðàíóëû                       │Roha Arzneimittel Gmbh        │006030,    

│ÿéöåâèäíîãî ñåìåíà}                │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │05.05.95   

                                   │[A06AB]                                                                                              

                                                                                                                                        

│Áåëëàñïîí {ýðãîòàìèí 0.3 ìã,       │ñåäàòèâíîå ñðåäñòâî [N05CB02] │äðàæå                         │Lechiva (×åõèÿ)               │007294,    

│ðàäîáåëèí 0.1 ìã, ôåíîáàðáèòàë 20                                                                                            │20.08.96   

│ìã}                                                                                                                                     

                                                                                                                                        

│Áåëëîèä {ãèîñöèàìèí 0.1 ìã,        │ñåäàòèâíîå ñðåäñòâî [N05CB02] │äðàæå                         │Gedeon Richter (Âåíãðèÿ)      │008254,    

│ñïîðûíüè àëêàëîèäû 0.3 ìã,                                                                                                   │09.04.97   

│Áóòîáàðáèòàë 30 ìã}                                                                                                                    

                                                                                                                                        

│Áåëîãåíò {áåòàìåòàçîíà äèïðîïèîíàò │ãëþêîêîðòèêîñòåðîèä           │ìàçü; êðåì                    │Podravka-Belupo (Õîðâàòèÿ)    │01763,     

│0.5 ìã, ãåíòàìèöèí 1 ìã - 1 ã}     │+ïðîòèâîìèêðîáíîå ñðåäñòâî                                                                │22.02.90,  

                                   │[D07CC01]                                                                                 │26.07.94   

                                                                                                                                        

│Áåëîäåðì [Áåòàìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì (òóáû) 0.05% - 30 ã;     │Belupo (Õîðâàòèÿ)             │008067,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC01] │ìàçü (òóáû) 0.05% - 30 ã                                    │25.11.96   

                                                                                                                                        

│Áåëîìåò [Öèìåòèäèí]                │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 200 ìã; ðàñòâîð äëÿ  │Podravka-Belupo (Õîðâàòèÿ)    │00900,     

                                   │áëîêàòîð [A02BA01]            │âíóòðèâåííîãî ââåäåíèÿ                                      │12.02.82,  

                                                                 │(àìïóëû) 200 ìã - 2 ìë                                      │21.09.94   

                                                                                                                                        

│Áåëîñàëèê {áåòàìåòàçîíà            │ïðîòèâîâîñïàëèòåëüíîå         │ëîñüîí                        │Belupo (Õîðâàòèÿ)             │005416,    

│äèïðîïèîíàò 0.5 ìã, ñàëèöèëîâàÿ    │ñðåäñòâî äëÿ ìåñòíîãî                                                                     │24.10.94   

│êèñëîòà 20 ìã - 1 ã}               │ïðèìåíåíèÿ [D07XC01]                                                                                 

                                                                                                                                       

│Áåëîñàëèê {áåòàìåòàçîíà            │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü (òóáû) 30 ã              │Belupo (Õîðâàòèÿ)             │008066,    

│äèïðîïèîíàò 0.5 ìã, ñàëèöèëîâàÿ    │ñðåäñòâî äëÿ ìåñòíîãî                                                                     │25.11.96   

│êèñëîòà 30 ìã - 1 ã}               │ïðèìåíåíèÿ [D07XC01]                                                                                 

                                                                                                                                        

│Áåíàëüãèí {ìåòàìèçîë 0.5 ã, êîôåèí │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Pharmachim Holding Ead,       │008572,    

│50 ìã, òèàìèí 38.75 ìã}            │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Pharmacia AD (Áîëãàðèÿ)       │14.07.98   

                                   │[N02BB72]                                                                                            

                                                                                                                                        

│Áåí-Ãåé {ìåíòîë 4% - êðåì;         │ïðîòèâîâîñïàëèòåëüíîå         │êðåì äëÿ äåòåé; ìàçü; áàëüçàì │Pfizer Ilaclari As (Òóðöèÿ)   │005539,    

│ìåòèëñàëèöèëàò 15%, ìåíòîë 10% -   │ñðåäñòâî äëÿ ìåñòíîãî         │ñïîðòèâíûé                                                  │05.12.94   

│ìàçü; ìåòèëñàëèöèëàò 28%, ìåíòîë   │ïðèìåíåíèÿ [M02AC]                                                                                   

│10% - áàëüçàì}                                                                                                                          

                                                                                                                                        

│Áåíåìèöèí [Ðèôàìïèöèí]             │àíòèáèîòèê [J04AB02]          │êàïñóëû 150 ìã                │Polfa, Tarchomin              │008543,    

                                                                                               │Pharmaceutical Works Sa       │26.05.98   

                                                                                               │(Ïîëüøà)                                 

                                                                                                                                        

│Áåíçàìèöèí {ýðèòðîìèöèí 30 ìã,     │àíòèñåïòè÷åñêîå ñðåäñòâî      │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Rhone-Poulenc Rorer (ÑØÀ)     │009118,    

│áåíçîèëïåðîêñèä 50 ìã - 1 ã}       │[D10AF52]                     │(áàíêè) 20 ã /â êîìïëåêòå ñ                                 │04.02.97   

                                                                 │ïîðîøêîì ýðèòðîìèöèíà                                                  

                                                                 │(ôëàêîíû) 0.8 ã/                                                       

                                                                                                                                        

│Áåíçèëïåíèöèëëèí [Áåíçèëïåíèöèëëèí]│àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sanavita Gesundcheitsmittel & │006757,    

                                   │[J01CE01]                     │èíúåêöèîííîãî ðàñòâîðà        │Co Kg (Ãåðìàíèÿ)              │27.10.95   

                                                                 │(ôëàêîíû) 1000000, 5000000 ÅÄ │                                         

                                                                                                                                        

│Áåíçèëïåíèöèëëèíà íàòðèåâàÿ ñîëü   │àíòèáèîòèê, ïåíèöèëëèí        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │64/228/41, 

│[Áåíçèëïåíèöèëëèí]                 │[J01CE01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │12.11.97   

                                                                 │(ôëàêîíû) 500000, 1000000 ÅÄ                                           

                                                                                                                                         

│Áåíôîãàììà 150 [Áåíôîòèàìèí]       │âèòàìèí [A11DA]               │äðàæå                         │Worwag Pharma Gmbh (Ãåðìàíèÿ) │006767,    

                                                                                                                            │31.10.95   

                                                                                                                                        

│Áåïàíòåí [Äåêñïàíòåíîë]            │ðåãåíåðàöèè ñòèìóëÿòîð        │êðåì (òóáû) 5% - 30 ã; ìàçü   │Hoffmann La Roche Ag          │009455,    

                                   │[D03AX03]                     │(òóáû) 5% - 30 ã              │(Ãåðìàíèÿ)                    │16.05.97   

                                                                                                                                        

│Áåïàíòåí [Äåêñïàíòåíîë]            │ðåãåíåðàöèè ñòèìóëÿòîð        │ëîñüîí (ôëàêîíû) 2.5% - 200 ìë│Roche Nicholas B.V.           │009711,    

                                   │[D03AX03]                                                   │(Íèäåðëàíäû)                  │05.09.97   

                                                                                                                                        

│Áåïàíòåí ïëþñ {äåêñïàíòåíîë 50 ìã  │ðåãåíåðàöèè ñòèìóëÿòîð        │êðåì (òóáû) 30 ã              │Hoffmann La Roche Ag          │010190,    

│õëîðãåêñèäèí 5 ìã - 1 ã}           │[D08AC52]                                                   │(Ãåðìàíèÿ)                    │29.04.98   

                                                                                                                                        

│Áåðåø ïëþñ {æåëåçî 6.7 ìã, öèíê    │ìóëüòèìèíåðàë [A12]           │êàïëè îðàëüíûå (ôëàêîíû)      │Beresh (Âåíãðèÿ)              │005223,    

│3.79 ìã, íàòðèé 2.14 ìã, ìàãíèé                                                                                              │12.08.94   

│1.35 ìã, ìàðãàíåö 1.02 ìã, êàëèé                                                                                                        

│0.924 ìã, ìåäü 0.848 ìã, ìîëèáäåí                                                                                                        

│0.634 ìã, âàíàäèé 0.406 ìã, íèêåëü │                                                                                                     

│0.362 ìã, áðîì 0.35 ìã, ôòîð 0.301 │                                                                                                    

│ìã, õëîðèäû 9 ìêã, êîáàëüò 8.3 ìêã │                                                                                                     

│- 6 ìë}                                                                                                                                 

                                                                                                                                        

│Áåðëèäîðì 5 [Íèòðàçåïàì]           │ñíîòâîðíîå ñðåäñòâî [N05CD02] │òàáëåòêè 5 ìã                 │Berlin-Chemie Ag (ÔÐÃ)        │002506,    

                                                                                                                             │09.06.92   

                                                                                                                                        

│Áåðëèêîðò [Òðèàìöèíîëîí]           │ãëþêîêîðòèêîñòåðîèä [H02AB08] │òàáëåòêè 4 ìã                 │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007366,    

                                                                                                                             │22.10.96   

                                                                                                                                        

│Áåðëèíñóëèí Í 10/90 U-40           │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005675,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 10/90 ïåí            │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005708,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │31.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 20/80 U-40           │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005677,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 20/80 ïåí            │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005706,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │31.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 30/70 U-40           │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005678,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 30/70 ïåí            │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005705,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │31.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í 40/60 U-40           │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005674,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                         

│Áåðëèíñóëèí Í 40/60 ïåí            │èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005704,    

│[Èíñóëèí-Êîìá]                     │[A10AD]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                               │31.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í Áàçàëü U-40          │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005676,    

│[Èíñóëèí-ÑðÄ]                      │[A10AC]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í Áàçàëü ïåí           │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005707,    

│[Èíñóëèí-ÑðÄ]                      │[A10AC]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │31.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í Íîðìàëü U-40         │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005673,    

│[Èíñóëèí-ÁÄ]                       │[A10AB]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │23.01.95   

                                                                                                                                        

│Áåðëèíñóëèí Í Íîðìàëü ïåí          │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005703,    

│[Èíñóëèí-ÁÄ]                       │[A10AB]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │31.01.95   

                                                                                                                                        

│Áåðëèïðèë 5 [Ýíàëàïðèë]            │ÀÊÔ áëîêàòîð [C09AA02]        │òàáëåòêè 5 ìã                 │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005564,    

                                                                                                                             │14.12.94   

                                                                                                                                       

│Áåðëîí {ìåòàìèçîë 500 ìã,          │àíàëüãåòè÷åñêîå è             │òàáëåòêè                      │Aurobindo Pharma Ltd (Èíäèÿ)  │006980,    

│ôåíïèâåðèíèÿ áðîìèä 100 ìêã,       │ñïàçìîëèòè÷åñêîå ñðåäñòâî                                                                 │12.01.96   

│ïèòîôåíîí 5 ìã}                    │[N02BB52]                                                                                            

                                                                                                                                        

│Áåðëîöèä 240 [Êî-òðèìîêñàçîë]      │ïðîòèâîìèêðîáíîå              │ñóñïåíçèÿ äëÿ ïðèåìà âíóòðü   │Berlin-Chemie Ag (Ãåðìàíèÿ)   │008351,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │(ôëàêîíû) 240 ìã|5 ìë - 100 ìë│                              │31.10.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áåðëîöèä 480 [Êî-òðèìîêñàçîë]      │ïðîòèâîìèêðîáíîå              │òàáëåòêè                      │Berlin-Chemie Ag (ÔÐÃ)        │003295,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │02.09.93   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áåðëîöèä 960 [Êî-òðèìîêñàçîë]      │ïðîòèâîìèêðîáíîå              │òàáëåòêè                      │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006256,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │10.07.95   

                                   │[J01EE01]                                                                                            

                                                                                                                                       

│Áåðîäóàë {èïðàòðîïèÿ áðîìèä 0.25   │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │ðàñòâîð äëÿ èíãàëÿöèé         │Boehringer Ingelheim Italy    │008714,    

│ìã, ôåíîòåðîë 0.5 ìã - 1 ìë}       │[R03AK03]                     │(ôëàêîíû) 20 ìë               │Spa, a division of Boehringer │22.10.98   

                                                                                               │Ingelheim International Gmbh             

                                                                                               │(Èòàëèÿ)                                 

                                                                                                                                        

│Áåðîäóàë {èïðàòðîïèÿ áðîìèä 0.25   │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │àýðîçîëü äîçèðîâàííûé         │Boehringer Ingelheim          │01104,     

│ìã, ôåíîòåðîë 0.5 ìã - 1 ìë}       │[R03AK03]                     │(èíãàëÿòîð); ðàñòâîð äëÿ      │International Gmbh (Ãåðìàíèÿ) │20.09.84,  

                                                                 │èíãàëÿöèé                                                   │04.05.95   

                                                                                                                                        

│Áåðîòåê [Ôåíîòåðîë]                │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé         │Boehringer Ingelheim          │00317,     

                                   │ñåëåêòèâíûé [R03AC04]         │(áàëëîí÷èêè 10 ìë) 200        │International Gmbh (Ãåðìàíèÿ) │30.10.74,  

                                                                 │ìêã/äîçà - 200 äîç; àýðîçîëü                                │24.04.84,  

                                                                 │äîçèðîâàííûé (áàëëîí÷èêè 15                                 │20.06.95   

                                                                 │ìë) 200 ìêã/äîçà - 300 äîç                                              

                                                                                                                                        

│Áåðîòåê [Ôåíîòåðîë]                │áåòà2-àäðåíîñòèìóëÿòîð        │ïîðîøîê äëÿ èíãàëÿöèé â       │Boehringer Ingelheim          │007197,    

                                   │ñåëåêòèâíûé [R03AC04]         │êàïñóëàõ 0.2 ìã               │International Gmbh (Ãåðìàíèÿ) │24.05.96   

                                                                                                                                        

│Áåðîòåê [Ôåíîòåðîë]                │áåòà2-àäðåíîñòèìóëÿòîð        │ðàñòâîð äëÿ èíãàëÿöèé         │Boehringer Ingelheim Italy    │008531,    

                                   │ñåëåêòèâíûé [R03AC04]         │(ôëàêîíû) 0.1% - 20, 40, 100  │Spa (Èòàëèÿ)                  │13.04.98   

                                                                 │ìë                                                                     

                                                                                                                                        

│Áåðîòåê [Ôåíîòåðîë]                │áåòà2-àäðåíîñòèìóëÿòîð        │ðàñòâîð äëÿ èíãàëÿöèé         │Boehringer Ingelheim          │009128,    

                                   │ñåëåêòèâíûé [R03AC04]         │(ôëàêîíû ñ êàïåëüíèöåé) 0.1%  │International Gmbh (Ãåðìàíèÿ) │05.02.97   

                                                                 │- 20, 40, 100 ìë                                                       

                                                                                                                                        

│Áåðîòåê-100 [Ôåíîòåðîë]            │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé 100     │Boehringer Ingelheim Pharma   │003773,    

                                   │ñåëåêòèâíûé [R03AC04]         │ìêã/äîçà - 15 ìë              │Gmbh (Ãåðìàíèÿ)               │17.03.94   

                                                                                                                                        

│Áåðîòåê-100 [Ôåíîòåðîë]            │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé 100     │Boehringer Ingelheim Pharma   │002966,    

                                   │ñåëåêòèâíûé [R03AC04]         │ìêã/äîçà - 15.9 ã|10 ìë       │Gmbh (ÔÐÃ)                    │16.04.93   

                                                                                                                                       

│Áåñòàòèí [Óáåíèìåêñ]               │èììóíîäåïðåññèâíîå ñðåäñòâî   │êàïñóëû 30 ìã                 │Nippon Kayaku Co Ltd (ßïîíèÿ) │005367,    

                                   │[L04AX]                                                                                   │27.09.94   

                                                                                                                                        

│Áåòàãåíòàì {áåòàìåòàçîí 5 ìã,      │ãëþêîêîðòèêîñòåðîèä           │êàïëè ãëàçíûå (ôëàêîíû) 5 ìë  │Dr.Robert Winzer Pharma Gmbh  │009604,    

│ãåíòàìèöèí 1 ìã - 1 ã}             │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │+ ìàçü ãëàçíàÿ (òóáû) 5 ã     │(Ãåðìàíèÿ)                    │17.07.97   

                                   │[S01CA]                       │(óïàêîâêè êîìáèíèðîâàííûå);                                            

                                                                 │êàïëè ãëàçíûå (ôëàêîíû) 5 ìë; │                                         

                                                                 │ìàçü ãëàçíàÿ (òóáû) 5 ã                                                

                                                                                                                                        

│Áåòàäåðìèê {áåòàìåòàçîíà           │ãëþêîêîðòèêîñòåðîèä äëÿ       │ìàçü (òóáû) 25, 50 ã          │Hexal Ag (Ãåðìàíèÿ)           │010254,    

│äèïðîïèîíàò 0.64 ìã, ñàëèöèëîâàÿ   │ìåñòíîãî ïðèìåíåíèÿ [D07XC01] │                                                            │18.06.98   

│êèñëîòà 30 ìã - 1 ã}                                                                                                                    

                                                                                                                                        

│Áåòàäèí [Ïîâèäîí-Éîä]              │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ ïîëîñêàíèÿ ðòà è  │Alkaloid (Ìàêåäîíèÿ)          │002770,    

                                   │[R02AA15]                     │ãîðëà (ôëàêîíû) 1% - 100 ìë                                 │21.12.92   

                                                                                                                                       

│Áåòàäèí [Ïîâèäîí-Éîä]              │àíòèñåïòè÷åñêîå ñðåäñòâî      │ìûëî æèäêîå                   │Egis (Âåíãðèÿ)                │005955,    

                                   │[D11AC06]                                                                                 │13.04.95   

                                                                                                                                        

│Áåòàäèí [Ïîâèäîí-Éîä]              │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Egis Pharmaceutical Works Sa  │008387,    

                                   │[D08AG02]                     │ïðèìåíåíèÿ (ôëàêîíû) 10% -    │(Âåíãðèÿ)                     │20.01.98   

                                                                 │30, 120, 1000 ìë; ìàçü (òóáû) │                                         

                                                                 │10% - 20 ã; ñóïïîçèòîðèè                                               

                                                                 │âàãèíàëüíûå 200 ìã                                                     

                                                                                                                                        

│Áåòàäèíå [Ïîâèäîí-Éîä]             │àíòèñåïòè÷åñêîå ñðåäñòâî      │ñâå÷è âàãèíàëüíûå 200 ìã;     │Alkaloid (Ìàêåäîíèÿ)          │008086,    

                                   │[D08AG02] [G01AX11]           │ðàñòâîð äëÿ íàðóæíîãî                                       │18.12.96   

                                                                 │ïðèìåíåíèÿ (ôëàêîíû) 7.5% -                                            

                                                                 │100, 500, 1000, 5000 ìë;                                               

                                                                 │ðàñòâîð äëÿ íàðóæíîãî                                                   

                                                                 │ïðèìåíåíèÿ (ôëàêîíû) 10% -                                             

                                                                 │100, 500, 1000, 5000 ìë                                               

                                                                                                                                        

│Áåòàäðèí {äèôåíãèäðàìèí 1 ìã,      │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │êàïëè ãëàçíûå                 │Polfa, Warszawskie            │006053,    

│íàôòèëìåòèëìèäàçîëèí 0.33 ìã,      │[S01GX]                                                     │Pharmaceutical Works (Ïîëüøà) │17.05.95   

│áîðíàÿ êèñëîòà 19 ìã - 1 ìë}                                                                                                            

                                                                                                                                        

│Áåòàäóð [Àòåíîëîë]                 │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Brown&Burk Pharmaceutical     │005370,    

                                   │ñåëåêòèâíûé [C07AB03]         │50, 100 ìã                    │Private Ltd (Èíäèÿ)           │27.09.94   

                                                                                                                                        

│Áåòàèí öèòðàò ÓÏÑÀ øèïó÷èé [Áåòàèí]│ïèùåâàðèòåëüíîå ôåðìåíòíîå    │òàáëåòêè øèïó÷èå              │Laboratoires Upsa (Ôðàíöèÿ)   │003434,    

                                   │ñðåäñòâî [A09AB02]                                                                        │19.10.93   

                                                                                                                                        

│Áåòàêàðä-100 [Àòåíîëîë]            │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Torrent Pharmaceuticals Ltd   │008615,    

                                   │ñåëåêòèâíûé [C07AB03]         │100 ìã                        │(Èíäèÿ)                       │28.04.98   

                                                                                                                                         

│Áåòàêàðä-50 [Àòåíîëîë]             │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Torrent Pharmaceuticals Ltd   │008614,    

                                   │ñåëåêòèâíûé [C07AB03]         │50 ìã                         │(Èíäèÿ)                       │28.04.98   

                                                                                                                                        

│Áåòàêîðòàë [Áåòàìåòàçîí]           │ãëþêîêîðòèêîñòåðîèä äëÿ       │êàïëè ãëàçíûå è óøíûå         │Darou Paksh Pharmaceutical    │006830,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [S01BA06] │(ôëàêîíû) 0.1%                │Company (Èðàí)                │13.11.95   

                                                                                                                                        

│Áåòàëîê [Ìåòîïðîëîë]               │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã; ðàñòâîð äëÿ  │Astra (Øâåöèÿ)                │002751,    

                                   │ñåëåêòèâíûé [C07AB02]         │èíúåêöèé (àìïóëû) 1 ìã/ìë - 5 │                              │15.12.92   

                                                                 │ìë                                                                     

                                                                                                                                        

│Áåòàëîê [Ìåòîïðîëîë]               │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã               │Egis Sa (Âåíãðèÿ)             │008074,    

                                   │ñåëåêòèâíûé [C07AB02]                                                                     │28.11.96   

                                                                                                                                        

│Áåòàì-Îôòàëü [Áåòàìåòàçîí]         │ãëþêîêîðòèêîñòåðîèä äëÿ       │ðàñòâîð-êàïëè ãëàçíûå         │Dr.Robert Winzer Pharma Gmbh  │010302,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [S01BA06] │(ôëàêîíû) 0.1% - 5 ìë; ìàçü   │(Ãåðìàíèÿ)                    │03.07.98   

                                                                 │ãëàçíàÿ (òóáû) 0.1% - 5 ã;                                              

                                                                 │íàáîð /ðàñòâîð-êàïëè ãëàçíûå                                           

                                                                 │âî ôëàêîíàõ 0.1% - 5 ìë è                                             

                                                                 │ìàçü ãëàçíàÿ â òóáàõ 0.1% - 5 │                                         

                                                                 │ã/ (óïàêîâêè êîìáèíèðîâàííûå) │                                         

                                                                                                                                        

│Áåòàíàç [Ãëèáåíêëàìèä]             │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Cadila Healthcare Ltd (Èíäèÿ) │008021,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │03.02.97   

                                                                                                                                        

│Áåòàñïîðèíà [Öåôòðèàêñîí]          │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratories Atral Sa         │002704,    

                                   │[J01DA13]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ïîðòóãàëèÿ)                  │23.11.92   

                                                                 │ðàñòâîðà (ôëàêîíû) 1000 ìã /â │                                         

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Áåòíîâåéò [Áåòàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì (òóáû) 0.1%; ìàçü (òóáû) │Glaxo-Wellcome                │006667,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC01] │0.1%                          │(Âåëèêîáðèòàíèÿ)              │22.03.96   

                                                                                                                                         

│Áåòîïòèê [Áåòàêñîëîë]              │áåòà1-àäðåíîáëîêàòîð          │êàïëè ãëàçíûå (ôëàêîíû) 0.5%  │Alcon-Couvreur (Áåëüãèÿ)      │008183,    

                                   │ñåëåêòèâíûé [S01ED02]         │- 5 ìë                                                     │30.07.97   

                                                                                                                                        

│Áåòîïòèê Ñ [Áåòàêñîëîë]            │áåòà1-àäðåíîáëîêàòîð          │ñóñïåíçèÿ îôòàëüìîëîãè÷åñêàÿ  │Alcon-Couvreur (Áåëüãèÿ)      │010218,    

                                   │ñåëåêòèâíûé [S01ED02]         │ñòåðèëüíàÿ (ôëàêîíû) 0.25% -                                │22.05.98   

                                                                 │5, 10 ìë                                                               

                                                                                                                                        

│Áåôîðàë [Áóòîðôàíîë]               │îïèîèäíûõ ðåöåïòîðîâ          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lechiva (×ÑÔÐ)                │002721,    

                                   │àãîíèñò-àíòàãîíèñò [N02AF01]  │2 ìã - 1 ìë                                                 │30.11.92   

                                                                                                                                        

│Áèàíîäèí [Ïåíèöèëëàìèí]            │ïðîòèâîâîñïàëèòåëüíîå         │êàïñóëû 150 ìã                │Biogal Sa (Âåíãðèÿ)           │007422,    

                                   │ñðåäñòâî [M01CC01]                                                                        │09.04.96   

                                                                                                                                        

│Áèâàöèí {íåîìèöèí 3 500 ÅÄ,        │àíòèáèîòèê êîìáèíèðîâàííûé    │ïîðîøîê 5, 50 ã; ïîðîøîê â    │Lek (ÑÔÐÞ)                    │01802,     

│áàöèòðàöèí 12 500 ÅÄ - 1 ã}        │[D06AX] [S01AA30]             │ñïðåå; ìàçü ãëàçíàÿ; ïîðîøîê                                │28.03.90   

                                                                 │äëÿ ïðèãîòîâëåíèÿ ðàñòâîðà /â │                                          

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                       

│Áèçîëâîí [Áðîìãåêñèí]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã; ðàñòâîð äëÿ    │Boehringer Ingelheim          │006585,    

                                   │[R05CB02]                     │èíúåêöèé (àìïóëû) 2 ìã/ìë - 4 │International Gmbh (Ãåðìàíèÿ) │16.10.95   

                                                                 │ìë; ðàñòâîð äëÿ ïðèåìà âíóòðü │                                         

                                                                 │(ôëàêîíû) 2 ìã/ìë                                                      

                                                                                                                                        

│Áèçîëâîí [Áðîìãåêñèí]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï (ôëàêîíû) 4 ìã|5 ìë -   │Boehringer Ingelheim          │009570,    

                                   │[R05CB02]                     │100, 250 ìë; ñèðîï (ôëàêîíû)  │International Gmbh (Ãåðìàíèÿ) │03.07.97   

                                                                 │8 ìã|5 ìë - 100, 250 ìë                                                

                                                                                                                                        

│ÁèÊÍÓ [Êàðìóñòèí]                  │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Bristol-Myers Squibb (Èòàëèÿ) │009927,    

                                   │[L01AD01]                     │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │25.12.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 100 ìã /â                                           

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │ôëàêîíû 3 ìë/                                                           

                                                                                                                                        

│ÁèÊÍÓ [Êàðìóñòèí]                  │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Bristol-Myers Squibb (ÑØÀ)    │006521,    

                                   │[L01AD01]                     │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │20.09.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 100 ìã /â                                           

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Áèêîòðèì [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │òàáëåòêè 480 ìã               │Agio Pharmaceuticals Ltd      │009481,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                    │(Èíäèÿ)                       │27.05.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áèêðîìàò [Êðîìîãëèöèíîâàÿ êèñëîòà] │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │êîëèð (àìïóëû) 2% - 10 ìë;    │Pharmachim (Áîëãàðèÿ)         │003930,    

                                   │[R03BC01]                     │ðàñòâîð äëÿ èíãàëÿöèé                                       │20.05.94   

                                                                 │(àìïóëû) 20 ìã - 2 ìë                                                  

                                                                                                                                        

│Áèêðîìàò [Êðîìîãëèöèíîâàÿ êèñëîòà] │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │àýðîçîëü äëÿ èíãàëÿöèé        │Pharmachim (ÍÐÁ)              │2989,      

                                   │[R03BC01]                     │äîçèðîâàííûé 15 ã                                           │30.10.90   

                                                                                                                                        

│Áèëåì [Òàìîêñèôåí]                 │àíòèýñòðîãåí [L02BA01]        │òàáëåòêè 10, 20 ìã            │Lemery (Ìåêñèêà)              │006239,    

                                                                                                                             │03.07.95   

                                                                                                                                        

│Áèëîáèë [Ãèíêãî Áèëîáà]            │àíãèîïðîòåêòîðíîå ñðåäñòâî    │êàïñóëû 40 ìã                 │Krka Pharmaceutical Factory   │007464,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ñëîâåíèÿ)                    │23.04.96   

                                   │[N06BX19]                                                                                            

                                                                                                                                        

│Áèëòðèöèä [Ïðàçèêâàíòåë]           │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Bayer Ag (Ãåðìàíèÿ)           │006644,    

                                   │[P02BA01]                     │600 ìã                                                      │13.02.96   

                                                                                                                                        

│Áèíäàðä [Ïàðàöåòàìîë]              │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │M.J.Pharmaceuticals Ltd       │007045,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Èíäèÿ)                       │02.02.96   

                                   │[N02BE01]                                                                                            

                                                                                                                                        

│Á-Èíñóëèí Áåðëèí-Õåìè [Èíñóëèí-ÑðÄ]│èíñóëèí ñðåäíåãî äåéñòâèÿ     │ðàñòâîð äëÿ èíúåêöèé          │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007192,    

                                   │[A10AC]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │16.05.96   

                                                                                                                                       

│Áèîâèòàëü âèòàìèí Å [Âèòàìèí Å]    │âèòàìèí [A11HA03]             │êàïñóëû 100 ÌÅ                │F.Hoffmann La Roche           │008494,    

                                                                                               │Ltd/a.Natterman Und Ci Gmbh   │15.01.98   

                                                                                               │(Ãåðìàíèÿ)                               

                                                                                                                                        

│Áèîâèòàëü âèòàìèí Ñ 500            │âèòàìèí [A11GA01]             │òàáëåòêè æåâàòåëüíûå          │F.Hoffmann La Roche           │008493,    

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                         │Ltd/a.Natterman Und Ci Gmbh   │15.01.98   

                                                                                               │(Ãåðìàíèÿ)                               

                                                                                                                                        

│Áèîãóëèí 30/70 Ó-100 [Èíñóëèí-Êîìá]│èíñóëèí êîìáèíèðîâàííûé       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006371,    

                                   │[A10AD]                       │(ïåíôèëë) 100 ÌÅ/ìë - 1.5 ìë                                │07.08.95   

                                                                                                                                        

│Áèîãóëèí NPH Ó-100 [Èíñóëèí-ÑðÄ]   │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006370,    

                                   │[A10AC]                       │(ïåíôèëë) 1.5 ìë                                            │07.08.95   

                                                                                                                                         

│Áèîãóëèí NPH Ó-40 [Èíñóëèí-ÑðÄ]    │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006369,    

                                   │[A10AC]                       │(ôëàêîíû) 40 ÅÄ/ìë                                         │07.08.95   

                                                                                                                                        

│Áèîãóëèí Ëåíòå Ó40 [Èíñóëèí-ÑðÄ]   │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │008547,    

                                   │[A10AC]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │03.06.98   

                                                                                                                                        

│Áèîãóëèí Ðåãóëÿð Ó-100 [Èíñóëèí-ÁÄ]│èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Biobras S/a (Áðàçèëèÿ)        │006419,    

                                   │[A10AB]                       │ñòåðèëüíûé (ïåíôèëë) 100                                    │18.08.95   

                                                                 │ÅÄ/ìë - 1.5 ìë                                                         

                                                                                                                                        

│Áèîãóëèí Ðåãóëÿð Ó40 [Èíñóëèí-ÁÄ]  │èíñóëèí êîðîòêîãî äåéñòâèÿ    │ðàñòâîð äëÿ èíúåêöèé          │Biobras S/a (Áðàçèëèÿ)        │008548,    

                                   │[A10AB]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │03.06.98   

                                                                                                                                        

│Áèîäðîêñèë [Öåôàäðîêñèë]           │àíòèáèîòèê, öåôàëîñïîðèí      │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Biochemie Gmbh (Àâñòðèÿ)      │009156,    

                                   │[J01DA09]                     │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                │18.02.97   

                                                                 │125 ìã|5 ìë - 60, 100 ìë;                                               

                                                                 │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ                                              

                                                                 │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                          

                                                                 │250 ìã|5 ìë - 60, 100                                                  

                                                                 │ìë;òàáëåòêè ïîêðûòûå                                                   

                                                                 │îáîëî÷êîé 1000 ìã; êàïñóëû                                             

                                                                 │500 ìã                                                                 

                                                                                                                                        

│Áèîêàëèïòîë {ôîëêîäèí 100 ìã,      │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï äëÿ ïðèåìà âíóòðü       │Laboratoires Laphal (Ôðàíöèÿ) │009013,    

│ãâàÿêîë 15 ìã, ýâêàëèïòîë 140 ìã,  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │(ôëàêîíû) 125, 200 ìë                                       │10.12.96   

│áåëëàäîííû íàñòîéêà 600 ìã - 100   │[R05FA02]                                                                                            

│ìë}                                                                                                                                     

                                                                                                                                        

│Áèîïàðîêñ [Ôóçàôóíæèí]             │àíòèáèîòèê [R02AB03]          │àýðîçîëü 400 äîç              │Laboratoires Servier (Ôðàíöèÿ)│003335,    

                                                                                                                             │14.09.93   

                                                                                                                                        

│Áèîðàë [Êàðáåíîêñîëîí]             │ïðîòèâîâîñïàëèòåëüíîå         │ãåëü (òóáû) 5 ã               │Sterling Health               │005628,    

                                   │ñðåäñòâî äëÿ ìåñòíîãî                                       │(Âåëèêîáðèòàíèÿ)              │10.01.95   

                                   │ïðèìåíåíèÿ [A02BX01]                                                                                

                                                                                                                                        

│Áèîðàí [Äèêëîôåíàê]                │ÍÏÂÑ [M02AA15]                │ãåëü                          │Rusan Pharma (Èíäèÿ)          │006455,    

                                                                                                                             │30.08.95   

                                                                                                                                        

│Áèîðàí [Äèêëîôåíàê]                │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã; ðàñòâîð äëÿ   │Rusan Pharma (Èíäèÿ)          │005722,    

                                                                 │èíúåêöèé (àìïóëû) 75 ìã - 3 ìë│                              │06.02.95   

                                                                                                                                        

│Áèîðàí ðàïèä [Äèêëîôåíàê]          │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã                │Rusan Pharma (Èíäèÿ)          │009822,    

                                                                                                                             │12.11.97   

                                                                                                                                        

│Áèîñîìà [Ñîìàòðîïèí]               │ñîìàòîòðîïíûé ãîðìîí [H01AC01]│ëèîôèëèç.ïîðîøîê äëÿ èíúåêöèé │Áèîôà (Ëèòâà)                 │010001,    

                                                                 │(ôëàêîíû) 4, 8 ÌÅ /â                                        │15.01.98   

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                         

│Áèîòåíçèä Äåçèíôåêòàíò             │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Johnson&Johnson (ÑØÀ)         │0031-15,   

                                   │ñðåäñòâî [D08AX]                                                                         │22.10.96   

                                                                                                                                        

│Áèñàäèë [Áèñàêîäèë]                │ñëàáèòåëüíîå ñðåäñòâî         │òàáëåòêè ïîêðûòûå îáîëî÷êîé 5 │Wave International (Èíäèÿ)    │003098,    

                                   │[A06AB02]                     │ìã                                                          │28.06.93   

                                                                                                                                        

│Áèñàêîäèë [Áèñàêîäèë]              │ñëàáèòåëüíîå ñðåäñòâî         │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Grindex Ëàòâ. Ãîñôèðìà ïî     │009167,    

                                   │[A06AB02]                     │îáîëî÷êîé 5 ìã                │èññëåä. è ïðîèçâ.             │22.07.97   

                                                                                               │ìåäïðåïàðàòîâ (Ëàòâèÿ)                   

                                                                                                                                        

│Áèñàêîäèë [Áèñàêîäèë]              │ñëàáèòåëüíîå ñðåäñòâî         │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Pharmacia-AD (Áîëãàðèÿ)       │009483,    

                                   │[A06AB02]                     │îáîëî÷êîé 5 ìã                                              │28.05.97   

                                                                                                                                        

│Áèñàêîäèë [Áèñàêîäèë]              │ñëàáèòåëüíîå ñðåäñòâî         │ñâå÷è 10 ìã                   │Polfa, Poznanskie             │008246,    

                                   │[A06AB02]                                                   │Pharmaceutical Works (Ïîëüøà) │03.04.97   

                                                                                                                                         

│Áèñàêîäèë [Áèñàêîäèë]              │ñëàáèòåëüíîå ñðåäñòâî         │äðàæå 5 ìã                    │Polfa, Rzeszowskie            │008421,    

                                   │[A06AB02]                                                   │Pharmaceutical Works Sa       │22.08.97   

                                                                                               │(Ïîëüøà)                                 

                                                                                                                                        

│Áèñàêîäèë [Áèñàêîäèë]              │ñëàáèòåëüíîå ñðåäñòâî         │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Remedica Ltd - Minnex (Êèïð)  │006818,    

                                   │[A06AB02]                     │îáîëî÷êîé 5 ìã                                              │10.11.95   

                                                                                                                                        

│Áèñåïòîë [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │òàáëåòêè 120, 480 ìã          │Polfa, Pabianickie            │006491,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                    │Pharmaceutical Works (Ïîëüøà) │12.09.95   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áèñåïòîë [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │òàáëåòêè 120, 480 ìã          │Terpol Pharmaceutical Works   │009568,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                    │Sa (Ïîëüøà)                   │03.07.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áèñåïòîë [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │ñóñïåíçèÿ äëÿ ïðèåìà âíóòðü   │Terpol Pharmaceutical Works   │008054,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │(ôëàêîíû) 240 ìã|5 ìë - 80 ìë │Sa (Ïîëüøà)                   │12.11.96   

                                   │[J01EE01]                                                                                           

                                                                                                                                        

│Áèñåïòîë [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Warszawskie            │008271,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │5 ìë                          │Pharmaceutical Works (Ïîëüøà) │24.04.97   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Áèñìîôàëüê {âèñìóòà ñóáãàëëàò 50   │ïðîòèâîÿçâåííîå ñðåäñòâî,     │òàáëåòêè 50 ìã/100 ìã         │Dr.Falk Pharma Gmbh (Ãåðìàíèÿ)│005218,    

│ìã, âèñìóòà ñóáíèòðàò 100 ìã}      │ïðåïàðàò âèñìóòà [A07BB]                                                                  │10.08.94   

                                                                                                                                        

│Áèñíîë [Âèñìóòà òðèêàëèÿ äèöèòðàò] │ïðîòèâîÿçâåííîå ñðåäñòâî,     │òàáëåòêè 120 ìã               │Wave International (Èíäèÿ)    │003097,    

                                   │ïðåïàðàò âèñìóòà [A02BX05]                                                                │28.06.93   

                                                                                                                                        

│Áèñóòðèì [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå              │òàáëåòêè 240 ìã               │Pharmimpex Ltd (Ãðóçèÿ)       │006750,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │26.10.95   

                                   │[J01EE01]                                                                                             

                                                                                                                                        

│Áèòòíåð òðàâÿíîé ýëèêñèð           │îáùåòîíèçèðóþùåå ñðåäñòâî     │ýëèêñèð îðàëüíûé (ôëàêîíû)    │Richard Bittner Gmbh (Àâñòðèÿ)│006179,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │14.06.95   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Áëàñòîêàðá [Êàðáîïëàòèí]           │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Lemery (Ìåêñèêà)              │009353,    

                                   │[L01XA02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │01.04.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 50, 150,                                            

                                                                 │450 ìã                                                                 

                                                                                                                                        

│Áëàñòîëåì [Öèñïëàòèí]              │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê (ôëàêîíû)    │Lemery (Ìåêñèêà)              │003621,    

                                   │[L01XA01]                     │10, 50 ìã                                                   │27.12.93   

                                                                                                                                        

│Áëàñòîöèí [Äîêñîðóáèöèí]           │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Menon Pharma (Èíäèÿ)          │003490,    

                                   │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │04.11.93   

                                                                 │ðàñòâîðà 10 ìã                                                          

                                                                                                                                        

│Áëåìàðåí {ëèìîííàÿ êèñëîòà 39.9 ã, │ñðåäñòâî ëå÷åíèÿ íåôðîëèòèàçà │ïîðîøîê ãðàíóëèðîâàííûé       │Esparma (Ãåðìàíèÿ)            │006049,    

│íàòðèÿ öèòðàò 27.85 ã, êàëèÿ       │[G04BC]                       │(ôëàêîíû)                                                   │17.05.95   

│ãèäðîêàðáîíàò 32.25 ã - 100 ã}                                                                                                          

                                                                                                                                        

│Áëåîöèí [Áëåîìèöèí]                │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Nippon Kayaku Co Ltd (ßïîíèÿ) │007204,    

                                   │[L01DC01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │03.06.96   

                                                                 │(àìïóëû) 15 ìã                                                         

                                                                                                                                        

│Áëåôàìèä Í ëèêâèôèëì               │ïðîòèâîâîñïàëèòåëüíîå         │êàïëè ãëàçíûå (ôëàêîíû) 100   │Krka (Ñëîâåíèÿ)               │005054,    

│{ñóëüôàöåòàìèä 100 ìã, ïðåäíèçîëîí │ñðåäñòâî äëÿ ìåñòíîãî         │ìã/2 ìã|1 ìë                                                │29.06.94   

│2 ìã - 1 ìë}                       │ïðèìåíåíèÿ [S01CA02]                                                                                 

                                                                                                                                        

│Áëîêàëüöèí 60 [Äèëòèàçåì]          │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Lachema (×åõèÿ)               │007426,    

                                                                                                                             │09.04.96   

                                                                                                                                         

│Áëîêàëüöèí 90 ðåòàðä [Äèëòèàçåì]   │ÁÌÊÊ [C08DB01]                │òàáëåòêè ðåòàðä 90 ìã         │Lachema (×åõèÿ)               │007425,    

                                                                                                                            │09.04.96   

                                                                                                                                        

│Áëîêàöèä [Ôàìîòèäèí]               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 20 ìã, 40 ìã         │Ipca Laboratories Ltd (Èíäèÿ) │005795,    

                                   │áëîêàòîð [A02BA03]                                                                        │27.02.95   

                                                                                                                                        

│Áëîêîòåíîë [Àòåíîëîë]              │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 25, 50, 100 ìã       │Azupharma Gmbh (Ãåðìàíèÿ)     │005383,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │05.10.94   

                                                                                                                                        

│Áîíäðîíàò [Èáàíäðîíîâàÿ êèñëîòà]   │êîñòíîé ðåçîðáöèè èíãèáèòîð,  │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │Boehringer Mannheim Gmbh      │007952,    

                                   │áèôîñôîíàò [M05BA06]          │1 ìã - 1 ìë                   │(Ãåðìàíèÿ)                    │13.11.96   

                                                                                                                                        

│Áîíåôîñ [Êëîäðîíîâàÿ êèñëîòà]      │êîñòíîé ðåçîðáöèè èíãèáèòîð,  │êàïñóëû 400 ìã; êîíöåíòðàò    │Leiras (Ôèíëÿíäèÿ)            │003166,    

                                   │áèôîñôîíàò [M05BA02]          │äëÿ ïðèãîòîâëåíèÿ                                           │20.07.93   

                                                                 │èíôóçèîííîãî ðàñòâîðà                                                  

                                                                 │(àìïóëû) 60 ìã/ìë - 5 ìë                                                

                                                                                                                                        

│Áîíèí [Ìåêëîçèí]                   │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 25 ìã                │Pfizer Gmbh (Ãåðìàíèÿ)        │007647,    

                                   │áëîêàòîð [R06AE05]                                                                        │17.07.96   

                                                                                                                                        

│Áîíèí [Ìåêëîçèí]                   │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè æåâàòåëüíûå 25 ìã    │Pfizer Inc (ÑØÀ)              │007648,    

                                   │áëîêàòîð [R06AE05]                                                                        │17.07.96   

                                                                                                                                        

│Áîíèôåí [Èáóïðîôåí]                │ÍÏÂÑ [M02AA13]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Krka Pharmaceutical Factory   │007159,    

                                                                 │200 ìã                        │(Ñëîâåíèÿ)                    │20.03.96   

                                                                                                                                        

│Áîíöåôèí [Öåôîêñèòèí]              │àíòèáèîòèê, öåôàëîñïîðèí      │ëèîôèëèç.ïîðîøîê äëÿ          │Alkaloid (Ìàêåäîíèÿ)          │008280,    

                                   │[J01DA05]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │19.05.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ã, 2 ã                                            

                                                                                                                                        

│Áîðíàÿ ìàçü [Áîðíàÿ êèñëîòà]       │àíòèñåïòè÷åñêîå ñðåäñòâî      │ìàçü (áàíêè) 5% - 15, 25 ã    │Áîðèñîâñêèé çàâîä             │71/146/9,  

                                   │[D08AD]                                                     │ìåäïðåïàðàòîâ (Áåëàðóñü)      │29.01.98   

                                                                                                                                        

│Áîðíîé êèñëîòû ðàñòâîð ñïèðòîâîé   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð ñïèðòîâîé             │Ôàðìàê ÀÎ (Óêðàèíà)           │73/461/27, 

│3% [Áîðíàÿ êèñëîòà]                │[D08AD]                       │(ôëàêîí-êàïåëüíèöû) 3% - 25 ìë│                              │17.03.98   

                                                                                                                                        

│Áîðíîé êèñëîòû ðàñòâîð ñïèðòîâîé   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð ñïèðòîâîé (ôëàêîíû)   │Áîðèñîâñêèé çàâîä             │73/461/27, 

│3% [Áîðíàÿ êèñëîòà]                │[D08AD]                       │3% - 10 ìë                    │ìåäïðåïàðàòîâ (Áåëàðóñü)      │14.04.98   

                                                                                                                                        

│Áîðöà áåëîóñòîãî òðàâà             │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ñûðüå (ìåøêè) 12 êã           │Èíñòèòóò õèìèè ðàñòèòåëüíûõ   │95/112/6   

                                   │ñðåäñòâî                                                    │âåùåñòâ ÀÍ Óçáåêèñòàíà                   

                                                                                               │(Óçáåêèñòàí)                             

                                                                                                                                        

│Áîðöà ñåâåðíîãî êîðíåâèùà ñ êîðíÿìè│ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ñûðüå (òþêè) 40 êã            │Èíñòèòóò õèìèè ðàñòèòåëüíûõ   │95/112/7   

                                   │ñðåäñòâî                                                    │âåùåñòâ ÀÍ Óçáåêèñòàíà                   

                                                                                               │(Óçáåêèñòàí)                             

                                                                                                                                        

│Áîòîêñ {Clostridium botulinum a    │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ëèîôèëèç.ïîðîøîê äëÿ          │Allergan (ÑØÀ)                │005062,    

│òîêñèí 100 ÅÄ, àëüáóìèí 0.5 ìã}    │[M03AX01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.06.94   

                                                                 │ðàñòâîðà (ôëàêîíû) 100 ÅÄ                                             

                                                                                                                                        

│Áîÿðûøíèêà íàñòîéêà                │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │íàñòîéêà (ôëàêîíû) 25 ìë      │Ñàíèòàñ ÀÎ (Ëèòâà)            │009212,    

                                   │ñðåäñòâî                                                                                  │02.12.97   

                                                                                                                                        

│Áîÿðûøíèêà íàñòîéêà                │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │íàñòîéêà (ôëàêîíû) 25, 50,    │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │67/554/131, │

                                   │ñðåäñòâî                      │100 ìë                                                      │05.01.98   

                                                                                                                                        

│Áðàë {ìåòàìèçîë 500 ìã,            │àíàëüãåòè÷åñêîå è             │òàáëåòêè 500 ìã               │Micro Labs Ltd (Èíäèÿ)        │003744,    

│ôåíïèâåðèíèÿ áðîìèä 100 ìêã,       │ñïàçìîëèòè÷åñêîå ñðåäñòâî                                                                 │04.03.94   

│ïèòîôåíîí 5 ìã}                    │[N02BB52]                                                                                            

                                                                                                                                        

│Áðåâèáëîê [Ýñìîëîë]                │áåòà1-àäðåíîáëîêàòîð          │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Gensia Automedics Ltd         │010444,    

                                   │ñåëåêòèâíûé [C07AB09]         │èíôóçèîííîãî ðàñòâîðà         │(Âåëèêîáðèòàíèÿ)              │28.08.98   

                                                                 │(àìïóëû) 250 ìã/ìë - 10 ìë;                                             

                                                                 │ðàñòâîð äëÿ èíúåêöèé                                                   

                                                                 │(ôëàêîíû) 10 ìã/ìë - 10 ìë                                            

                                                                                                                                        

│Áðåêñèê-ÄÒ [Ïèðîêñèêàì]            │ÍÏÂÑ [M02AA07]                │òàáëåòêè ðàñòâîðèìûå 20 ìã    │Wockhardt Ltd (Èíäèÿ)         │007726,    

                                                                                                                             │14.08.96   

                                                                                                                                        

│Áðåí [Èáóïðîôåí]                   │ÍÏÂÑ [M02AA13]                │òàáëåòêè 200, 400, 600 ìã     │Kopran Ltd (Èíäèÿ)            │005404,    

                                                                                                                             │17.10.94   

                                                                                                                                        

│Áðåòèëàò [Áðåòèëèÿ òîñèëàò]        │àíòèàðèòìè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Wellcome Foundation Ltd       │003338,    

                                   │[C01BD02]                     │50 ìã/ìë - 2, 10 ìë           │(Âåëèêîáðèòàíèÿ)              │17.09.93   

                                                                                                                                        

│Áðèåòàë [Ìåòîãåêñèòàë]             │íàðêîçíîå íåèíãàëÿöèîííîå     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (Ãåðìàíèÿ)          │008661,    

                                   │ñðåäñòâî [N05CA15]            │èíúåêöèîííîãî ðàñòâîðà                                      │24.07.98   

                                                                 │(ôëàêîíû) 500 ìã                                                       

                                                                                                                                         

│Áðèåòàë [Ìåòîãåêñèòàë]             │íàðêîçíîå íåèíãàëÿöèîííîå     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (ÑØÀ)               │006477,    

                                   │ñðåäñòâî [N05CA15]            │èíúåêöèîííîãî ðàñòâîðà                                     │06.09.95   

                                                                 │(ôëàêîíû) 100 ìã                                                       

                                                                                                                                        

│Áðèêàíèë [Òåðáóòàëèí]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 2.5 ìã; ðàñòâîð äëÿ  │Astra (Øâåöèÿ)                │00427,     

                                   │ñåëåêòèâíûé [R03CC03]         │èíúåêöèé (àìïóëû) 0.5 ìã - 1                                │26.01.93,  

                                                                 │ìë                                                          │27.12.76   

                                                                                                                                        

│Áðèêàíèë [Òåðáóòàëèí]              │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé 0.25    │Eczacibasi (Òóðöèÿ)           │005048,    

                                   │ñåëåêòèâíûé [R03AC03]         │ìã/äîçà                                                     │27.06.94   

                                                                                                                                        

│Áðèêàíèë [Òåðáóòàëèí]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 2.5 ìã; ðàñòâîð äëÿ  │Egis Sa (Âåíãðèÿ)             │007332,    

                                   │ñåëåêòèâíûé [R03CC03]         │èíúåêöèé (àìïóëû) 0.5 ìã/ìë                                 │30.09.96   

                                                                                                                                        

│Áðèêàíèë èíõàëåð [Òåðáóòàëèí]      │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé 0.25    │Astra (Øâåöèÿ)                │006944,    

                                   │ñåëåêòèâíûé [R03AC03]         │ìã/äîçà 400 äîç                                             │26.12.95   

                                                                                                                                        

│Áðèêàíèë òóðáóõàëåð [Òåðáóòàëèí]   │áåòà2-àäðåíîñòèìóëÿòîð        │ïîðîøîê äëÿ èíãàëÿöèé         │Astra (Øâåöèÿ)                │006136,    

                                   │ñåëåêòèâíûé [R03AC03]         │(òóðáóõàëåðû) 0.5 ìã/äîçà -                                 │01.06.95   

                                                                 │200 äîç                                                                

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áîðùàãîâñêèé ÕÔÇ (Óêðàèíà)    │70/183/38, 

│ñïèðòîâîé 1%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé                                        │20.04.98   

                                                                 │(ôëàêîíû) 1% - 20 ìë                                                   

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áîðèñîâñêèé çàâîä             │70/183/38, 

│ñïèðòîâîé 1%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé (àìïóëû) │ìåäïðåïàðàòîâ (Áåëàðóñü)      │14.04.98   

                                                                 │1% - 1 ìë                                                              

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/183/38, 

│ñïèðòîâîé 1%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé                                        │10.07.98   

                                                                 │(ôëàêîíû) 1% - 10, 15 ìë                                                

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áîðùàãîâñêèé ÕÔÇ (Óêðàèíà)    │70/183/38, 

│ñïèðòîâîé 2%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé                                        │20.04.98   

                                                                 │(ôëàêîíû) 2% - 20 ìë                                                   

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áîðèñîâñêèé çàâîä             │70/183/38, 

│ñïèðòîâîé 2%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé (àìïóëû) │ìåäïðåïàðàòîâ (Áåëàðóñü)      │14.04.98   

                                                                 │2% - 1 ìë                                                              

                                                                                                                                        

│Áðèëëèàíòîâîãî çåëåíîãî ðàñòâîð    │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/183/38, 

│ñïèðòîâîé 2%                       │[D08A]                        │ïðèìåíåíèÿ ñïèðòîâîé                                        │09.04.98   

                                                                 │(ôëàêîíû) 2% - 10, 15 ìë                                               

                                                                                                                                        

│Áðèíàëäèêñ [Êëîïàìèä]              │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 20 ìã                │Egis Sa (Âåíãðèÿ)             │007325,    

                                   │[C03BA03]                                                                                 │27.09.96   

                                                                                                                                         

│Áðèíàëüäèêñ [Êëîïàìèä]             │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 20 ìã                │Sandoz (India) Ltd (Èíäèÿ)    │007956,    

                                   │[C03BA03]                                                                                │15.11.96   

                                                                                                                                        

│Áðèíåðäèí {ðåçåðïèí 0.1 ìã,        │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │äðàæå                         │Krka (Ñëîâåíèÿ)               │008097,    

│êëîïàìèä 5 ìã, äèãèäðîýðãîêðèñòèí  │ñðåäñòâî [C02LA51]                                                                        │20.12.96   

│0.5 ìã}                                                                                                                                 

                                                                                                                                        

│Áðèíåðäèí {ðåçåðïèí 0.1 ìã,        │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Sandoz (India) Ltd (Èíäèÿ)    │007237,    

│êëîïàìèä 5 ìã, äèãèäðîýðãîêðèñòèí  │ñðåäñòâî [C02LA51]                                                                        │26.06.96   

│0.5 ìã}                                                                                                                                 

                                                                                                                                        

│Áðèíåðäèí {ðåçåðïèí 0.1 ìã,        │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sandoz Pharma Ltd (Øâåéöàðèÿ) │007310,    

│êëîïàìèä 5 ìã, äèãèäðîýðãîêðèñòèí  │ñðåäñòâî [C02LA51]                                                                        │12.09.96   

│0.5 ìã}                                                                                                                                 

                                                                                                                                        

│Áðîìàçåï [Áðîìàçåïàì]              │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 6 ìã                 │Ct-Arzneimittel Chemishe      │003967,    

                                   │[N05BA08]                                                   │Tempelchof Gmbh (Ãåðìàíèÿ)    │01.06.94   

                                                                                                                                       

│Áðîìàçåïàì Ëàííàõåð [Áðîìàçåïàì]   │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lannacher Heilmittel Gmbh     │007821,    

                                   │[N05BA08]                     │3, 6 ìã                       │(Àâñòðèÿ)                     │16.09.96   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 4, 8 ìã              │Pharbita B.V. (Íèäåðëàíäû)    │009995,    

                                   │[R05CB02]                                                                                 │23.02.98   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │ìèêñòóðà îðàëüíàÿ (ôëàêîíû)   │Nycomed Dak As (Äàíèÿ)        │005408,    

                                   │[R05CB02]                     │0.8 ìã/ìë                                                   │19.10.94   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã                 │Pharmacia-AD (Áîëãàðèÿ)       │010169,    

                                   │[R05CB02]                                                                                 │17.04.98   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã; ýëèêñèð        │Rusan Pharma (Èíäèÿ)          │005715,    

                                   │[R05CB02]                     │(ôëàêîíû) 4 ìã|5 ìë                                         │06.02.95   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │äðàæå 4 ìã                    │Salutas Fahlberg-List Pharma  │008014,    

                                   │[R05CB02]                                                   │Gmbh (Ãåðìàíèÿ)               │27.12.96   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã; äðàæå 12 ìã    │Salutas Pharma Gmbh (Ãåðìàíèÿ)│008305,    

                                   │[R05CB02]                                                                                 │24.06.97   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã; ýëèêñèð        │Simpex Pharma Pvt Ltd (Èíäèÿ) │009665,    

                                   │[R05CB02]                     │(ôëàêîíû) 4 ìã|5 ìë - 100 ìë                                │12.08.97   

                                                                                                                                        

│Áðîìãåêñèí [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã                 │Wave International (Èíäèÿ)    │003545,    

                                   │[R05CB02]                                                                                 │06.12.93   

                                                                                                                                        

│Áðîìãåêñèí 10 Áåðëèí-Õåìè          │ìóêîëèòè÷åñêîå ñðåäñòâî       │ìèêñòóðà (ôëàêîíû) 10 ìã|5 ìë │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007221,    

│[Áðîìãåêñèí]                       │[R05CB02]                     │- 60, 100 ìë                                                │18.06.96   

                                                                                                                                         

│Áðîìãåêñèí 4 Áåðëèí-Õåìè           │ìóêîëèòè÷åñêîå ñðåäñòâî       │ìèêñòóðà (ôëàêîíû) 4 ìã|5 ìë  │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007219,    

│[Áðîìãåêñèí]                       │[R05CB02]                     │- 60, 100 ìë                                               │18.06.96   

                                                                                                                                        

│Áðîìãåêñèí 4 ìã äëÿ äåòåé          │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 4 ìã                 │Grindex ëàòâ. ãîñôèðìà ïî     │009171,    

│[Áðîìãåêñèí]                       │[R05CB02]                                                   │èññëåä. è ïðîèçâ.             │01.09.97   

                                                                                               │ìåäïðåïàðàòîâ (Ëàòâèÿ)                   

                                                                                                                                        

│Áðîìãåêñèí 8 Áåðëèí-Õåìè           │ìóêîëèòè÷åñêîå ñðåäñòâî       │äðàæå 8 ìã                    │Berlin-Chemie Ag (Ãåðìàíèÿ)   │008607,    

│[Áðîìãåêñèí]                       │[R05CB02]                                                                                 │21.04.98   

                                                                                                                                        

│Áðîìãåêñèí 8 Áåðëèí-Õåìè           │ìóêîëèòè÷åñêîå ñðåäñòâî       │ìèêñòóðà (ôëàêîíû) 8 ìã|5 ìë  │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007220,    

│[Áðîìãåêñèí]                       │[R05CB02]                     │- 60, 100 ìë                                                │18.06.96   

                                                                                                                                        

│Áðîìãåêñèí 8 ìã [Áðîìãåêñèí]       │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã                 │Grindex Ëàòâ.Ãîñôèðìà Ïî      │009170,    

                                   │[R05CB02]                                                   │Èññëåä.È Ïðîèçâ.Ìåäïðåïàðàòîâ │01.09.97   

                                                                                               │(Ëàòâèÿ)                                  

                                                                                                                                        

│Áðîìãåêñèí 8-êàïëè {áðîìãåêñèí 0.8 │îòõàðêèâàþùåå ñðåäñòâî        │êàïëè (ôëàêîíû) 20, 50, 100 ìë│Krewel Meuselbach Gmbh        │008179,    

│ã, ôåíõåëÿ ìàñëî 75 ìã, àíèñîâîå   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │14.03.97   

│ìàñëî 25 ìã, ìåíòîë 0.15 ã, äóøèöû │[R05CB10]                                                                                            

│ìàñëî 25 ìã, ìÿòû ïåðå÷íîé ìàñëî                                                                                                        

│25 ìã, êàìôîðíîå ìàñëî 25 ìã - 100 │                                                                                                     

│ìë}                                                                                                                                     

                                                                                                                                        

│Áðîìãåêñèí Íèêîìåä [Áðîìãåêñèí]    │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 8 ìã; ðàñòâîð äëÿ    │Nycomed Denmark a/S (Äàíèÿ)   │009737,    

                                   │[R05CB02]                     │âíóòðåííåãî ïðèìåíåíèÿ                                      │23.09.97   

                                                                 │(ôëàêîíû) 0.8 ìã/ìë - 150 ìë                                           

                                                                                                                                        

│Áðîìãåêñèí Ðèâî [Áðîìãåêñèí]       │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 4, 8 ìã; ñèðîï       │Rivopharm Sa (Øâåéöàðèÿ)      │007728,    

                                   │[R05CB02]                     │(ôëàêîíû) 4 ìã|5 ìë, 10 ìã|5                                │14.08.96   

                                                                 │ìë - 60 ìë                                                             

                                                                                                                                         

│Áðîìãåêñèí ýëèêñèð [Áðîìãåêñèí]    │ìóêîëèòè÷åñêîå ñðåäñòâî       │ýëèêñèð                       │Wave International (Èíäèÿ)    │006299,    

                                   │[R05CB02]                                                                                │18.07.95   

                                                                                                                                        

│Áðîìãåêñèíà ñèðîï [Áðîìãåêñèí]     │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï (ôëàêîíû) 100 ìë        │Grindex (Ëàòâèÿ)              │007913,    

                                   │[R05CB02]                                                                                 │25.10.96   

                                                                                                                                        

│Áðîìãåêñèí-Ðàòèîôàðì [Áðîìãåêñèí]  │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï 4 ìã|5 ìë               │Ratiopharm Gmbh & Co          │003608,    

                                   │[R05CB02]                                                   │(Ãåðìàíèÿ)                    │20.12.93   

                                                                                                                                        

│Áðîìèäåì [Áðîìàçåïàì]              │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 6, 12 ìã             │Nycomed Christians (Áåëüãèÿ)  │006831,    

                                   │[N05BA08]                                                                                 │15.11.95   

                                                                                                                                        

│Áðîìîêðèïòèí [Áðîìîêðèïòèí]        │äîôàìèí-ñòèìóëÿòîð [N04BC01]  │òàáëåòêè 2.5 ìã               │Gedeon Richter (Âåíãðèÿ)      │002723,    

                                                                                                                             │02.12.92   

                                                                                                                                        

│Áðîìîêðèïòèí Ïîëè [Áðîìîêðèïòèí]   │äîôàìèí-ñòèìóëÿòîð [N04BC01]  │òàáëåòêè 2.5 ìã; êàïñóëû 5,   │Poli Industria Chimica Spa    │009134,    

                                                                 │10 ìã                         │(Èòàëèÿ)                      │11.02.97   

                                                                                                                                       

│Áðîìýðãîí [Áðîìîêðèïòèí]           │äîôàìèí-ñòèìóëÿòîð [N04BC01]  │òàáëåòêè 2.5, 10 ìã           │Lek D.D. (Ñëîâåíèÿ)           │008603,    

                                                                                                                             │16.04.98   

                                                                                                                                        

│Áðîíàë [Òåðôåíàäèí]                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 60 ìã                │ICN Galenika (Þãîñëàâèÿ)      │003920,    

                                   │áëîêàòîð [R06AX12]                                                                        │18.05.94   

                                                                                                                                        

│Áðîíêàòàð [Êàðáîöèñòåèí]           │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï äëÿ âçðîñëûõ (ôëàêîíû)  │Group Synthelabo (Ôðàíöèÿ)    │007108,    

                                   │[R05CB03]                     │5 ã|100 ìë; ñèðîï äëÿ äåòåé                                 │27.02.96   

                                                                 │(ôëàêîíû) 2 ã|100 ìë                                                   

                                                                                                                                        

│Áðîíõèêóì {òèìüÿíà íàñòîéêà 22 ìë, │îòõàðêèâàþùåå ñðåäñòâî        │êàïëè îðàëüíûå (ôëàêîíû);     │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005174,    

│ìûëüíîãî êîðíÿ áåëîãî íàñòîéêà 19  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ýëèêñèð îðàëüíûé (ôëàêîíû)                                  │26.07.94   

│ìë, êâåáðàõî êîðû íàñòîéêà 14 ìë - │[R05X]                                                                                               

│êàïëè 100 ìë; ãðèíäåëèè íàñòîéêà 1 │                                                                                                      

│ã, ïîëåâîãî öâåòà êîðíÿ íàñòîéêà                                                                                                        

│0.2 ã, ïåðâîöâåòà êîðíÿ íàñòîéêà                                                                                                       

│0.5 ã, êâåáðàõî êîðû íàñòîéêà 0.7                                                                                                       

│ã, òèìüÿíà íàñòîéêà 1 ã, ýòàíîë                                                                                                         

│29.5% - ýëèêñèð 100 ìë}                                                                                                                 

                                                                                                                                        

│Áðîíõèêóì áàëüçàì ñ ýâêàëèïòîâûì   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ãåëü (ôëàêîíû) 55 ã           │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003563,    

│ìàñëîì {ýâêàëèïòîâîå ìàñëî 14 ã,   │ñðåäñòâî [R05X]                                                                           │08.12.93   

│êàìôîðà 4 ã, ñîñíû õâîè ìàñëî 10 ã │                                                                                                     

│- 100 ã}                                                                                                                                

                                                                                                                                        

│Áðîíõèêóì èíãàëÿò {ýâêàëèïòîâîå    │îòõàðêèâàþùåå ñðåäñòâî        │ýìóëüñèÿ (ôëàêîíû) 50 ìë      │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003564,    

│ìàñëî 7 ìã, òèìüÿíà ìàñëî 1 ìã -   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │08.12.93   

│100 ìë}                            │[R05X]                                                                                               

                                                                                                                                        

│Áðîíõèêóì ìåäèöèíñêèå âàííû ñ      │îòõàðêèâàþùåå ñðåäñòâî        │ðàñòâîð (ôëàêîíû) 15 ìã/100 ìë│Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003670,    

│òèìüÿíîì {òèìüÿíà ìàñëî}           │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │03.02.94   

                                   │[R05X]                                                                                              

                                                                                                                                        

│Áðîíõèêóì ïàñòèëêè îò êàøëÿ        │îòõàðêèâàþùåå ñðåäñòâî        │ïàñòèëêè 100 ìã               │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005118,    

│{òèìüÿíà ýêñòðàêò 100 ìã}          │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │11.07.94   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Áðîíõèêóì ñèðîï îò êàøëÿ {òèìüÿíà  │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû)               │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005519,    

│íàñòîéêà 1.2 ìë, ãðèíäåëèè         │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │22.11.94   

│íàñòîéêà 0.2 ìë, ïèìïèíåëëû        │[R05X]                                                                                               

│íàñòîéêà 0.2 ìë, áåäðåíöà íàñòîéêà │                                                                                                     

│1 ìë, øèïîâíèêà íàñòîéêà 1 ìë -                                                                                                         

│100 ìë}                                                                                                                                 

                                                                                                                                        

│Áðîíõîâàëåàñ [Ñàëüáóòàìîë]         │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü äîçèðîâàííûé 100     │Valeas (Èòàëèÿ)               │003751,    

                                   │ñåëåêòèâíûé [R03AC02]         │ìêã/äîçà                                                    │11.03.94   

                                                                                                                                        

│Áðîíõîëèòèí {ãëàóöèí 0.1 ìã,       │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 125 ìë        │Bulgarska Rosa - Sevtopolis   │008701,    

│ýôåäðèí 0.8 ìã, ëèìîííàÿ êèñëîòà 1 │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Ead (Ðåñïóáëèêà Áîëãàðèÿ)     │24.08.98   

│ìã, áàçèëèêîâîå ìàñëî 1 ìã - 1 ìë} │[R05X]                                                                                               

                                                                                                                                        

│Áðîíõîëèòèí {ãëàóöèí 0.125 ã,      │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï                         │Pharmachim (ÍÐÁ)              │2381,      

│ýôåäðèíà ãèäðîõëîðèä 0.1 ã,        │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │25.07.74,  

│ëèìîííàÿ êèñëîòà 0.125 ã,          │[R05X]                                                                                    │29.11.89   

│áàçèëèêîâîå ìàñëî 0.125 ã}                                                                                                              

                                                                                                                                        

│Áðîíõîëèòèí {ãëàóöèí 0.125 ã,      │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 125 ã         │Pharmachim Holding Ead,       │008563,    

│ýôåäðèíà ãèäðîõëîðèä 0.1 ã}        │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Sopharma Ead (Áîëãàðèÿ)       │07.07.98   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Áðîíõîëèòèí ñèðîï {ãëàóöèí 0.125   │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 125 ìë        │Pharmachim Holding Ead,       │008296,    

│ã, ýôåäðèíà ãèäðîõëîðèä 0.1 ã,     │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Troyapharm Sa (Áîëãàðèÿ)      │24.06.97   

│ëèìîííàÿ êèñëîòà 0.125 ã,          │[R05X]                                                                                               

│áàçèëèêîâîå ìàñëî 0.125 ã}                                                                                                             

                                                                                                                                        

│Áðîíõîñàí [Áðîìãåêñèí]             │ìóêîëèòè÷åñêîå ñðåäñòâî       │êàïëè äëÿ âíóòðåííåãî         │Slovakofarma Sa (Ñëîâàêèÿ)    │007657,    

                                   │[R05CB02]                     │ïðèìåíåíèÿ (ôëàêîíû) 25 ìë                                  │22.07.96   

                                                                                                                                        

│Áðîíõîòóðáèíàë [Áåêëîìåòàçîí]      │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé         │Valeas (Èòàëèÿ)               │006114,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA01] │(ôëàêîíû) 50 ìêã/äîçà                                       │29.05.95   

                                                                                                                                        

│Áðóëàìèöèí [Òîáðàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │êàïëè ãëàçíûå (ôëàêîíû) 0.3%  │Biogal (Âåíãðèÿ)              │003786,    

                                   │[S01AA12]                     │- 5 ìë                                                      │25.03.94   

                                                                                                                                        

│Áðóëàìèöèí [Òîáðàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Biogal (Âåíãðèÿ)              │2759,      

                                   │[J01GB01]                     │40 ìã/1 ìë, 80 ìã/2 ìë                                      │24.11.83,  

                                                                                                                             │04.08.95   

                                                                                                                                         

│Áðóñòàí {èáóïðîôåí 400 ìã,         │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Ranbaxy Laboratories Ltd      │006269,    

│ïàðàöåòàìîë 325 ìã}                │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Èíäèÿ)                       │13.07.95   

                                   │[N02B]                                                                                               

                                                                                                                                        

│Áðóôåí [Èáóïðîôåí]                 │ÍÏÂÑ [M02AA13]                │òàáëåòêè 200, 400 ìã          │Boots Company (Âåëèêîáðèòàíèÿ)│003651,    

                                                                                                                             │31.01.94   

                                                                                                                                        

│Áðóôåí [Èáóïðîôåí]                 │ÍÏÂÑ [M02AA13]                │ñèðîï äëÿ äåòåé (ôëàêîíû) 100 │Boots Company (Âåëèêîáðèòàíèÿ)│005068,    

                                                                 │ìã|5 ìë                                                     │30.06.94   

                                                                                                                                        

│Áðóôåí [Èáóïðîôåí]                 │ÍÏÂÑ [M02AA13]                │òàáëåòêè ïîêðûòûå ñàõàðíîé    │Knoll Ag (Ãåðìàíèÿ)           │009395,    

                                                                 │îáîëî÷êîé 200, 400 ìã; ñèðîï                                │21.04.97   

                                                                 │(ôëàêîíû) 100 ìã|5 ìë - 100,                                           

                                                                 │200 ìë                                                                 

                                                                                                                                        

│Áðóôåí [Èáóïðîôåí]                 │ÍÏÂÑ [M02AA13]                │ãåëü (òóáû) 10% - 30 ã        │Knoll Pharmaceuticals Ltd     │009799,    

                                                                                               │(Èíäèÿ)                       │22.10.97   

                                                                                                                                       

│Áóäåñîíèä ìèòå [Áóäåñîíèä]         │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü ìèòå 0.05 ìã/äîçà    │Polfa, Poznanskie             │006377,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA02] │                              │Pharmaceutical Works (Ïîëüøà) │08.08.95   

                                                                                                                                        

│Áóäåñîíèä ôîðòå [Áóäåñîíèä]        │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü ôîðòå 0.2 ìã/äîçà    │Polfa, Poznanskie             │006351,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA02] │                              │Pharmaceutical Works (Ïîëüøà) │07.08.95   

                                                                                                                                        

│Áóåðëåöèòèí {ëåöèòèí ñîåâûé}       │îáùåòîíèçèðóþùåå ñðåäñòâî     │æèäêîñòü îðàëüíàÿ (ôëàêîíû)   │Roland (Ãåðìàíèÿ)             │003632,    

                                   │[N06BX]                                                                                   │20.01.94   

                                                                                                                                        

│Áóêàðáàí [Êàðáóòàìèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 500 ìã               │Chinoin (Âåíãðèÿ)             │2018,      

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB06] │                                                            │01.07.70,  

                                                                                                                             │09.11.83,  

                                                                                                                             │30.01.95   

                                                                                                                                         

│Áóïðåìåí [Áóïðåíîðôèí]             │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │òàáëåòêè 0.2 ìã; ðàñòâîð äëÿ  │Menon Pharma (Èíäèÿ)          │005328,    

                                   │ñðåäñòâî [N02AE01]            │èíúåêöèé (àìïóëû) 0.3 ìã/1                                 │15.09.94   

                                                                 │ìë, 0.6 ìã/2 ìë                                                        

                                                                                                                                        

│Áóïðåíîðôèíà ãèäðîõëîðèäà ðàñòâîð  │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Õàðüêîâñêèé ÃÍÖËÑ (Óêðàèíà)   │95/43/6,   

│äëÿ èíúåêöèé 0.03% [Áóïðåíîðôèí]   │ñðåäñòâî [N02AE01]            │0.03% - 1 ìë                                                │02.03.95   

                                                                                                                                        

│Áóïðåñèê [Áóïðåíîðôèí]             │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │òàáëåòêè ñóáëèíãâàëüíûå 0.2   │Tata Pharma (Èíäèÿ)           │006424,    

                                   │ñðåäñòâî [N02AE01]            │ìã; ðàñòâîð äëÿ èíúåêöèé                                    │21.08.95   

                                                                 │(àìïóëû) 0.3 ìã/1 ìë, 0.6                                              

                                                                 │ìã/2 ìë                                                                

                                                                                                                                        

│Áóðàíà [Èáóïðîôåí]                 │ÍÏÂÑ [M02AA13]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Orion Corporation (Ôèíëÿíäèÿ) │007240,    

                                                                 │200, 400 ìã                                                 │05.07.96   

                                                                                                                                        

│Áóñêîïàí [Ãèîñöèíà áóòèëáðîìèä]    │ì-õîëèíîáëîêàòîð [A03BB01]    │äðàæå 10 ìã; ñâå÷è 10 ìã;     │Boehringer Ingelheim (ÔÐÃ)    │003231,    

                                                                 │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │12.08.93   

                                                                 │20 ìã - 1 ìë                                                          

                                                                                                                                        

│Áóñêîïàí [Ãèîñöèíà áóòèëáðîìèä]    │ì-õîëèíîáëîêàòîð [A03BB01]    │ñâå÷è 10 ìã                   │Boehringer Ingelheim Italy    │009639,    

                                                                                               │Spa (Èòàëèÿ)                  │31.07.97   

                                                                                                                                        

│Áóñêîïàí [Ãèîñöèíà áóòèëáðîìèä]    │ì-õîëèíîáëîêàòîð [A03BB01]    │äðàæå 10 ìã                   │Boehringer Ingelheim France,  │008478,    

                                                                                               │a division of Boehringer      │26.12.97   

                                                                                               │Ingelheim International Gmbh             

                                                                                               │(Ôðàíöèÿ)                                

                                                                                                                                        

│Áóòàäèîí [Ôåíèëáóòàçîí]            │ÍÏÂÑ [M02AA01]                │ìàçü 5%                       │Gedeon Richter (Âåíãðèÿ)      │2238,      

                                                                                                                             │29.07.71,  

                                                                                                                             │22.12.83,  

                                                                                                                             │09.02.87   

                                                                                                                                         

│Áóòîðôàíîëà òàðòðàòà ðàñòâîð äëÿ   │îïèîèäíûõ ðåöåïòîðîâ          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │010051,    

│èíúåêöèé 0.2% [Áóòîðôàíîë]         │àãîíèñò-àíòàãîíèñò [N02AF01]  │0.2% - 1, 2 ìë                                             │10.08.98   

                                                                                                                                        

│Áóôôåðàí [Àöåòèëñàëèöèëîâàÿ        │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ohm Laboratories Inc (ÑØÀ)    │010241,    

│êèñëîòà]                                                         │325 ìã                                                      │10.06.98   

                                                                                                                                        

│Áóôôåðèí [Àöåòèëñàëèöèëîâàÿ        │ÍÏÂÑ [N02BA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Bristol-Myers Squibb (ÑØÀ)    │007032,    

│êèñëîòà]                                                         │325, 500 ìã; êàïëåòû ïîêðûòûå │                              │31.01.96   

                                                                 │îáîëî÷êîé 325 ìã                                                       

                                                                                                                                        

│Â12 Àíêåðìàí [Öèàíîêîáàëàìèí]      │âèòàìèí [B03BA01]             │ðàñòâîð äëÿ èíúåêöèé          │Worwag Pharma Gmbh (Ãåðìàíèÿ) │006766,    

                                                                 │(ôëàêîíû) 100, 1000 ìêã                                     │31.10.95   

                                                                                                                                        

│Âàãîñ [Èïðàòðîïèÿ áðîìèä]          │ì-õîëèíîáëîêàòîð [R03BB01]    │àýðîçîëü äîçèðîâàííûé 20      │Valeas (Èòàëèÿ)               │006072,    

                                                                 │ìêã/äîçà                                                    │22.05.95   

                                                                                                                                         

│Âàãîòèë [Ïîëèêðåçóëåí]             │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Polfa, Pabianickie            │2169,      

                                   │[D08AE02]                     │ïðèìåíåíèÿ 36%                │Pharmaceutical Works (Ïîëüøà) │02.04.76,  

                                                                                                                             │03.07.95   

                                                                                                                                        

│Âàçàïðîñòàí [Àëïðîñòàäèë]          │âàçîäèëàòèðóþùåå ñðåäñòâî     │âåùåñòâî ñóõîå äëÿ            │Schwarz Pharma Ag (Ãåðìàíèÿ)  │007292,    

                                   │[C01EA01]                     │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │15.08.96   

                                                                 │ðàñòâîðà (àìïóëû) 20 ìêã                                               

                                                                                                                                        

│Âàçåëèíîâîå ìàñëî [Ïàðàôèí æèäêèé] │ñëàáèòåëüíîå ñðåäñòâî [A06AX] │ìàñëî (ôëàêîíû) 30 ìë         │Áîðèñîâñêèé çàâîä             │71/273/2,  

                                                                                               │ìåäïðåïàðàòîâ (Áåëàðóñü)      │01.06.98   

                                                                                                                                        

│Âàçêîòåí [Àòåíîëîë]                │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Medochemie Ltd (Êèïð)         │003080,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │17.06.93   

                                                                                                                                        

│Âàçîáðàë {äèãèäðîýðãîêðèïòèíà      │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð îðàëüíûé (ôëàêîíû) 50 │Laboratoires Jacques Logeais  │003275,    

│ìåçèëàò 1 ìã, êîôåèí 10 ìã - 1 ìë} │[C04AE51]                     │ìë                            │(Ôðàíöèÿ)                     │27.08.93   

                                                                                                                                        

│Âàçîáðàë {äèãèäðîýðãîêðèïòèíà      │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè                      │Laboratoires Jacques Logeais  │010162,    

│ìåçèëàò 4 ìã, êîôåèí 40 ìã}        │[C04AE51]                                                   │(Ôðàíöèÿ)                     │14.04.98   

                                                                                                                                        

│Âàçîçàí Ï {êîëåñòèðàìèí 74 ã,      │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │ïîðîøîê ãðàíóëèðîâàííûé       │Dr.Felgentrager & Co (ÔÐÃ)    │002814,    

│ïåêòèí 20 ã, ñàõàðîçà 5 ã,         │[C10AC01]                                                                                 │19.01.93   

│ñîðáèíîâàÿ êèñëîòà 0.18 ã - 100 ã} │                                                                                                     

                                                                                                                                        

│Âàçîçàí Ñ {êîëåñòèðàìèí 74 ã,      │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │ïîðîøîê ãðàíóëèðîâàííûé       │Dr.Felgentrager & Co (ÔÐÃ)    │002815,    

│ïåêòèí 5 ã, ñàõàðîçà 20 ã,         │[C10AC01]                                                                                 │19.01.93   

│ñîðáèíîâàÿ êèñëîòà 0.18 ã - 100 ã} │                                                                                                     

                                                                                                                                        

│Âàçîêàðäèí [Ìåòîïðîëîë]            │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 100 ìã               │Slovakofarma Sa (Ñëîâàêèÿ)    │003598,    

                                   │ñåëåêòèâíûé [C07AB02]                                                                     │17.12.93   

                                                                                                                                        

│Âàçîëàïðèë [Ýíàëàïðèë]             │ÀÊÔ áëîêàòîð [C09AA02]        │òàáëåòêè 10, 20 ìã            │Deva Holding As (Òóðöèÿ)      │006352,    

                                                                                                                             │07.08.95   

                                                                                                                                       

│Âàçîíèò [Ïåíòîêñèôèëëèí]           │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lannacher Heilmittel Gmbh     │009070,    

                                   │[C04AD03]                     │ðåòàðä 600 ìã                 │(Àâñòðèÿ)                     │13.01.97   

                                                                                                                                        

│Âàçîïðåí [Ýíàëàïðèë]               │ÀÊÔ áëîêàòîð [C09AA02]        │òàáëåòêè 5, 10, 20 ìã         │Sopharma Ead (Áîëãàðèÿ)       │009819,    

                                                                                                                             │11.11.97   

                                                                                                                                        

│Âàëèäîë [Ìåíòîëà ðàñòâîð â ìåíòèë  │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │òàáëåòêè                      │Natur Produkt (Ôðàíöèÿ)       │007417,    

│èçîâàëåðàòå]                       │[C01EX]                                                                                   │05.04.96   

                                                                                                                                        

│Âàëèäîë [Ìåíòîëà ðàñòâîð â ìåíòèë  │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │ðàñòâîð äëÿ âíóòðåííåãî       │Ôàðìàê ÀÎ (Óêðàèíà)           │009166,    

│èçîâàëåðàòå]                       │[C01EX]                       │ïðèìåíåíèÿ                                                  │15.07.97   

                                                                 │(ôëàêîí-êàïåëüíèöû) 5 ìë                                               

                                                                                                                                        

│Âàëèäîë â êàïñóëàõ 0.01 ã [Ìåíòîëà │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │êàïñóëû 100 ìã                │Ìèíñêèíòåðêàïñ ÑÏ             │78/580/3,  

│ðàñòâîð â ìåíòèë èçîâàëåðàòå]      │[C01EX]                                                     │Áåëàðóññêî-Àìåðèêàíñêîå       │09.06.98   

                                                                                               │(Áåëàðóñü)                               

                                                                                                                                        

│Âàëèäîëà òàáëåòêè [Ìåíòîëà ðàñòâîð │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │òàáëåòêè 60 ìã                │Ôàðìàê ÀÎ (Óêðàèíà)           │70/183/45, 

│â ìåíòèë èçîâàëåðàòå]              │[C01EX]                                                                                   │15.07.97   

                                                                                                                                        

│Âàëèäîëà òàáëåòêè 0.06 ã [Ìåíòîëà  │êîðîíàðîäèëàòèðóþùåå ñðåäñòâî │òàáëåòêè 60 ìã                │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/183/45, 

│ðàñòâîð â ìåíòèë èçîâàëåðàòå]      │[C01EX]                                                                                   │05.01.98   

                                                                                                                                        

│Âàëèóì Ðîø [Äèàçåïàì]              │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5, 10 ìã; ðàñòâîð    │F.Hoffmann La Roche Ltd       │008084,    

                                   │[N05BA01]                     │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │(Øâåéöàðèÿ)                   │17.12.96   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Âàëîäåðì [Áåòàìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì (òóáû) 0.1% - 15, 30 ã   │Rusan Pharma (Èíäèÿ)          │009358,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC01] │                                                            │04.04.97   

                                                                                                                                         

│Âàëîäåðì-à {áåòàìåòàçîíà âàëåðàò 1 │ãëþêîêîðòèêîñòåðîèä           │êðåì (òóáû) 15, 30 ã          │Rusan Pharma (Èíäèÿ)          │009357,    

│ìã, ãåíòàìèöèí 1 ìã - 1 ã}         │+ïðîòèâîìèêðîáíîå ñðåäñòâî                                                               │04.04.97   

                                   │[D07CC01]                                                                                            

                                                                                                                                        

│Âàëîêîðäèí {ôåíîáàðáèòàë 2 ã,      │ñåäàòèâíîå ñðåäñòâî           │êàïëè äëÿ ïðèåìà âíóòðü       │Krewel Meuselbach Gmbh        │006670,    

│ýòèëáðîìèçîâàëåðèàíàò 2 ã, ìÿòû    │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │(ôëàêîíû)                     │(Ãåðìàíèÿ)                    │26.03.96   

│ïåðå÷íîé ìàñëî 0.14 ã, õìåëÿ ìàñëî │[N05CM]                                                                                              

│20 ìã - 100 ìë}                                                                                                                         

                                                                                                                                        

│Âàëòðåêñ [Âàëàöèêëîâèð]            │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 500 ìã               │Glaxo-Wellcome Operations Ltd │009291,    

                                   │[J05AB11]                                                   │(Âåëèêîáðèòàíèÿ)              │11.03.97   

                                                                                                                                        

│Âàìèí 14                           │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé âîäíûé    │Pharmacia (Ôðàíöèÿ)           │008029,    

                                   │ïèòàíèÿ [B05BA10]             │(ôëàêîíû) 500, 1000 ìë                                      │25.02.97   

                                                                                                                                        

│Âàìèí 14 áåç ýëåêòðîëèòîâ          │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé âîäíûé    │Pharmacia (Ôðàíöèÿ)           │008027,    

                                   │ïèòàíèÿ [B05BA01]             │(ôëàêîíû) 500, 1000 ìë                                      │25.02.97   

                                                                                                                                       

│Âàìèí 18 áåç ýëåêòðîëèòîâ          │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé âîäíûé    │Pharmacia (Ôðàíöèÿ)           │008028,    

                                   │ïèòàíèÿ [B05BA01]             │(ôëàêîíû) 500, 1000 ìë                                      │25.02.97   

                                                                                                                                        

│Âàìèí Ãëþêîçà                      │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ âíóòðèâåííîãî     │Pharmacia Ab (Øâåöèÿ)         │006664,    

                                   │ïèòàíèÿ [B05BA10]             │ââåäåíèÿ (ôëàêîíû)                                          │20.03.96   

                                                                                                                                        

│Âàìèíîëàêò                         │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé âîäíûé    │Pharmacia (Ôðàíöèÿ)           │008026,    

                                   │ïèòàíèÿ [B05BA01]             │(ôëàêîíû) 100, 500 ìë                                       │25.02.97   

                                                                                                                                        

│Âàí-Àëüôà [Àëüôàêàëüöèäîë]         │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │òàáëåòêè 0.25, 0.5, 1 ìêã     │Teijin Limited (ßïîíèÿ)       │009745,    

                                   │ôîñôîðà [A11CC03]                                                                         │26.09.97   

                                                                                                                                        

│Âàíêîëåä [Âàíêîìèöèí]              │àíòèáèîòèê [J01XA01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Lederle (ÑØÀ)                 │005973,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │18.04.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 500, 1000                                           

                                                                 │ìã                                                                    

                                                                                                                                        

│Âàíêîìèöèí [Âàíêîìèöèí]            │àíòèáèîòèê [J01XA01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │009982,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │11.02.98   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.5, 1 ã                                            

                                                                                                                                        

│Âàíêîìèöèí Êâàëèìåä [Âàíêîìèöèí]   │àíòèáèîòèê [J01XA01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Solymes, Roussel │006964,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Uclaf Groupe (Ôðàíöèÿ)        │09.01.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 500 ìã                                              

                                                                                                                                        

│Âàíêîöèí [Âàíêîìèöèí]              │àíòèáèîòèê [J01XA01]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (Ãåðìàíèÿ)          │008335,    

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                      │09.10.97   

                                                                 │(ôëàêîíû) 0.5, 1 ã                                                     

                                                                                                                                        

│Âàíìèêñàí [Âàíêîìèöèí]             │àíòèáèîòèê [J01XA01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Sanofi-Winthrop (Ôðàíöèÿ)     │007946,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │11.11.96   

                                                                 │ðàñòâîðà (ôëàêîíû ñòåêëÿííûå) │                                         

                                                                 │500 ìã - 20 ìë                                                         

                                                                                                                                        

│Âåêòàâèð [Ïåíöèêëîâèð]             │ïðîòèâîâèðóñíîå ñðåäñòâî      │êðåì (òóáû) 1% - 2, 5 ã       │Smithkline Beecham Consumer   │009821,    

                                   │[D06BB06]                                                   │Healthcare (Âåëèêîáðèòàíèÿ)   │12.11.97   

                                                                                                                                        

│Âåëáå [Âèíáëàñòèí]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (Ôðàíöèÿ)           │008610,    

                                   │[L01CA01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │24.04.98   

                                                                 │(ôëàêîíû) 10 ìã                                                        

                                                                                                                                        

│Âåëîíàðêîí 0.1 [Êåòàìèí]           │íàðêîçíîå íåèíãàëÿöèîííîå     │ðàñòâîð äëÿ èíúåêöèé          │Arzneimittelwerk Dresden Gmbh │009474,    

                                   │ñðåäñòâî [N01AX03]            │(ôëàêîíû) 10 ìë/ìë            │(Ãåðìàíèÿ)                    │23.05.97   

                                                                                                                                        

│Âåëîíàðêîí 0.5 [Êåòàìèí]           │íàðêîçíîå íåèíãàëÿöèîííîå     │ðàñòâîð äëÿ èíúåêöèé          │Arzneimittelwerk Dresden Gmbh │009475,    

                                   │ñðåäñòâî [N01AX03]            │(ôëàêîíû) 50 ìë/ìë - 10 ìë    │(Ãåðìàíèÿ)                    │23.05.97   

                                                                                                                                        

│Âåëîðèí 100 [Àòåíîëîë]             │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Remedica Ltd - Minnex (Êèïð)  │009765,    

                                   │ñåëåêòèâíûé [C07AB03]         │100 ìã                                                      │06.10.97   

                                                                                                                                        

│Âåíåí {êàøòàíà êîíñêîãî ñåìÿí      │âåíîòîíèçèðóþùåå ñðåäñòâî     │äðàæå; ìàçü (òóáû)            │Ct-Arzneimittel Chemishe      │005771,    

│ýêñòðàêò}                          │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Tempelchof Gmbh (Ãåðìàíèÿ)    │22.02.95   

                                   │[C05B]                                                                                               

                                                                                                                                        

│Âåíåí {êàøòàíà êîíñêîãî ñåìÿí      │âåíîòîíèçèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ íàðóæíîãî         │Ct-Arzneimittel Chemishe      │006196,    

│ýêñòðàêò}                          │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïðèìåíåíèÿ (ôëàêîíû)          │Tempelchof Gmbh (Ãåðìàíèÿ)    │16.06.95   

                                   │[C05B]                                                                                               

                                                                                                                                        

│Âåíåí ãåëü äîêòîðà Òàéññà {êàøòàíà │âåíîòîíèçèðóþùåå ñðåäñòâî     │ãåëü (òóáû) 100 ã             │Naturwaren, Dr.P.Theiss       │007446,    

│êîíñêîãî ñåìÿí ýêñòðàêò 3 ã,       │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │17.04.96   

│êàëåíäóëû ýêñòðàêò 400 ìã - 100 ìë}│[C05B]                                                                                               

                                                                                                                                         

│Âåíèòàí [Ýñöèí]                    │âåíîòîíèçèðóþùåå ñðåäñòâî     │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Lek D.D. (Ñëîâåíèÿ)           │009816,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │(òóáû) 1% - 50 ã                                           │04.11.97   

                                   │[C05CX]                                                                                              

                                                                                                                                        

│Âåíèòàí [Ýñöèí]                    │âåíîòîíèçèðóþùåå ñðåäñòâî     │êðåì (òóáû)                   │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005039,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │24.06.94   

                                   │[C05CX]                                                                                              

                                                                                                                                        

│Âåíîáåíå {ãåïàðèí 30000 ÌÅ,        │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │êðåì (òóáû)                   │Ludwig Merckle Gmbh (Àâñòðèÿ) │006715,    

│äåêñïàíòåíîë 5 ã - 100 ã}          │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │                                                            │18.10.95   

                                                                                                                                        

│Âåíîðóòîí [Ðóòîçèä]                │àíãèîïðîòåêòîðíîå ñðåäñòâî    │êàïñóëû 300 ìã; ãåëü (òóáû)   │Zyma Sa (Øâåéöàðèÿ)           │008105,    

                                   │[C05CA01]                     │2% - 40, 100 ã                                              │24.12.96   

                                                                                                                                        

│Âåíîðóòîí ôîðòå [Ðóòîçèä]          │àíãèîïðîòåêòîðíîå ñðåäñòâî    │òàáëåòêè 500 ìã               │Zyma Sa (Øâåéöàðèÿ)           │008104,    

                                   │[C05CA01]                                                                                 │24.12.96   

                                                                                                                                        

│Âåíîôåð [Æåëåçî (III) ãèäðîêñèä    │ãåìîïîýçà ñòèìóëÿòîð [B03AC]  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Vifor (International) Inc     │009709,    

│ñàõàðîçíûé êîìïëåêñ]                                             │100 ìã - 5 ìë                 │(Øâåéöàðèÿ)                   │02.09.97   

                                                                                                                                        

│Âåíòàêñ [Òåîôèëëèí]                │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │êàïñóëû äëèòåëüíîãî           │Yamanouchi Europe B.V.        │006205,    

                                   │[R03DA04]                     │âûñâîáîæäåíèÿ 100, 200, 300 ìã│(Íèäåðëàíäû)                  │21.06.95   

                                                                                                                                        

│Âåíòåð [Ñóêðàëüôàò]                │ïðîòèâîÿçâåííîå ñðåäñòâî      │òàáëåòêè 1 ã                  │Krka (Ñëîâåíèÿ)               │008096,    

                                   │[A02BX02]                                                                                 │20.12.96   

                                                                                                                                        

│Âåíòåð [Ñóêðàëüôàò]                │ïðîòèâîÿçâåííîå ñðåäñòâî      │ãðàíóëû (ïàêåòèêè) 1 ã        │Krka (Ñëîâåíèÿ)               │008018,    

                                   │[A02BX02]                                                                                 │03.02.97   

                                                                                                                                        

│Âåíòîäèñê [Ñàëüáóòàìîë]            │áåòà2-àäðåíîñòèìóëÿòîð        │ïîðîøîê äëÿ èíãàëÿöèé         │Glaxo-Wellcome Laboratories   │007978,    

                                   │ñåëåêòèâíûé [R03AC02]         │äîçèðîâàííûé (ðîòîäèñêè) 200, │(Ôðàíöèÿ)                     │25.11.96   

                                                                 │400 ìêã                                                                 

                                                                                                                                        

│Âåíòîëèí [Ñàëüáóòàìîë]             │áåòà2-àäðåíîñòèìóëÿòîð        │ñèðîï (ôëàêîíû) 2 ìã/ìë - 150 │Glaxo (Âåëèêîáðèòàíèÿ)        │005576,    

                                   │ñåëåêòèâíûé [R03CC02]         │ìë                                                          │15.12.94   

                                                                                                                                        

│Âåíòîëèí ëåãêîå äûõàíèå            │áåòà2-àäðåíîñòèìóëÿòîð        │àýðîçîëü (èíãàëÿòîð ñ         │Norton Healthcare For         │008597,    

│[Ñàëüáóòàìîë]                      │ñåëåêòèâíûé [R03AC02]         │îïòèìèçàòîðîì äîçû) 100       │Glaxo-Wellcome                │14.08.98   

                                                                 │ìêã/äîçà - 200 äîç; àýðîçîëü  │(Âåëèêîáðèòàíèÿ)                         

                                                                 │(áàëëîí÷èêè) 100 ìêã/äîçà -                                            

                                                                 │200 äîç                                                                

                                                                                                                                        

│Âåíòðèñîë [Âèñìóòà òðèêàëèÿ        │ïðîòèâîÿçâåííîå ñðåäñòâî,     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Poznanskie             │005577,    

│äèöèòðàò]                          │ïðåïàðàò âèñìóòà [A02BX05]                                  │Pharmaceutical Works (Ïîëüøà) │16.12.94   

                                                                                                                                        

│Âåïåçèä [Ýòîïîçèä]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bristol-Myers Squibb          │007443,    

                                   │[L01CB01]                     │100 ìã - 5 ìë                 │(Ãåðìàíèÿ)                    │16.04.96   

                                                                                                                                         

│Âåïåçèä [Ýòîïîçèä]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êàïñóëû 50, 100 ìã            │Bristol-Myers Squibb (Èòàëèÿ) │009920,    

                                   │[L01CB01]                                                                                │24.12.97   

                                                                                                                                        

│Âåïåçèä [Ýòîïîçèä]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bristol-Myers Squibb (Èòàëèÿ) │009963,    

                                   │[L01CB01]                     │100 ìã - 5 ìë                                               │23.01.98   

                                                                                                                                        

│Âåïåçèä [Ýòîïîçèä]                 │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êàïñóëû 50, 100 ìã            │Bristol-Myers Squibb (ÑØÀ)    │002903,    

                                   │[L01CB01]                                                                                 │12.03.93   

                                                                                                                                        

│Âåðàêàðä [Âåðàïàìèë]               │ÁÌÊÊ [C08DA01]                │êàïñóëû-äåïî 120, 180, 240 ìã │Nycomed Pharma As (Íîðâåãèÿ)  │007413,    

                                                                                                                             │04.04.96   

                                                                                                                                        

│Âåðàë [Äèêëîôåíàê]                 │ÍÏÂÑ [M01AB05] [M02AA15]      │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Slovakofarma Sa (Ñëîâàöêàÿ    │009936,    

                                                                 │îáîëî÷êîé 25, 50 ìã; ãåëü     │Ðåñïóáëèêà)                   │26.12.97   

                                                                 │(òóáû) 1% - 55 ã                                                       

                                                                                                                                         

│Âåðàïàáåíå [Âåðàïàìèë]             │ÁÌÊÊ [C08DA01]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ludwig Merckle Gmbh (Àâñòðèÿ) │005133,    

                                                                 │5 ìã - 2 ìë                                                │15.07.94   

                                                                                                                                        

│Âåðàïàìèë (Ìèâàë) [Âåðàïàìèë]      │ÁÌÊÊ [C08DA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Mir Pharmaceutical            │007673,    

                                                                 │40, 80, 120 ìã                │Inc/Pharbita B.V.             │23.07.96   

                                                                                               │(Íèäåðëàíäû) (ÑØÀ)                       

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │äðàæå 40, 80 ìã               │Alkaloid (Ìàêåäîíèÿ)          │003197,    

                                                                                                                             │05.08.93   

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Belupo (Õîðâàòèÿ)             │007112,    

                                                                 │80, 120 ìã; ðàñòâîð äëÿ                                     │29.02.96   

                                                                 │èíúåêöèé (àìïóëû) 5 ìã - 2 ìë │                                         

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │äðàæå 80 ìã                   │Chinoin (Âåíãðèÿ)             │005377,    

                                                                                                                             │03.10.94   

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │äðàæå 80 ìã                   │Hemofarm D.D. (Þãîñëàâèÿ)     │010116,    

                                                                                                                             │12.03.98   

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │äðàæå 40 ìã                   │Hemofarm Dd (Þãîñëàâèÿ)       │010514,    

                                                                                                                             │26.10.98   

                                                                                                                                        

│Âåðàïàìèë [Âåðàïàìèë]              │ÁÌÊÊ [C08DA01]                │òàáëåòêè 40, 80, 120 ìã       │Norton Healthcare Ltd         │003594,    

                                                                                               │(Âåëèêîáðèòàíèÿ)              │16.12.93   

                                                                                                                                        

│Âåðàïàìèëà ãèäðîõëîðèäà ðàñòâîð    │ÁÌÊÊ [C08DA01]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áîðèñîâñêèé Çàâîä             │84/881/10, 

│äëÿ èíúåêöèé 0.25% [Âåðàïàìèë]                                   │0.25% - 2 ìë                  │Ìåäïðåïàðàòîâ (Áåëàðóñü)      │16.01.98   

                                                                                                                                        

│Âåðàïàìèë-Ðàòèîôàðì [Âåðàïàìèë]    │ÁÌÊÊ [C08DA01]                │òàáëåòêè 40, 80, 120 ìã       │Ratiopharm Gmbh & Co          │003415,    

                                                                                               │(Ãåðìàíèÿ)                    │12.10.93   

                                                                                                                                         

│Âåðìàêàð [Ìåáåíäàçîë]              │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 100 ìã; ñóñïåíçèÿ    │Pharmacar Ltd (Èçðàèëü)       │006683,    

                                   │[P02CA01]                     │îðàëüíàÿ (ôëàêîíû) 100 ìã|5 ìë│                              │29.09.95   

                                                                                                                                        

│Âåðìîêñ [Ìåáåíäàçîë]               │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 100 ìã               │Gedeon Richter (Âåíãðèÿ)      │007223,    

                                   │[P02CA01]                                                                                 │24.06.96   

                                                                                                                                        

│Âåðìîêñ [Ìåáåíäàçîë]               │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 100 ìã; ñóñïåíçèÿ 20 │Janssen Pharmaceutica         │003783,    

                                   │[P02CA01]                     │ìã/ìë                         │(Áåëüãèÿ)                     │24.03.94   

                                                                                                                                        

│Âåðíàê [Äèêëîôåíàê]                │ÍÏÂÑ [M01AB05]                │òàáëåòêè 25, 50 ìã; ðàñòâîð   │M.J.Pharmaceuticals Ltd       │003030,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 2.5% -  │(Èíäèÿ)                       │01.06.93   

                                                                 │3 ìë                                                                   

                                                                                                                                        

│Âåðîøïèðîí [Ñïèðîíîëàêòîí]         │äèóðåòè÷åñêîå                 │òàáëåòêè 25 ìã                │Gedeon Richter (Âåíãðèÿ)      │2122,      

                                   │êàëèéñáåðåãàþùåå ñðåäñòâî                                                                 │01.07.70,  

                                   │[C03DA01]                                                                                 │22.05.84,  

                                                                                                                             │27.02.95   

                                                                                                                                       

│Âåððóìàë {ôòîðóðàöèë 5 ìã,         │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ íàðóæíîãî         │Boots Healthcare              │010315,    

│ñàëèöèëîâàÿ êèñëîòà 100 ìã - 1 ìë} │[L01BC52]                     │ïðèìåíåíèÿ (ôëàêîíû) 13 ìë    │International/Hermal Kurt     │10.07.98   

                                                                                               │Hermann (Ãåðìàíèÿ)                       

                                                                                                                                        

│Âåðòèçèí [Öèííàðèçèí]              │ÁÌÊÊ [N07CA02]                │òàáëåòêè 25 ìã                │Torrent Pharmaceuticals Ltd   │008619,    

                                                                                               │(Èíäèÿ)                       │28.04.98   

                                                                                                                                        

│Âåðòèçèí ôîðòå [Öèííàðèçèí]        │ÁÌÊÊ [N07CA02]                │òàáëåòêè ôîðòå 75 ìã          │Torrent Pharmaceuticals Ltd   │008618,    

                                                                                               │(Èíäèÿ)                       │28.04.98   

                                                                                                                                        

│Âåðöåô [Öåôàêëîð]                  │àíòèáèîòèê, öåôàëîñïîðèí      │òàáëåòêè ïîêðûòûå îáîëî÷êîé ñ │Ranbaxy Laboratories Ltd      │010180,    

                                   │[J01DA08]                     │ðåãóëèðóåìûì âûñâîáîæäåíèåì   │(Èíäèÿ)                       │27.04.98   

                                                                 │375 ìã                                                                 

                                                                                                                                         

│Âåðöåô [Öåôàêëîð]                  │àíòèáèîòèê, öåôàëîñïîðèí      │êàïñóëû 250 ìã; ñóñïåíçèÿ     │Ranbaxy Laboratories Ltd      │002930,    

                                   │[J01DA08]                     │îðàëüíàÿ 125 ìã|5 ìë          │(Èíäèÿ)                       │30.03.93   

                                                                                                                                        

│Âåñàíîèä [Òðåòèíîèí]               │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êàïñóëû 10 ìã                 │F.Hoffmann La Roche           │009962,    

                                   │[L01XX14]                                                   │Ltd/R.P.Sherer (Øâåéöàðèÿ)    │23.01.98   

                                                                                                                                        

│Âåññåë Äóý Ô [Ñóëîäåêñèä]          │àíòèêîàãóëÿíò [B01AB11]       │êàïñóëû 250 ÅÄ; ðàñòâîð äëÿ   │Alfa Schiapparelli Wassermann │003150,    

                                                                 │èíúåêöèé (àìïóëû) 600 ÅÄ - 2  │Spa (Èòàëèÿ)                  │08.07.93   

                                                                 │ìë                                                                     

                                                                                                                                        

│Âèàãðà [Ñèëäåíàôèë öèòðàò]         │ïîòåíöèè ñòèìóëÿòîð [G04BE]   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pfizer (ÑØÀ)                  │010344,    

                                                                 │25, 50, 100 ìã                                              │16.07.98   

                                                                                                                                        

│Âèáðàìèöèí [Äîêñèöèêëèí]           │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Krka (Ñëîâåíèÿ)               │00133,     

                                   │[J01AA02]                                                                                 │09.03.71,  

                                                                                                                             │13.02.84,  

                                                                                                                             │18.04.95   

                                                                                                                                       

│Âèáðàìèöèí [Äîêñèöèêëèí]           │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã; ñèðîï         │Pfizer Sa (Áåëüãèÿ)           │007205,    

                                   │[J01AA02]                     │(ôëàêîíû) 10 ìã/ìë - 20, 60 ìë│                              │04.06.96   

                                                                                                                                        

│Âèáðîöèë {äèìåòèíäåí 0.25 ìã,      │ïðîòèâîêîíãåñòèâíîå ñðåäñòâî  │êàïëè íàçàëüíûå (ôëàêîíû ñ    │Zyma Sa (Øâåéöàðèÿ)           │009683,    

│ôåíèëýôðèí 2.5 ìã - 1 ã}           │[R01AB01]                     │êðûøêîé êàïåëüíèöåé) 15 ìë;                                 │15.08.97   

                                                                 │ñïðåé íàçàëüíûé                                                        

                                                                 │(òþáèê-êàïåëüíèöû) 10 ìë;                                              

                                                                 │ãåëü (òóáû) 12 ã                                                       

                                                                                                                                        

│Âèâîðàêñ [Àöèêëîâèð]               │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200, 400 ìã; êðåì    │Cadila Pharmaceuticals Ltd    │007898,    

                                   │[D06BB03] [J05AB01]           │(òóáû) 5% - 5 ã               │(Èíäèÿ)                       │15.10.96   

                                                                                                                                        

│Âèãàíòîë [Êîëåêàëüöèôåðîë]         │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │ðàñòâîð ìàñëÿíûé (ôëàêîíû) 10 │Merck (ÔÐÃ)                   │003252,    

                                   │ôîñôîðà [A11CC05]             │ìë                                                          │19.08.93   

                                                                                                                                        

│Âèäåêñ [Äèäàíîçèí]                 │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè äëÿ ïðèãîòîâëåíèÿ    │Bristol-Myers Squibb (ÑØÀ)    │006888,    

                                   │[J05AB07]                     │îðàëüíîãî ðàñòâîðà 25, 50,                                  │14.12.95   

                                                                 │100, 150 ìã; ïîðîøîê äëÿ                                               

                                                                 │ïðèãîòîâëåíèÿ îðàëüíîãî                                                

                                                                 │ðàñòâîðà (ñàøå) 100, 167,                                              

                                                                 │250, 375 ìã; ïîðîøîê äëÿ                                               

                                                                 │ïðèãîòîâëåíèÿ îðàëüíîãî                                                

                                                                 │ðàñòâîðà äëÿ äåòåé (ôëàêîíû)                                           

                                                                 │2 ã, 4 ã                                                               

                                                                                                                                        

│Âèäèñèê {öèòðèìèä 0.1 ìã,          │îôòàëüìîëîãè÷åñêîå ñðåäñòâî   │ãåëü ãëàçíîé (òóáû) 10 ã      │Bausch&Lomb Gmbh, Doctor Mann │010468,    

│ïîëèàêðèëîâàÿ êèñëîòà 2 ìã, ñîðáèò │[S01XA20]                                                   │Pharma Gmbh (Ãåðìàíèÿ)        │18.09.98   

│40 ìã - 1 ã}                                                                                                                            

                                                                                                                                        

│Âèçèí [Òåòðèçîëèí]                 │àëüôà-àäðåíîñòèìóëÿòîð        │êàïëè ãëàçíûå (ôëàêîíû) 0.05% │Pfizer Canada Inc (Êàíàäà)    │007375,    

                                   │[S01GA02]                                                                                 │28.03.96   

                                                                                                                                       

│Âèê Ñàéíåêñ [Îêñèìåòàçîëèí]        │àëüôà-àäðåíîñòèìóëÿòîð        │ñïðåé íàçàëüíûé (ôëàêîíû)     │Procter & Gamble &            │009561,    

                                   │[R01AA05]                     │0.05% - 15 ìë                 │Manufacturing Ohg (Ãåðìàíèÿ)  │30.06.97   

                                                                                                                                        

│Âèê ñèðîï ýêñïåêòîðàíò ôîðìóëà 44  │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 200 ìã|15 ìë  │Procter & Gamble &            │009631,    

│ïëþñ äëÿ âçðîñëûõ [Ãâàéôåíåçèí]    │[R05CA03]                     │- 120, 180, 250 ìë            │Manufacturing Ohg (Ãåðìàíèÿ)  │29.07.97   

                                                                                                                                        

│Âèêàäåðì [Êëîòðèìàçîë]             │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì (òóáû) 1%                │Milpharma (Àâñòðàëèÿ)         │005391,    

                                   │[D01AC01]                                                                                 │13.10.94   

                                                                                                                                        

│Âèêàèð òàáëåòêè {âèñìóòà ñóáíèòðàò │ïðîòèâîÿçâåííîå ñðåäñòâî      │òàáëåòêè                      │Ãàëè÷ôàðì ÀÎ (Óêðàèíà)        │67/85/16,  

│0.35 ã, ìàãíèÿ êàðáîíàò 0.4 ã,     │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │11.02.98   

│íàòðèÿ ãèäðîêàðáîíàò 0.2 ã, àèðà   │[A02BX]                                                                                              

│êîðíåâèùå 25 ìã, êðóøèíû êîðà 25                                                                                                        

│ìã}                                                                                                                                      

                                                                                                                                        

│Âèêàëèí òàáëåòêè {âèñìóòà          │ïðîòèâîÿçâåííîå ñðåäñòâî      │òàáëåòêè                      │Ãàëè÷ôàðì ÀÎ (Óêðàèíà)        │67/554/22, 

│ñóáíèòðàò 0.35 ã, ìàãíèÿ êàðáîíàò  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │25.12.97   

│0.4 ã, íàòðèÿ ãèäðîêàðáîíàò 0.2 ã, │[A02BX]                                                                                              

│àèðà êîðíåâèùå 25 ìã, êðóøèíû êîðà │                                                                                                     

│25 ìã, ðóòîçèä 5 ìã, êåëëèí 5 ìã}                                                                                                       

                                                                                                                                        

│Âèêàñîëà ðàñòâîð äëÿ èíúåêöèé 1%   │âèòàìèí [B02BA02]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ôàðìàêî ÀÎ (Ìîëäîâà)          │70/183/50, 

│[Ìåíàäèîíà íàòðèÿ áèñóëüôèò]                                     │1% - 1 ìë                                                   │15.07.98   

                                                                                                                                        

│Âèëüïðàôåí [Äæîçàìèöèí]            │àíòèáèîòèê, ìàêðîëèä [J01FA07]│òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Heinrich Mack Nachf.          │003115,    

                                                                 │500 ìã; ñóñïåíçèÿ 150 ìã|5 ìë │(Ãåðìàíèÿ)                    │29.06.93   

                                                                 │- 100 ìë; ñóñïåíçèÿ ôîðòå 300 │                                         

                                                                 │ìã|5 ìë - 100 ìë                                                       

                                                                                                                                        

│Âèíáëàñòèí [Âèíáëàñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê (ôëàêîíû) 5  │Gedeon Richter (Âåíãðèÿ)      │2123,      

                                   │[L01CA01]                     │ìã /â êîìïëåêòå ñ                                           │01.07.70,  

                                                                 │ðàñòâîðèòåëåì/                                             │29.12.83,  

                                                                                                                             │19.12.94   

                                                                                                                                        

│Âèíáëàñòèíà ñóëüôàò [Âèíáëàñòèí]   │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Therabel Pharma, Laboratories │006699,    

                                   │[L01CA01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Tissen (Áåëüãèÿ)              │29.09.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã                                               

                                                                                                                                        

│Âèíáëàñòèí-Òåâà [Âèíáëàñòèí]       │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │005864,    

                                   │[L01CA01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │27.03.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã /â                                            

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Âèíêðèñòèí [Âèíêðèñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Gedeon Richter (Âåíãðèÿ)      │009334,    

                                   │[L01CA02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │25.03.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ìã /â                                              

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                       

│Âèíêðèñòèí [Âèíêðèñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Gedeon Richter (Âåíãðèÿ)      │006571,    

                                   │[L01CA02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │28.09.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.5 ìã /â                                           

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Âèíêðèñòèí [Âèíêðèñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Pierre Fabre Medicament       │008319,    

                                   │[L01CA02]                     │(ôëàêîíû) 1 ìã/ìë - 1, 2, 3,  │(Ôðàíöèÿ)                     │19.08.97   

                                                                 │5 ìë                                                                   

                                                                                                                                        

│Âèíêðèñòèí [Âèíêðèñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Tissen Laboratories (Áåëüãèÿ) │007018,    

                                   │[L01CA02]                     │(ôëàêîíû) 5 ìã - 5 ìë                                       │28.01.96   

                                                                                                                                        

│Âèíêðèñòèí [Âèíêðèñòèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Tissen Laboratories (Áåëüãèÿ) │003829,    

                                   │[L01CA02]                     │(ôëàêîíû) 1 ìã/ìë                                           │05.04.94   

                                                                                                                                        

│Âèíêðèñòèí ëèêâèä-Ðèõòåð           │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Chemical Industries Gedeon    │009746,    

│[Âèíêðèñòèí]                       │[L01CA02]                     │(ôëàêîíû) 1 ìã/ìë             │Richter Ag (Âåíãðèÿ)          │29.09.97   

                                                                                                                                        

│Âèíêðèñòèíà ñóëüôàò [Âèíêðèñòèí]   │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèçàò äëÿ ïðèãîòîâëåíèÿ  │Eli Lilly & Elanco (ÑØÀ)      │002592,    

                                   │[L01CA02]                     │èíúåêöèîííîãî ðàñòâîðà                                      │06.08.92   

                                                                 │(àìïóëû) 1 ìã; ðàñòâîð äëÿ                                             

                                                                 │èíúåêöèé (àìïóëû) 1 ìã/ìë                                              

                                                                                                                                        

│Âèíêðèñòèíà ñóëüôàò [Âèíêðèñòèí]   │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Delta West (Àâñòðàëèÿ)        │003143,    

                                   │[L01CA02]                     │(ôëàêîíû) 1 ìã/1 ìë, 2 ìã/2 ìë│                              │07.07.93   

                                                                                                                                        

│Âèíêðèñòèí-Òåâà [Âèíêðèñòèí]       │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │005975,    

                                   │[L01CA02]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │19.04.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ìã /â                                             

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/;                                             

                                                                 │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                         

                                                                 │1 ìã/ìë                                                               

                                                                                                                                        

│Âèíïîöåòèí [Âèíïîöåòèí]            │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Covex Sa (Èñïàíèÿ)            │008396,    

                                   │[N06BX18]                                                                                 │10.03.98   

                                                                                                                                        

│Âèíïîöåòèí [Âèíïîöåòèí]            │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Gedeon Richter (Âåíãðèÿ)      │009038,    

                                   │[N06BX18]                                                                                 │19.12.96   

                                                                                                                                        

│Âèíïîöåòèí-Ðèâîôàðì [Âèíïîöåòèí]   │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 5, 10 ìã             │Rivopharm Sa (Øâåéöàðèÿ)      │006948,    

                                   │[N06BX18]                                                                                 │27.12.95   

                                                                                                                                        

│Â-Èíñóëèí ÑÖ Áåðëèí-Õåìè           │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ðàñòâîð äëÿ èíúåêöèé          │Berlin-Chemie Ag (ÔÐÃ)        │002445,    

│[Èíñóëèí-ÑðÄ]                      │[A10AC]                       │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │03.04.92   

                                                                                                                                        

│Âèîñåïò {òðèïåëåíàìèí 20 ìã,       │àíòèñåïòè÷åñêîå ñðåäñòâî      │ìàçü (òóáû) 15 ã              │Jelfa Sa (Ïîëüøà)             │008156,    

│êëèîõèíîë 20 ìã, äîìèôåí 0.5 ìã -  │[D08AH]                                                                                   │11.02.97   

│1 ã}                                                                                                                                   

                                                                                                                                        

│Âèïðàòîêñ {ÿä çìåèíûé 0.1 ìã,      │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû) 45 ã              │Serumwerk Bernburg Ag         │008414,    

│ìåòèëñàëèöèëàò 6 ã, êàìôîðà 3 ã}   │[M02AX]                                                     │(Ãåðìàíèÿ)                    │07.08.97   

                                                                                                                                        

│Âèïðîñàë  ìàçü {ÿä ãàäþêè 5 ÌÅÄ,  │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû) 50 ã              │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │010037,    

│êàìôîðà, ñàëèöèëîâàÿ êèñëîòà,      │[M02AX]                                                     │çàâîä ÀÎ (Ýñòîíèÿ)            │10.06.98   

│ïèõòîâîå ìàñëî, âàçåëèí, ãëèöåðîë, │                                                                                                      

│ïàðàôèí, ýìóëüãàòîð, âîäà - 100 ã} │                                                                                                     

                                                                                                                                        

│Âèïðîñàë  ìàçü {ÿä ãàäþêè 5 ÌÅÄ,  │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû) 50 ã              │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │010037,    

│êàìôîðà, ñàëèöèëîâàÿ êèñëîòà,      │[M02AX]                                                    │çàâîä ÀÎ (Ýñòîíèÿ)            │10.09.98   

│ïèõòîâîå ìàñëî, âàçåëèí, ãëèöåðîë, │                                                                                                     

│ïàðàôèí, ýìóëüãàòîð, âîäà - 100 ã} │                                                                                                     

                                                                                                                                        

│Âèïðîñàë  ìàçü {ÿä ãàäþêè 5 ÌÅÄ,  │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (áàíêè) 15, 25, 30 ã;    │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │72/911/7,  

│êàìôîðà, ñàëèöèëîâàÿ êèñëîòà,      │[M02AX]                       │ìàçü (òóáû) 15, 25, 30 ã                                    │10.06.98   

│ïèõòîâîå ìàñëî, âàçåëèí, ãëèöåðîë, │                                                                                                     

│ïàðàôèí, ýìóëüãàòîð, âîäà - 100 ã} │                                                                                                     

                                                                                                                                        

│Âèïñîãàë {áåòàìåòàçîíà äèïðîïèîíàò │ãëþêîêîðòèêîñòåðîèä äëÿ       │ìàçü (òóáû) 30, 100 ã         │ICN Galenika (Þãîñëàâèÿ)      │008297,    

│175 ìêã, ôëóîöèíîëîíà àöåòîíèä 175 │ìåñòíîãî ïðèìåíåíèÿ [D07XC01] │                                                            │24.06.97   

│ìêã, ãåíòàìèöèí 350 ÈÅ,                                                                                                                 

│ñàëèöèëîâàÿ êèñëîòà 50 ìã,                                                                                                               

│äåêñïàíòåíîë 5 ìã - 1 ã}                                                                                                                

                                                                                                                                        

│Âèðàçîë [Ðèáàâèðèí]                │ïðîòèâîâèðóñíîå ñðåäñòâî      │êðåì (òóáû) 7.5% - 5, 15, 30 ã│ICN (Ìåêñèêà)                 │010445,    

                                   │[J05AB04]                                                                                 │31.08.98   

                                                                                                                                        

│Âèðàçîë [Ðèáàâèðèí]                │ïðîòèâîâèðóñíîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │ICN Pharmaceuticals Inc (ÑØÀ) │009528,    

                                   │[J05AB04]                     │ïðèãîòîâëåíèÿ èíãàëÿöèîííîãî                                │16.06.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 6 ã                                                 

                                                                                                                                        

│Âèðà-ÌÏ [Âèäàðàáèí]                │ïðîòèâîâèðóñíîå ñðåäñòâî      │ãåëü (òóáû) 10% - 15 ã        │Pierre Fabre (Ôðàíöèÿ)        │007853,    

                                   │[D06BB]                                                                                   │30.09.96   

                                                                                                                                        

│Âèðàñåïò [Íåëüôèíàâèð]             │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 250 ìã; ïîðîøîê äëÿ  │F.Hoffmann La Roche Ltd/Mova  │010308,    

                                   │[J05AE04]                     │ïðèåìà âíóòðü (ôëàêîíû) 50    │Pharmaceutical Corporation    │07.07.98   

                                                                 │ìã/ã /â êîìïëåêòå ñ ìåðíîé    │(Ïóýðòî-Ðèêî)                            

                                                                 │ëîæå÷êîé/                                                               

                                                                                                                                        

│Âèðîëåêñ [Àöèêëîâèð]               │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200 ìã;              │Krka (Ñëîâåíèÿ)               │007315,    

                                   │[D06BB03] [J05AB01] [S01AD03] │ëèîôèëèç.ïîðîøîê äëÿ                                        │23.09.96   

                                                                 │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                             

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã;                                             

                                                                 │ìàçü ãëàçíàÿ (òóáû) 30 ìã/ã - │                                         

                                                                 │4.5 ã; êðåì (òóáû) 50 ìã/ã -                                           

                                                                 │5 ã                                                                    

                                                                                                                                        

│Âèðó-Ìåðö ñåðîë [Òðîìàíòàäèí]      │ïðîòèâîâèðóñíîå ñðåäñòâî      │ìàçü                          │Merz Co Gmbh (ÔÐÃ)            │002654,    

                                   │[D06BB02]                                                                                 │08.10.92   

                                                                                                                                        

│Âèñêàëäèêñ {ïèíäîëîë 10 ìã,        │ãèïîòåíçèâíîå êîìáèíèðîâàííîå │òàáëåòêè                      │Egis Sa (Âåíãðèÿ)             │007324,    

│êëîïàìèä 5 ìã}                     │ñðåäñòâî [C03BK]                                                                          │27.09.96   

                                                                                                                                        

│Âèñêåí [Ïèíäîëîë]                  │áåòà-àäðåíîáëîêàòîð ñ ÑÌÀ     │òàáëåòêè 5 ìã                 │Egis Sa (Âåíãðèÿ)             │007326,    

                                   │[C07AA03]                                                                                 │27.09.96   

                                                                                                                                        

│Âèñêåí [Ïèíäîëîë]                  │áåòà-àäðåíîáëîêàòîð ñ ÑÌÀ     │òàáëåòêè 5 ìã                 │Sandoz (India) Ltd (Èíäèÿ)    │007852,    

                                   │[C07AA03]                                                                                 │27.09.96   

                                                                                                                                        

│Âèñêåí [Ïèíäîëîë]                  │áåòà-àäðåíîáëîêàòîð ñ ÑÌÀ     │òàáëåòêè 5 ìã                 │Sandoz Pharma Ltd (Øâåéöàðèÿ) │007199,    

                                   │[C07AA03]                                                                                 │28.05.96   

                                                                                                                                       

│Âèñòàãàí [Ëåâîáóíîëîë]             │áåòà-àäðåíîáëîêàòîð [S01ED03] │êàïëè ãëàçíûå (ôëàêîíû)       │Krka (Ñëîâåíèÿ)               │006315,    

                                                                 │0.25%, 0.5%                                                 │26.07.95   

                                                                                                                                        

│Âèò Ñ [Àñêîðáèíîâàÿ êèñëîòà]       │âèòàìèí [A11GA01]             │òàáëåòêè æåâàòåëüíûå 500 ìã   │Gulf Pharmaceutical           │010200,    

                                                                                               │Industries (Julphar) (ÎÀÝ)    │07.05.98   

                                                                                                                                        

│Âèòàáàêò [Ïèêëîêñèäèíà             │ïðîòèâîìèêðîáíîå ñðåäñòâî     │êàïëè ãëàçíûå (ôëàêîíû) 0.05% │Ciba Vision Ophthalmics       │009316,    

│äèãèäðîõëîðèä]                     │[S01AX16]                     │- 10 ìë                       │(Ôðàíöèÿ)                     │19.03.97   

                                                                                                                                        

│Âèòàäðàë [Ðåòèíîë]                 │âèòàìèí [S01XA02]             │ìàñëî ãëàçíîå                 │Ankerpharm Gmbh, Ankerwerk    │003743,    

                                                                                               │Rudolstadt (Ãåðìàíèÿ)         │04.03.94   

                                                                                                                                        

│Âèòà-Èîäóðîë {öèñòåèíà ãèäðîõëîðèä │ïðîòèâîêàòàðàêòíîå ñðåäñòâî   │ðàñòâîð-êàïëè ãëàçíûå         │Ciba Vision Ophthalmics       │008679,    

│30 ìã, ÀÒÔ 2.7 ìã, íèêîòèíîâàÿ     │[S01XA]                       │(ôëàêîíû) 10 ìë               │(Ôðàíöèÿ)                     │16.09.98   

│êèñëîòà 30 ìã, ãëóòàòèîí 6 ìã,                                                                                                          

│òèàìèí 30 ìã, êàëüöèÿ õëîðèä 0.3                                                                                                        

│ã, ìàãíèÿ õëîðèä 0.3 ã, êàëèÿ                                                                                                           

│éîäèä 1.5 ã - 100 ìë}                                                                                                                   

                                                                                                                                        

│Âèòàëüï ëèìîííûå ñ ýêñòðàêòàìè     │îòõàðêèâàþùåå ñðåäñòâî        │ïàñòèëêè                      │Domaco - Dr.Aufdemaur Sa      │005479,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Øâåéöàðèÿ)                   │11.11.94   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Âèòàëüï ìåäîâûå ñ ýêñòðàêòàìè      │îòõàðêèâàþùåå ñðåäñòâî        │ïàñòèëêè                      │Domaco - Dr.Aufdemaur Sa      │005478,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Øâåéöàðèÿ)                   │11.11.94   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Âèòàìèí À [Ðåòèíîë]                │âèòàìèí [A11CA01]             │êàïñóëû 25000, 50000 ÅÄ       │Sanavita Gesundcheitsmittel & │006819,    

                                                                                               │Co Kg (Ãåðìàíèÿ)              │13.11.95   

                                                                                                                                        

│Âèòàìèí Â1 [Òèàìèí]                │âèòàìèí [A11DA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009250,    

                                                                 │50 ìã/ìë - 1 ìë               │çàâîä ÀÎ (Ýñòîíèÿ)            │29.12.97   

                                                                                                                                        

│Âèòàìèí Â-12 [Öèàíîêîáàëàìèí]      │âèòàìèí [B03BA01]             │òàáëåòêè 100 ìêã              │General Pharma Inc (ÑØÀ)      │007824,    

                                                                                                                            │17.09.96   

                                                                                                                                        

│Âèòàìèí Â12 [Öèàíîêîáàëàìèí]       │âèòàìèí [B03BA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009218,    

                                                                 │200, 500 ìêã - 1 ìë           │çàâîä ÀÎ (Ýñòîíèÿ)            │04.12.97   

                                                                                                                                        

│Âèòàìèí Ä3 [Êîëåêàëüöèôåðîë]       │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │ðàñòâîð âîäíûé äëÿ            │Terpol Pharmaceutical Works   │009492,    

                                   │ôîñôîðà [A11CC05]             │âíóòðåííåãî ïðèìåíåíèÿ        │Sa (Ïîëüøà)                   │29.05.97   

                                                                 │(ôëàêîíû) 15000 ÌÅ/ìë /â                                               

                                                                 │êîìïëåêòå ñ ïèïåòêîé/                                                  

                                                                                                                                        

│Âèòàìèí Ä3 ÁÎÍ [Êîëåêàëüöèôåðîë]   │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │ðàñòâîð ìàñëÿíûé (àìïóëû) 5   │Laboratoires Doms Adrian      │006884,    

                                   │ôîñôîðà [A11CC05]             │ìã - 1 ìë                     │(Ôðàíöèÿ)                     │08.12.95   

                                                                                                                                         

│Âèòàìèí Å [Âèòàìèí Å]              │âèòàìèí [A11HA03]             │êàïñóëû 200 ÌÅ                │Sagmel Inc (ÑØÀ)              │009861,    

                                                                                                                             │25.11.97   

                                                                                                                                        

│Âèòàìèí Å [Âèòàìèí Å]              │âèòàìèí [A11HA03]             │êàïñóëû 100 ìã                │Slovakofarma Sa (Ñëîâàêèÿ)    │005867,    

                                                                                                                             │27.03.95   

                                                                                                                                        

│Âèòàìèí Å Ñëîâàêîôàðìà [Âèòàìèí Å] │âèòàìèí [A11HA03]             │êàïñóëû 100 ìã                │Slovakofarma Sa (Ñëîâàêèÿ)    │009033,    

                                                                                                                             │19.12.96   

                                                                                                                                        

│Âèòàìèí Å Ñëîâàêîôàðìà [Âèòàìèí Å] │âèòàìèí [A11HA03]             │êàïñóëû 200, 400 ìã           │Slovakofarma Sa (Ñëîâàêèÿ)    │009378,    

                                                                                                                             │14.04.97   

                                                                                                                                        

│Âèòàìèí Ñ [Àñêîðáèíîâàÿ êèñëîòà]   │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå              │Pliva (Õîðâàòèÿ)              │006932,    

                                                                                                                             │21.12.95   

                                                                                                                                        

│Âèòàìèí Ñ àïåëüñèíîâûé 500 ìã      │âèòàìèí [A11GA01]             │òàáëåòêè 500 ìã               │Êîíöåðí Ñòèðîë ÎÀÎ (Óêðàèíà)  │009168,    

│[Àñêîðáèíîâàÿ êèñëîòà]                                                                                                       │31.07.97   

                                                                                                                                       

│Âèòàìèí Ñ Íèêîìåä [Àñêîðáèíîâàÿ    │âèòàìèí [A11GA01]             │òàáëåòêè æåâàòåëüíûå 200 ìã   │Nycomed Pharma As (Íîðâåãèÿ)  │006914,    

│êèñëîòà]                                                                                                                     │19.12.95   

                                                                                                                                        

│Âèòàìèí Ñ ïëþñ [Àñêîðáèíîâàÿ       │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå              │Pharmavit (Âåíãðèÿ)           │3003,      

│êèñëîòà]                                                                                                                     │23.11.90   

                                                                                                                                        

│Âèòàìèí Ñ ïëþñ {àñêîðáèíîâàÿ       │âèòàìèí [A11GB]               │òàáëåòêè æåâàòåëüíûå          │Sagmel Inc (ÑØÀ)              │010349,    

│êèñëîòà 100 ìã, öèíê 1 ìã}                                                                                                   │21.07.98   

                                                                                                                                        

│Âèòàìèí Ñ1000 [Àñêîðáèíîâàÿ        │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå              │Pharmavit (Âåíãðèÿ)           │3002,      

│êèñëîòà]                                                                                                                     │23.11.90   

                                                                                                                                        

│Âèòàìèí Ô99 {ýòèëëèíîàò,           │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │êàïñóëû 250 ìã; ìàçü æèðíàÿ   │Doetsch, Grether&Co Ag        │002891,    

│ýòèëëèíîëåàò}                      │[D11A]                        │2%; ìàçü ïîëóæèðíàÿ 2%        │(Øâåéöàðèÿ)                   │03.03.93   

                                                                                                                                        

│Âèòàñèê {àäåíîçèí 2 ìã, òèìèäèí 2  │ðåãåíåðàöèè ñòèìóëÿòîð [S01XA]│êàïëè ãëàçíûå                 │Laboratoires H.Faure (Ôðàíöèÿ)│00909,     

│ìã, óðèäèí 7 ìã,                                                                                                             │05.04.82,  

│ìîíîôîñôàòãóàíîçèí äèíàòðèÿ 12 ìã, │                                                                                          │21.03.95   

│öèòèäèí 6 ìã - 1 ìë}                                                                                                                    

                                                                                                                                        

│Âèòðóì âèòàìèí Å [Âèòàìèí Å]       │âèòàìèí [A11HA03]             │êàïñóëû æåëàòèíîâûå ìÿãêèå    │Unipharm Inc (ÑØÀ)            │009804,    

                                                                │400 ÌÅ                                                      │24.10.97   

                                                                                                                                        

│Âèòðóì Êàëüöèóì {êàëüöèé 500 ìã,   │ðåãóëÿòîð îáìåíà êàëüöèÿ è    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Unipharm Inc (ÑØÀ)            │009049,    

│êîëåêàëüöèôåðîë 200 ÅÄ}            │ôîñôîðà [A12AX]                                                                           │25.12.96   

                                                                                                                                        

│Âèòðóì ïëþñ âèòàìèí Ñ              │âèòàìèí [A11GA01]             │òàáëåòêè øèïó÷èå ñ àðîìàòîì   │Unipharm Inc (ÑØÀ)            │010400,    

│[Àñêîðáèíîâàÿ êèñëîòà]                                           │ëèìîíà 1 ã; òàáëåòêè øèïó÷èå                                │06.08.98   

                                                                 │ñ àðîìàòîì àïåëüñèíà 1 ã                                               

                                                                                                                                        

│Âîáý-ìóãîñ Å {òðèïñèí 40 ìã,       │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå             │Mucos Pharma (Ãåðìàíèÿ)       │009824,    

│õèìîòðèïñèí 40 ìã, ïàïàèí 100 ìã}  │[L01XX]                       │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │12.11.97   

                                                                                                                                        

│Âîáýíçèì {ïàíêðåàòèí 100 ìã,       │ïðîòèâîâîñïàëèòåëüíîå         │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Mucos Pharma Gmbh (Ãåðìàíèÿ)  │005507,    

│ïàïàèí 60 ìã, áðîìåëèí 45 ìã,      │ñðåäñòâî [V03A]                                                                           │18.11.94   

│òðèïñèí 24 ìã, õèìîòðèïñèí 1 ìã,                                                                                                        

│ðóòîçèä 50 ìã}                                                                                                                          

                                                                                                                                       

│Âîäà äëÿ èíúåêöèé â àìïóëàõ        │ðàñòâîðèòåëü, âñïîìîãàòåëüíîå │âîäà äëÿ èíúåêöèé (àìïóëû) 2, │Áîðèñîâñêèé çàâîä             │74/331/36, 

                                   │âåùåñòâî [V07AB]              │5 ìë                          │ìåäïðåïàðàòîâ (Áåëàðóñü)      │16.01.98   

                                                                                                                                        

│Âîäà äëÿ èíúåêöèé-Äàðíèöà          │ðàñòâîðèòåëü, âñïîìîãàòåëüíîå │âîäà äëÿ èíúåêöèé (àìïóëû) 2, │Äàðíèöà Ôàðìàöåâòè÷åñêàÿ      │010073,    

                                   │âåùåñòâî [V07AB]              │5 ìë                          │Ôèðìà ÇÀÎ (Óêðàèíà)           │20.10.98   

                                                                                                                                        

│Âîäîðîäà ïåðåêèñü Æèôðåð [Âîäîðîäà │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Gifrer Barbezat (Ôðàíöèÿ)     │007477,    

│ïåðåêèñü]                          │[D08AX01]                     │ïðèìåíåíèÿ (ôëàêîíû) 3% - 5,                                │29.04.96   

                                                                 │125 ìë; ñïðåé 125 ìë                                                   

                                                                                                                                        

│Âîêàäèí [Ïîâèäîí-Éîä]              │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ íàðóæíîãî         │Wockhardt Ltd (Èíäèÿ)         │007385,    

                                   │[D08AG02] [G01AX11] [R02AA15] │ïðèìåíåíèÿ âîäíûé (ôëàêîíû)                                 │01.04.96   

                                                                 │5%; ðàñòâîð äëÿ ïîëîñêàíèÿ                                             

                                                                 │ðòà è ãîðëà ñïèðòîâîé                                                  

                                                                 │(ôëàêîíû) 1%; ìàçü (òóáû) 5%; │                                          

                                                                 │òàáëåòêè âàãèíàëüíûå 200 ìã                                            

                                                                                                                                        

│Âîëìàêñ [Ñàëüáóòàìîë]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 4 ìã                 │Glaxo (Âåëèêîáðèòàíèÿ)        │003100,    

                                   │ñåëåêòèâíûé [R03CC02]                                                                    │28.06.93   

                                                                                                                                        

│Âîëìàêñ [Ñàëüáóòàìîë]              │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 8 ìã                 │Glaxo (Âåëèêîáðèòàíèÿ)        │002877,    

                                   │ñåëåêòèâíûé [R03CC02]                                                                     │25.02.93   

                                                                                                                                        

│Âîëüòàðåí Ýìóëüãåëü [Äèêëîôåíàê]   │ÍÏÂÑ [M02AA15]                │ýìóëüãåëü (òóáû) 1% - 20, 50 ã│Ciba-Geigy (Øâåéöàðèÿ)        │008093,    

                                                                                                                             │24.12.96   

                                                                                                                                        

│Âîëüòàðåí [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ciba-Geigy (Øâåéöàðèÿ)        │008051,    

                                                                 │25, 50, 100 ìã; ñâå÷è 25, 100 │                              │10.11.96   

                                                                 │ìã                                                                     

                                                                                                                                        

│Âîëüòàðåí [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05]                │ñâå÷è 50 ìã; ðàñòâîð äëÿ      │Ciba-Geigy (Øâåéöàðèÿ)        │00464,     

                                                                 │èíúåêöèé (àìïóëû) 75 ìã - 3 ìë│                              │03.05.77,  

                                                                                                                             │15.11.93   

                                                                                                                                        

│Âîëüòàðåí ðàïèä [Äèêëîôåíàê]       │ÍÏÂÑ [M01AB05]                │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Ciba-Geigy (Øâåéöàðèÿ)        │002776,    

                                                                 │25, 50 ìã                                                   │28.12.92   

                                                                                                                                        

│Âîðìèí [Ìåáåíäàçîë]                │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 100 ìã               │Cadila Laboratories Ltd       │01034,     

                                   │[P02CA01]                                                   │(Èíäèÿ)                       │09.09.83,  

                                                                                                                             │20.09.94   

                                                                                                                                        

│Âîòðåêñ [Äèêëîôåíàê]               │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Al-Hikma Pharmaceuticals      │002642,    

                                                                 │75 ìã - 3 ìë                  │(Èîðäàíèÿ)                    │04.10.92   

                                                                                                                                        

│Âóëìèçîëèí [Öåôàçîëèí]             │àíòèáèîòèê, öåôàëîñïîðèí      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biotika Sa (Ñëîâàöêàÿ         │009793,    

                                   │[J01DA04]                     │èíúåêöèîííîãî ðàñòâîðà        │Ðåñïóáëèêà)                   │20.10.97   

                                                                 │(ôëàêîíû) 1 ã                                                           

                                                                                                                                        

│Âóëíóçàí                           │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü                          │Pharmachim (Áîëãàðèÿ)         │2287,      

                                   │ñðåäñòâî äëÿ ìåñòíîãî                                                                     │24.02.72,  

                                   │ïðèìåíåíèÿ [M09AX]                                                                        │28.04.84   

                                                                                                                                        

│Âóìîí [Òåíèïîçèä]                  │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bristol-Myers Squibb (Èòàëèÿ) │009938,    

                                   │[L01CB02]                     │50 ìã - 5 ìë                                                │26.12.97   

                                                                                                                                        

│Âýéòàé {ýâîäèè ñòåáëè 3846 ã,      │ïðîòèâîÿçâåííîå ñðåäñòâî      │êàïñóëû 500 ìã; ãðàíóëû       │Nanfang Pharmaceutical        │007034,    

│ìóððåè ëèñò 3846 ã, øëåìíèêà       │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │îðàëüíûå (ïàêåòèêè            │Factory (Êèòàé)               │31.01.96   

│êîðåíü 1539 ã, ðåìàíèè êîðåíü 1539 │[A02BX]                       │îäíîðàçîâûå) 20 ã                                                      

│ã, àóêëàíäèè êîðåíü 2308 ã,                                                                                                             

│çàíòîêñèëà êîðåíü 3846 ã, ïîðèà                                                                                                         

│1539 ã, ïèîíà êîðåíü 1539 ã - 500                                                                                                       

│äîç}                                                                                                                                    

                                                                                                                                        

│Ãàááðîðàë [Ïàðîìîìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │òàáëåòêè 250 ìã; ñèðîï 1.5 ã  │Farmitalia Carlo Erba (Èòàëèÿ)│003775,    

                                   │[A07AA06]                     │- 60 ìë                                                     │18.03.94   

                                                                                                                                        

│Ãàëàçîëèí [Êñèëîìåòàçîëèí]         │àëüôà-àäðåíîñòèìóëÿòîð        │ãåëü äëÿ íîñà (òóáû) 0.05% -  │Polfa, Warszawskie            │009453,    

                                   │[R01AA07]                     │5, 10 ã; ãåëü äëÿ íîñà        │Pharmaceutical Works (Ïîëüøà) │16.05.97   

                                                                 │(ôëàêîíû) 0.1% - 10 ã                                                  

                                                                                                                                        

│Ãàëàçîëèí [Êñèëîìåòàçîëèí]         │àëüôà-àäðåíîñòèìóëÿòîð        │êàïëè äëÿ íîñà (ôëàêîíû)      │Polfa, Warszawskie            │008190,    

                                   │[R01AA07]                     │0.1%, 0.05% - 10 ìë           │Pharmaceutical Works (Ïîëüøà) │23.04.97   

                                                                                                                                        

│Ãàëèäîð [Áåíöèêëàí]                │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Egis (Âåíãðèÿ)                │2049,      

                                   │[C04AX11]                     │50 ìã - 2 ìë                                                │01.07.70,  

                                                                                                                             │28.02.84,  

                                                                                                                             │13.07.95   

                                                                                                                                        

│Ãàëèäîð [Áåíöèêëàí]                │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 100 ìã               │Egis Sa (Âåíãðèÿ)             │008284,    

                                   │[C04AX11]                                                                                 │02.06.97   

                                                                                                                                        

│Ãàëîïåð [Ãàëîïåðèäîë]              │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 0.5, 1.5, 5, 10 ìã   │Cts Chemical Industries Ltd   │005281,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                 │(Èçðàèëü)                     │30.08.94   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2054,      

                                  │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │1 ìë                                                        │01.07.70,  

                                   │[N05AD01]                                                                                 │22.12.83,  

                                                                                                                             │19.12.94   

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Copley Pharmaceutical Inc     │003590,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │îðàëüíîãî ðàñòâîðà 2 ìã/ìë    │(ÑØÀ)                         │16.12.93   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 1.5 ìã               │Gedeon Richter (Âåíãðèÿ)      │2052,      

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │01.07.70,  

                                   │[N05AD01]                                                                                 │22.12.83,  

                                                                                                                             │19.12.94   

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │òàáëåòêè ôîðòå 5 ìã           │Gedeon Richter (Âåíãðèÿ)      │2669,      

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │10.11.81,  

                                   │[N05AD01]                                                                                 │25.01.93   

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │êàïëè äëÿ ïðèåìà âíóòðü       │Gedeon Richter (Âåíãðèÿ)      │008152,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │(ôëàêîíû) 2 ìã/ìë - 10 ìë                                   │04.02.97   

                                   │[N05AD01]                                                                                           

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 2 ìã                 │Hemofarm D.D. (Þãîñëàâèÿ)     │010397,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │05.08.98   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé          │Biologici Italia Laboratories │006265,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │(ôëàêîíû) 5 ìã/ìë             │(Èòàëèÿ)                      │11.07.95   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 1 ìã, 5 ìã           │Mir Pharmaceutical            │007674,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                 │Inc/Pharmachemie B.V.         │23.07.96   

                                   │[N05AD01]                                                   │(Íèäåðëàíäû) (ÑØÀ)                        

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │òàáëåòêè 1 ìã                 │Polfa (Ïîëüøà)                │002879,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî                                                               │26.02.93   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Warszawskie            │005259,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │5 ìã/ìë                       │Pharmaceutical Works (Ïîëüøà) │22.08.94   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë [Ãàëîïåðèäîë]          │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Weimer Pharma Gmbh (Ãåðìàíèÿ) │002824,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │5 ìã - 1 ìë                                                 │01.02.93   

                                   │[N05AD01]                                                                                            

                                                                                                                                        

│Ãàëîïåðèäîë äåêàíîàò [Ãàëîïåðèäîë] │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │Gedeon Richter (Âåíãðèÿ)      │008087,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │(àìïóëû) 50 ìã/ìë                                           │18.12.96   

                                   │[N05AD01]                                                                                             

                                                                                                                                        

│Ãàëîïåðèäîë-Ðàòèîôàðì [Ãàëîïåðèäîë]│àíòèïñèõîòè÷åñêîå             │òàáëåòêè 1 ìã, 5 ìã, 10 ìã;   │Ratiopharm Gmbh & Co          │003509,    

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │êàïëè 2 ìã/ìë; ðàñòâîð äëÿ    │(Ãåðìàíèÿ)                    │17.11.93   

                                   │[N05AD01]                     │èíúåêöèé 5 ìã/ìë                                                       

                                                                                                                                        

│Ãàëîòàí [Ãàëîòàí]                  │íàðêîçíîå èíãàëÿöèîííîå       │ðàñòâîð äëÿ èíãàëÿöèîíîé      │Turk Hoechst As (Òóðöèÿ)      │007610,    

                                   │ñðåäñòâî [N01AB01]            │àíåñòåçèè (ôëàêîíû) 50, 250 ìë│                              │27.06.96   

                                                                                                                                        

│Ãàëüìàíèí {ñàëèöèëîâàÿ êèñëîòà 2   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïîðîøîê äëÿ íàðóæíîãî         │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │67/554/25, 

│ã, öèíêà îêñèä 10 ã, òàëüê 44 ã,   │[D08A]                        │ïðèìåíåíèÿ (áàíêè) 50 ã                                     │05.01.98   

│êðàõìàë 44 ã}                                                                                                                           

                                                                                                                                        

│Ãàììàëîí [Ãàììà-àìèíîìàñëÿíàÿ      │íîîòðîïíîå ñðåäñòâî [N03AG03] │òàáëåòêè 250 ìã               │Daiichi Pharmaceutical Co Ltd │007289,    

│êèñëîòà]                                                                                       │(ßïîíèÿ)                      │15.08.96   

                                                                                                                                        

│Ãàíüìàîëèí{ïàðàöåòàìîë 100 ìã,     │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │ãðàíóëû (ïàêåòèêè) 10 ã;      │Nanfang (Êèòàé)               │009950,    

│êîôåèí 2 ìã, õëîðôåíàìèí 2 ìã,     │ÎÐÇ è ïðîñòóäû [N02BE71]      │êàïñóëû 0.5 ã                                               │14.01.98   

│ìåíòîë, ýôåäðû ïîáåãè è ñòåáëè 6                                                                                                        

│÷, õðèçàíòåìû èíäèéñêîé öâåòû 3 ÷, │                                                                                                     

│÷åðåäû âîëîñèñòîé òðàâà 4 ÷,                                                                                                            

│÷åðåäû òðåõðàçäåëüíîé òðàâà 4 ÷,                                                                                                        

│ïàäóáà øåðîõîâàòîãî êîðåíü 9 ÷ -                                                                                                        

│300 ã}                                                                                                                                  

                                                                                                                                       

│Ãàðàçîí {áåòàìåòàçîíà äèíàòðèÿ     │ãëþêîêîðòèêîñòåðîèä           │ìàçü ãëàçíàÿ (òóáû) 5 ã;      │Schering-Plough (Áåëüãèÿ)     │009088,    

│ôîñôàò 1 ìã, ãåíòàìèöèí 3 ìã - 1   │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │êàïëè ãëàçíûå è óøíûå                                       │21.01.97   

│ã; áåòàìåòàçîíà äèíàòðèÿ ôîñôàò 1  │[S01CA]                       │(ôëàêîíû) 5 ìë                                                         

│ìã, ãåíòàìèöèí 3 ìã - 1 ìë}                                                                                                             

                                                                                                                                        

│Ãàðàçîí {áåòàìåòàçîíà äèíàòðèÿ     │ãëþêîêîðòèêîñòåðîèä           │êàïëè ãëàçíûå è óøíûå         │Schering-Plough (ÑØÀ)         │003986,    

│ôîñôàò 1 ìã, ãåíòàìèöèí 3 ìã - 1   │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │(ôëàêîíû) 3 ìã/1 ìã|1 ìë - 5                                │06.06.94   

│ìë}                                │[S01CA]                       │ìë                                                                     

                                                                                                                                        

│Ãàðàìèöèí [Ãåíòàìèöèí]             │àíòèáèîòèê, àìèíîãëèêîçèä     │êðåì (òóáû) 0.1%; ìàçü (òóáû) │Schering-Plough (Áåëüãèÿ)     │007453,    

                                   │[D06AX07] [J01GB03]           │0.1%; ðàñòâîð äëÿ èíúåêöèé                                  │18.04.96   

                                                                 │(àìïóëû) 40 ìã/1 ìë, 80 ìã/2                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Ãàñêîí Äðîï [Äèìåòèêîí â           │âåòðîãîííîå ñðåäñòâî [A02DA]  │ýìóëüñèÿ îðàëüíàÿ (ôëàêîíû)   │Kissei Pharmaceutical Co Ltd  │005988,    

│êîìáèíàöèè ñ äâóîêèñüþ êðåìíèÿ]                                                                │(ßïîíèÿ)                      │24.04.95   

                                                                                                                                        

│Ãàñòàë {àëãåëäðàò 0.45 ã, ìàãíèÿ   │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè                      │Pliva Sa (Õîðâàòèÿ)           │007359,    

│êàðáîíàò 0.45 ã, ìàãíèÿ ãèäðîêñèä                                                                                            │17.10.96   

│0.3 ã}                                                                                                                                  

                                                                                                                                        

│Ãàñòåðèí [Àëþìèíèÿ ôîñôàò]         │àíòàöèäíîå ñðåäñòâî [A02AB03] │ãåëü                          │Slovakofarma Sa (Ñëîâàêèÿ)    │005475,    

                                                                                                                             │10.11.94   

                                                                                                                                        

│Ãàñòåðîãåí [Ôàìîòèäèí]             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Faran Laboratories Sa (Ãðåöèÿ)│005817,    

                                   │áëîêàòîð [A02BA03]            │20 ìã                                                       │13.03.95   

                                                                                                                                        

│Ãàñòðèë [Ïèðåíçåïèí]               │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 25 ìã                │Torrent Pharmaceuticals Ltd   │008620,    

                                                                                               │(Èíäèÿ)                       │28.04.98   

                                                                                                                                        

│Ãàñòðîçåì [Ïèðåíçåïèí]             │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 25 ìã                │Alkaloid (Ðåñïóáëèêà          │008623,    

                                                                                               │Ìàêåäîíèÿ)                    │18.05.98   

                                                                                                                                        

│Ãàñòðîëèò {íàòðèÿ õëîðèä 30 ìã,    │ðåãèäðàòèðóþùåå ñðåäñòâî äëÿ  │òàáëåòêè äëÿ ïðèãîòîâëåíèÿ    │Polfa (Ïîëüøà)                │003566,    

│êàëèÿ õëîðèä 75 ìã, íàòðèÿ         │ïåðîðàëüíîãî ïðèåìà [A07CA]   │ðàñòâîðà                                                    │08.12.93   

│ãèäðîêàðáîíàò 0.125 ã, ãëþêîçà                                                                                                          

│1.625 ã, ðîìàøêè ýêñòðàêò 25 ìã}                                                                                                        

                                                                                                                                        

│Ãàñòðîìåí [Ïèðåíçåïèí]             │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Menon Pharma (Èíäèÿ)          │003528,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │                              │25.11.93   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Ãàñòðîïèí [Ïèðåíçåïèí]             │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Rusan Pharma (Èíäèÿ)          │005035,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │                              │22.06.94   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Ãàñòðîñèäèí [Ôàìîòèäèí]            │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Eczacibasi Ilac Sanayi        │002237,    

                                   │áëîêàòîð [A02BA03]            │40 ìã                         │(Òóðöèÿ)                      │16.07.97   

                                                                                                                                        

│Ãàñòðîñèë [Ìåòîêëîïðàìèä]          │ïðîòèâîðâîòíîå ñðåäñòâî,      │òàáëåòêè 10 ìã; êàïëè         │Heumann Pharma (Ãåðìàíèÿ)     │003925,    

                                   │äîôàìèí áëîêàòîð öåíòðàëüíûé  │îðàëüíûå (ôëàêîíû)                                          │19.05.94   

                                   │[A03FA01]                                                                                            

                                                                                                                                        

│Ãàñòðîñòàò {âèñìóòà òðèêàëèÿ       │ïðîòèâîäèàðåéíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Stephen Hunter Pty Ltd        │007552,    

│äèöèòðàò 107.7 ìã - òàáëåòêè       │[A07AX]                                                     │(Àâñòðàëèÿ)                   │30.05.96   

│çåëåíûå; òåòðàöèêëèí 250 ìã -                                                                                                           

│òàáëåòêè æåëòûå; ìåòðîíèäàçîë 200                                                                                                       

│ìã - òàáëåòêè êðàñíûå}                                                                                                                  

                                                                                                                                        

│Ãàñòðîöåïèí [Ïèðåíçåïèí]           │ì-õîëèíîáëîêàòîð [A02BX03]    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Boehringer Ingelheim Gmbh     │003427,    

                                                                 │10 ìã - 2 ìë                  │(Ãåðìàíèÿ)                    │18.10.93   

                                                                                                                                        

│Ãàñòðîöåïèí [Ïèðåíçåïèí]           │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 50 ìã                │Boehringer Ingelheim Pharma   │008541,    

                                                                                               │Kg, a division of Boehringer  │15.05.98   

                                                                                               │Ingelheim International Gmbh             

                                                                                               │(Ãåðìàíèÿ)                               

                                                                                                                                        

│Ãàñòðîöåïèí [Ïèðåíçåïèí]           │ì-õîëèíîáëîêàòîð [A02BX03]    │òàáëåòêè 25 ìã                │Boehringer Ingelheim Ellas    │008496,    

                                                                                               │a.E., a division of           │31.12.97   

                                                                                               │Boehringer Ingelheim                     

                                                                                               │International Gmbh (Ãðåöèÿ)              

                                                                                                                                        

│Ãåâàäàë {êîôåèí 50 ìã, ïàðàöåòàìîë │àíàëüãåòè÷åñêîå               │òàáëåòêè 250 ìã/250 ìã/50 ìã  │Hafslund Nycomed Pharma Ag    │003169,    

│250 ìã, ïðîïèôåíàçîí 250 ìã}       │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Àâñòðèÿ)                     │21.07.93   

                                   │[N02BE71]                                                                                            

                                                                                                                                        

│Ãåâèçîø [Ýïåðâóäèí]                │ïðîòèâîâèðóñíîå ñðåäñòâî      │ìàçü (òóáû) 3, 10 ã           │Biogal (Âåíãðèÿ)              │005540,    

                                   │[D06BB]                                                                                   │05.12.94   

                                                                                                                                        

│Ãåäåëèêñ {ïëþùà òðàâû ýêñòðàêò 100 │îòõàðêèâàþùåå ñðåäñòâî        │êàïëè (ôëàêîíû) 50 ìë         │Krewel Meuselbach Gmbh        │007232,    

│ìã - 1 ìë = 30 êàïåëü}             │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │26.06.96   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Ãåäåëèêñ ñèðîï îò êàøëÿ {ïëþùà     │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 100 ìë        │Krewel Meuselbach Gmbh        │007233,    

│òðàâû ýêñòðàêò 100 ìã - 5 ìë}      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │26.06.96   

                                   │[R05X]                                                                                               

                                                                                                                                       

│Ãåêñàäðåïñ [Áèêëîòèìîë]            │ïðîòèâîìèêðîáíîå ñðåäñòâî     │ïàñòèëêè äëÿ ðàññàñûâàíèÿ     │Laboratoires Doms Adrian      │006695,    

                                   │[R02AA20]                                                   │(Ôðàíöèÿ)                     │29.09.95   

                                                                                                                                        

│Ãåêñàëèç {áèêëîòèìîë 5 ìã, ëèçîöèì │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè ñóáëèíãâàëüíûå       │Laboratoires Doms Adrian      │008170,    

│5 ìã, ýíîêñîëîí 5 ìã}              │[R02AA20]                                                   │(Ôðàíöèÿ)                     │18.02.97   

                                                                                                                                        

│Ãåêñàïíåâìèí {áèêëîòèìîë 198       │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │ñèðîï äëÿ âçðîñëûõ (ôëàêîíû)  │Laboratoires Doms Adrian      │003421,    

│ìã/150 ìã, ôîëêîäèí 133 ìã/100 ìã, │ÎÐÇ è ïðîñòóäû [R05X]         │200 ìë; ñèðîï äëÿ äåòåé       │(Ôðàíöèÿ)                     │15.10.93   

│õëîðôåíàìèí 13.3 ìã/10 ìã,                                       │(ôëàêîíû) 200 ìë; ñèðîï äëÿ                                            

│ãâàéôåíåçèí 200 ìã - ñèðîï äëÿ                                   │ãðóäíûõ äåòåé (ôëàêîíû) 100 ìë│                                         

│âçðîñëûõ/ñèðîï äëÿ äåòåé 100 ìë;                                                                                                        

│áèêëîòèìîë 100 ìã, õëîðôåíàìèí 5                                                                                                        

│ìã, òîëóàíñêîãî áàëüçàìà ýêñòðàêò                                                                                                       

│10 ìã, ãâàéôåíåçèí 200 ìã,                                                                                                              

│ïàðàöåòàìîë 500 ìã - ñèðîï äëÿ                                                                                                          

│ãðóäíûõ äåòåé 100 ìë}                                                                                                                   

                                                                                                                                        

│Ãåêñàïíåâìèí {áèêëîòèìîë 30 ìã,    │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè                      │Laboratoires Doms Adrian      │006696,    

│ôåíèëýôðèí 10 ìã, õëîðôåíàìèí 2 ìã}│ÎÐÇ è ïðîñòóäû [R05X]                                       │(Ôðàíöèÿ)                     │29.09.95   

                                                                                                                                        

│Ãåêñàñïðåé [Áèêëîòèìîë]            │ïðîòèâîìèêðîáíîå ñðåäñòâî     │ñïðåé (ôëàêîíû)               │Laboratoires Doms Adrian      │006694,    

                                   │[R02AA20]                                                   │(Ôðàíöèÿ)                     │29.09.95   

                                                                                                                                        

│Ãåêñåíàë [Ãåêñîáàðáèòàë]           │íàðêîçíîå íåèíãàëÿöèîííîå     │ìàññà ïåíîîáðàçíàÿ äëÿ        │Ìåäïðî Èíê Îîî (Ëàòâèÿ)       │010007,    

                                   │ñðåäñòâî [N05CA16]            │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │26.01.98   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ã                                                 

                                                                                                                                        

│Ãåêñîðàë [Ãåêñåòèäèí]              │àíòèñåïòè÷åñêîå ñðåäñòâî      │ðàñòâîð; ñïðåé                │Godecke Ag (Ãåðìàíèÿ)         │01077,     

                                   │[A01AB12]                                                                                 │04.05.84   

                                                                                                                                        

│Ãåëàñïîí {æåëàòèí}                 │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ãóáêà ãåìîñòàòè÷åñêàÿ 8.5õ4õ1 │Ankerpharm Gmbh (Ãåðìàíèÿ)    │009011,    

                                   │[B02BC01]                     │ñì                                                          │04.12.96   

                                                                                                                                        

│Ãåëèöèäèí {Helix pmatia            │ïðîòèâîêàøëåâîå ñðåäñòâî      │ñèðîï (ôëàêîíû) 10% - 125,    │Therabel Lucien Pharma        │010123,    

│(ìóêîïîëèñàõàðèäû)}                │[R05X]                        │250 ìë                        │(Ôðàíöèÿ)                     │17.03.98   

                                                                                                                                        

│Ãåëîìèðòîë ôîðòå {ìèðòîë (ëèìîíåí  │îòõàðêèâàþùåå ñðåäñòâî        │êàïñóëû 300 ìã                │G.Pohl-Boscamp Gmbh & Co      │007650,    

│75 ìã; öèíåîë 75 ìã, ïèíåí 20 ìã)} │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │17.07.96   

                                   │[R05X]                                                                                               

                                                                                                                                        

│Ãåëîôóçèí {æåëàòèí                 │ïëàçìîçàìåùàþùåå ñðåäñòâî     │ðàñòâîð äëÿ âíóòðèâåííîãî     │B.Braun Melsungen Ag          │009066,    

│ñóêöèíèëèðîâàííûé 20 ã, íàòðèÿ     │[B05AA06]                     │ââåäåíèÿ (ôëàêîíû) 250, 500   │(Ãåðìàíèÿ)                    │10.01.97   

│õëîðèä 3.51 ã, íàòðèÿ ãèäðîêñèä                                  │ìë; ðàñòâîð äëÿ âíóòðèâåííîãî │                                         

│0.68 ã, íàòðèé 77 ììîëü, õëîðèäû                                 │ââåäåíèÿ (êîíòåéíåðû) 500,                                             

│60 ììîëü - 500 ìë}                                               │1000 ìë                                                                

                                                                                                                                        

│Ãåëóñèë ëàê [Ñèìàëäðàò]            │àíòàöèäíîå ñðåäñòâî [A02AD05] │òàáëåòêè 500 ìã; ïîðîøîê äëÿ  │Hemofarm D.D. (Þãîñëàâèÿ)     │008085,    

                                                                 │ïðèåìà âíóòðü (ïàêåòèêè) 6.5 ã│                              │17.12.96   

                                                                                                                                        

│Ãåëóñèë-ñóñïåíçèÿ [Ñèìàëäðàò]      │àíòàöèäíîå ñðåäñòâî [A02AD05] │ñóñïåíçèÿ îðàëüíàÿ (ïàêåòû)   │Hemofarm D.D. (Þãîñëàâèÿ)     │003800,    

                                                                 │12 ìë                                                       │29.03.94   

                                                                                                                                        

│Ãåëü äëÿ äåñåí {õëîðáóòàíîë 2%,    │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ãåëü                          │Gerber Products (ÑØÀ)         │003900,    

│ìåòèëñàëèöèëàò 0.5%, ìåíòîë 2%,    │[A01AD11]                                                                                 │10.05.94   

│áåíçîêàèí 1%}                                                                                                                           

                                                                                                                                        

│Ãåëüìèíòîêñ [Ïèðàíòåë]             │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 125, 250 ìã;         │Innothera/Innotech            │003899,    

                                   │[P02CC01]                     │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │International (Ôðàíöèÿ)       │10.05.94   

                                                                 │125 ìã|2.5 ìë                                                          

                                                                                                                                        

│Ãåëüôîóì {æåëàòèí}                 │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ãóáêà ñòåðèëüíàÿ; ãóáêà       │Upjohn Company (ÑØÀ)          │007456,    

                                   │[B02BC01]                     │ñòåðèëüíàÿ ïðåñîâàííàÿ;                                     │18.04.96   

                                                                 │òàìïîíû ñòîìàòîëîãè÷åñêèå                                               

                                                                                                                                        

│Ãåëþñèë [Ñèìàëäðàò]                │àíòàöèäíîå ñðåäñòâî [A02AD05] │òàáëåòêè; ñóñïåíçèÿ           │Godecke Ag (ÔÐÃ)              │01075,     

                                                                                                                             │04.05.84   

                                                                                                                                        

│Ãåìçàð [Ãåìöèòàáèí]                │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Eli Lilly (Ôðàíöèÿ)           │007080,    

                                   │[L01BC05]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │13.02.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.2, 1 ã                                            

                                                                                                                                        

│Ãåìèíåâðèí [Êëîìåòèàçîë]           │ñíîòâîðíîå ñðåäñòâî [N05CM02] │êàïñóëû 300 ìã;               │Astra (Øâåöèÿ)                │00868,     

                                                                 │ëèîôèëèç.ïîðîøîê äëÿ                                        │28.07.81,  

                                                                 │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │21.07.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 4 ã /â                                              

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Ãåìèòîí [Êëîíèäèí]                 │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè 0.075, 0.3 ìã        │Arzneimittelwerk Dresden Gmbh │008685,    

                                   │öåíòðàëüíûé [S01EA04]                                       │(Ãåðìàíèÿ)                    │12.10.98   

                                                                                                                                        

│Ãåìèòîí [Êëîíèäèí]                 │àëüôà2-àäðåíîñòèìóëÿòîð       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arzneimittelwerk Dresden Gmbh │009081,    

                                   │öåíòðàëüíûé [S01EA04]         │0.15 ìã/ìë                    │(Ãåðìàíèÿ)                    │15.01.97   

                                                                                                                                        

│Ãåìîäåç [Ïîâèäîí]                  │äåçèíòîêñèêàöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû  │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/367/17, 

                                   │[B05BC]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë                                │20.10.98   

                                                                                                                                        

│Ãåìîðîë {àêóëû ïå÷åíè ýêñòðàêò 3%, │ïðîòèâîãåìîððîèäàëüíîå        │ìàçü (òóáû) 57 ã              │Four Ventures Enterprises     │009997,    

│ôåíèëýôðèí 0.25%, âàçåëèí 71.9%,   │ñðåäñòâî [C05AX03]                                          │(ÑØÀ)                         │27.02.98   

│ìèíåðàëüíîå ìàñëî 14%}                                                                                                                  

                                                                                                                                        

│Ãåìîððîí {àêóëû ïå÷åíè ýêñòðàêò    │ïðîòèâîãåìîððîèäàëüíîå        │ìàçü (òóáû) 57 ã /â êîìïëåêòå │Pharmascience Inc (Êàíàäà)    │010500,    

│3%, ôåíèëýôðèí 0.25%, âàçåëèí      │ñðåäñòâî [C05AX03]            │ñ àïïëèêàòîðîì/                                             │14.10.98   

│71.9%, ìèíåðàëüíîå ìàñëî 14%}                                                                                                           

                                                                                                                                        

│Ãåìîôåð [Æåëåçà õëîðèä]            │ãåìîïîýçà ñòèìóëÿòîð,         │êàïëè (ôëàêîíû) 10 ìë         │Terpol (Ïîëüøà)               │2649,      

                                   │ïðåïàðàò æåëåçà [B03AA05]                                                                 │08.12.80,  

                                                                                                                             │26.01.93   

                                                                                                                                        

│Ãåìîôåð ïðîëîíãàòóì [Æåëåçà        │ãåìîïîýçà ñòèìóëÿòîð,         │äðàæå 325 ìã                  │Polfa, Poznanskie             │006051,    

│ñóëüôàò]                           │ïðåïàðàò æåëåçà [B03AA07]                                   │Pharmaceutical Works (Ïîëüøà) │17.05.95   

                                                                                                                                        

│Ãåìîôèë Ì [Ôàêòîð ñâåðòûâàíèÿ      │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │Baxter (ÑØÀ)                  │007060,    

│êðîâè VIII]                        │[B02BD02]                     │ïðèãîòîâëåíèÿ âíóòðèâåííîãî                                 │07.02.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 250, 500,                                           

                                                                 │1000 ÌÅ                                                                

                                                                                                                                        

│Ãåí-Àòåíîëîë [Àòåíîëîë]            │áåòà1-àäðåíîáëîêàòîð          │òàáëåòêè 50, 100 ìã           │Genpharm Inc (Êàíàäà)         │006877,    

                                   │ñåëåêòèâíûé [C07AB03]                                                                     │06.12.95   

                                                                                                                                        

│Ãåíàòðîï {ãåíòàìèöèí 0.5%, àòðîïèí │ïðîòèâîìèêðîáíîå ñðåäñòâî     │êàïëè ãëàçíûå (ôëàêîíû) 10 ìë │Alfa Intes-Industria          │009145,    

│1%}                                │+ì-õîëèíîáëîêàòîð [S01AA20]   │/â êîìïëåêòå ñ êàïåëüíèöåé/;  │Terapeutica Splendore (Èòàëèÿ)│17.02.97   

                                                                 │ìàçü ãëàçíàÿ (òóáû) 5 ã                                                

                                                                                                                                        

│Ãåí-Ãëèá [Ãëèáåíêëàìèä]            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 2.5, 5 ìã            │Genpharm Inc (Êàíàäà)         │006876,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │06.12.95   

                                                                                                                                        

│Ãåí-Çîëåðîë [Ìåòðîíèäàçîë]         │ïðîòèâîìèêðîáíîå ñðåäñòâî     │òàáëåòêè 200, 400 ìã          │Genpharm Inc (Êàíàäà)         │007000,    

                                   │[J01XD01]                                                                                 │24.01.96   

                                                                                                                                        

│Ãåí-Êàïòîïðèë [Êàïòîïðèë]          │ÀÊÔ áëîêàòîð [C09AA01]        │òàáëåòêè 12.5, 25, 50, 100 ìã │Genpharm Inc (Êàíàäà)         │006879,    

                                                                                                                             │06.12.95   

                                                                                                                                       

│Ãåí-Êàðïàç [Êàðáàìàçåïèí]          │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè 200 ìã               │Genpharm Inc (Êàíàäà)         │007048,    

                                   │[N03AF01]                                                                                 │05.02.96   

                                                                                                                                        

│Ãåíîòðîïèí [Ñîìàòðîïèí]            │ñîìàòîòðîïíûé ãîðìîí [H01AC01]│ëèîôèëèç.ïîðîøîê äëÿ          │Pharmacia&Upjohn Ab (Øâåöèÿ)  │008400,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.03.98   

                                                                 │ðàñòâîðà (êàðòðèäæè                                                    

                                                                 │äâóõñåêöèîííûå ñ                                                       

                                                                 │ðàñòâîðèòåëåì) 16 ÌÅ                                                   

                                                                                                                                        

│Ãåí-Ïèðîêñèêàì [Ïèðîêñèêàì]        │ÍÏÂÑ [M02AA07]                │êàïñóëû 10, 20 ìã             │Genpharm Inc (Êàíàäà)         │006880,    

                                                                                                                             │06.12.95   

                                                                                                                                         

│Ãåí-Ðàíèòèäèí [Ðàíèòèäèí]          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150, 300 ìã          │Genpharm Inc (Êàíàäà)         │006966,    

                                   │áëîêàòîð [A02BA02]                                                                        │10.01.96   

                                                                                                                                        

│Ãåí-Ñàëüáóòàìîë [Ñàëüáóòàìîë]      │áåòà2-àäðåíîñòèìóëÿòîð        │ðàñòâîð äëÿ èíãàëÿöèé         │Genpharm Inc (Êàíàäà)         │006178,    

                                   │ñåëåêòèâíûé [R03AC02]         │(àìïóëû) 2.5 ìã - 2.5 ìë;                                   │14.06.95   

                                                                 │àýðîçîëü äîçèðîâàííûé 100                                              

                                                                 │ìêã/äîçà - 200 äîç                                                     

                                                                                                                                        

│Ãåíòàìèñèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Deva Holding As (Òóðöèÿ)      │008647,    

                                   │[J01GB03]                     │40 ìã/1 ìë, 20 ìã/2 ìë, 80                                  │08.07.98   

                                                                 │ìã/2 ìë                                                                

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Agio Pharmaceuticals Ltd      │007131,    

                                   │[J01GB03]                     │80 ìã - 2 ìë                  │(Èíäèÿ)                       │06.03.96   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Alkaloid (Ìàêåäîíèÿ)          │003791,    

                                   │[J01GB03]                     │20 ìã/2 ìë, 40 ìã/2 ìë, 80                                  │28.03.94   

                                                                 │ìã/2 ìë, 120 ìã/2 ìë                                                  

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Astrapin (Ãåðìàíèÿ)           │005313,    

                                   │[J01GB03]                     │10, 40 ìã/ìë                                                │14.09.94   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Biochemie Gmbh (Àâñòðèÿ)      │005508,    

                                   │[J01GB03]                     │40 ìã/ìë                                                    │18.11.94   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé 80 ìã -  │Biochemie Gmbh (Àâñòðèÿ)      │003626,    

                                   │[J01GB03]                     │2 ìë                                                        │17.01.94   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Chinoin (Âåíãðèÿ)             │007290,    

                                   │[J01GB03]                     │40 ìã/2 ìë, 80 ìã/2 ìë                                      │15.08.96   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hemofarm D.D. (Þãîñëàâèÿ)     │003795,    

                                   │[J01GB03]                     │80 ìã - 2 ìë                                                │29.03.94   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │ICN Galenika (Þãîñëàâèÿ)      │009530,    

                                   │[J01GB03]                     │20000, 40000, 80000 ÌÅ - 2 ìë │                              │17.06.97   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lek D.D. (Ñëîâåíèÿ)           │008705,    

                                   │[J01GB03]                     │40 ìã/2 ìë, 80 ìã/2 ìë                                      │31.08.98   

                                                                                                                                       

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Life Pharma (Èòàëèÿ)          │006996,    

                                   │[J01GB03]                     │40 ìã/2 ìë, 80 ìã/2 ìë                                      │19.01.96   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lisapharma (Èòàëèÿ)           │007818,    

                                   │[J01GB03]                     │40 ìã - 1 ìë; ðàñòâîð äëÿ                                   │13.09.96   

                                                                 │èíúåêöèé (ôëàêîíû) 40 ìã - 1                                           

                                                                 │ìë; ðàñòâîð äëÿ èíúåêöèé                                               

                                                                 │(àìïóëû) 80 ìã - 2 ìë;                                                 

                                                                 │ðàñòâîð äëÿ èíúåêöèé                                                   

                                                                 │(ôëàêîíû) 80 ìã - 2 ìë                                                 

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Panpharma (Ôðàíöèÿ)           │005362,    

                                   │[J01GB03]                     │10 ìã/1 ìë, 40 ìã/2 ìë, 80                                  │26.09.94   

                                                                 │ìã/2 ìë                                                                

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ìàçü; êðåì                    │Pharmachim (Áîëãàðèÿ)         │2319,      

                                   │[D06AX07]                                                                                 │07.05.73,  

                                                                                                                             │10.11.85   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (Áîëãàðèÿ)         │2289,      

                                   │[J01GB03]                     │20, 40 ìã/ìë                                                │23.03.72,  

                                                                                                                             │10.11.85   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé äëÿ      │Pharmachim (Áîëãàðèÿ)         │2380,      

                                   │[J01GB03]                     │äåòåé (àìïóëû) 10 ìã/ìë                                     │25.07.74,  

                                                                                                                             │10.11.85   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Tarchomin              │009116,    

                                   │[J01GB03]                     │40 ìã/2 ìë, 80 ìã/2 ìë        │Pharmaceutical Works (Ïîëüøà) │04.02.97   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │êàïëè ãëàçíûå (ôëàêîíû) 0.3%  │Polfa, Warszawskie            │006204,    

                                   │[S01AA11]                                                   │Pharmaceutical Works (Ïîëüøà) │21.06.95   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rugby (ÑØÀ)                   │005072,    

                                   │[J01GB03] [S01AA11]           │80 ìã - 2 ìë; êàïëè ãëàçíûå                                 │01.07.94   

                                                                 │0.3%; ìàçü ãëàçíàÿ 0.1%                                                

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │003721,    

                                   │[J01GB03]                     │80 ìã - 2 ìë                  │Laboratories (Èíäèÿ)          │24.02.94   

                                                                                                                                        

│Ãåíòàìèöèí [Ãåíòàìèöèí]            │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Zdravle (Þãîñëàâèÿ)           │002795,    

                                   │[J01GB03]                     │20 ìã/2 ìë, 40 ìã/2 ìë, 80                                  │12.01.93   

                                                                 │ìã/2 ìë, 120 ìã/2 ìë                                                   

                                                                                                                                        

│Ãåíòàìèöèí Ëåðêåí [Ãåíòàìèöèí]     │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Laboratoires Lercen (Ôðàíöèÿ) │006119,    

                                   │[J01GB03]                     │40, 80 ìã                                                   │30.05.95   

                                                                                                                                         

│Ãåíòàìèöèíà ñóëüôàò 0.08 ã         │àíòèáèîòèê, àìèíîãëèêîçèä     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │76/1177/3, 

│[Ãåíòàìèöèí]                       │[J01GB03]                     │èíúåêöèîííîãî ðàñòâîðà                                      │12.11.97   

                                                                 │(ôëàêîíû) 0.08 ã                                                       

                                                                                                                                        

│Ãåíòàìèöèíà ñóëüôàòà ðàñòâîð 0.3%  │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð-êàïëè ãëàçíûå         │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │84/881/11, 

│[Ãåíòàìèöèí]                       │[S01AA11]                     │(òþáèê-êàïåëüíèöû) 0.3% - 1 ìë│                              │12.05.98   

                                                                                                                                        

│Ãåíòàìèöèíà ñóëüôàòà ðàñòâîð äëÿ   │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ñàíèòàñ ÀÎ (Ëèòâà)            │010033,    

│èíúåêöèé 4% [Ãåíòàìèöèí]           │[J01GB03]                     │4% - 2 ìë                                                   │14.05.98   

                                                                                                                                        

│Ãåíòàìèöèíà ñóëüôàòà ðàñòâîð äëÿ   │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │83/247/5,  

│èíúåêöèé 4% [Ãåíòàìèöèí]           │[J01GB03]                     │4% - 1, 2 ìë                  │ôèðìà ÎÀÎ (Óêðàèíà)           │14.10.98   

                                                                                                                                        

│Ãåíòàìèöèíà ñóëüôàòà ðàñòâîð äëÿ   │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │83/247/5,  

│èíúåêöèé 4% [Ãåíòàìèöèí]           │[J01GB03]                     │4% - 2 ìë                                                   │15.09.98   

                                                                                                                                         

│Ãåíòàìèöèí-Ê [Ãåíòàìèöèí]          │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Krka (Ñëîâåíèÿ)               │007304,    

                                   │[J01GB03]                     │40 ìã/1 ìë, 80 ìã/2 ìë                                     │10.09.96   

                                                                                                                                        

│Ãåíòàìèöèíîâàÿ ìàçü 0.1%           │àíòèáèîòèê, àìèíîãëèêîçèä     │ìàçü (áàíêè) 0.1% - 15 ã      │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │82/1265/4, 

│[Ãåíòàìèöèí]                       │[D06AX07]                                                                                 │06.10.97   

                                                                                                                                        

│Ãåíòàìèöèíîâàÿ ìàçü 0.1%           │àíòèáèîòèê, àìèíîãëèêîçèä     │ìàçü (áàíêè) 0.1% - 15, 25,   │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │82/1265/4, 

│[Ãåíòàìèöèí]                       │[D06AX07]                     │30 ã; ìàçü (òóáû) 0.1% - 15,                                │15.09.98   

                                                                 │25, 30 ã                                                               

                                                                                                                                        

│Ãåíòàìèöèí-Ðàòèîôàðì [Ãåíòàìèöèí]  │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ratiopharm Gmbh & Co          │005602,    

                                   │[J01GB03]                     │80 ìã - 2 ìë                  │(Ãåðìàíèÿ)                    │26.12.94   

                                                                                                                                        

│Ãåíòàìèöèí-Òåâà [Ãåíòàìèöèí]       │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Teva Pharmaceutical           │006731,    

                                   │[J01GB03]                     │80 ìã - 2 ìë                  │Industries Ltd (Èçðàèëü)      │19.10.95   

                                                                                                                                        

│Ãåí-Òàìîêñèôåí [Òàìîêñèôåí]        │àíòèýñòðîãåí [L02BA01]        │òàáëåòêè 10, 20 ìã            │Genpharm Inc (Êàíàäà)         │006878,    

                                                                                                                             │06.12.95   

                                                                                                                                        

│Ãåíòèíà [Ãåíòàìèöèí]               │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Brown&Burk Pharmaceutical     │009677,    

                                   │[J01GB03]                     │40 ìã/ìë - 2 ìë; ðàñòâîð äëÿ  │Private Ltd (Èíäèÿ)           │13.08.97   

                                                                 │èíúåêöèé (ôëàêîíû) 40 ìã/ìë - │                                         

                                                                 │2 ìë                                                                   

                                                                                                                                       

│Ãåí-Óëüòðàçîë [Êî-òðèìîêñàçîë]     │ïðîòèâîìèêðîáíîå              │òàáëåòêè 480, 960 ìã          │Genpharm Inc (Êàíàäà)         │007535,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │23.05.96   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Ãåíöèí [Ãåíòàìèöèí]                │àíòèáèîòèê, àìèíîãëèêîçèä     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ipca Laboratories Ltd (Èíäèÿ) │005154,    

                                   │[J01GB03]                     │40 ìã/ìë                                                    │20.07.94   

                                                                                                                                        

│Ãåîêîðòîí {ãèäðîêîðòèçîí 10 ìã,    │ãëþêîêîðòèêîñòåðîèä           │ìàçü (òóáû) 5, 20 ã           │Pliva Sa (Õîðâàòèÿ)           │008048,    

│îêñèòåòðàöèêëèí 30 ìã - 1 ã}       │+ïðîòèâîìèêðîáíîå ñðåäñòâî                                                                │05.11.96   

                                   │[D07CA01]                                                                                            

                                                                                                                                        

│Ãåïàáåíå {ðàñòîðîïøè ïÿòíèñòîé     │æåë÷åãîííîå ñðåäñòâî          │êàïñóëû                       │Ludwig Merckle Gmbh (Àâñòðèÿ) │006087,    

│ïëîäîâ ýêñòðàêò 100 ìã, äûìÿíêè    │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │23.05.95   

│ýêñòðàêò 275 ìã}                   │[A05AX]                                                                                              

                                                                                                                                        

│Ãåïàëüïàí {ãåïàðèí 30000 ÅÄ,       │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ìàçü; ãåëü                    │ICN Galenika (Þãîñëàâèÿ)      │003477,    

│àëëàíòîèí 0.3 ã, äåêñïàíòåíîë 0.4  │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │                                                            │01.11.93   

│ã - ìàçü 100 ã; ãåïàðèí 30000 ÅÄ,                                                                                                       

│àëëàíòîèí 0.25 ã, äåêñïàíòåíîë                                                                                                          

│0.25 ã - ãåëü 100 ã}                                                                                                                    

                                                                                                                                        

│Ãåïà-Ìåðö [Îðíèòèí]                │ãèïîàçîòåìè÷åñêîå ñðåäñòâî    │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Merz Co Gmbh (Ãåðìàíèÿ)       │003759,    

                                   │[A05BA]                       │èíôóçèîííîãî ðàñòâîðà                                       │16.03.94   

                                                                 │(àìïóëû) 5 ã - 10 ìë; ãðàíóëû │                                         

                                                                 │îðàëüíûå 3 ã|5 ìë                                                      

                                                                                                                                        

│Ãåïàðèáåíå êàëüöèé [Ãåïàðèí        │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ludwig Merckle Gmbh (Àâñòðèÿ) │006086,    

│êàëüöèé]                                                         │12500 ÌÅ - 0.5 ìë                                           │23.05.95   

                                                                                                                                        

│Ãåïàðèí [Ãåïàðèí íàòðèé]           │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Gedeon Richter (Âåíãðèÿ)      │2055,      

                                                                 │(ôëàêîíû) 25000 ÌÅ - 5 ìë                                   │01.07.70,  

                                                                                                                             │22.12.83,  

                                                                                                                             │19.12.94   

                                                                                                                                        

│Ãåïàðèí [Ãåïàðèí íàòðèé]           │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │ICN Galenika (Þãîñëàâèÿ)      │007914,    

                                                                 │5000 ÌÅ/1 ìë, 5000 ÌÅ/0.25 ìë │                              │28.10.96   

                                                                                                                                        

│Ãåïàðèí [Ãåïàðèí íàòðèé]           │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Polfa (ÏÍÐ)                   │2176,      

                                                                 │(ôëàêîíû) 25000 ÌÅ - 5 ìë                                   │02.10.70,  

                                                                                                                             │19.12.88   

                                                                                                                                        

│Ãåïàðèí Áèîõåìè [Ãåïàðèí íàòðèé]   │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Biochemie Gmbh (Àâñòðèÿ)      │008169,    

                                                                 │(ôëàêîíû) 25000 ÌÅ - 5 ìë                                   │18.02.97   

                                                                                                                                        

│Ãåïàðèí Ëå÷èâà [Ãåïàðèí íàòðèé]    │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Lechiva Sa (×åõèÿ)            │009571,    

                                                                 │(ôëàêîíû) 5000 ÌÅ/ìë - 5 ìë                                 │03.07.97   

                                                                                                                                         

│Ãåïàðèíà ðàñòâîð äëÿ èíúåêöèé      │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Ýíäîêðèíèíÿé Ïðåïàðàòàé ÀΠ   │010016,    

│[Ãåïàðèí íàòðèé]                                                 │(ôëàêîíû) 5000 ÅÄ/ìë - 5 ìë   │(Ëèòâà)                       │10.03.98   

                                                                                                                                        

│Ãåïàðèíà ðàñòâîð äëÿ èíúåêöèé      │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/367/19, 

│[Ãåïàðèí íàòðèé]                                                 │(ôëàêîíû) 5000 ÅÄ/ìë - 5 ìë                                 │02.02.98   

                                                                                                                                        

│Ãåïàðèí-íàòðèé Áðàóí 25000 ÌÅ/5 ìë │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]│ðàñòâîð äëÿ èíúåêöèé          │B.Braun Melsungen Ag          │007121,    

│[Ãåïàðèí íàòðèé]                                                 │(ôëàêîíû) 25000 ÌÅ - 5 ìë     │(Ãåðìàíèÿ)                    │01.03.96   

                                                                                                                                        

│Ãåïàðèíîâàÿ ìàçü {ãåïàðèí 100 ÅÄ,  │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ìàçü (òóáû) 15, 25, 30 ã;     │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │72/911/8,  

│áåíçîêàèí 40 ìã, áåíçîíèêîòèíîâàÿ  │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │ìàçü (áàíêè) 15, 25, 30 ã                                   │15.09.98   

│êèñëîòà 0.8 ìã - 1 ã}                                                                                                                   

                                                                                                                                        

│Ãåïàðîèä Ëå÷èâà [Ãåïàðèíîèä]       │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ìàçü (òóáû) 100 ÅÄ/ìã - 30 ã  │Lechiva Sa (×åõèÿ)            │008165,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [C05BA01] │                                                            │17.02.97   

                                                                                                                                         

│Ãåïàñòåðèë À                       │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Hemofarm D.D. (Þãîñëàâèÿ)     │005263,    

                                   │ïèòàíèÿ [B05BA10]             │500 ìë                                                     │23.08.94   

                                                                                                                                        

│Ãåïàñòåðèë Á                       │ñðåäñòâî ïàðåíòåðàëüíîãî      │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Hemofarm D.D. (Þãîñëàâèÿ)     │005382,    

                                   │ïèòàíèÿ [B05BA10]             │500 ìë                                                      │05.10.94   

                                                                                                                                        

│Ãåïàòîôàëüê ïëàíòà {ðàñòîðîïøè     │æåë÷åãîííîå ñðåäñòâî          │êàïñóëû                       │Dr.Falk Pharma Gmbh (Ãåðìàíèÿ)│005219,    

│ïÿòíèñòîé ïëîäîâ ýêñòðàêò 140 ìã,  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │10.08.94   

│÷èñòîòåëà ýêñòðàêò 100 ìã,         │[A05AX]                                                                                              

│òóðìåðèêà ÿâàíñêîãî ýêñòðàêò 25 ìã}│                                                                                                     

                                                                                                                                        

│Ãåïàòðîìáèí {ãåïàðèí 50000 ÅÄ,     │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ìàçü; ãåëü                    │Godecke Ag (ÔÐÃ)              │01076,     

│àëëàíòîèí 0.3 ã, äåêñïàíòåíîë 0.4  │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │                                                            │04.05.84   

│ã - ìàçü 100 ã; ãåïàðèí 50000 ÅÄ,                                                                                                       

│àëëàíòîèí 0.25 ã, äåêñïàíòåíîë                                                                                                          

│0.25 ã, ñîñíû õâîè ìàñëî 160 ìã -                                                                                                       

│ãåëü 100 ã}                                                                                                                             

                                                                                                                                        

│Ãåïàòðîìáèí {ãåïàðèí 50000 ÅÄ,     │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ìàçü (òóáû) 40 ã; ãåëü (òóáû) │Hemofarm D.D. (Þãîñëàâèÿ)     │007288,    

│àëëàíòîèí 0.3 ã, äåêñïàíòåíîë 0.4  │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │40 ã                                                        │15.08.96   

│ã - ìàçü 100 ã; ãåïàðèí 50000 ÅÄ,                                                                                                       

│àëëàíòîèí 0.25 ã, äåêñïàíòåíîë                                                                                                          

│0.25 ã, ñîñíû õâîè ìàñëî 160 ìã -                                                                                                       

│ãåëü 100 ã}                                                                                                                             

                                                                                                                                        

│Ãåïòðàë [Àäåìåòèîíèí]              │ãåïàòîïðîòåêòîðíîå ñðåäñòâî   │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Knoll Ag, Basf Pharma         │005536,    

                                   │[A16AA02]                     │îáîëî÷êîé 400 ìã;             │(Ãåðìàíèÿ)                    │05.12.94   

                                                                 │ëèîôèëèç.ïîðîøîê äëÿ                                                   

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                            

                                                                 │ðàñòâîðà (ôëàêîíû) 400 ìã                                              

                                                                                                                                        

│Ãåðáåññåð [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │òàáëåòêè 30, 60 ìã            │Tanabe Seiaku Co Ltd (ßïîíèÿ) │002549,    

                                                                                                                             │09.07.92   

                                                                                                                                        

│Ãåðáèîí æåëóäî÷íûå êàïëè           │âåòðîãîííîå ñðåäñòâî          │êàïëè (ôëàêîí-êàïåëüíèöû) 30, │Krka (Ñëîâåíèÿ)               │009546,    

│{ãîðå÷àâêè êîðåíü 5 ã,             │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │60 ìë                                                       │23.06.97   

│çîëîòîòûñÿ÷íèêà òðàâà 5 ã, ðîìàøêè │[A02DA]                                                                                              

│öâåòêè 5 ã, òìèíà ïëîäû 5 ã,                                                                                                            

│ýòàíîë 70% - 100 ìë}                                                                                                                    

                                                                                                                                       

│Ãåðáèîí êàïëè äëÿ äåñåí {øàëôåÿ    │àíòèñåïòè÷åñêîå ñðåäñòâî      │êàïëè (ôëàêîí-êàïåëüíèöû) 30, │Krka (Ñëîâåíèÿ)               │009543,    

│ëèñò 6 ã, ëàï÷àòêè êîðíåâèùå 6 ã,  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │60 ìë                                                       │23.06.97   

│ðîìàøêè öâåòêè 5 ã,                │[A01AB11]                                                                                            

│ìåòèëñàëèöèëàò, ýòàíîë 54% - 100                                                                                                        

│ìë}                                                                                                                                     

                                                                                                                                        

│Ãåðáèîí êàïëè äëÿ ïî÷åê è ìî÷åâîãî │àíòèñåïòè÷åñêîå ñðåäñòâî      │êàïëè (ôëàêîíû ñ êàïåëüíèöåé) │Krka (Ñëîâåíèÿ)               │009572,    

│ïóçûðÿ {ïåòðóøêè êîðåíü 10 ã,      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │- 30, 40 ìë                                                 │04.07.97   

│õâîùà ïîëåâîãî òðàâà 10 ã,         │[C03]                                                                                                

│òîëîêíÿíêè ëèñò 8 ã, áåðåçû ëèñò 4 │                                                                                                     

│ã, ñòàëüíèêà êîðåíü 4 ã, ýòàíîë                                                                                                         

│75% - 100 ìë}                                                                                                                           

                                                                                                                                        

│Ãåðáèîí êàïëè æåë÷åãîííûå {ìÿòû    │æåë÷åãîííîå ñðåäñòâî          │êàïëè (ôëàêîí-êàïåëüíèöû) 30, │Krka (Ñëîâåíèÿ)               │009545,    

│ïåðå÷íîé ëèñò 10 ã, ðåïåéíèê 10 ã, │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │60 ìë                                                       │23.06.97   

│ðîìàøêè àïòå÷íîé öâåòêè 3.5 ã,     │[A05AX]                                                                                              

│òìèíà ïëîäû 3.5 ã, àðòèøîêà                                                                                                             

│ýêñòðàêò 2.5 ã, ýòàíîë 70% - 100                                                                                                        

│ìë}                                                                                                                                    

                                                                                                                                        

│Ãåðáèîí ñåðäå÷íûå êàïëè            │êàðäèîòîíè÷åñêîå ñðåäñòâî     │êàïëè äëÿ âíóòðåííåãî         │Krka (Ñëîâåíèÿ)               │009633,    

│{áîÿðûøíèêà ëèñòüÿ è öâåòêè 20 ã,  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïðèìåíåíèÿ (ôëàêîíû ñ                                       │29.07.97   

│îìåëû áåëîé íàñòîéêà 14 ã,         │[C01AX]                       │êàïåëüíèöåé) 30, 60 ìë                                                 

│âàëåðèàíû êîðíåâèùå 15 ã, ýòàíîë                                                                                                        

│73% - 100 ìë}                                                                                                                           

                                                                                                                                        

│Ãåðáèîí ñèðîï ïåðâîöâåòà           │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 150 ìë        │Krka (Ñëîâåíèÿ)               │009544,    

│{ïåðâîöâåòà êîðíåé ýêñòðàêò âîäíûé │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │23.06.97   

│16.5 ã, òèìüÿíà ýêñòðàêò âîäíûé 33 │[R05X]                                                                                               

│ã, ìåíòîë 10 ìã - 100 ã}                                                                                                                

                                                                                                                                         

│Ãåðáèîí ñèðîï ïîäîðîæíèêà          │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï (ôëàêîíû) 150 ìë        │Krka (Ñëîâåíèÿ)               │009573,    

│{ïîäîðîæíèêà ëàíöåòîâèäíîãî        │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │04.07.97   

│ýêñòðàêò âîäíûé, ìàëüâû öâåòêîâ    │[R05X]                                                                                               

│ýêñòðàêò âîäíûé 19 ã, àñêîðáèíîâàÿ │                                                                                                     

│êèñëîòà 1 ã - 100 ìë}                                                                                                                   

                                                                                                                                        

│Ãåðáèîí óñïîêîèòåëüíûå êàïëè       │ñåäàòèâíîå ñðåäñòâî           │êàïëè (ôëàêîí-êàïåëüíèöû) 30, │Krka (Ñëîâåíèÿ)               │009542,    

│{âàëåðèàíû êîðíåâèùå 15 ã, õìåëÿ   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │60 ìë                                                       │23.06.97   

│øèøêè 6 ã, ìÿòû ïåðå÷íîé ëèñò 1 ã, │[N05CM]                                                                                              

│ìåëèññû òðàâà 1 ã, ýòàíîë 70% -                                                                                                         

│100 ìë}                                                                                                                                 

                                                                                                                                        

│Ãåðïåðàêñ [Àöèêëîâèð]              │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè 200 ìã; ìàçü (òóáû)  │Micro Labs Ltd (Èíäèÿ)        │005461,    

                                   │[D06BB03] [J05AB01]           │5%                                                          │08.11.94   

                                                                                                                                        

│Ãåðïåñèí [Àöèêëîâèð]               │ïðîòèâîâèðóñíîå ñðåäñòâî      │ëèîôèëèç.ïîðîøîê äëÿ          │Lachema (×åõèÿ)               │007682,    

                                   │[J05AB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.07.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã;                                            

                                                                 │òàáëåòêè 200, 400 ìã                                                   

                                                                                                                                        

│Ãåðòîêàëì [Ðàíèòèäèí]              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Faran Laboratories Sa (Ãðåöèÿ)│005818,    

                                   │áëîêàòîð [A02BA02]            │150, 300 ìã                                                 │13.03.95   

                                                                                                                                        

│Ãåðôîíàë [Òðèìèïðàìèí]             │àíòèäåïðåññàíò [N06AA06]      │äðàæå 25 ìã                   │Arzneimittelwerk Dresden Gmbh │00947,     

                                                                                               │(Ãåðìàíèÿ)                    │15.11.82,  

                                                                                                                             │20.05.94   

                                                                                                                                        

│Ãåñòèä {àëãåëäðàò 0.45 ã, ìàãíèÿ   │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè                      │Ranbaxy Laboratories Ltd      │005405,    

│ãèäðîêñèä 0.3 ã, ìàãíèÿ êàðáîíàò                                                               │(Èíäèÿ)                       │19.10.94   

│0.45 ã - òàáëåòêè}                                                                                                                      

                                                                                                                                        

│Ãèãðîòîí [Õëîðòàëèäîí]             │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 50 ìã                │Ciba-Geigy (Øâåéöàðèÿ)        │008094,    

                                   │[C03BA04]                                                                                 │12.12.96   

                                                                                                                                        

│Ãèäèôåí [Êëîìèïðàìèí]              │àíòèäåïðåññàíò [N06AA04]      │äðàæå 25 ìã; ðàñòâîð äëÿ      │Arzneimittelwerk Dresden Gmbh │006506,    

                                                                 │èíúåêöèé (àìïóëû) 25 ìã - 2 ìë│(Ãåðìàíèÿ)                    │18.09.95   

                                                                                                                                        

│Ãèäðåà [Ãèäðîêñèêàðáàìèä]          │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êàïñóëû 500 ìã                │Bristol-Myers Squibb (Èòàëèÿ) │008455,    

                                   │[L01XX05]                                                                                 │20.10.97   

                                                                                                                                       

│Ãèäðîêîðò [Ãèäðîêîðòèçîí]          │ãëþêîêîðòèêîñòåðîèä [D07AA02] │ìàçü 1%                       │Ct-Arzneimittel Chemishe      │003972,    

                                                                                               │Tempelchof Gmbh (Ãåðìàíèÿ)    │01.06.94   

                                                                                                                                        

│Ãèäðîêîðòèçîí [Ãèäðîêîðòèçîí]      │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ñóñïåíçèÿ                     │Gedeon Richter (Âåíãðèÿ)      │2057,      

                                                                 │ìèêðîêðèñòàëëè÷åñêàÿ äëÿ                                    │01.07.70,  

                                                                 │èíúåêöèé (ôëàêîíû) 125 ìã - 5 │                              │22.12.83,  

                                                                 │ìë                                                          │09.08.88   

                                                                                                                                        

│Ãèäðîêîðòèçîí [Ãèäðîêîðòèçîí]      │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ëèîôèëèç.ïîðîøîê äëÿ          │Hemofarm D.D. (Þãîñëàâèÿ)     │008233,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.03.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 500 ìã /â                                           

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                            

                                                                 │áåíçèëîâûé ñïèðò (àìïóëû)                                              

                                                                 │0.9% - 4 ìë/                                                           

                                                                                                                                        

│Ãèäðîêîðòèçîí [Ãèäðîêîðòèçîí]      │ãëþêîêîðòèêîñòåðîèä [S01BA02] │ìàçü ãëàçíàÿ (òóáû) 0.5% - 3 ã│Polfa, Poznanskie             │007187,    

                                                                                               │Pharmaceutical Works (Ïîëüøà) │07.05.96   

                                                                                                                                        

│Ãèäðîêîðòèçîí Ëåðêåí               │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Lercen (Ôðàíöèÿ) │006184,    

│[Ãèäðîêîðòèçîí]                                                  │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │14.06.95   

                                                                 │ðàñòâîðà 100 ìã /â êîìïëåêòå                                           

                                                                 │ñ ðàñòâîðèòåëåì/                                                       

                                                                                                                                        

│Ãèäðîêîðòèçîí Íèêîìåä              │ãëþêîêîðòèêîñòåðîèä [D07AA02] │êðåì 1%                       │Nycomed Dak As (Äàíèÿ)        │005240,    

│[Ãèäðîêîðòèçîí]                                                                                                              │19.08.94   

                                                                                                                                        

│Ãèäðîêîðòèçîí Òåâà [Ãèäðîêîðòèçîí] │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │007895,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │15.10.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 100, 500 ìã│                                         

                                                                                                                                        

│Ãèäðîêîðòèçîíà àöåòàòà ñóñïåíçèÿ   │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ñóñïåíçèÿ äëÿ èíúåêöèé        │Áèîëåê - àðåíäíîå ïðåäïðèÿòèå │83/1252/7, 

│äëÿ èíúåêöèé 2.5% [Ãèäðîêîðòèçîí]                                │(àìïóëû) 2.5% - 1, 2 ìë       │ïî ïðîèçâîäñòâó               │24.06.98   

                                                                                               │èììóíîáèîëîãè÷åñêèõ è                    

                                                                                               │ëåêàðñòâåííûõ ïðåïàðàòîâ                 

                                                                                              │(Óêðàèíà)                                

                                                                                                                                        

│Ãèäðîêîðòèçîíà íàòðèÿ ñóêöèíàò     │ãëþêîêîðòèêîñòåðîèä [H02AB09] │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Dee-Pharma Ltd (Èíäèÿ)        │006123,    

│[Ãèäðîêîðòèçîí]                                                  │èíúåêöèîííîãî ðàñòâîðà                                      │30.05.95   

                                                                 │(ôëàêîíû) 100, 500 ìã                                                  

                                                                                                                                        

│Ãèäðîêîðòèçîí-Ïîñ N1%              │ãëþêîêîðòèêîñòåðîèä [S01BA02] │ìàçü ãëàçíàÿ (òóáû) 1%        │Ursapharm Arzneimittel Gmbh   │007510,    

│[Ãèäðîêîðòèçîí]                                                                                │(Ãåðìàíèÿ)                    │15.05.96   

                                                                                                                                        

│Ãèäðîêîðòèçîí-Ïîñ N2.5%            │ãëþêîêîðòèêîñòåðîèä [S01BA02] │ìàçü ãëàçíàÿ (òóáû) 2.5%      │Ursapharm Arzneimittel Gmbh   │007511,    

│[Ãèäðîêîðòèçîí]                                                                                │(Ãåðìàíèÿ)                    │15.05.96   

                                                                                                                                        

│Ãèäðîêñèçèí [Ãèäðîêñèçèí]          │àíêñèîëèòè÷åñêîå ñðåäñòâî     │äðàæå 10, 25 ìã               │Polfa, Rzeszowskie            │009305,    

                                   │[N05BB01]                                                   │Pharmaceutical Works Sa       │14.03.97   

                                                                                               │(Ïîëüøà)                                 

                                                                                                                                        

│Ãèäðîêñèóðåà [Ãèäðîêñèêàðáàìèä]    │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êàïñóëû 500 ìã                │Polfa, Krakowskie             │008256,    

                                   │[L01XX05]                                                   │Pharmaceutical Works (Ïîëüøà) │10.04.97   

                                                                                                                                        

│Ãèäðîïåðèòà òàáëåòêè 1.5 ã         │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè 1.5 ã                │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │74/331/62, 

│[Ìî÷åâèíû ïåðîêñèä]                │[D02AE01]                                                                                 │29.10.97   

                                                                                                                                        

│Ãèäðîõëîðòèàçèä [Ãèäðîõëîðîòèàçèä] │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 25, 50, 100 ìã       │Rugby (ÑØÀ)                   │005741,    

                                   │[C03AA03]                                                                                 │14.02.95   

                                                                                                                                        

│Ãèçààð {ëîçàðòàí êàëèÿ 50 ìã,      │àíãèîòåíçèíà II ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Merck Sharp & Dohme           │009144,    

│ãèäðîõëîðîòèàçèä 12.5 ìã}          │àíòàãîíèñò+äèóðåòè÷åñêîå                                    │(Íèäåðëàíäû)                  │17.02.97   

                                   │ñðåäñòâî [C09DA01]                                                                                   

                                                                                                                                         

│Ãè-êàð [Ðàíèòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150 ìã               │Pharmacar Ltd (Èçðàèëü)       │006684,    

                                   │áëîêàòîð [A02BA02]                                                                       │29.09.95   

                                                                                                                                        

│Ãèëåìàë [Ãëèáåíêëàìèä]             │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Chinoin (Âåíãðèÿ)             │008606,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │20.04.98   

                                                                                                                                        

│Ãèëóêîð [Ñîòàëîë]                  │áåòà-àäðåíîáëîêàòîð [C07AA07] │òàáëåòêè 80, 160 ìã           │Giulini Pharma Gmbh (Ãåðìàíèÿ)│007768,    

                                                                                                                             │28.08.96   

                                                                                                                                        

│Ãèëóðèòìàë 10 [Àéìàëèí]            │àíòèàðèòìè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Solvay Pharmaceuticals Gmbh   │008509,    

                                   │[C01BA05]                     │50 ìã - 10 ìë                 │(Ãåðìàíèÿ)                    │05.02.98   

                                                                                                                                        

│Ãèíàëãèí {ìåòðîíèäàçîë 250 ìã,     │ïðîòèâîìèêðîáíîå              │òàáëåòêè âàãèíàëüíûå          │Polfa, Rzeszowskie            │006233,    

│õëîðõèíàëäîë 100 ìã}               │êîìáèíèðîâàííîå ñðåäñòâî [G01]│                              │Pharmaceutical Works (Ïîëüøà) │30.06.95   

                                                                                                                                        

│Ãèíäæàëåëèíã {îðòîñèôîíà           │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │êàïñóëû 500 ìã                │Darya-Varia Laboratoria       │007892,    

│òû÷èíî÷íîãî ëèñò 27.7%,            │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Èíäîíåçèÿ)                   │11.10.96   

│êåäæèáåëèíãà 27.7%, ìåíèðàí 22.3%, │[A03]                                                                                                

│àëàíã-àëàíã 22.3%}                                                                                                                      

                                                                                                                                        

│Ãèíåçîë 7 [Ìèêîíàçîë]              │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ñóïïîçèòîðèè âàãèíàëüíûå 100  │Sagmel Inc (ÑØÀ)              │010264,    

                                   │[G01AF04]                     │ìã                                                          │23.06.98   

                                                                                                                                        

│Ãèíå-Ëîòðèìèí [Êëîòðèìàçîë]        │ïðîòèâîãðèáêîâîå ñðåäñòâî     │òàáëåòêè âàãèíàëüíûå 100 ìã;  │Schering-Plough (Ïîðòóãàëèÿ)  │007829,    

                                   │[G01AF02]                     │êðåì âàãèíàëüíûé (òóáû) 1% -                                │18.09.96   

                                                                 │50 ã                                                                   

                                                                                                                                        

│Ãèíèïðàë [Ãåêñîïðåíàëèí]           │áåòà2-àäðåíîñòèìóëÿòîð        │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Hafslund Nycomed Pharma Ag    │002555,    

                                   │ñåëåêòèâíûé [R03CC05]         │âíóòðèâåííîãî ââåäåíèÿ        │(Àâñòðèÿ)                     │14.07.92   

                                                                 │(àìïóëû) 10 ìêã - 2 ìë;                                                

                                                                 │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ                                           

                                                                 │èíôóçèîííîãî ðàñòâîðà                                                  

                                                                 │(àìïóëû) 25 ìêã - 5 ìë                                                 

                                                                                                                                        

│Ãèíêèî [Ãèíêãî Áèëîáà]             │àíãèîïðîòåêòîðíîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lichtwer Pharma Ag (Ãåðìàíèÿ) │007607,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │50 ìã                                                       │24.06.96   

                                   │[N06BX19]                                                                                            

                                                                                                                                        

│Ãèíêîáà [Ãèíêãî Áèëîáà]            │àíãèîïðîòåêòîðíîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Boehringer Ingelheim Pharma   │010510,    

                                  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │40 ìã                         │Kg, a division of Boehringer  │22.10.98   

                                   │[N06BX19]                                                   │Ingelheim International Gmbh             

                                                                                               │(Ãåðìàíèÿ)                               

                                                                                                                                        

│Ãèíêîãèíê [Ãèíêãî Áèëîáà]          │àíãèîïðîòåêòîðíîå ñðåäñòâî    │ðàñòâîð äëÿ âíóòðåííåãî       │Beaufour-Ipsen International  │007719,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïðèìåíåíèÿ (ôëàêîíû) 40 ìã/ìë │(Ôðàíöèÿ)                     │13.08.96   

                                   │[N06BX19]                     │- 30, 90 ìë                                                            

                                                                                                                                        

│Ãèíêîð ïðîêòî {Ginkgo Biloba       │ïðîòèâîãåìîððîèäàëüíîå        │ñâå÷è                         │Beaufour-Ipsen International  │006405,    

│ýêñòðàêò 20 ìã, áóòîôîðì 40 ìã}    │ñðåäñòâî ðàñòèòåëüíîãî                                      │(Ôðàíöèÿ)                     │15.08.95   

                                   │ïðîèñõîæäåíèÿ [C05AX03]                                                                              

                                                                                                                                        

│Ãèíêîð ôîðò {Ginkgo Biloba         │âåíîòîíèçèðóþùåå ñðåäñòâî     │êàïñóëû                       │Beaufour-Ipsen (Ôðàíöèÿ)      │005279,    

│ýêñòðàêò 14 ìã, ãåïòàìèíîëà õëîðèä │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │30.08.94   

│0.3 ã, òðîêñåðóòèí 0.3 ã}          │[C05B]                                                                                               

                                                                                                                                         

│Ãèíî-Äàêòàíîë [Ìèêîíàçîë]          │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ñâå÷è âàãèíàëüíûå 200 ìã      │ICN Galenika (Þãîñëàâèÿ)      │009344,    

                                   │[G01AF04]                                                                                 │26.03.97   

                                                                                                                                        

│Ãèíî-Äàêòàðèí [Ìèêîíàçîë]          │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ñóïïîçèòîðèè âàãèíàëüíûå 100  │Janssen Pharmaceutica         │008629,    

                                   │[G01AF04]                     │ìã                            │(Áåëüãèÿ)                     │28.05.98   

                                                                                                                                        

│Ãèíîäèàí äåïî {ïðàñòåðîí 200 ìã,   │ïðîòèâîêëèìàêòåðè÷åñêîå       │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │Schering Ag (Ãåðìàíèÿ)        │003672,    

│ýñòðàäèîë 4 ìã}                    │ñðåäñòâî [G03EA03]            │(øïðèö-àìïóëû) 4 ìã/200 ìã -                                │03.02.94   

                                                                 │1 ìë                                                                   

                                                                                                                                        

│Ãèíî-Ïåâàðèë [Ýêîíàçîë]            │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ñâå÷è âàãèíàëüíûå 50, 150 ìã  │Cilag (Øâåéöàðèÿ)             │007180,    

                                   │[G01AF05]                                                                                 │15.04.96   

                                                                                                                                        

│Ãèíî-Ïåâàðèë [Ýêîíàçîë]            │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì âàãèíàëüíûé (òóáû) 1% -  │Cilag Ag (Øâåéöàðèÿ)          │009301,    

                                   │[G01AF05]                     │78 ã /â êîìïëåêòå ñ                                         │13.03.97   

                                                                 │àïïëèêàòîðîì/; ñâå÷è                                                    

                                                                 │âàãèíàëüíûå 150 ìã /â                                                  

                                                                 │êîìïëåêòå ñ êðåìîì (òóáû) 1%                                           

                                                                 │- 15 ã/                                                                

                                                                                                                                        

│Ãèíî-òàðäèôåðîí {æåëåçà ñóëüôàò    │ãåìîïîýçà ñòèìóëÿòîð,         │òàáëåòêè çàìåäëåííîãî         │Robapharm Ag (Øâåéöàðèÿ)      │002537,    

│256.3 ìã (æåëåçî 80 ìã),           │ïðåïàðàò æåëåçà [B03AE10]     │âûñâîáîæäåíèÿ â îáîëî÷êå èç                                 │02.07.92   

│ìóêîïðîòåîçà 80 ìã, ôîëèåâàÿ                                     │ñàõàðà                                                                 

│êèñëîòà 0.35 ìã, àñêîðáèíîâàÿ                                                                                                           

│êèñëîòà 30 ìã}                                                                                                                          

                                                                                                                                        

│Ãèíî-òðàâîãåí îâóëóì [Èçîêîíàçîë]  │ïðîòèâîãðèáêîâîå ñðåäñòâî     │òàáëåòêè âàãèíàëüíûå 600 ìã   │Schering Ag (Ãåðìàíèÿ)        │002912,    

                                   │[G01AF07]                                                                                 │17.03.93   

                                                                                                                                        

│Ãèíî-Òðîçèä [Òèîêîíàçîë]           │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ñóïïîçèòîðèè âàãèíàëüíûå 300  │Pfizer (Ôðàíöèÿ)              │009893,    

                                   │[D01AC07]                     │ìã                                                          │10.12.97   

                                                                                                                                         

│Ãèíñàíà [Æåíü-øåíü]                │àäàïòîãåííîå ñðåäñòâî         │êàïñóëû 100 ìã                │Pharmaton Sa (Øâåéöàðèÿ)      │009641,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                              │31.07.97   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Ãèíñàíà òîíèê [Æåíü-øåíü]          │àäàïòîãåííîå ñðåäñòâî         │ðàñòâîð ñïèðòîâîé äëÿ ïðèåìà  │Pharmaton Sa (Øâåéöàðèÿ)      │010405,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │âíóòðü (ôëàêîíû) 140 ìã|15 ìë │                              │14.08.98   

                                   │[A13A]                        │- 50, 100, 250 ìë                                                      

                                                                                                                                        

│Ãèíñàíà òîíèê áåç àëêîãîëÿ         │àäàïòîãåííîå ñðåäñòâî         │ðàñòâîð äëÿ âíóòðåííåãî       │Pharmaton Sa (Øâåéöàðèÿ)      │009642,    

│[Æåíü-øåíü]                        │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │ïðèìåíåíèÿ (ôëàêîíû) 140                                    │31.07.97   

                                   │[A13A]                        │ìã|15 ìë - 50, 100, 250 ìë                                             

                                                                                                                                        

│Ãèîñöèí-Í-áóòèëáðîìèä [Ãèîñöèíà    │ì-õîëèíîáëîêàòîð [A03BB01]    │ðàñòâîð äëÿ èíúåêöèé 20 ìã/ìë │Weimer Pharma Gmbh (Ãåðìàíèÿ) │003911,    

│áóòèëáðîìèä]                                                                                                                 │16.05.94   

                                                                                                                                        

│Ãèïåðíàë [Íèôåäèïèí]               │ÁÌÊÊ [C08CA05]                │òàáëåòêè ðåòàðä 10, 20 ìã     │Berlin-Chemie Ag (Ãåðìàíèÿ)   │005458,    

                                                                                                                             │04.11.94   

                                                                                                                                        

│Ãèïåðíàë 10 [Íèôåäèïèí]            │ÁÌÊÊ [C08CA05]                │êàïñóëû 10 ìã; òàáëåòêè       │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007450,    

                                                                 │ïîêðûòûå îáîëî÷êîé 10 ìã                                    │17.04.96   

                                                                                                                                        

│Ãèïåðíàë 5 [Íèôåäèïèí]             │ÁÌÊÊ [C08CA05]                │êàïñóëû 5 ìã                  │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007449,    

                                                                                                                             │17.04.96   

                                                                                                                                       

│Ãèïåðíàë êàïëè [Íèôåäèïèí]         │ÁÌÊÊ [C08CA05]                │ðàñòâîð îðàëüíûé (ôëàêîíû) 20 │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007468,    

                                                                 │ìã/ìë - 30 ìë                                               │23.04.96   

                                                                                                                                        

│Ãèïåðñòàò [Äèàçîêñèä]              │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Schering-Plough (Áåëüãèÿ)     │006959,    

                                   │[C02DA01]                     │15 ìã/ìë                                                    │05.01.96   

                                                                                                                                        

│Ãèïíîìèäàò [Ýòîìèäàò]              │íàðêîçíîå íåèíãàëÿöèîííîå     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Janssen Pharmaceutica         │007239,    

                                   │ñðåäñòâî [N01AX07]            │2 ìã/ìë - 10 ìë               │(Áåëüãèÿ)                     │04.07.96   

                                                                                                                                        

│Ãèïîðàìèí ëèîôèëèçèðîâàííûé äëÿ    │ïðîòèâîâèðóñíîå ñðåäñòâî      │ëèîôèëèçàò äëÿ ïðèãîòîâëåíèÿ  │Äàðíèöà ôàðìàöåâòè÷åñêàÿ      │98/305/11, 

│ðàñòâîðîâ 0.02 ã {îáëåïèõè         │[J05AX]                       │ðàñòâîðà (ôëàêîíû) 20 ìã      │ôèðìà ÇÀÎ (Óêðàèíà)           │13.10.98   

│êðóøèíîâèäíîé ëèñòüå ïðåïàðàò}                                                                                                          

                                                                                                                                        

│Ãèïîðàìèíà òàáëåòêè ñóáëèíãâàëüíûå │ïðîòèâîâèðóñíîå ñðåäñòâî      │òàáëåòêè ñóáëèíãâàëüíûå 20 ìã │Äàðíèöà ôàðìàöåâòè÷åñêàÿ      │98/305/10, 

│0.02 ã {îáëåïèõè êðóøèíîâèäíîé     │[J05AX]                                                     │ôèðìà ÇÀÎ (Óêðàèíà)           │13.10.98   

│ëèñòüå ïðåïàðàò}                                                                                                                        

                                                                                                                                        

│Ãèïîðàìèíîâàÿ ìàçü 0.5% {îáëåïèõè  │ïðîòèâîâèðóñíîå ñðåäñòâî      │ìàçü (áàíêè) 0.5% - 20 ã      │Äàðíèöà ôàðìàöåâòè÷åñêàÿ      │98/305/12, 

│êðóøèíîâèäíîé ëèñòüå ïðåïàðàò}     │[D06BB]                                                     │ôèðìà ÇÀÎ (Óêðàèíà)           │13.10.98   

                                                                                                                                        

│Ãèïîòèàçèä [Ãèäðîõëîðîòèàçèä]      │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 25, 100 ìã           │Chinoin (Âåíãðèÿ)             │006529,    

                                   │[C03AA03]                                                                                 │20.09.95   

                                                                                                                                        

│Ãèðàáëîê [Íîðôëîêñàöèí]            │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │ôèëìòàáëåòêè 200, 400 ìã      │Medochemie Ltd (Êèïð)         │005123,    

                                   │ôòîðõèíîëîí [J01MA06]                                                                     │13.07.94   

                                                                                                                                        

│Ãèðóäîèä [Ãåïàðèíîèä]              │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ãåëü (òóáû) 300 ìã|100 ã -    │Luitpold Pharma Gmbh          │007186,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [C05BA01] │40, 100 ã; ìàçü (òóáû) 300    │(Ãåðìàíèÿ)                    │26.04.96   

                                                                 │ìã|100 ã - 40, 100 ã                                                   

                                                                                                                                        

│Ãèñìàíàë [Àñòåìèçîë]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ñóñïåíçèÿ äëÿ âíóòðåííåãî     │Janssen Pharmaceutica         │009268,    

                                   │áëîêàòîð [R06AX11]            │ïðèìåíåíèÿ (ôëàêîíû) 1 ìã/ìë  │(Áåëüãèÿ)                     │21.02.97   

                                                                 │- 100 ìë                                                               

                                                                                                                                        

│Ãèñìàíàë [Àñòåìèçîë]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Janssen Pharmaceu-tica        │007176,    

                                   │áëîêàòîð [R06AX11]                                          │(Áåëüãèÿ)                     │08.04.96   

                                                                                                                                        

│Ãèñòàäèí [Òåðôåíàäèí]              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 60 ìã                │Amoun Pharmaceu-tical         │007862,    

                                   │áëîêàòîð [R06AX12]                                          │Industries Co (Åãèïåò)        │30.09.96   

                                                                                                                                        

│Ãèñòàçîë [Àñòåìèçîë]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã                │Dr.Ibrahim Atem Ulagay Sanayi │003483,    

                                   │áëîêàòîð [R06AX11]                                          │As (Òóðöèÿ)                   │03.11.93   

                                                                                                                                        

│Ãèñòàçîë [Àñòåìèçîë]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 10 ìã; ñóñïåíçèÿ     │Krka (Ñëîâåíèÿ)               │003701,    

                                   │áëîêàòîð [R06AX11]            │îðàëüíàÿ (ôëàêîíû) 10 ìã|5 ìë │                              │15.02.94   

                                                                                                                                        

│Ãèñòàê [Ðàíèòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 300 ìã; ðàñòâîð äëÿ  │Ranbaxy Laboratories Ltd      │005379,    

                                   │áëîêàòîð [A02BA02]            │èíúåêöèé (àìïóëû) 50 ìã - 2 ìë│(Èíäèÿ)                       │05.10.94   

                                                                                                                                        

│Ãèñòàê [Ðàíèòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ranbaxy Laboratories Ltd      │002561,    

                                   │áëîêàòîð [A02BA02]            │150 ìã                        │(Èíäèÿ)                       │15.07.92,  

                                                                                                                             │24.09.97   

                                                                                                                                        

│Ãèñòàê [Ðàíèòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè øèïó÷èå              │Ranbaxy Laboratories Ltd      │009590,    

                                   │áëîêàòîð [A02BA02]            │áûñòðîðàñòâîðèìûå 150 ìã      │(Èíäèÿ)                       │11.07.97   

                                                                                                                                        

│Ãèñòàëîíã [Àñòåìèçîë]              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 5, 10 ìã             │Dr.Reddy'S Laboratories Ltd   │002687,    

                                   │áëîêàòîð [R06AX11]                                          │(Èíäèÿ)                       │13.11.92   

                                                                                                                                        

│Ãèñòèìåò [Ëåâîêàáàñòèí]            │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │êàïëè ãëàçíûå (ôëàêîíû) 0.5   │Janssen Pharmaceutica         │006677,    

                                   │áëîêàòîð [R01AC02] [S01GX02]  │ìã/ìë; ñïðåé íàçàëüíûé        │(Áåëüãèÿ)                     │29.09.95   

                                                                 │(ôëàêîíû) 0.5 ìã/ìë                                                    

                                                                                                                                         

│Ãèñòîäèë [Öèìåòèäèí]               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 200 ìã               │Gedeon Richter (Âåíãðèÿ)      │006655,    

                                   │áëîêàòîð [A02BA01]                                                                       │29.02.96   

                                                                                                                                        

│Ãèñòîäèë [Öèìåòèäèí]               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2858,      

                                   │áëîêàòîð [A02BA01]            │200 ìã - 2 ìë                                               │02.02.87   

                                                                                                                                        

│Ãëàêñåííà {ñåííû ýêñòðàêò}         │ñëàáèòåëüíîå ñðåäñòâî         │òàáëåòêè                      │Glaxo Laboratories Ltd (Èíäèÿ)│00575,     

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │24.05.78   

                                   │[A06AB06]                                                                                            

                                                                                                                                        

│Ãëàìèä [Ãëèáåíêëàìèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Cadila Pharmaceuticals Ltd    │007910,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Èíäèÿ)                       │23.10.96   

                                                                                                                                        

│Ãëàóâåíò [Ãëàóöèí]                 │ïðîòèâîêàøëåâîå ñðåäñòâî      │äðàæå 10, 40 ìã               │Pharmachim Holding Ead,       │008559,    

                                   │[R05DB]                                                     │Sopharma Ead (Áîëãàðèÿ)       │06.07.98   

                                                                                                                                        

│Ãëàóìîë [Òèìîëîë]                  │áåòà-àäðåíîáëîêàòîð [S01ED01] │êàïëè ãëàçíûå (ôëàêîíû) 0.5%  │ICN Galenika (Þãîñëàâèÿ)      │006991,    

                                                                                                                             │17.01.96   

                                                                                                                                        

│Ãëàóôîñ [Îôëîêñàöèí]               │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Jaka-80 (Ìàêåäîíèÿ)           │009098,    

                                   │ôòîðõèíîëîí [J01MA01]         │200 ìã                                                      │29.01.97   

                                                                                                                                        

│Ãëèàòèëèí [Õîëèíà àëüôîñöåðàò]     │íîîòðîïíîå ñðåäñòâî [N07AX02] │êàïñóëû 400 ìã; ðàñòâîð äëÿ   │Italfarmaco (Èòàëèÿ)          │003561,    

                                                                │èíúåêöèé (àìïóëû) 1 ã - 4 ìë                                │07.12.93   

                                                                                                                                        

│Ãëèáàìèä [Ãëèáåíêëàìèä]            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Cts Chemical Industries Ltd   │006889,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Èçðàèëü)                     │14.12.95   

                                                                                                                                        

│Ãëèáåíåç [Ãëèïèçèä]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Pfizer Sa (Áåëüãèÿ)           │007278,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB07] │                                                            │09.08.96   

                                                                                                                                        

│Ãëèáåíåç-ðåòàðä [Ãëèïèçèä]         │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè ïîêðûòûå             │Pfizer Amboise (Ôðàíöèÿ)      │009059,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB07] │îñìîòè÷åñêîé îáîëî÷êîé 5 ìã,                                │05.01.97   

                                                                 │10 ìã                                                                  

                                                                                                                                        

│Ãëèáåíêëàìèä [Ãëèáåíêëàìèä]        │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │010027,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │çàâîä ÀÎ (Ýñòîíèÿ)            │20.04.98   

                                                                                                                                        

│Ãëèáåíêëàìèä ÀÂÄ 5 [Ãëèáåíêëàìèä]  │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Arzneimittelwerk Dresden Gmbh │003292,    

                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(ÔÐÃ)                         │02.09.93   

                                                                                                                                        

│Ãëèáåíêëàìèä Íèêîìåä [Ãëèáåíêëàìèä]│ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Hafslund Nycomed Pharma Ag    │005632,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Àâñòðèÿ)                     │11.01.95   

                                                                                                                                        

│Ãëèáåíêëàìèäà òàáëåòêè 0.005 ã     │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Çäîðîâüå - ôàðìàöåâòè÷åñêàÿ   │82/374/11, 

│[Ãëèáåíêëàìèä]                     │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │ôèðìà ÎÀÎ (Óêðàèíà)           │14.10.98   

                                                                                                                                        

│Ãëèáåíêëàìèä-Òåâà [Ãëèáåíêëàìèä]   │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Teva Pharmaceutical           │009738,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │Industries Ltd                │24.09.97   

                                                                                               │(Âåëèêîáðèòàíèÿ)                         

                                                                                                                                        

│Ãëèáåíêëàìèä-Òåâà [Ãëèáåíêëàìèä]   │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Teva Pharmaceutical           │009615,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │Industries Ltd (Èçðàèëü)      │23.07.97   

                                                                                                                                        

│Ãëèâåíîë [Òðèáåíîçèä]              │âåíîòîíèçèðóþùåå ñðåäñòâî     │êàïñóëû 400 ìã                │Ciba-Geigy (Øâåéöàðèÿ)        │008255,    

                                   │[C05AX05]                                                                                 │09.04.97   

                                                                                                                                        

│Ãëèêëàçèä [Ãëèêëàçèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 80 ìã                │Rivopharm Sa (Øâåéöàðèÿ)      │009597,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB09] │                                                            │15.07.97   

                                                                                                                                        

│Ãëèêîí [Ìåòôîðìèí]                 │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │ICN (Êàíàäà)                  │009775,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BA02] │îáîëî÷êîé 500 ìã                                            │10.10.97   

                                                                                                                                        

│Ãëèìèäñòàäà 1.75 ìåæäóíàðîäíûé     │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 1.75 ìã              │Stada Arzneimittel Ag         │007858,    

│[Ãëèáåíêëàìèä]                     │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Ãåðìàíèÿ)                    │30.09.96   

                                                                                                                                        

│Ãëèìèäñòàäà 3.5 ìåæäóíàðîäíûé      │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 3.5 ìã               │Stada Arzneimittel Ag         │007859,    

│[Ãëèáåíêëàìèä]                     │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Ãåðìàíèÿ)                    │30.09.96   

                                                                                                                                        

│Ãëèîðàë [Ãëèêëàçèä]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 80 ìã                │ICN Galenika (Þãîñëàâèÿ)      │009673,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB09] │                                                            │13.08.97   

                                                                                                                                        

│Ãëèòèçîë [Ãëèáåíêëàìèä]            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Remedica Ltd - Minnex (Êèïð)  │009764,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │06.10.97   

                                                                                                                                        

│Ãëèöåðîëèò-57 {ãëèöåðîë 57 ìã,     │ãåìîêîíñåðâàíò,               │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │007165,    

│íàòðèÿ ëàêòàò 1.6 ìã, êàëèÿ õëîðèä │âñïîìîãàòåëüíîå âåùåñòâî      │ñòåêëÿííûå) 400, 500 ìë                                     │22.03.96   

│30 ìã, íàòðèÿ ôîñôàò 51.7 ìã,      │[V07AC]                                                                                              

│íàòðèÿ äèãèäðîêñèôîñôàò 124.2 ìã - │                                                                                                     

│100 ìë}                                                                                                                                 

                                                                                                                                        

│Ãëèöèí [Ãëèöèí]                    │äåçèíòîêñèêàöèîííîå ñðåäñòâî  │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00825,     

                                   │[B05CX03]                     │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │20.10.80,  

                                                                                                                             │09.12.93   

                                                                                                                                        

│Ãëóêîìîë 0.25% [Òèìîëîë]           │áåòà-àäðåíîáëîêàòîð [S01ED01] │êàïëè ãëàçíûå (ôëàêîíû) 0.25% │Torrent Pharmaceuticals Ltd   │007327,    

                                                                 │- 5 ìë                        │(Èíäèÿ)                       │27.09.96   

                                                                                                                                        

│Ãëóêîìîë 0.5% [Òèìîëîë]            │áåòà-àäðåíîáëîêàòîð [S01ED01] │êàïëè ãëàçíûå (ôëàêîíû) 0.5%  │Torrent Pharmaceuticals Ltd   │007328,    

                                                                 │- 5 ìë                        │(Èíäèÿ)                       │27.09.96   

                                                                                                                                        

│Ãëþãèöèð ðàñòâîð {íàòðèÿ öèòðàò 20 │ãåìîêîíñåðâàíò,               │ðàñòâîð äëÿ ïðèãîòîâëåíèÿ     │Íåñâèæñêèé çàâîä              │81/312/4,  

│ã, äåêñòðîçà 30 ã - 1 ë}           │âñïîìîãàòåëüíîå âåùåñòâî      │èíôóçèîííîãî ðàñòâîðà         │ìåäïðåïàðàòîâ (Áåëàðóñü)      │26.01.98   

                                   │[V07AC]                       │(ôëàêîíû äëÿ                                                           

                                                                 │êðîâåçàìåíèòåëåé) 50 ìë - 250 │                                         

                                                                 │ìë; ðàñòâîð äëÿ ïðèãîòîâëåíèÿ │                                         

                                                                 │èíôóçèîííîãî ðàñòâîðà                                                  

                                                                 │(ôëàêîíû äëÿ                                                           

                                                                 │êðîâåçàìåíèòåëåé) 75 ìë - 450 │                                         

                                                                 │ìë                                                                     

                                                                                                                                        

│ÃëþêàÃåí 1 ìã ÃèïîÊèò [Ãëþêàãîí]   │èíñóëèíà àíòàãîíèñò [H04AA01] │ëèîôèëèç.ïîðîøîê äëÿ          │Novo Nordisk a/S (Äàíèÿ)      │010139,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │02.04.98   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ìã /â                                             

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì                                              

                                                                 │(øïðèöû îäíîðàçîâûå) 1 ìë/                                             

                                                                                                                                        

│Ãëþêàãîí [Ãëþêàãîí]                │èíñóëèíà àíòàãîíèñò [H04AA01] │ëèîôèëèç.ïîðîøîê äëÿ          │Eli Lilly (ÑØÀ)               │005908,    

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │04.04.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ìã /â                                             

                                                                │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Ãëþêàãîí [Ãëþêàãîí]                │èíñóëèíà àíòàãîíèñò [H04AA01] │ëèîôèëèç.ïîðîøîê äëÿ          │Novo Industry (Äàíèÿ)         │01598,     

                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │27.04.89   

                                                                 │ðàñòâîðà (ôëàêîíû) 1 ìã, 10 ìã│                                         

                                                                                                                                        

│Ãëþêàíòèì [Ìåãëóìèíà àíòèìîíàò]    │ïðîòèâîëåéøìàíèîçíîå ñðåäñòâî │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Rorer (Ôðàíöèÿ) │00854,     

                                   │[P01CB01]                     │5 ìë                                                        │17.04.81,  

                                                                                                                             │05.03.94   

                                                                                                                                        

│Ãëþêîáàé [Àêàðáîçà]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 50, 100 ìã           │Bayer Ag (Ãåðìàíèÿ)           │003753,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BF01] │                                                            │11.03.94   

                                                                                                                                        

│Ãëþêîáåíå [Ãëèáåíêëàìèä]           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 1.75, 3.5 ìã         │Merckle Gmbh (Ãåðìàíèÿ)       │009697,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │21.08.97   

                                                                                                                                        

│Ãëþêîáåíå [Ãëèáåíêëàìèä]           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 1.75, 3.5 ìã         │Ludwig Merckle Gmbh (Àâñòðèÿ) │002514,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │18.06.92   

                                                                                                                                        

│Ãëþêîçà [Äåêñòðîçà]                │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé           │Baxter Healthcare Corp        │005716,    

                                   │[B05CX01]                     │(êîíòåéíåðû ïëàñòèêîâûå -     │(Âåëèêîáðèòàíèÿ)              │06.02.95   

                                                                 │âèàôëåêñ) 5%                                                           

                                                                                                                                        

│Ãëþêîçà 10% [Äåêñòðîçà]            │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé (ìåøî÷êè  │Ilsanta (Ëèòâà)               │007663,    

                                   │[B05CX01]                     │ïîëèïðîïèëåíîâûå) 10% - 250,                                │22.07.96   

                                                                 │500, 1000 ìë                                                           

                                                                                                                                        

│Ãëþêîçà 10% [Äåêñòðîçà]            │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé          │Laboratoires Aguettant        │007122,    

                                   │[B05CX01]                     │(ôëàêîíû) 10%; ðàñòâîð äëÿ    │(Ôðàíöèÿ)                     │04.03.96   

                                                                 │èíúåêöèé (ïàêåòû                                                       

                                                                 │ïîëèõëîðâèíèëîâûå) 10%                                                 

                                                                                                                                         

│Ãëþêîçà 5% [Äåêñòðîçà]             │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé (ìåøî÷êè  │Ilsanta (Ëèòâà)               │007663,    

                                   │[B05CX01]                     │ïîëèïðîïèëåíîâûå) 5% - 250,                                 │22.07.96   

                                                                 │500, 1000 ìë                                                           

                                                                                                                                       

│Ãëþêîçà 5% [Äåêñòðîçà]             │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé          │Laboratoires Aguettant        │007122,    

                                   │[B05CX01]                     │(ôëàêîíû) 5%; ðàñòâîð äëÿ     │(Ôðàíöèÿ)                     │04.03.96   

                                                                 │èíúåêöèé (ïàêåòû                                                       

                                                                 │ïîëèõëîðâèíèëîâûå) 5%                                                  

                                                                                                                                        

│Ãëþêîçà äëÿ âíóòðèâåííîãî âëèâàíèÿ │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð (áóòûëè               │Gulf Inject L.L.C.            │007476,    

│50 ã/ë [Äåêñòðîçà]                 │[B05CX01]                     │ïîëèýòèëåíîâûå) 50 ã/ë - 500  │(Îáúåäèíåííûå Àðàáñêèå        │26.04.96   

                                                                 │ìë                            │Ýìèðàòû)                                 

                                                                                                                                        

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 10%   │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Íåñâèæñêèé çàâîä              │74/500/5,  

│[Äåêñòðîçà]                        │[B05CX01]                     │äëÿ êðîâåçàìåíèòåëåé) 10% -   │ìåäïðåïàðàòîâ (Áåëàðóñü)      │26.01.98   

                                                                 │200, 400 ìë                                                             

                                                                                                                                        

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 10%   │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │74/500/5,  

│[Äåêñòðîçà]                        │[B05CX01]                     │äëÿ êðîâåçàìåíèòåëåé) 10% -                                 │09.04.98   

                                                                 │400 ìë                                                                 

                                                                                                                                        

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 40%   │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áîðèñîâñêèé çàâîä             │70/367/32, 

│[Äåêñòðîçà]                        │[B05CX01]                     │40% - 5 ìë                    │ìåäïðåïàðàòîâ (Áåëàðóñü)      │18.11.97   

                                                                                                                                        

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 5%    │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Íåñâèæñêèé çàâîä              │70/528/6,  

│[Äåêñòðîçà]                        │[B05CX01]                     │äëÿ êðîâåçàìåíèòåëåé) 5% -    │ìåäïðåïàðàòîâ (Áåëàðóñü)      │26.01.98   

                                                                 │200, 400 ìë                                                            

                                                                                                                                        

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 5%    │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Êîíîòîïìÿñî ÀÎ (Óêðàèíà)      │70/528/6,  

│[Äåêñòðîçà]                        │[B05CX01]                     │äëÿ êðîâåçàìåíèòåëåé) 5% -                                  │17.09.98   

                                                                 │200, 400 ìë                                                            

                                                                                                                                         

│Ãëþêîçû ðàñòâîð äëÿ èíúåêöèé 5%    │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/528/6,  

│[Äåêñòðîçà]                        │[B05CX01]                     │äëÿ êðîâåçàìåíèòåëåé) 5% -                                 │09.04.98   

                                                                 │400 ìë                                                                 

                                                                                                                                        

│Ãëþêîçû òàáëåòêè [Äåêñòðîçà]       │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │òàáëåòêè 0.5, 1 ã             │Áîðèñîâñêèé çàâîä             │70/367/39, 

                                   │[B05CX01]                                                   │ìåäïðåïàðàòîâ (Áåëàðóñü)      │12.09.97   

                                                                                                                                        

│Ãëþêîìèä [Ãëèáåíêëàìèä]            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Arab Pharmaceutical           │003758,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │Manufacturing Co Ltd          │15.03.94   

                                                                                               │(Èîðäàíèÿ)                               

                                                                                                                                        

│Ãëþêîñòåðèë 10% [Äåêñòðîçà]        │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé 10%       │Fresenius (ÔÐÃ)               │002538,    

                                   │[B05CX01]                                                                                 │02.07.92   

                                                                                                                                        

│Ãëþêîñòåðèë 20% [Äåêñòðîçà]        │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé 20%       │Fresenius (ÔÐÃ)               │002538,    

                                   │[B05CX01]                                                                                 │02.07.92   

                                                                                                                                        

│Ãëþêîòðîë ÕË [Ãëèïèçèä]            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè ïîêðûòûå             │Pfizer Amboise (Ôðàíöèÿ)      │009365,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB07] │îñìîòè÷åñêîé îáîëî÷êîé 5, 10                                │08.04.97   

                                                                 │ìã                                                                     

                                                                                                                                        

│Ãëþêîôàã [Ìåòôîðìèí]               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 500, 850 ìã          │Laboratoires Aron (Ôðàíöèÿ)   │00372,     

                                   │ïåðîðàëüíîãî ïðèåìà [A10BA02] │                                                            │24.12.76,  

                                                                                                                            │09.12.93   

                                                                                                                                        

│Ãëþêîôàã [Ìåòôîðìèí]               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lipha Sante (Ôðàíöèÿ)         │009434,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BA02] │850 ìã                                                      │06.05.97   

                                                                                                                                        

│Ãëþðåíîðì [Ãëèêâèäîí]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 30 ìã                │Boehringer Ingelheim Ellas    │008497,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB08] │                              │a.E., a division of           │31.12.97   

                                                                                               │Boehringer Ingelheim                     

                                                                                               │International Gmbh (Ãðåöèÿ)              

                                                                                                                                        

│Ãíàäèîí [Áåêëîìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü íàçàëüíûé            │Pliva (Õîðâàòèÿ)              │00893,     

                                   │ìåñòíîãî ïðèìåíåíèÿ [R01AD01] │äîçèðîâàííûé 50 ìêã/äîçà                                    │19.01.82,  

                                                                 │(áàëëîíû) 200 äîç                                           │12.04.95   

                                                                                                                                        

│Ãîíàë-Ô [Ôîëëèòðîïèí-àëüôà]        │ôîëëèêóëîñòèìóëèðóþùåå        │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoires Serono Sa        │009839,    

                                   │ñðåäñòâî [G03GA05]            │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Øâåéöàðèÿ)                   │18.11.97   

                                                                │ðàñòâîðà (àìïóëû) 75, 150 ÌÅ                                           

                                                                 │/â êîìïëåêòå ñ ðàñòâîðèòåëåì                                           

                                                                 │- âîäà äëÿ èíúåêöèé (àìïóëû)/ │                                         

                                                                                                                                        

│Ãîíàë-Ô [Ôîëëèòðîïèí-àëüôà]        │ôîëëèêóëîñòèìóëèðóþùåå        │ëèîôèëèç.ïîðîøîê äëÿ          │Serono Pharma Spa (Èòàëèÿ)    │009838,    

                                   │ñðåäñòâî [G03GA05]            │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │18.11.97   

                                                                 │ðàñòâîðà (àìïóëû) 75, 150 ÌÅ                                           

                                                                 │/â êîìïëåêòå ñ ðàñòâîðèòåëåì                                           

                                                                 │- âîäà äëÿ èíúåêöèé (àìïóëû)/ │                                         

                                                                                                                                        

│Ãîíîôîðì [Àìîêñèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè ïîêðûòûå îáîëî÷êîé 1 │Ludwig Merckle Gmbh (Àâñòðèÿ) │003790,    

                                   │[J01CA04]                     │ã                                                           │28.03.94   

                                                                                                                                        

│Ãîïòåí [Òðàíäîëàïðèë]              │ÀÊÔ áëîêàòîð [C09AA10]        │êàïñóëû 0.5, 2 ìã             │Knoll Ag (Ãåðìàíèÿ)           │007580,    

                                                                                                                             │10.06.96   

                                                                                                                                         

│Ãîðàêîðò [Áóäåñîíèä]               │ãëþêîêîðòèêîñòåðîèä äëÿ       │àýðîçîëü äîçèðîâàííûé 160     │Instytut Farmaceutyczny       │006293,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [R03BA02] │ìêã/äîçà (ôëàêîíû) 200 äîç    │Warszawa (Ïîëüøà)             │17.07.95   

                                                                                                                                        

│Ãîðäîêñ [Àïðîòèíèí]                │ïðîòåîëèçà èíãèáèòîð [B02AB01]│ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2308,      

                                                                 │100000 ÊÈÅ - 10 ìë                                          │02.11.84,  

                                                                                                                             │22.12.72,  

                                                                                                                             │19.12.94   

                                                                                                                                        

│Ãîðïèëñ {àìèëìåòàêðåçîë 0.6 ìã,    │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè äëÿ ðàññàñûâàíèÿ ñ   │Gepach International (Èíäèÿ)  │010113,    

│äèõëîðáåíçèëîâûé ñïèðò 1.2 ìã}     │[R02AA20]                     │àïåëüñèíîâûì âêóñîì; òàáëåòêè │                              │11.03.98   

                                                                 │äëÿ ðàññàñûâàíèÿ ñ ëèìîííûì                                            

                                                                 │âêóñîì; òàáëåòêè äëÿ                                                   

                                                                 │ðàññàñûâàíèÿ ñ                                                         

                                                                 │ëèìîííî-ìåäîâûì âêóñîì;                                                

                                                                 │òàáëåòêè äëÿ ðàññàñûâàíèÿ ñ                                            

                                                                 │ìåíòîëîâî-ýâêàëèïòîâûì                                                  

                                                                 │âêóñîì; òàáëåòêè äëÿ                                                   

                                                                 │ðàññàñûâàíèÿ ñ îáûêíîâåííûì                                            

                                                                 │âêóñîì                                                                 

                                                                                                                                        

│Ãîð÷è÷íèêè                         │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ïîðîøîê (óïàêîâêè êîíòóðíûå   │Âåðò-Êîíòóð Êîìïàíèÿ Îîî      │010028,    

                                   │[M02AX]                       │èç ìàòåðèàëà íåòêàííîãî) 1.8 ã│(Ìîëäîâà)                     │28.04.98   

                                                                                                                                        

│Ãðàìóðèí [Îêñîëèíîâàÿ êèñëîòà]     │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │òàáëåòêè 250 ìã               │Chinoin (Âåíãðèÿ)             │008604,    

                                   │õèíîëîí [G04AB04]                                                                         │20.04.98   

                                                                                                                                        

│Ãðàíäàêñèí [Òîôèçîïàì]             │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 50 ìã                │Egis Sa (Âåíãðèÿ)             │008079,    

                                   │[N05BA23]                                                                                 │03.12.96   

                                                                                                                                        

│Ãðàíîöèò [Ëåíîãðàñòèì]             │ëåéêîïîýçà ñòèìóëÿòîð         │ëèîôèëèç.ïîðîøîê äëÿ          │Rhone-Poulenc Rorer (Ôðàíöèÿ) │007163,    

                                   │[L03AA10]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │22.03.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 13400000,                                            

                                                                 │33600000, 47000000 ÌÅ /â                                               

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                            

                                                                                                                                        

│Ãðèïïîñòàä {ïàðàöåòàìîë 600 ìã,    │àíàëüãåòè÷åñêîå               │ðàñòâîð äëÿ ïðèãîòîâëåíèÿ     │Stada Arzneimittel Ag         │005585,    

│àñêîðáèíîâàÿ êèñëîòà 50 ìã - 5 ã}  │íåíàðêîòè÷åñêîå ñðåäñòâî      │ðàñòâîðà äëÿ âíóòðåííåãî      │(Ãåðìàíèÿ)                    │20.12.94   

                                   │[N02BE51]                     │ïðèìåíåíèÿ                                                             

                                                                                                                                        

│Ãðèïïîñòàä Ñ {ïàðàöåòàìîë 200 ìã,  │àíàëüãåòè÷åñêîå               │êàïñóëû 375.5 ìã              │Stada Arzneimittel Ag         │005584,    

│àñêîðáèíîâàÿ êèñëîòà 150 ìã,       │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Ãåðìàíèÿ)                    │20.12.94   

│êîôåèí 25 ìã, õëîðôåíàìèí 2.5 ìã}  │[N02B]                                                                                               

                                                                                                                                        

│Ãðîïðèíîñèí [Èíîçèí Ïðàíîáåêñ]     │èììóíîñòèìóëèðóþùåå ñðåäñòâî  │òàáëåòêè 500 ìã               │Polfa, Grodziskie             │005951,    

                                   │[J05AX05]                                                   │Pharmaceutical Works (Ïîëüøà) │12.04.95   

                                                                                                                                        

│Ãðîñåïòîë [Êî-òðèìîêñàçîë]         │ïðîòèâîìèêðîáíîå              │òàáëåòêè 100 ìã/20 ìã, 400    │Grodziskie Mazovezkie (Ïîëüøà)│003642,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî      │ìã/80 ìã                                                    │26.01.94   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Ãðîôèáðàò [Ôåíîôèáðàò]             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî   │êàïñóëû 100 ìã                │Polfa, Grodziskie             │009278,    

                                   │[C10AB05]                                                   │Pharmaceutical Works (Ïîëüøà) │27.02.97   

                                                                                                                                        

│Ãðþíàìèöèí ñèðîï [Ýðèòðîìèöèí]     │àíòèáèîòèê, ìàêðîëèä [J01FA01]│ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Grunenthal Gmbh (Ãåðìàíèÿ)    │007508,    

                                                                 │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                │15.05.96   

                                                                │200 ìã|5 ìë - 60, 100 ìë                                               

                                                                                                                                        

│Ãðþíàìîêñ [Àìîêñèöèëëèí]           │àíòèáèîòèê, ïåíèöèëëèí        │òàáëåòêè ðàñòâîðèìûå 750,     │Grunenthal Gmbh (Ãåðìàíèÿ)    │005993,    

                                   │[J01CA04]                     │1000 ìã; ïîðîøîê äëÿ                                        │24.04.95   

                                                                 │ïðèãîòîâëåíèÿ îðàëüíîé                                                 

                                                                 │ñóñïåíçèè (ôëàêîíû) 250 ìã|5                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Ãóàðåì {õüþàðîâàÿ ñìîëà}           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │ìèêðîãðàíóëû äîçèðîâàííûå 5 ã │Orion Pharmaceutica           │01910,     

                                   │ïåðîðàëüíîãî ïðèåìà [A10BX01] │                              │(Ôèíëÿíäèÿ)                   │20.08.90   

                                                                                                                                        

│Ãóìáèêñ [Àìèíîìåòèëáåíçîéíàÿ       │ãåìîñòàòè÷åñêîå ñðåäñòâî      │òàáëåòêè 100 ìã; ðàñòâîð äëÿ  │Kali-Chemie Pharma Gmbh       │006840,    

│êèñëîòà]                           │[B02AA03]                     │èíúåêöèé (àìïóëû) 50 ìã - 5 ìë│(Ãåðìàíèÿ)                    │17.11.95   

                                                                                                                                        

│Ãóìåò-Ð {ãóìèíîâàÿ êèñëîòà 2.25 ã, │ìóëüòèìèíåðàë [A12]           │ñèðîï (ôëàêîíû) 120, 300 ìë   │Horizon-Multiplan Ltd         │010209,    

│ôèòîìåíàäèîí, ìàãíèé 450 ìã,                                                                   │(Âåíãðèÿ)                     │18.05.98   

│æåëåçî 420 ìã, öèíê 300 ìã,                                                                                                             

│ìàðãàíåö 90 ìã, ìåäü 60 ìã,                                                                                                             

│ìîëèáäåí 5.25 ìã, ñåëåí 3.75 ìã,                                                                                                        

│âàííàäèé 15 ìã, êîáàëüò 6 ìã}                                                                                                           

                                                                                                                                        

│Ãóìèçîëü {õààïñàëóñêîé ìîðñêîé     │áèîñòèìóëèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009256,    

│ëå÷åáíîé ãðÿçè ãóìèíîâûõ êèñëîò    │[A16A]                        │1, 2 ìë                       │çàâîä ÀÎ (Ýñòîíèÿ)            │29.12.97   

│ôðàêöèé ðàñòâîð 0.01%}                                                                                                                  

                                                                                                                                        

│Ãóòðîí [Ìèäîäðèí]                  │àëüôà-àäðåíîñòèìóëÿòîð        │òàáëåòêè 2.5, 5 ìã; êàïëè     │Hafslund Nycomed Pharma Ag    │002631,    

                                   │[C01CA17]                     │(ôëàêîíû) 1% - 10, 20, 25 ìë; │(Àâñòðèÿ)                     │18.09.92   

                                                                 │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                         

                                                                 │5 ìã - 2 ìë                                                            

                                                                                                                                        

│Ãóòòàëàêñ [Íàòðèÿ ïèêîñóëüôàò]     │ñëàáèòåëüíîå ñðåäñòâî         │êàïëè (ôëàêîíû) 7.5 ìã/ìë -   │Boehringer Ingelheim Italy    │002828,    

                                   │[A06AB58]                     │15, 30 ìë                     │Spa, a division of Boehringer │08.02.93,  

                                                                                               │Ingelheim International Gmbh  │22.04.98   

                                                                                               │(Èòàëèÿ)                                 

                                                                                                                                        

│Äàéâîíåêñ [Êàëüöèïîòðèîë]          │ïðîòèâîïñîðèàòè÷åñêîå         │ìàçü 50 ìêã/ã                 │Leo Pharmaceutical Products   │003456,    

                                   │ñðåäñòâî [D05AX02]                                          │(Äàíèÿ)                       │25.10.93   

                                                                                                                                        

│Äàéäæèí {ìàãíèÿ ãèäðîêñèä 25 ìã,   │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè æåâàòåëüíûå ñ        │Boots Pharmaceuticals Ltd     │007782,    

│àëãåëäðàò 300 ìã,                                                │àðîìàòîì ìÿòû; òàáëåòêè       │(Èíäèÿ)                       │04.09.96   

│ïîëèäèìåòèëñèëîêñàí 25 ìã, ìàãíèÿ                                │æåâàòåëüíûå ñ àðîìàòîì                                                 

│àëþìîñèëèêàò 50 ìã}                                              │àïåëüñèíà; òàáëåòêè                                                    

                                                                 │æåâàòåëüíûå ñ àðîìàòîì                                                 

                                                                 │ôðóêòîâûì ñìåøàííûì; ãåëü ñ                                            

                                                                 │àðîìàòîì ìÿòû; ãåëü ñ                                                  

                                                                 │àðîìàòîì àïåëüñèíà; ãåëü ñ                                             

                                                                 │àðîìàòîì ôðóêòîâûì ñìåøàííûì                                           

                                                                                                                                         

│Äàéäæèí {ìàãíèÿ ãèäðîêñèä 25 ìã,   │àíòàöèäíîå ñðåäñòâî [A02AX]   │òàáëåòêè æåâàòåëüíûå ñ        │Knoll Pharmaceuticals Limited │009441,    

│àëãåëäðàò 300 ìã,                                                │àðîìàòîì ìÿòû; òàáëåòêè       │(Èíäèÿ)                       │13.05.97   

│ïîëèäèìåòèëñèëîêñàí 25 ìã, ìàãíèÿ                                │æåâàòåëüíûå ñ àðîìàòîì                                                 

│àëþìîñèëèêàò 50 ìã - òàáëåòêè;                                   │àïåëüñèíà; òàáëåòêè                                                    

│ìàãíèÿ ãèäðîêñèä 185 ìã, àëãåëäðàò │                              │æåâàòåëüíûå ñ àðîìàòîì                                                 

│830 ìã, ïîëèäèìåòèëñèëîêñàí 50 ìã, │                              │ôðóêòîâûì ñìåøàííûì; ãåëü ñ                                            

│êàðáîêñèìåòèëöåëëþëîçà 100 ìã - 10 │                              │àðîìàòîì ìÿòû (ôëàêîíû) 170                                            

│ìë}                                                              │ìë; ãåëü ñ àðîìàòîì àïåëüñèíà │                                         

                                                                 │(ôëàêîíû) 170 ìë; ãåëü ñ                                               

                                                                 │àðîìàòîì ôðóêòîâûì ñìåøàííûì                                           

                                                                 │(ôëàêîíû) 170 ìë                                                       

                                                                                                                                        

│Äàéíàôåä ÅÕ [Ïàðàöåòàìîë]          │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Bdi Pharmaceuticals (ÑØÀ)     │006226,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │21.07.95   

                                   │[N02BE01]                                                                                            

                                                                                                                                         

│Äàéíàôåä ïëþñ {ïàðàöåòàìîë 500 ìã, │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè                      │Bdi Pharmaceuticals (ÑØÀ)     │006308,    

│ïñåâäîýôåäðèí 30 ìã}               │ÎÐÇ è ïðîñòóäû [R01BA52]                                                                 │21.07.95   

                                                                                                                                        

│Äàéíàôåä þíèîð [Ïàðàöåòàìîë]       │àíàëüãåòè÷åñêîå               │òàáëåòêè æåâàòåëüíûå äëÿ      │Bdi Pharmaceuticals (ÑØÀ)     │006307,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │äåòåé 80 ìã                                                 │21.07.95   

                                   │[N02BE01]                                                                                            

                                                                                                                                        

│Äàêàðáàçèí [Äàêàðáàçèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Tissen Laboratories,          │006220,    

                                   │[L01AX04]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Bio-Therabel (Áåëüãèÿ)        │26.06.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 100, 200 ìã│                                         

                                                                                                                                        

│Äàêàðáàçèí Ëàõåìà [Äàêàðáàçèí]     │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ èíúåêöèé │Lachema As (×åøñêàÿ           │008667,    

                                   │[L01AX04]                     │(ôëàêîíû) 100, 200 ìã         │Ðåñïóáëèêà)                   │03.08.98   

                                                                                                                                        

│Äàêðîëþêñ [Ãèïðîìåëëîçà]           │îôòàëüìîëîãè÷åñêîå ñðåäñòâî   │êàïëè ãëàçíûå                 │Laboratorious Cusi (Èñïàíèÿ)  │005071,    

                                   │[S01KA02]                                                                                 │01.07.94   

                                                                                                                                        

│Äàêñèí [Äåêñàìåòàçîí]              │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Wave International (Èíäèÿ)    │003544,    

                                                                 │èíúåêöèé (àìïóëû) 4 ìã - 1 ìë │                              │06.12.93   

                                                                                                                                        

│Äàêòàíîë [Ìèêîíàçîë]               │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì (òóáû) 2 ã|100 ã - 30 ã  │ICN Galenika (Þãîñëàâèÿ)      │009343,    

                                   │[D01AC02]                                                                                 │26.03.97   

                                                                                                                                        

│Äàêòàðèí [Ìèêîíàçîë]               │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ãåëü (òóáû) 20 ìã/ã           │Janssen Pharmaceutica         │007057,    

                                   │[D01AC02]                                                   │(Áåëüãèÿ)                     │07.02.96   

                                                                                                                                        

│Äàêòàðèí [Ìèêîíàçîë]               │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì (òóáû) 20 ìã/ã - 15, 30 ã│Janssen Pharmaceutica         │008630,    

                                   │[D01AC02]                                                   │(Áåëüãèÿ)                     │28.05.98   

                                                                                                                                        

│Äàêòîöèí {ìèêîíàçîë 2.5 ìã, öèíêà  │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ìàçü (òóáû)                   │Janssen Pharmaceutica         │006678,    

│îêñèä 150 ìã - 1 ã}                │[D01AE20]                                                   │(Áåëüãèÿ)                     │29.09.95   

                                                                                                                                        

│Äàëàöèí [Êëèíäàìèöèí]              │àíòèáèîòèê, ëèíêîçàìèä        │êðåì âàãèíàëüíûé 2%           │Upjohn (ÑØÀ)                  │003618,    

                                   │[G01AA10]                                                                                 │24.12.93   

                                                                                                                                        

│Äàëàöèí Ò [Êëèíäàìèöèí]            │àíòèáèîòèê, ëèíêîçàìèä        │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Upjohn Company (ÑØÀ)          │005447,    

                                   │[D10AF01]                     │1%                                                          │01.11.94   

                                                                                                                                        

│Äàëàöèí Ö [Êëèíäàìèöèí]            │àíòèáèîòèê, ëèíêîçàìèä        │êàïñóëû 150 ìã                │Eczacibasi Ilac Sanayi        │008523,    

                                  │[J01FF01]                                                   │(Òóðöèÿ)                      │10.03.98   

                                                                                                                                        

│Äàëàöèí Ö [Êëèíäàìèöèí]            │àíòèáèîòèê, ëèíêîçàìèä        │êàïñóëû 75, 150, 300 ìã;      │Upjohn (Áåëüãèÿ)              │002316,    

                                   │[J01FF01]                     │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ                                   │10.01.92   

                                                                 │ñèðîïà àðîìàòèçèðîâàííûå 75                                            

                                                                 │ìã|5 ìë                                                                

                                                                                                                                        

│Äàëàöèí Ö ôîñôàò [Êëèíäàìèöèí]     │àíòèáèîòèê, ëèíêîçàìèä        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Eczacibasi (Òóðöèÿ)           │01855,     

                                   │[J01FF01]                     │150 ìã/ìë - 2 ìë                                            │31.05.90   

                                                                                                                                        

│Äàëàöèí Ö ôîñôàò [Êëèíäàìèöèí]     │àíòèáèîòèê, ëèíêîçàìèä        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Upjohn (Áåëüãèÿ)              │008052,    

                                   │[J01FF01]                     │150 ìã/ìë - 2, 4, 6 ìë                                      │22.11.96   

                                                                                                                                        

│Äàëàöèí Ö ôîñôàò [Êëèíäàìèöèí]     │àíòèáèîòèê, ëèíêîçàìèä        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Upjohn Company (Èíäîíåçèÿ)    │005572,    

                                   │[J01FF01]                     │150 ìã/ìë                                                   │15.12.94   

                                                                                                                                         

│Äàëüôàç [Àëüôóçîçèí]               │àëüôà-àäðåíîáëîêàòîð [G04CA01]│òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Synthelabo       │007414,    

                                                                 │2.5 ìã; òàáëåòêè ïîêðûòûå     │(Ôðàíöèÿ)                     │05.04.96   

                                                                 │îáîëî÷êîé ðåòàðä 5 ìã                                                  

                                                                                                                                       

│Äàíåìîêñ [Àìîêñèöèëëèí]            │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250, 500 ìã           │Sol Pharmaceuticals Ltd       │003603,    

                                   │[J01CA04]                                                   │(Èíäèÿ)                       │17.12.93   

                                                                                                                                        

│Äàíèñòîë [Âåðàïàìèë]               │ÁÌÊÊ [C08DA01]                │êàïñóëû 120, 180, 240 ìã      │Ethypharm (Ôðàíöèÿ)           │007501,    

                                                                                                                             │14.05.96   

                                                                                                                                        

│Äàíîâàë [Äàíàçîë]                  │ïðîòèâîãîíàäîòðîïíîå ñðåäñòâî │êàïñóëû 100, 200 ìã           │Krka (Ñëîâåíèÿ)               │007306,    

                                   │[G03XA01]                                                                                 │10.09.96   

                                                                                                                                        

│Äàíîãåí [Äàíàçîë]                  │ïðîòèâîãîíàäîòðîïíîå ñðåäñòâî │êàïñóëû 200 ìã                │Cipla Limited (Èíäèÿ)         │008550,    

                                   │[G03XA01]                                                                                 │08.06.98   

                                                                                                                                         

│Äàíîäèîë [Äàíàçîë]                 │ïðîòèâîãîíàäîòðîïíîå ñðåäñòâî │êàïñóëû 200 ìã                │Remedica Ltd - Minnex (Êèïð)  │009769,    

                                   │[G03XA01]                                                                                 │06.10.97   

                                                                                                                                        

│Äàíîë [Äàíàçîë]                    │ïðîòèâîãîíàäîòðîïíîå ñðåäñòâî │êàïñóëû 100, 200 ìã           │Sanofi-Winthrop               │008083,    

                                   │[G03XA01]                                                   │(Âåëèêîáðèòàíèÿ)              │17.12.96   

                                                                                                                                        

│Äàîíèë [Ãëèáåíêëàìèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè                      │Hoechst (ÔÐÃ)                 │00236,     

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │28.12.72,  

                                                                                                                             │20.12.83   

                                                                                                                                        

│Äàîíèë [Ãëèáåíêëàìèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Hoechst Marion Roussel Ltd    │008281,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │(Èíäèÿ)                       │22.05.97   

                                                                                                                                        

│Äàïðèë [Ëèçèíîïðèë]                │ÀÊÔ áëîêàòîð [C09AA03]        │òàáëåòêè 5, 10, 20 ìã         │Medochemie Ltd (Êèïð)         │003878,    

                                                                                                                             │26.04.94   

                                                                                                                                         

│Äàïðîêñ ýíòåðî [Íàïðîêñåí]         │ÍÏÂÑ [M01AE02]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Nycomed Dak As (Äàíèÿ)        │003364,    

                                                                 │îáîëî÷êîé 500 ìã                                           │28.09.93   

                                                                                                                                        

│Äàðàïðèì [Ïèðèìåòàìèí]             │ïðîòèâîìàëÿðèéíîå ñðåäñòâî    │òàáëåòêè 25 ìã                │Wellcome Foundation Ltd       │002508,    

                                   │[P01BD01]                                                   │(Âåëèêîáðèòàíèÿ)              │09.06.92   

                                                                                                                                        

│Äàðâàë {êîôåèí 25 ìã, ïàðàöåòàìîë  │àíàëüãåòè÷åñêîå               │òàáëåòêè                      │Eczacibasi (Òóðöèÿ)           │003381,    

│325 ìã}                            │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │06.10.93   

                                   │[N02BE71]                                                                                            

                                                                                                                                        

│Äàðäóì [Öåôîïåðàçîí]               │àíòèáèîòèê, öåôàëîñïîðèí      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lisapharma (Èòàëèÿ)           │003264,    

                                   │[J01DA32]                     │èíúåêöèîííîãî ðàñòâîðà                                      │24.08.93   

                                                                 │(ôëàêîíû) 1 ã /â êîìïëåêòå ñ                                           

                                                                 │ðàñòâîðèòåëåì/                                                         

                                                                                                                                        

│Äàðîá [Ñîòàëîë]                    │áåòà-àäðåíîáëîêàòîð [C07AA07] │òàáëåòêè 80, 160 ìã; ðàñòâîð  │Knoll Ag (Ãåðìàíèÿ)           │007579,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 40 ìã - │                              │10.06.96   

                                                                 │4 ìë                                                                   

                                                                                                                                        

│Äàóíîçîì [Äàóíîðóáèöèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð êîíöåíòðèðîâàííûé äëÿ │Nexstar Pharmaceuticals       │008704,    

                                   │[L01DB02]                     │èíôóçèé (ôëàêîíû) 50 ìã - 25  │International Ltd             │26.08.98   

                                                                 │ìë                            │(Âåëèêîáðèòàíèÿ)                         

                                                                                                                                        

│Äàôíåäæèí [Öèêëîïèðîêñ]            │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êðåì 1%; ðàñòâîð äëÿ          │Poli Industria Chimica Spa    │006951,    

                                   │[D01AE14] [G01AX12]           │íàðóæíîãî ïðèìåíåíèÿ 2%;      │(Èòàëèÿ)                      │28.12.95   

                                                                 │ñâå÷è âàãèíàëüíûå 50, 100 ìã                                           

                                                                                                                                        

│ÄÃ-Ýðãîòàìèí [Äèãèäðîýðãîòàìèí]    │àëüôà-àäðåíîáëîêàòîð [N02CA01]│êàïëè äëÿ ïðèåìà âíóòðü       │Galena a/S (×åõèÿ)            │007348,    

                                                                 │(ôëàêîíû) 2 ìã/ìë - 10 ìë                                   │09.10.96   

                                                                                                                                        

│ÄÃ-Ýðãîòîêñèí [Äèãèäðîýðãîòîêñèí]  │àëüôà-àäðåíîáëîêàòîð [C04AE]  │êàïëè äëÿ ïðèåìà âíóòðü       │Galena a/S (×åõèÿ)            │007347,    

                                                                 │(ôëàêîíû) 1 ìã/ìë - 10, 25 ìë │                              │08.10.96   

                                                                                                                                        

│Äåáðèäàò [Òðèìåáóòèí]              │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratoires Jouveinal        │006094,    

                                   │[A03AA05]                     │îðàëüíîé ñóñïåíçèè (ôëàêîíû)  │(Ôðàíöèÿ)                     │24.05.95   

                                                                 │1.2 ã - 250 ìë                                                         

                                                                                                                                        

│Äåáðèäàò [Òðèìåáóòèí]              │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 100 ìã               │Laboratoires Jouveinal        │005991,    

                                   │[A03AA05]                                                   │(Ôðàíöèÿ)                     │24.04.95   

                                                                                                                                       

│Äåâàëæèí [Ìåòàìèçîë íàòðèÿ]        │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Deva Holding As (Òóðöèÿ)      │002857,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî      │èíúåêöèé (àìïóëû) 1 ã - 2 ìë                                │18.02.93   

                                   │[N02BB02]                                                                                            

                                                                                                                                        

│Äåãåñò {ôåíèëïðîïàíîëàìèí 25 ìã,   │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │òàáëåòêè 25 ìã/325 ìã         │Eczacibasi (Òóðöèÿ)           │005230,    

│ïàðàöåòàìîë 325 ìã}                │ÎÐÇ è ïðîñòóäû [N02B]                                                                     │17.08.94   

                                                                                                                                        

│Äåçóðèê [Áåíçáðîìàðîí]             │ïðîòèâîïîäàãðè÷åñêîå ñðåäñòâî │òàáëåòêè 100 ìã               │Sanofi-Winthrop (Ôðàíöèÿ)     │008124,    

                                   │[M04AB03]                                                                                 │20.01.97   

                                                                                                                                        

│Äåêàäðîí [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Merck Sharp & Dohme           │005412,    

                                                                 │èíúåêöèé (àìïóëû) 4 ìã/ìë     │(Íèäåðëàíäû)                  │19.10.94   

                                                                                                                                        

│Äåêà-äóðàáîëèí [Íàíäðîëîí]         │àíàáîëè÷åñêîå ñòåðîèäíîå      │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │N.V.Organon (Íèäåðëàíäû)      │00164,     

                                   │ñðåäñòâî [A14AB01]            │(àìïóëû) 25 ìã/1 ìë, 50 ìã/1                                │14.07.71,  

                                                                 │ìë                                                          │31.03.83,  

                                                                                                                             │09.06.94   

                                                                                                                                        

│Äåêàìåòîêñèíà ðàñòâîð 0.02%        │àíòèñåïòè÷åñêîå ñðåäñòâî      │êàïëè ãëàçíûå (ôëàêîíû) 0.02% │Âèííèöêèé ìåäèíñòèòóò         │93/59/5,   

│(ãëàçíûå êàïëè) [Äåêàìåòîêñèí]     │[S01A]                        │- 5, 10 ìë                    │(Óêðàèíà)                     │01.04.93   

                                                                                                                                        

│Äåêàìåòîêñèíà ðàñòâîð ñïèðòîâîé    │àíòèñåïòè÷åñêîå ñðåäñòâî      │êàïëè óøíûå (ôëàêîíû) 0.05% - │Âèííèöêèé ìåäèíñòèòóò         │93/59/6,   

│0.05% [Äåêàìåòîêñèí]               │[S02AA]                       │5, 10 ìë                      │(Óêðàèíà)                     │01.04.93   

                                                                                                                                        

│Äåêàïåí [Àìïèöèëëèí]               │àíòèáèîòèê, ïåíèöèëëèí        │êàïñóëû 250 ìã; ïîðîøîê äëÿ   │Beximco Pharmaceuticals Ltd   │005076,    

                                   │[J01CA01]                     │ïðèãîòîâëåíèÿ îðàëüíîé        │(Áàíãëàäåø)                   │04.07.94   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                           

                                                                 │ìë                                                                     

                                                                                                                                        

│Äåêàïåïòèë [Òðèïòîðåëèí]           │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé          │Ferring Arzneimittel Gmbh     │007323,    

                                   │[L02AE04]                     │(øïðèö-àìïóëû îäíîðàçîâûå)    │(ÔÐÃ)                         │30.09.96   

                                                                 │0.1 ìã/ìë, 0.5 ìã/ìë                                                   

                                                                                                                                        

│Äåêàïåïòèë äåïî [Òðèïòîðåëèí]      │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ìèêðîêàïñóëû (øïðèö           │Ferring Arzneimittel Gmbh     │008612,    

                                   │[L02AE04]                     │îäíîðàçîâûé) 3.75 ìã - 172 ìã │(Ãåðìàíèÿ)                    │28.04.98   

                                                                 │/â êîìïëåêòå ñ ñóñïåíçèðóþùèì │                                         

                                                                 │âåùåñòâîì (øïðèö îäíîðàçîâûé) │                                         

                                                                 │1 ìë, ñîåäèíèòåëüíûé ýëåìåíò, │                                         

                                                                 │èãëû äëÿ èíúåêöèé/                                                     

                                                                                                                                        

│Äåêàðèñ [Ëåâàìèçîë]                │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 150 ìã               │Gedeon Richter (Âåíãðèÿ)      │007291,    

                                   │[P02CE01]                                                                                 │15.08.96   

                                                                                                                                        

│Äåêàðèñ [Ëåâàìèçîë]                │ïðîòèâîãåëüìèíòíîå ñðåäñòâî   │òàáëåòêè 50 ìã                │Gedeon Richter (Âåíãðèÿ)      │006653,    

                                   │[P02CE01]                                                                                 │29.02.96   

                                                                                                                                        

│Äåêäàí [Äåêñàìåòàçîí]              │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Merind Ltd (Èíäèÿ)            │005286,    

                                                                 │èíúåêöèé (ôëàêîíû) 4 ìã/ìë                                  │01.09.94   

                                                                                                                                       

│Äåêîðòèí Í20 [Ïðåäíèçîëîí]         │ãëþêîêîðòèêîñòåðîèä [H02AB06] │òàáëåòêè 20 ìã                │Merck (Ãåðìàíèÿ)              │003552,    

                                                                                                                             │07.12.93   

                                                                                                                                        

│Äåêîðòèí Í5 [Ïðåäíèçîëîí]          │ãëþêîêîðòèêîñòåðîèä [H02AB06] │òàáëåòêè 5 ìã                 │Merck (Ãåðìàíèÿ)              │003552,    

                                                                                                                             │07.12.93   

                                                                                                                                        

│Äåêîðòèí Í50 [Ïðåäíèçîëîí]         │ãëþêîêîðòèêîñòåðîèä [H02AB06] │òàáëåòêè 50 ìã                │Merck (Ãåðìàíèÿ)              │003552,    

                                                                                                                             │07.12.93   

                                                                                                                                        

│Äåêîñåïò                           │àíòèñåïòè÷åñêîå êîæíîå        │æèäêîñòü                      │Borer Chemie Ag (Øâåéöàðèÿ)   │0026-10,   

                                   │ñðåäñòâî [D08AX]                                                                          │20.10.95   

                                                                                                                                        

│Äåêñà-Àëëâîðàí [Äåêñàìåòàçîí]      │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Tad Pharmazeutisches Werk     │006277,    

                                                                 │4 ìã/ìë                       │Gmbh (Ãåðìàíèÿ)               │12.07.95   

                                                                                                                                        

│Äåêñàáåíå [Äåêñàìåòàçîí]           │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ludwig Merckle Gmbh (Àâñòðèÿ) │005019,    

                                                                 │4 ìã, 8 ìã                                                  │20.06.94   

                                                                                                                                        

│Äåêñàâåí [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Jelfa Pharmaceutical Works Sa │006524,    

                                                                 │4 ìã/1 ìë, 8 ìã/2 ìë          │(Ïîëüøà)                      │20.09.95   

                                                                                                                                        

│Äåêñà-Ãåíòàìèöèí {äåêñàìåòàçîí 1   │ãëþêîêîðòèêîñòåðîèä           │êàïëè ãëàçíûå (ôëàêîíû) 5 ìë; │Ursapharm Arzneimittel Gmbh   │009390,    

│ìã, ãåíòàìèöèí 5 ìã}               │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │ìàçü ãëàçíàÿ (òóáû) 2.5 ã     │(Ãåðìàíèÿ)                    │18.04.97   

                                   │[D07CB04]                                                                                            

                                                                                                                                        

│Äåêñàçîí [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │ICN Galenika (Þãîñëàâèÿ)      │007329,    

                                                                 │èíúåêöèé (àìïóëû) 4 ìã/ìë                                   │27.09.96   

                                                                                                                                        

│Äåêñàêâà [Äåêñòðîçà]               │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Beximco Infusions (Áàíãëàäåø) │005329,    

                                   │[B05CX01]                                                                                 │19.09.94   

                                                                                                                                        

│Äåêñàêîðò [Äåêñàìåòàçîí]           │ãëþêîêîðòèêîñòåðîèä [S01BA01] │êàïëè ãëàçíûå è óøíûå         │Darou Paksh Pharmaceutical    │006729,    

                                                                 │(ôëàêîíû) 0.1% - 5 ìë         │Company (Èðàí)                │19.10.95   

                                                                                                                                        

│Äåêñàìåä [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5, 1.5 ìã; ðàñòâîð │Medochemie Ltd (Êèïð)         │010181,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 8 ìã|2                                │27.04.98   

                                                                 │ìë - 1, 2, 5 ìë                                                        

                                                                                                                                       

│Äåêñàìåòàçîí Õàôñëóíä Íèêîìåä      │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hafslund Nycomed Pharma Ag    │003321,    

│[Äåêñàìåòàçîí]                                                   │4 ìã - 1 ìë                   │(Àâñòðèÿ)                     │10.09.93   

                                                                                                                                        

│Äåêñàìåòàçîí [Äåêñàìåòàçîí]        │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã               │General Drug House (Òàéëàíä)  │005589,    

                                                                                                                             │20.12.94   

                                                                                                                                        

│Äåêñàìåòàçîí [Äåêñàìåòàçîí]        │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Krka (Ñëîâåíèÿ)               │00105,     

                                                                 │èíúåêöèé (àìïóëû) 4 ìã - 1 ìë │                              │28.12.72,  

                                                                                                                             │07.05.84,  

                                                                                                                             │01.12.94   

                                                                                                                                        

│Äåêñàìåòàçîí [Äåêñàìåòàçîí]        │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã               │Orion Corporation (Ôèíëÿíäèÿ) │008501,    

                                                                                                                             │23.01.98   

                                                                                                                                        

│Äåêñàìåòàçîí [Äåêñàìåòàçîí]        │ãëþêîêîðòèêîñòåðîèä [S01BA01] │ñóñïåíçèÿ ãëàçíàÿ (ôëàêîíû)   │Polfa, Warsaw Pharmaceutical  │008073,    

                                                                 │0.1% - 10 ìë                  │Works Sa (Ïîëüøà)             │26.11.96   

                                                                                                                                        

│Äåêñàìåòàçîí [Äåêñàìåòàçîí]        │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã               │Sanavita Gesundcheitsmittel & │006752,    

                                                                                              │Co Kg (Ãåðìàíèÿ)              │27.10.95   

                                                                                                                                        

│Äåêñàìåòàçîí ôîñôàò [Äåêñàìåòàçîí] │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Weimer Pharma Gmbh (Ãåðìàíèÿ) │005164,    

                                                                 │4 ìã/ìë                                                     │21.07.94   

                                                                                                                                        

│Äåêñàìåòàçîíà íàòðèÿ ôîñôàò        │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rotexmedica Osoo (Ãåðìàíèÿ)   │005500,    

│[Äåêñàìåòàçîí]                                                   │5 ìã/ìë                                                     │15.11.94   

                                                                                                                                        

│Äåêñàìåòàçîíà òàáëåòêè 0.0005 ã    │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã               │Îïûòíûé çàâîä ÃÍÖËÑ (Óêðàèíà) │70/421/6,  

│[Äåêñàìåòàçîí]                                                                                                               │16.07.98   

                                                                                                                                        

│Äåêñàïîñ [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [S01BA01] │êàïëè ãëàçíûå (ôëàêîíû) 0.1%  │Ursapharm Arzneimittel Gmbh   │009391,    

                                                                 │- 5 ìë                        │(Ãåðìàíèÿ)                    │18.04.97   

                                                                                                                                        

│Äåêñàôàð [Äåêñàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Faran Laboratories Sa (Ãðåöèÿ)│003303,    

                                                                 │4 ìã - 1 ìë                                                 │06.09.93   

                                                                                                                                        

│Äåêñîíà [Äåêñàìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä [H02AB02] │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Cadila Healthcare Pvt Ltd     │007273,    

                                                                 │èíúåêöèé (ôëàêîíû) 4 ìã - 2 ìë│(Èíäèÿ)                       │06.08.96   

                                                                                                                                        

│Äåêñîíà {äåêñàìåòàçîí 0.1%,        │ãëþêîêîðòèêîñòåðîèä           │êàïëè äëÿ ìåñòíîãî ïðèìåíåíèÿ │Cadila Healthcare Pvt Ltd     │007309,    

│íåîìèöèí 0.5%}                     │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │(ôëàêîíû) 2.5, 5 ìë           │(Èíäèÿ)                       │12.09.96   

                                   │[S01CA01]                                                                                            

                                                                                                                                        

│Äåêñîðèä [Äåêñòðîçà]               │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Beximco Infusions (Áàíãëàäåø) │005331,    

                                   │[B05CX01]                                                                                 │19.09.94   

                                                                                                                                        

│Äåêñòðîçà [Äåêñòðîçà]              │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé 5%, 10%,  │Core Parenterals Ltd (Èíäèÿ)  │005043,    

                                   │[B05CX01]                     │20%                                                         │24.06.94   

                                                                                                                                        

│Äåêñòðîçà [Äåêñòðîçà]              │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé âîäíûé    │Promed Exports Pvt Ltd (Èíäèÿ)│009449,    

                                   │[B05CX01]                     │(ôëàêîíû ïëàñòèêîâûå) 5%,                                   │14.05.97   

                                                                 │10%, 20% - 500 ìë; ðàñòâîð                                             

                                                                 │äëÿ âíóòðèâåííûõ èíôóçèé â                                             

                                                                 │ðàñòâîðå íàòðèÿ õëîðèäà 0.9%                                           

                                                                 │(ôëàêîíû ïëàñòèêîâûå) 5% -                                             

                                                                 │500 ìë                                                                 

                                                                                                                                        

│Äåêñòðîçà 10% [Äåêñòðîçà]          │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé 10%      │Wockhardt Ltd (Èíäèÿ)         │002664,    

                                   │[B05CX01]                                                                                 │13.10.92   

                                                                                                                                        

│Äåêñòðîçà 20% [Äåêñòðîçà]          │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé 20%      │Wockhardt Ltd (Èíäèÿ)         │002664,    

                                   │[B05CX01]                                                                                 │13.10.92   

                                                                                                                                        

│Äåêñòðîçà 5% [Äåêñòðîçà]           │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Ahlcon Parenterals (India)    │009569,    

                                   │[B05CX01]                     │5% - 500 ìë                   │Limited (Èíäèÿ)               │03.07.97   

                                                                                                                                        

│Äåêñòðîçà 5% [Äåêñòðîçà]           │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ èíúåêöèé 5%       │Wockhardt Ltd (Èíäèÿ)         │002664,    

                                   │[B05CX01]                                                                                 │13.10.92   

                                                                                                                                        

│Äåêñòðîçà 5% ñ 0.9% íàòðèÿ õëîðèäà │ñðåäñòâî óãëåâîäíîãî ïèòàíèÿ  │ðàñòâîð äëÿ âíóòðèâåííûõ      │Core Parenterals Ltd (Èíäèÿ)  │007109,    

│[Äåêñòðîçà]                        │[B05CX01]                     │èíúåêöèé 5% (ôëàêîíû) 500,                                  │27.02.96   

                                                                │1000 ìë /ñ íàòðèÿ õëîðèäîì                                             

                                                                 │0.9%/                                                                  

                                                                                                                                        

│Äåëàãèë [Õëîðîõèí]                 │ïðîòèâîìàëÿðèéíîå ñðåäñòâî    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Egis (Âåíãðèÿ)                │2030,      

                                   │[P01BA01]                     │250 ìã - 5 ìë                                               │01.07.70,  

                                                                                                                             │03.05.84,  

                                                                                                                             │13.07.95   

                                                                                                                                        

│Äåëàãèë [Õëîðîõèí]                 │ïðîòèâîìàëÿðèéíîå ñðåäñòâî    │òàáëåòêè 250 ìã               │ICN Alkaloida (Âåíãðèÿ)       │008487,    

                                   │[P01BA01]                                                                                 │08.01.98   

                                                                                                                                        

│Äåëôèêîðò [Òðèàìöèíîëîí]           │ãëþêîêîðòèêîñòåðîèä [H02AB08] │òàáëåòêè 4 ìã                 │Lederle (ÑØÀ)                 │003660,    

                                                                                                                             │01.02.94   

                                                                                                                                        

│Äåìåïðàçîë [Îìåïðàçîë]             │ïðîòèâîÿçâåííîå ñðåäñòâî,     │êàïñóëû 20 ìã                 │Deva Holding As (Òóðöèÿ)      │009668,    

                                   │ïðîòîííîãî íàñîñà èíãèáèòîð                                                               │12.08.97   

                                  │[A02BC01]                                                                                            

                                                                                                                                        

│Äåìèíîôåí [Ïàðàöåòàìîë]            │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Deva Holding As (Òóðöèÿ)      │003199,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │05.08.93   

                                   │[N02BE01]                                                                                            

                                                                                                                                        

│Äåìóëåí 1/35 {ýòèíîäèîë 1 ìã,      │êîíòðàöåïòèâíîå ñðåäñòâî      │òàáëåòêè 1 ìã/35 ìêã          │Searle and Co (ÑØÀ)           │01853,     

│ýòèíèëýñòðàäèîë 0.035 ìã}          │[G03AA01]                                                                                 │28.05.90   

                                                                                                                                        

│Äåìóëåí 1/50 {ýòèíîäèîë 1 ìã,      │êîíòðàöåïòèâíîå ñðåäñòâî      │òàáëåòêè 1 ìã/50 ìêã          │Searle (ÑØÀ)                  │01853,     

│ýòèíèëýñòðàäèîë 0.05 ìã}           │[G03AA01]                                                                                 │28.05.90   

                                                                                                                                        

│Äåíåðåë [Êåòîòèôåí]                │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî │òàáëåòêè 1 ìã; ñèðîï îðàëüíûé │Medochemie Ltd (Êèïð)         │003131,    

                                   │[R06AX17]                     │1 ìã|5 ìë                                                   │01.07.93   

                                                                                                                                        

│Äå-Íîë [Âèñìóòà òðèêàëèÿ äèöèòðàò] │ïðîòèâîÿçâåííîå ñðåäñòâî,     │òàáëåòêè 120 ìã               │Yamanouchi Europe B.V.        │006465,    

                                   │ïðåïàðàò âèñìóòà [A02BX05]                                  │(Íèäåðëàíäû)                  │04.09.95   

                                                                                                                                        

│Äåíòèíîêñ {ðîìàøêè ýêñòðàêò 0.15   │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî │ðàñòâîð (ôëàêîíû); ãåëü (òóáû)│Dentinox (Ãåðìàíèÿ)           │005250,    

│ã, ëèäîêàèí 3.4 ìã - 1 ìë}         │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                              │19.08.94   

                                   │[A01AD11]                                                                                            

                                                                                                                                        

│Äåïàêèí [Âàëüïðîåâàÿ êèñëîòà]      │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Sanofi-Winthrop (Ôðàíöèÿ)     │006990,    

                                   │[N03AG01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │17.01.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 400 ìã - 4 │                                         

                                                                 │ìë /â êîìïëåêòå ñ                                                      

                                                                 │ðàñòâîðèòåëåì/                                                         

                                                                                                                                        

│Äåïàêèí [Âàëüïðîåâàÿ êèñëîòà]      │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │ñèðîï äëÿ äåòåé (ôëàêîíû) 5.7%│Sanofi-Winthrop (Ôðàíöèÿ)     │005662,    

                                   │[N03AG01]                                                                                 │16.01.95   

                                                                                                                                        

│Äåïàêèí [Âàëüïðîåâàÿ êèñëîòà]      │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Torrent Pharmaceuticals Ltd   │008287,    

                                   │[N03AG01]                     │îáîëî÷êîé 300 ìã              │(Èíäèÿ)                       │03.06.97   

                                                                                                                                        

│Äåïàêèí 300 ýíòåðèê [Âàëüïðîåâàÿ   │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Sanofi-Winthrop (Ôðàíöèÿ)     │007244,    

│êèñëîòà]                           │[N03AG01]                     │îáîëî÷êîé 300 ìã                                            │10.07.96   

                                                                                                                                        

│Äåïàêèí õðîíî [Âàëüïðîåâàÿ êèñëîòà]│ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sanofi-Winthrop (Ôðàíöèÿ)     │006224,    

                                   │[N03AG01]                     │ïðîëîíãèðîâàííîãî äåéñòâèÿ                                  │27.06.95   

                                                                 │300 ìã                                                                 

                                                                                                                                        

│Äåïàêèí õðîíî 500 [Âàëüïðîåâàÿ     │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sanofi-Winthrop (Ôðàíöèÿ)     │006834,    

│êèñëîòà]                           │[N03AG01]                     │äåëèìûå                                                     │15.11.95   

                                                                                                                                        

│Äåïàìèä [Âàëüïðîìèä]               │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Sanofi-Winthrop (Ôðàíöèÿ)     │008244,    

                                   │[N03AG02]                     │îáîëî÷êîé 300 ìã                                            │01.04.97   

                                                                                                                                        

│Äåïåðçîëîí [Ìàçèïðåäîí]            │ãëþêîêîðòèêîñòåðîèä [D07AA]   │ìàçü 0.25%                    │Gedeon Richter (Âåíãðèÿ)      │2232,      

                                                                                                                             │29.12.83,  

                                                                                                                            │19.12.94   

                                                                                                                                        

│Äåïèí-Å [Íèôåäèïèí]                │ÁÌÊÊ [C08CA05]                │êàïñóëû 10 ìã; òàáëåòêè       │Cadila Healthcare Pvt Ltd     │007274,    

                                                                 │ðåòàðä 20 ìã                  │(Èíäèÿ)                       │06.08.96   

                                                                                                                                        

│Äåïî-Èíñóëèí Ñ [Èíñóëèí-ÑðÄ]       │èíñóëèí ñðåäíåãî äåéñòâèÿ     │ðàñòâîð äëÿ èíúåêöèé          │Hoechst Ag (Ãåðìàíèÿ)         │006175,    

                                   │[A10AC]                       │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │13.06.95   

                                                                                                                                        

│Äåïî-Ìåäðîë [Ìåòèëïðåäíèçîëîí]     │ãëþêîêîðòèêîñòåðîèä [H02AB04] │ñóñïåíçèÿ äëÿ èíúåêöèé        │Upjohn (Áåëüãèÿ)              │00274,     

                                                                 │(ôëàêîíû) 40 ìã/ìë                                          │18.01.74,  

                                                                                                                             │03.01.85,  

                                                                                                                             │07.07.95   

                                                                                                                                        

│Äåïîíèò 10 [Íèòðîãëèöåðèí]         │âàçîäèëàòèðóþùåå ñðåäñòâî     │ïëàñòûðü 32 ìã                │Schwarz Pharma Ag (Ãåðìàíèÿ)  │003582,    

                                   │[C01DA02]                                                                                 │13.12.93   

                                                                                                                                        

│Äåïîíèò 5 [Íèòðîãëèöåðèí]          │âàçîäèëàòèðóþùåå ñðåäñòâî     │ïëàñòûðü 16 ìã                │Schwarz Pharma Ag (Ãåðìàíèÿ)  │003582,    

                                   │[C01DA02]                                                                                 │13.12.93   

                                                                                                                                        

│Äåïî-Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí] │ïðîãåñòàãåí [G03DA02]         │ñóñïåíçèÿ äëÿ èíúåêöèé âîäíàÿ │Upjohn (Áåëüãèÿ)              │003704,    

                                                                 │(øïðèö îäíîðàçîâûé) 150 ìã;                                 │17.02.94   

                                                                 │ñóñïåíçèÿ äëÿ èíúåêöèé âîäíàÿ │                                         

                                                                │(ôëàêîíû) 150 ìã                                                       

                                                                                                                                        

│Äåïî-Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí] │ïðîãåñòàãåí [G03DA02]         │ñóñïåíçèÿ äëÿ èíúåêöèé        │Upjohn (Áåëüãèÿ)              │007280,    

                                                                 │(ôëàêîíû) 500 ìã/3.3 ìë, 1000 │                              │09.08.96   

                                                                 │ìã/6.7 ìë                                                              

                                                                                                                                        

│Äåïî-Ïðîâåðà [Ìåäðîêñèïðîãåñòåðîí] │ïðîãåñòàãåí [G03DA02]         │ñóñïåíçèÿ äëÿ èíúåêöèé        │Upjohn Company (Èíäîíåçèÿ)    │005573,    

                                                                 │(ôëàêîíû) 150 ìã/ìë                                         │15.12.94   

                                                                                                                                        

│Äåïîñòàò [Ãåñòîíîðîíà êàïðîàò]     │ïðîãåñòàãåí [G03DA01]         │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Schering Ag (ÔÐÃ)             │00732,     

                                                                 │èíúåêöèé â ìàñëå (àìïóëû) 100 │                              │21.01.80,  

                                                                 │ìã/ìë - 2 ìë                                                │25.01.93   

                                                                                                                                        

│Äåïðåêñ [Ôëóîêñåòèí]               │àíòèäåïðåññàíò [N06AB03]      │êàïñóëû 20 ìã                 │Lechiva Jsc (×åøñêàÿ          │010501,    

                                                                                               │Ðåñïóáëèêà)                   │14.10.98   

                                                                                                                                        

│Äåïðèì {çâåðîáîÿ òðàâû ýêñòðàêò}   │îáùåòîíèçèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │009532,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │17.06.97   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Äåïóðàôëóêñ {êðóøèíû êîðû          │ñëàáèòåëüíîå ñðåäñòâî         │÷àé ðàñòèòåëüíûé              │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│006607,    

│ýêñòðàêò18 ã, àíèñà ïëîäîâ         │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │áûñòðîðàñòâîðèìûé                                           │20.12.95   

│ýêñòðàêò 5 ã, òìèíà ïëîäîâ         │[A06AB]                       │ëåêàðñòâåííûé (ôëàêîíû)                                                

│ýêñòðàêò3.7 ã, êîðèàíäðà ïëîäîâ                                                                                                         

│ýêñòðàêò 6 ã, ôåíõåëÿ ïëîäîâ                                                                                                            

│ýêñòðàêò 3.5 ã, ìÿòû ïåðå÷íîé                                                                                                           

│ëèñòà ýêñòðàêò 1.5 ã, ñåííû                                                                                                             

│ýêñòðàêò 15 ã, çîëîòîòûñÿ÷íèêà                                                                                                          

│òðàâû ýêñòðàêò 0.4 ã, õâîùà òðàâû                                                                                                       

│ýêñòðàêò 24 ã}                                                                                                                          

                                                                                                                                        

│Äåðìàçèí [Ñóëüôàäèàçèí ñåðåáðà]    │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │êðåì 1%                       │Lek D.D. (Ñëîâåíèÿ)           │005398,    

                                   │ñóëüôàíèëàìèä [D06BA01]                                                                   │14.10.94   

                                                                                                                                        

│Äåðìàòîï [Ïðåäíèêàðáàò]            │ãëþêîêîðòèêîñòåðîèä äëÿ       │ìàçü; êðåì                    │Hoechst Ag (ÔÐÃ)              │002340,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC18] │                                                            │15.01.92   

                                                                                                                                        

│Äåðìåñòðèë [Ýñòðàäèîë]             │ýñòðîãåí [G03CA03]            │òðàíñäåðìàëüíàÿ ïðîâîäÿùàÿ    │Rottapharm (Èòàëèÿ)           │009132,    

                                                                 │ñèñòåìà 25, 50, 100 ìêã                                     │11.02.97   

                                                                                                                                        

│Äåðìîâåéò [Êëîáåòàçîë]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì (òóáû) 0.05% - 25 ã;     │Glaxo-Wellcome Operations Ltd │008201,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AB01] │ìàçü (òóáû) 0.05% - 25 ã      │(Âåëèêîáðèòàíèÿ)              │03.03.97   

                                                                                                                                        

│Äåðìîçîëîí {ïðåäíèçîëîí 5 ìã,      │ãëþêîêîðòèêîñòåðîèä           │ìàçü (òóáû)                   │Gedeon Richter (Âåíãðèÿ)      │006645,    

│êëèîõèíîë 30 ìã - 1 ã}             │+ïðîòèâîìèêðîáíîå ñðåäñòâî                                                                │16.02.96   

                                   │[D07BA01]                                                                                            

                                                                                                                                        

│Äåðìîôèë Èíäèåí {áàëüçàì Ïåðó 0.5  │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïîìàäà äëÿ ãóá (òþáèêè) 3.5 ã │Laboratoires Dermophil Indien │010351,    

│ã, õëîðàëãèäðàò 0.5 ã,             │[D08AX]                                                     │(Ôðàíöèÿ)                     │23.07.98   

│ôåíèëñàëèöèëàò 1 ã, ýêñöèïèåíò äî                                                                                                       

│100 ã}                                                                                                                                  

                                                                                                                                        

│Äåñèòèí [Öèíêà îêèñü]              │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü (òóáû) 40% - 57, 113 ã   │Pfizer Inc (ÑØÀ)              │007649,    

                                   │ñðåäñòâî äëÿ ìåñòíîãî                                                                     │17.07.96   

                                   │ïðèìåíåíèÿ [D02AB]                                                                                   

                                                                                                                                        

│Äåñêâàì [Áåíçîèëà ïåðîêñèä]        │àíòèñåïòè÷åñêîå ñðåäñòâî      │ãåëü (òóáû) 2.5% - 42.5 ã;    │Bristol-Myers Squibb (ÑØÀ)    │007589,    

                                   │[D10AE01]                     │ëîñüîí (ôëàêîíû ïëàñòèêîâûå)                                │18.06.96   

                                                                 │5% - 140 ã; ìûëî 10% - 106.25 │                                         

                                                                 │ã                                                                      

                                                                                                                                        

│Äåñìîë [Âèñìóòà ñóáñàëèöèëàò]      │àíòèñåïòè÷åñêîå êèøå÷íîå      │òàáëåòêè æåâàòåëüíûå          │Myevska Pharmaceuticals (ÑØÀ) │009040,    

                                   │ñðåäñòâî [A02BX05]                                                                        │19.12.96   

                                                                                                                                         

│Äåñìîë [Âèñìóòà ñóáñàëèöèëàò]      │àíòèñåïòè÷åñêîå êèøå÷íîå      │òàáëåòêè 262 ìã; æèäêîñòü     │Pennex Labs (ÑØÀ)             │005294,    

                                   │ñðåäñòâî [A02BX05]            │îðàëüíàÿ (ôëàêîíû) 1.75%                                   │05.09.94   

                                                                                                                                        

│Äåñôåðàë [Äåôåðîêñàìèí]            │êîìïëåêñîîáðàçóþùåå ñðåäñòâî  │ëèîôèëèç.ïîðîøîê äëÿ          │Ciba-Geigy (Øâåéöàðèÿ)        │008100,    

                                   │[V03AC01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.12.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 500 ìã                                              

                                                                                                                                        

│Äåòàçîí [Äåêñàìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä [H02AB02] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │M.J.Pharmaceuticals Ltd       │007156,    

                                                                 │4 ìã - 1 ìë                   │(Èíäèÿ)                       │19.03.96   

                                                                                                                                        

│Äåòîêñ {êîøà÷èé êîãîòü 380 ìã}     │îáùåòîíèçèðóþùåå ñðåäñòâî     │êàïñóëû æåëàòèíîâûå           │Arkopharma Laboratoires       │007938,    

                                   │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Pharmaceutic (Ôðàíöèÿ)        │05.11.96   

                                   │[A13A]                                                                                               

                                                                                                                                        

│Äåòðàëåêñ {äèîñìèí 450 ìã,         │âåíîòîíèçèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Servier (Ôðàíöèÿ)│003983,    

│ãåñïåðèäèí 50 ìã}                  │[C05CA53]                     │500 ìã                                                      │03.06.94   

                                                                                                                                        

│Äåòñêèé Ìîòðèí [Èáóïðîôåí]         │ÍÏÂÑ [M02AA13]                │ñóñïåíçèÿ äëÿ ïðèåìà âíóòðü   │Mcneil Consumer Products      │009983,    

                                                                 │100 ìã|5 ìë - 60, 120 ìë      │Company, division of Mcneil   │10.02.98   

                                                                                               │Ppc Inc (ÑØÀ)                            

                                                                                                                                        

│Äåòñêèé Ìîòðèí [Èáóïðîôåí]         │ÍÏÂÑ [M02AA13]                │ñóñïåíçèÿ-êàïëè äëÿ ïðèåìà    │Mcneil Consumer Products      │010269,    

                                                                 │âíóòðü (ôëàêîíû ñ ìåðíîé      │Company, division of Mcneil   │26.06.98   

                                                                │ïèïåòêîé) 50 ìã|1.25 ìë - 15  │Ppc Inc (ÑØÀ)                            

                                                                 │ìë                                                                     

                                                                                                                                        

│Äåòñêèé Ïàíàäîë [Ïàðàöåòàìîë]      │àíàëüãåòè÷åñêîå               │ñóïïîçèòîðèè 125 ìã           │Sterling Health Productos     │008495,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Pharmaceuticos Ltd, a         │16.01.98   

                                   │[N02BE01]                                                   │division of Smithkline                   

                                                                                               │Beecham Consumer Healthcare              

                                                                                               │(Ïîðòóãàëèÿ)                             

                                                                                                                                        

│Äåòñêèé Òàéëåíîë îò ïðîñòóäû       │ñðåäñòâî óñòðàíåíèÿ ñèìïòîìîâ │ñèðîï (ôëàêîíû) 60, 120 ìë    │Mcneil (ÑØÀ)                  │009667,    

│{ïàðàöåòàìîë 160 ìã, õëîðôåíèðàìèí │ÎÐÇ è ïðîñòóäû [R06AD52]                                                                  │12.08.97   

│1 ìã, äåêñòðîìåòîðôàí 5 ìã,                                                                                                             

│ïñåâäîýôåäðèí 15 ìã - 5 ìë}                                                                                                             

                                                                                                                                        

│Äåôëàìîí [Ìåòðîíèäàçîë]            │ïðîòèâîìèêðîáíîå ñðåäñòâî     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Spa (Èòàëèÿ)                  │006868,    

                                   │[J01XD01]                     │500 ìã - 100 ìë                                             │30.11.95   

                                                                                                                                       

│Äåôëåãìèí [Àìáðîêñîë]              │ìóêîëèòè÷åñêîå ñðåäñòâî       │òàáëåòêè 30 ìã; êàïëè äëÿ     │Polfa, Rzeszowskie            │009304,    

                                   │[R05CB06]                     │âíóòðåííåãî ïðèìåíåíèÿ        │Pharmaceutical Works Sa       │14.03.97   

                                                                 │(ôëàêîíû) 0.75% - 50 ìë       │(Ïîëüøà)                                 

                                                                                                                                        

│Äèà-Àêòèâàíàä-Í {ýêñòðàêò ïå÷åíè   │îáùåòîíèçèðóþùåå ñðåäñòâî     │ñîê (ôëàêîíû) 200, 500 ìë     │Knoll Ag (Ãåðìàíèÿ)           │009294,    

│253 ìã, äðîææåé ýêñòðàêò 3 ìã,     │[A13A]                                                                                    │12.03.97   

│êîôåèí 53.3 ìã, øèïîâíèêà ïëîäîâ                                                                                                        

│ýêñòðàêò 150 ã, ñîðáèò 4.7 ã,                                                                                                           

│ýòàíîë 11% - 100 ìë}                                                                                                                    

                                                                                                                                        

│Äèàáåñò [Ãëèêëàçèä]                │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 80 ìã                │Promed Exports Pvt Ltd (Èíäèÿ)│009797,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB09] │                                                            │22.10.97   

                                                                                                                                        

│Äèàáåòà [Ãëèáåíêëàìèä]             │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 1.25, 2.5, 5 ìã      │Hoechst-Roussel               │005025,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                              │Pharmaceutical (ÑØÀ)          │20.06.94   

                                                                                                                                        

│Äèàáåòîí [Ãëèêëàçèä]               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 80 ìã                │Servier (Ôðàíöèÿ)             │00934,     

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB09] │                                                            │10.09.82,  

                                                                                                                            │28.04.93   

                                                                                                                                        

│Äèàá-êîíòðîëü [Ãëèáåíêëàìèä]       │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 5 ìã                 │Promed Exports Pvt Ltd (Èíäèÿ)│007861,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB01] │                                                            │30.09.96   

                                                                                                                                        

│Äèàáðåçèä [Ãëèêëàçèä]              │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ  │òàáëåòêè 80 ìã                │Molteni Farmaceutici (Èòàëèÿ) │006198,    

                                   │ïåðîðàëüíîãî ïðèåìà [A10BB09] │                                                            │20.06.95   

                                                                                                                                        

│Äèàäåðì [Öèíêà îêèñü]              │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü (òóáû)                   │American Drug Company (ÑØÀ)   │006188,    

                                   │ñðåäñòâî äëÿ ìåñòíîãî                                                                     │14.06.95   

                                   │ïðèìåíåíèÿ [D02AB]                                                                                   

                                                                                                                                        

│Äèàçåì [Äèëòèàçåì]                 │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Medochemie Ltd (Êèïð)         │002979,    

                                                                                                                             │27.04.93   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │äðàæå 2 ìã, 5 ìã; ðàñòâîð äëÿ │Alkaloid (Ìàêåäîíèÿ)          │003738,    

                                   │[N05BA01]                     │èíúåêöèé (àìïóëû) 10 ìã - 2 ìë│                              │02.03.94   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arab Pharmaceutical           │003757,    

                                   │[N05BA01]                     │10 ìã - 2 ìë                  │Manufacturing Co Ltd          │15.03.94   

                                                                                               │(Èîðäàíèÿ)                               

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2 ìã                 │General Drug House (Òàéëàíä)  │005588,    

                                   │[N05BA01]                                                                                 │20.12.94   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2 ìã, 5 ìã           │Nycomed Dak As (Äàíèÿ)        │002924,    

                                   │[N05BA01]                                                                                 │29.03.93   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Rivopharm Sa (Øâåéöàðèÿ)      │003088,    

                                   │[N05BA01]                                                                                 │17.06.93   

                                                                                                                                       

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5, 10 ìã             │Terapia Sa, Romferchim        │2368,      

                                   │[N05BA01]                                                   │(Ðóìûíèÿ)                     │14.05.74,  

                                                                                                                             │28.09.84,  

                                                                                                                             │20.10.94   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │Rusan Pharma (Èíäèÿ)          │007093,    

                                   │[N05BA01]                     │èíúåêöèé (àìïóëû) 10 ìã - 2 ìë│                              │15.02.96   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │Simpex Pharma Pvt Ltd (Èíäèÿ) │009676,    

                                   │[N05BA01]                     │èíúåêöèé (àìïóëû) 10 ìã/2 ìë                                │13.08.97   

                                                                                                                                        

│Äèàçåïàì [Äèàçåïàì]                │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2, 5, 10 ìã; ðàñòâîð │Weimer Pharma Gmbh (Ãåðìàíèÿ) │005520,    

                                   │[N05BA01]                     │äëÿ èíúåêöèé (àìïóëû) 5 ìã/ìë │                              │22.11.94   

                                                                                                                                        

│Äèàçåïàì Äåñèòèí ðåêòàëüíûé òþáèê  │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ ðåêòàëüíîãî       │Desitin Arzneimittel Gmbh     │010304,    

│10 ìã [Äèàçåïàì]                   │[N05BA01]                     │ââåäåíèÿ (òþáèêè) 10 ìã - 2.5 │(Ãåðìàíèÿ)                    │06.07.98   

                                                                 │ìë                                                                     

                                                                                                                                        

│Äèàçåïàì Äåñèòèí ðåêòàëüíûé òþáèê  │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ ðåêòàëüíîãî       │Desitin Arzneimittel Gmbh     │010303,    

│5 ìã [Äèàçåïàì]                    │[N05BA01]                     │ââåäåíèÿ (òþáèêè) 5 ìã - 2.5  │(Ãåðìàíèÿ)                    │06.07.98   

                                                                 │ìë                                                                     

                                                                                                                                       

│Äèàçåïàì Íèêîìåä [Äèàçåïàì]        │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hafslund Nycomed Pharma Ag    │003430,    

                                   │[N05BA01]                     │10 ìã - 2 ìë                  │(Àâñòðèÿ)                     │19.10.93   

                                                                                                                                        

│Äèàçåïàì-Ðàòèîôàðì [Äèàçåïàì]      │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5, 10 ìã             │Ratiopharm Gmbh & Co          │005003,    

                                   │[N05BA01]                                                   │(Ãåðìàíèÿ)                    │15.06.94   

                                                                                                                                        

│Äèàçåïàì-Ðàòèîôàðì [Äèàçåïàì]      │àíêñèîëèòè÷åñêîå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ratiopharm Gmbh & Co          │003510,    

                                   │[N05BA01]                     │10 ìã - 2 ìë                  │(Ãåðìàíèÿ)                    │17.11.93   

                                                                                                                                        

│Äèàçåïàì-Òåâà [Äèàçåïàì]           │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2 ìã, 5 ìã; ðàñòâîð  │Teva Pharmaceutical           │005484,    

                                   │[N05BA01]                     │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │Industries Ltd (Èçðàèëü)      │14.11.94   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Äèàçåïåêñ [Äèàçåïàì]               │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2 ìã, 5 ìã           │Grindex (Ëàòâèÿ)              │007807,    

                                   │[N05BA01]                                                                                 │11.09.96   

                                                                                                                                       

│Äèàçèä {ãèäðîõëîðîòèàçèä 25 ìã,    │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │êàïñóëû                       │Smithkline Beecham            │006558,    

│òðèàìòåðåí 50 ìã}                  │ñðåäñòâî [C03EA01]                                          │Pharmaceuticals (ÑØÀ)         │27.09.95   

                                                                                                                                        

│Äèàêàðá [Àöåòàçîëàìèä]             │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 250 ìã               │Polpharma Pharmaceutical      │008485,    

                                   │[S01EC01]                                                   │Works Sa (Ïîëüøà)             │08.01.98   

                                                                                                                                        

│Äèàêîðäèí [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã; òàáëåòêè      │Lechiva Sa (×åøñêàÿ           │010222,    

                                                                 │ïîêðûòûå îáîëî÷êîé ðåòàðä 90  │Ðåñïóáëèêà)                   │26.05.98   

                                                                 │ìã; òàáëåòêè ðåòàðä 120 ìã                                             

                                                                                                                                        

│Äèàìåëèòóñ [Áðîìãåêñèí]            │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï (ôëàêîíû) 8 ìã - 5 ìë   │Biospray N.G.Zikidis (Ãðåöèÿ) │007152,    

                                   │[R05CB02]                                                                                 │19.03.96   

                                                                                                                                        

│Äèàíå-35 {ýòèíèëýñòðàäèîë 35 ìêã,  │êîíòðàöåïòèâíîå ñðåäñòâî      │äðàæå                         │Schering Ag (ÔÐÃ)             │01039,     

│öèïðîòåðîí 2 ìã}                   │[G03HB01]                                                                                 │12.09.83,  

                                                                                                                             │10.01.95   

                                                                                                                                        

│Äèàíèë {äåêñòðîçà ãèäðàò 1.5 ã/2.5 │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî   │ðàñòâîð ñ íèçêèì ñîäåðæàíèåì  │Baxter Healthcare Corp (ÑØÀ)  │005217,    

│ã/4.25 ã, íàòðèÿ õëîðèä 0.538 ã,   │äèàëèçà [B05D]                │êàëüöèÿ (êîíòåéíåðû                                         │10.08.94   

│íàòðèÿ ëàêòàò 0.448 ã, êàëüöèÿ                                   │ïëàñòèêîâûå)                                                           

│õëîðèä 18.3 ìã, ìàãíèÿ õëîðèä 5.08 │                                                                                                     

│ìã - 100 ìë}                                                                                                                            

                                                                                                                                        

│Äèàíèë ÏÄ4 ñ ãëþêîçîé {íàòðèÿ      │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî   │ðàñòâîð äëÿ èíôóçèé           │Baxter Healthcare Corp        │009104,    

│õëîðèä 5.38 ã, íàòðèÿ ëàêòàò 4.48  │äèàëèçà [B05D]                │(êîíòåéíåðû ïëàñòèêîâûå)      │(Èðëàíäèÿ)                    │31.01.97   

│ã, êàëüöèÿ õëîðèä 184 ìã, ìàãíèÿ                                 │1.36%, 2.27%, 3.86%                                                    

│õëîðèä 51 ìã, äåêñòðîçà 13.6                                                                                                            

│ã/22.7 ã/38.6 ã}                                                                                                                        

                                                                                                                                        

│Äèàïàì [Äèàçåïàì]                  │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Sun Pharmaceutical Industries │005626,    

                                   │[N05BA01]                                                   │Ltd (Èíäèÿ)                   │10.01.95   

                                                                                                                                        

│Äèàðîë [Ëîïåðàìèä]                 │ïðîòèâîäèàðåéíîå ñðåäñòâî     │êàïëåòû 2 ìã                  │Four Ventures Enterprises     │009350,    

                                   │[A07DA03]                                                   │(ÑØÀ)                         │31.03.97   

                                                                                                                                        

│Äèàñòàò [Íèôóðîêñàçèä]             │ïðîòèâîìèêðîáíîå ñðåäñòâî,    │êàïñóëû 200 ìã                │Amoun Pharmaceutical          │010141,    

                                   │íèòðîôóðàí [A07AX03]                                        │Industries Co (Åãèïåò)        │03.04.98   

                                                                                                                                        

│Äèáàçîëà ðàñòâîð äëÿ èíúåêöèé      │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ñàíèòàñ ÀÎ (Ëèòâà)            │010010,    

│[Áåíäàçîë]                         │[C04AX]                       │1% - 1 ìë                                                   │02.03.98   

                                                                                                                                        

│Äèáàçîëà ðàñòâîð äëÿ èíúåêöèé      │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │010008,    

│[Áåíäàçîë]                         │[C04AX]                       │1% - 1 ìë                     │çàâîä ÀÎ (Ýñòîíèÿ)            │26.01.98   

                                                                                                                                        

│Äèáàçîëà ðàñòâîð äëÿ èíúåêöèé      │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ôàðìàêî ÀÎ (Ìîëäîâà)          │70/421/15, 

│[Áåíäàçîë]                         │[C04AX]                       │1% - 1 ìë                                                   │07.10.98   

                                                                                                                                         

│Äèáàçîëà ðàñòâîð äëÿ èíúåêöèé      │âàçîäèëàòèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áîðèñîâñêèé çàâîä             │70/421/15, 

│[Áåíäàçîë]                         │[C04AX]                       │0.5% - 2 ìë                   │ìåäïðåïàðàòîâ (Áåëàðóñü)      │15.07.98   

                                                                                                                                        

│Äèáàçîëà òàáëåòêè 0.02 ã [Áåíäàçîë]│âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 20 ìã                │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/421/16, 

                                   │[C04AX]                                                                                   │05.01.98   

                                                                                                                                        

│Äèáàçîëà òàáëåòêè 0.02 ã [Áåíäàçîë]│âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 20 ìã                │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/421/16, 

                                   │[C04AX]                                                                                   │17.12.97   

                                                                                                                                        

│Äèáåðòèë [Ìåòîêëîïðàìèä]           │ïðîòèâîðâîòíîå ñðåäñòâî,      │êàïñóëû 5, 10 ìã              │Nycomed Christians (Áåëüãèÿ)  │005237,    

                                   │äîôàìèí áëîêàòîð öåíòðàëüíûé                                                              │19.08.94   

                                   │[A03FA01]                                                                                            

                                                                                                                                        

│Äèâàñêàí [Èïðàçîõðîì]              │ïðîòèâîìèãðåíîçíîå ñðåäñòâî   │òàáëåòêè 2.5 ìã               │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007367,    

                                   │[N02CX03]                                                                                 │22.10.96   

                                                                                                                                        

│Äèâèãåëü [Ýñòðàäèîë]               │ýñòðîãåí [G03CA03]            │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Orion Corporation (Ôèíëÿíäèÿ) │010316,    

                                                                 │(ïàêåòèêè) 0.1% - 0.5, 1 ã                                  │13.07.98   

                                                                                                                                        

│Äèâèíà {ýñòðàäèîë 2 ìã - òàáëåòêè  │ïðîòèâîêëèìàêòåðè÷åñêîå       │òàáëåòêè                      │Orion Pharmaceutica           │002072,    

│áåëûå; ýñòðàäèîë 2 ìã,             │ñðåäñòâî [G03FA12]                                          │(Ôèíëÿíäèÿ)                   │14.03.91   

│ìåäðîêñèïðîãåñòåðîí 10 ìã -                                                                                                             

│òàáëåòêè ãîëóáûå}                                                                                                                       

                                                                                                                                       

│Äèâèòðåí {ýñòðàäèîë 2 ìã -         │ïðîòèâîêëèìàêòåðè÷åñêîå       │òàáëåòêè                      │Orion Corporation/ Ercopharm  │009287,    

│òàáëåòêè áåëûå; ýñòðàäèîë 2 ìã,    │ñðåäñòâî [G03FA12]                                          │As (Ôèíëÿíäèÿ/Äàíèÿ)          │05.03.97   

│ìåäðîêñèïðîãåñòåðîí 20 ìã -                                                                                                             

│òàáëåòêè ãîëóáûå; ïëàöåáî -                                                                                                             

│òàáëåòêè æåëòûå}                                                                                                                        

                                                                                                                                        

│Äèãåñòàë {ïàíêðåàòèí 0.2 ã, æåë÷è  │ïèùåâàðèòåëüíîå ôåðìåíòíîå    │äðàæå                         │ICN Galenika (ÑÐ Þãîñëàâèÿ)   │008464,    

│êîìïîíåíòû 25 ìã, ãåìèöåëëþëàçà 50 │ñðåäñòâî [A09AA02]                                                                        │30.10.97   

│ìã}                                                                                                                                     

                                                                                                                                        

│Äèãåñòàë ôîðòå {ïàíêðåàòèí 0.2 ã,  │ïèùåâàðèòåëüíîå ôåðìåíòíîå    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │ICN Galenika (Þãîñëàâèÿ)      │009406,    

│æåë÷è êîìïîíåíòû 25 ìã,            │ñðåäñòâî [A09AA02]                                                                        │22.04.97   

│ãåìèöåëëþëàçà 50 ìã}                                                                                                                    

                                                                                                                                        

│Äèãèäåðãîò íàçàëüíûé àýðîçîëü      │ïðîòèâîìèãðåíîçíîå ñðåäñòâî   │àýðîçîëü íàçàëüíûé (àìïóëû) 1 │Sandoz Pharma Ltd (Øâåéöàðèÿ) │009644,    

│{äèãèäðîýðãîòàìèí 4 ìã, êîôåèí 10  │[N02CA51]                     │ìë /ñ óñòðîéñòâîì äëÿ                                       │31.07.97   

│ìã - 1 ìë}                                                       │ðàñïûëåíèÿ/                                                            

                                                                                                                                        

│Äèãíîáðîêñîë [Àìáðîêñîë]           │ìóêîëèòè÷åñêîå ñðåäñòâî       │ðàñòâîð äëÿ âíóòðåííåãî       │Luitpold Pharma Gmbh          │007996,    

                                   │[R05CB06]                     │ïðèìåíåíèÿ (ôëàêîíû) 7.5      │(Ãåðìàíèÿ)                    │02.12.96   

                                                                 │ìã/ìë - 50, 100 ìë /â                                                  

                                                                 │êîìïëåêòå ñ ìåðíûì                                                     

                                                                 │ñòàêàí÷èêîì/                                                           

                                                                                                                                        

│Äèãíîôåíàê 100 [Äèêëîôåíàê]        │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Luitpold Pharma (Ãåðìàíèÿ)    │006934,    

                                                                 │ðåòàðä 100 ìã                                               │21.12.95   

                                                                                                                                        

│Äèãíîôåíàê 50 [Äèêëîôåíàê]         │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Luitpold Pharma (Ãåðìàíèÿ)    │006935,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │21.12.95   

                                                                 │50 ìã                                                                  

                                                                                                                                         

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Creat Laboratoires (Ôðàíöèÿ)  │009060,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                                              │05.01.97   

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Gedeon Richter (Âåíãðèÿ)      │2033,      

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                                              │01.07.70,  

                                                                                                                             │26.04.84,  

                                                                                                                             │21.03.95   

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Sandoz (India) Ltd (Èíäèÿ)    │007732,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                                              │15.08.96   

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè ìèòå 0.0625 ìã;      │Orion Pharmaceutica           │01506,     

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]  │òàáëåòêè ñåìè 0.125 ìã;       │(Ôèíëÿíäèÿ)                   │26.10.88   

                                                                 │òàáëåòêè 0.25 ìã; ðàñòâîð äëÿ │                                         

                                                                 │èíúåêöèé (àìïóëû) 0.25 ìã - 1 │                                         

                                                                 │ìë                                                                      

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Polfa, Warsaw Pharmaceutical  │007636,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                │Works Sa (Ïîëüøà)             │10.07.96   

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Ñàíèòàñ ÀÎ (Ëèòâà)            │010045,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                                              │07.07.98   

                                                                                                                                        

│Äèãîêñèí [Äèãîêñèí]                │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009253,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                │çàâîä ÀÎ (Ýñòîíèÿ)            │29.12.97   

                                                                                                                                        

│Äèãîêñèí Íèêîìåä [Äèãîêñèí]        │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 62.5 ìêã, 0.25 ìã;   │Nycomed Dak As (Äàíèÿ)        │005874,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │30.03.95   

                                                                 │0.25 ìã/ìë                                                             

                                                                                                                                        

│Äèãîêñèíà ðàñòâîð äëÿ èíúåêöèé     │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Îïûòíûé çàâîä ÃÍÖËÑ (Óêðàèíà) │83/1348/8, 

│0.025% [Äèãîêñèí]                  │ñåðäå÷íûé ãëèêîçèä [C01AA05]  │0.025% - 1 ìë                                               │07.10.98   

                                                                                                                                        

│Äèãîêñèíà òàáëåòêè äëÿ äåòåé       │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè äëÿ äåòåé 0.1 ìã     │Îïûòíûé çàâîä ÃÍÖËÑ (Óêðàèíà) │80/1339/6, 

│0.0001 ã [Äèãîêñèí]                │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                                              │07.10.98   

                                                                                                                                        

│Äèãîêñèí-Òåâà [Äèãîêñèí]           │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Teva Pharmaceutical           │005946,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                │Industries Ltd (Èçðàèëü)      │11.04.95   

                                                                                                                                        

│Äèãîôòîí {äèãèòîêñèí 2 ìã,         │îôòàëüìîëîãè÷åñêîå ñðåäñòâî   │êàïëè ãëàçíûå                 │Ankerpharm Gmbh, Ankerwerk    │003297,    

│áåíçàëêîíèÿ õëîðèä 2 ìã, íàòðèÿ    │[S01XA]                                                     │Rudolstadt (ÔÐÃ)              │02.09.93   

│àöåòàò 0.2 ã, áîðíàÿ êèñëîòà 165                                                                                                        

│ìã, ïðîïèëåíãëèêîëü 5.2 ã, ýòàíîë                                                                                                       

│170 ìã - 100 ìë}                                                                                                                        

                                                                                                                                        

│Äèäåïèë {ïðîöèêëèäèí 10 ìã,        │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè; òàáëåòêè äëÿ äåòåé; │Pharmachim (ÍÐÁ)              │2662,      

│ôåíîáàðáèòàë 25 ìã - òàáëåòêè;     │[N03AX]                       │àìïóëû                                                      │02.07.81   

│ïðîöèêëèäèí 6 ìã, ôåíîáàðáèòàë 20                                                                                                       

│ìã - òàáëåòêè äëÿ äåòåé;                                                                                                                

│ïðîöèêëèäèí 14 ìã, ôåíîáàðáèòàë 40 │                                                                                                     

│ìã - 1 ìë}                                                                                                                              

                                                                                                                                        

│Äèåòðèí {ôåíèëïðîïàíîëàìèí 75 ìã,  │àíîðåêñèãåííîå ñðåäñòâî [A08A]│êàïñóëû 75 ìã/9 ìã            │Four Ventures Enterprises     │005211,    

│áåíçîêàèí 9 ìã}                                                                                │(ÑØÀ)                         │04.08.94   

                                                                                                                                        

│Äèçàëóíèë [Ãèäðîõëîðîòèàçèä]       │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 25 ìã                │Berlin-Chemie Ag (ÔÐÃ)        │005463,    

                                   │[C03AA03]                                                                                 │09.11.94   

                                                                                                                                        

│Äèçåï-5 [Äèàçåïàì]                 │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Intas                         │005763,    

                                   │[N05BA01]                                                   │International-Pharmaceuticals │20.02.95   

                                                                                               │(Èíäèÿ)                                  

                                                                                                                                        

│Äèçèðîí [Öèííàðèçèí]               │ÁÌÊÊ [N07CA02]                │òàáëåòêè 25 ìã                │Glenmark Pharmaceuticals Ltd  │005824,    

                                                                                               │(Èíäèÿ)                       │15.03.95   

                                                                                                                                        

│Äèêàì [Äèàçåïàì]                   │àíêñèîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 2, 5, 10 ìã; ðàñòâîð │Ipca Laboratories Ltd (Èíäèÿ) │005560,    

                                   │[N05BA01]                     │äëÿ èíúåêöèé (àìïóëû) 10 ìã - │                              │09.12.94   

                                                                 │2 ìë                                                                   

                                                                                                                                        

│Äèêëî [Äèêëîôåíàê]                 │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ct-Arzneimittel Chemishe      │006195,    

                                                                 │25, 50 ìã                     │Tempelchof Gmbh (Ãåðìàíèÿ)    │16.06.95   

                                                                                                                                       

│Äèêëî [Äèêëîôåíàê]                 │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ct-Arzneimittel Chemishe      │005777,    

                                                                 │75 ìã - 2 ìë                  │Tempelchof Gmbh (Ãåðìàíèÿ)    │24.02.95   

                                                                                                                                        

│Äèêëî [Äèêëîôåíàê]                 │ÍÏÂÑ [M01AB05]                │òàáëåòêè ðåòàðä 100 ìã; ñâå÷è │Ct-Arzneimittel Chemishe      │006772,    

                                                                 │25, 50, 100 ìã                │Tempelchof Gmbh (Ãåðìàíèÿ)    │31.10.95   

                                                                                                                                        

│Äèêëîáåíå [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05] [M02AA15]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Merckle Gmbh (Ãåðìàíèÿ)       │008539,    

                                                                 │25, 50 ìã; êàïñóëû ðåòàðä 100 │                              │12.05.98   

                                                                 │ìã; ãåëü (òóáû) 1% - 40, 100                                           

                                                                 │ã; ñóïïîçèòîðèè 25, 50 ìã;                                             

                                                                 │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                         

                                                                 │75 ìã - 2 ìë                                                           

                                                                                                                                        

│Äèêëîáåðë 100 [Äèêëîôåíàê]         │ÍÏÂÑ [M01AB05]                │ñâå÷è 100 ìã                  │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006893,    

                                                                                                                             │18.12.95   

                                                                                                                                        

│Äèêëîáåðë 25 [Äèêëîôåíàê]          │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007538,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │23.05.96   

                                                                 │25 ìã                                                                  

                                                                                                                                        

│Äèêëîáåðë 50 [Äèêëîôåíàê]          │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Berlin-Chemie Ag (Ãåðìàíèÿ)   │007537,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │23.05.96   

                                                                 │50 ìã                                                                  

                                                                                                                                        

│Äèêëîáåðë 50 [Äèêëîôåíàê]          │ÍÏÂÑ [M01AB05]                │ñâå÷è 50 ìã                   │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006625,    

                                                                                                                             │15.01.96   

                                                                                                                                        

│Äèêëîáåðë 75 [Äèêëîôåíàê]          │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006650,    

                                                                 │75 ìã - 3 ìë                                                │22.02.96   

                                                                                                                                        

│Äèêëîáåðë ðåòàðä [Äèêëîôåíàê]      │ÍÏÂÑ [M01AB05]                │êàïñóëû ðåòàðä 100 ìã         │Berlin-Chemie Ag (Ãåðìàíèÿ)   │006624,    

                                                                                                                             │15.01.96   

                                                                                                                                        

│Äèêëîãåí [Äèêëîôåíàê]              │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Agio Pharmaceuticals Ltd      │007921,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé  │(Èíäèÿ)                       │01.11.96   

                                                                 │50 ìã; ðàñòâîð äëÿ èíúåêöèé                                            

                                                                 │(àìïóëû) 75 ìã - 3 ìë                                                  

                                                                                                                                        

│Äèêëîãåí [Äèêëîôåíàê]              │ÍÏÂÑ [M02AA15]                │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Agio Pharmaceuticals Ltd      │007970,    

                                                                 │(òóáû) 1% - 30 ã              │(Èíäèÿ)                       │22.11.96   

                                                                                                                                        

│Äèêëîæåñèê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Dar Al Dava (Èîðäàíèÿ)        │003355,    

                                                                 │50 ìã; òàáëåòêè ïîêðûòûå                                    │21.09.93   

                                                                 │ïëåíî÷íîé îáîëî÷êîé ðåòàðä                                             

                                                                 │100 ìã; ðàñòâîð äëÿ èíúåêöèé                                           

                                                                 │(àìïóëû) 75 ìã - 3 ìë; ñâå÷è                                           

                                                                 │100 ìã                                                                  

                                                                                                                                        

│Äèêëîìàêñ [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05]                │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Torrent Exports Ltd (Èíäèÿ)   │003291,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 2.5% -                                │02.09.93   

                                                                 │75 ìã                                                                  

                                                                                                                                        

│Äèêëîìåëàí [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lannacher Heilmittel Gmbh     │007967,    

                                                                 │ðåòàðä 100 ìã; òàáëåòêè       │(Àâñòðèÿ)                     │21.11.96   

                                                                 │ïîêðûòûå îáîëî÷êîé 50 ìã;                                              

                                                                 │ðàñòâîð äëÿ èíúåêöèé 75 ìã -                                           

                                                                 │3 ìë; ñâå÷è 100 ìã                                                     

                                                                                                                                        

│Äèêëîíàê [Äèêëîôåíàê]              │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã                │Lupin Laboratories Ltd (Èíäèÿ)│003998,    

                                                                                                                             │14.06.94   

                                                                                                                                        

│Äèêëîíàê [Äèêëîôåíàê]              │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lupin International (Èíäèÿ)   │002834,    

                                                                 │75 ìã - 3 ìë                                                │10.02.93   

                                                                                                                                        

│Äèêëîíàò Ï [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │ñóïïîçèòîðèè 50 ìã; ðàñòâîð   │Pliva D.D. (Ðåñïóáëèêà        │008649,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 75 ìã - │Õîðâàòèÿ)                     │13.07.98   

                                                                 │3 ìë                                                                   

                                                                                                                                        

│Äèêëîíàò Ï ðåòàðä 100 [Äèêëîôåíàê] │ÍÏÂÑ [M01AB05]                │òàáëåòêè ðåòàðä 100 ìã        │Pliva D.D. (Ðåñïóáëèêà        │008648,    

                                                                                               │Õîðâàòèÿ)                     │13.07.98   

                                                                                                                                       

│Äèêëîðàí [Äèêëîôåíàê]              │ÍÏÂÑ [M02AA15]                │ãåëü 1%                       │Unique Pharmaceutical         │003723,    

                                                                                               │Laboratories (Èíäèÿ)          │24.02.94   

                                                                                                                                        

│Äèêëîðàí [Äèêëîôåíàê]              │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │003045,    

                                                                 │75 ìã - 3 ìë                  │Laboratories (Èíäèÿ)          │08.06.93   

                                                                                                                                        

│Äèêëîðàí [Äèêëîôåíàê]              │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã; òàáëåòêè      │Unique Pharmaceutical         │003641,    

                                                                 │ðåòàðä 100 ìã                 │Laboratories (Èíäèÿ)          │25.01.94   

                                                                                                                                        

│Äèêëîðèóì [Äèêëîôåíàê]             │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã; òàáëåòêè      │Alfa Schiapparelli Wassermann │006692,    

                                                                 │ðåòàðä 100 ìã; ðàñòâîð äëÿ    │Spa (Èòàëèÿ)                  │11.10.95   

                                                                 │èíúåêöèé (àìïóëû) 75 ìã - 3 ìë│                                         

                                                                                                                                        

│Äèêëî-Ô [Äèêëîôåíàê]               │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Promed Exports Pvt Ltd (Èíäèÿ)│009858,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │24.11.97   

                                                                │25, 50 ìã; ðàñòâîð äëÿ                                                 

                                                                 │èíúåêöèé (àìïóëû) 25 ìã/ìë -                                           

                                                                 │3 ìë                                                                   

                                                                                                                                        

│Äèêëî-Ô [Äèêëîôåíàê]               │ÍÏÂÑ [S01BC03]                │êàïëè ãëàçíûå                 │Promed Exports Pvt Ltd (Èíäèÿ)│009554,    

                                                                 │(ôëàêîí-êàïåëüíèöû) 0.1% - 5                                │26.06.97   

                                                                 │ìë                                                                     

                                                                                                                                        

│Äèêëîôåí êðåìîãåëü [Äèêëîôåíàê]    │ÍÏÂÑ [M02AA15]                │êðåìîãåëü                     │United Pharmaceutical         │003586,    

                                                                                               │Manufacturing Co Ltd          │14.12.93   

                                                                                               │(Èîðäàíèÿ)                               

                                                                                                                                        

│Äèêëîôåíàê (Áèêëîïàí) [Äèêëîôåíàê] │ÍÏÂÑ [M01AB05]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Mir Pharmaceutical            │007681,    

                                                                 │îáîëî÷êîé 25, 50 ìã           │Inc/Pharbita B.V.             │23.07.96   

                                                                                               │(Íèäåðëàíäû) (ÑØÀ)                       

                                                                                                                                         

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå             │Cts Chemical Industries Ltd   │009969,    

                                                                 │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé  │(Èçðàèëü)                     │29.01.98   

                                                                 │25 ìã                                                                  

                                                                                                                                       

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M02AA15]                │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Hemofarm D.D. (Þãîñëàâèÿ)     │009988,    

                                                                 │(òóáû) 1% - 40 ã                                            │16.02.98   

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã; òàáëåòêè      │Hemofarm D.D. (Þãîñëàâèÿ)     │003797,    

                                                                 │ðåòàðä 100 ìã; ðàñòâîð äëÿ                                  │29.03.94   

                                                                 │èíúåêöèé (àìïóëû) 75 ìã - 3 ìë│                                         

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Hexal Ag (Ãåðìàíèÿ)           │008475,    

                                                                 │25, 50 ìã; òàáëåòêè ðåòàðä                                  │04.12.97   

                                                                 │100 ìã                                                                 

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Jaka-80 (Ìàêåäîíèÿ)           │009356,    

                                                                 │ôîðòå 50 ìã                                                 │04.04.97   

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │ñâå÷è 50, 100 ìã              │Polfa, Poznanskie             │009037,    

                                                                                               │Pharmaceutical Works (Ïîëüøà) │19.12.96   

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè 25, 50 ìã; òàáëåòêè  │Heumann Pharma (Ãåðìàíèÿ)     │003923,    

                                                                 │ðåòàðä 100 ìã                                               │19.05.94   

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè ðåòàðä 100 ìã        │Sofar Industria               │006515,    

                                                                                               │Pharmaceutical (Èòàëèÿ)       │20.09.95   

                                                                                                                                        

│Äèêëîôåíàê [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Wave International (Èíäèÿ)    │003516,    

                                                                 │äëÿ èíúåêöèé (àìïóëû) 75 ìã - │                              │24.10.93   

                                                                 │3 ìë                                                                   

                                                                                                                                        

│Äèêëîôåíàê íàòðèÿ [Äèêëîôåíàê]     │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Astrapin (Ãåðìàíèÿ)           │003974,    

                                                                 │25 ìã/ìë                                                    │02.06.94   

                                                                                                                                       

│Äèêëîôåíàê íàòðèÿ [Äèêëîôåíàê]     │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rotexmedica Osoo (Ãåðìàíèÿ)   │005501,    

                                                                 │75 ìã - 3 ìë                                                │15.11.94   

                                                                                                                                        

│Äèêëîôåíàê ðåòàðä [Äèêëîôåíàê]     │ÍÏÂÑ [M01AB05]                │òàáëåòêè 75, 100 ìã           │Euderma (Èòàëèÿ)              │005376,    

                                                                                                                             │29.09.94   

                                                                                                                                        

│Äèêëîôåíàê-íàòðèé [Äèêëîôåíàê]     │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã; ðàñòâîð äëÿ   │ICN Galenika (Þãîñëàâèÿ)      │003474,    

                                                                 │èíúåêöèé (àìïóëû) 2.5% - 3 ìë │                              │01.11.93   

                                                                                                                                        

│Äèêëîôåíàê-Ðàòèîôàðì [Äèêëîôåíàê]  │ÍÏÂÑ [M01AB05]                │êàïñóëû ðåòàðä 100 ìã; ñâå÷è  │Ratiopharm Gmbh & Co          │005819,    

                                                                 │50, 100 ìã                    │(Ãåðìàíèÿ)                    │13.03.95   

                                                                                                                                        

│Äèêëîôåíàê-Ðàòèîôàðì [Äèêëîôåíàê]  │ÍÏÂÑ [M01AB05]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Ratiopharm Gmbh & Co          │003459,    

                                                                 │îáîëî÷êîé 25, 50 ìã           │(Ãåðìàíèÿ)                    │26.10.93   

                                                                                                                                        

│Äèêëîôåíàê-Ðèâî [Äèêëîôåíàê]       │ÍÏÂÑ [M01AB05]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Rivopharm Sa (Øâåéöàðèÿ)      │007755,    

                                                                 │50 ìã                                                       │21.08.96   

                                                                                                                                        

│Äèêëîôåíàê-Ðèâîôàðì [Äèêëîôåíàê]   │ÍÏÂÑ [M01AB05]                │òàáëåòêè ðåòàðä 100 ìã        │Rivopharm Sa (Øâåéöàðèÿ)      │003855,    

                                                                                                                             │18.04.94   

                                                                                                                                        

│Äèêëîôåíàê-Òåâà [Äèêëîôåíàê]       │ÍÏÂÑ [M01AB05]                │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Teva Pharmaceutical           │005651,    

                                                                 │îáîëî÷êîé 25 ìã; òàáëåòêè     │Industries Ltd (Èçðàèëü)      │16.01.95   

                                                                 │ðåòàðä 100 ìã; ñâå÷è 50 ìã;                                            

                                                                 │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                         

                                                                 │75 ìã - 3 ìë                                                           

                                                                                                                                        

│Äèëàêîð [Äèãîêñèí]                 │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã; ðàñòâîð äëÿ │Zdravle (Þãîñëàâèÿ)           │007928,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]  │èíúåêöèé (àìïóëû) 0.25 ìã - 2 │                              │05.11.96   

                                                                 │ìë; êàïëè äëÿ ïðèåìà âíóòðü                                            

                                                                 │(ôëàêîíû) 0.75 ìã/ìë - 10 ìë                                           

                                                                                                                                        

│Äèëàêîð XR [Äèëòèàçåì]             │ÁÌÊÊ [C08DB01]                │êàïñóëû ïðîëîíãèðîâàííîãî     │Rhone-Poulenc Rorer (ÑØÀ)     │006242,    

                                                                 │äåéñòâèÿ 120, 180, 240 ìã                                   │03.07.95   

                                                                                                                                        

│Äèëàíàöèí [Äèãîêñèí]               │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │òàáëåòêè 0.25 ìã              │Arzneimittelwerk Dresden Gmbh │008157,    

                                   │ñåðäå÷íûé ãëèêîçèä [C01AA05]                                │(Ãåðìàíèÿ)                    │11.02.97   

                                                                                                                                       

│Äèëàòðåíä [Êàðâåäèëîë]             │àëüôà- è áåòà-àäðåíîáëîêàòîð  │òàáëåòêè 6.25, 12.5, 25 ìã    │Boehringer Mannheim Gmbh      │009420,    

                                   │[C07AG02]                                                   │(Ãåðìàíèÿ)                    │29.04.97   

                                                                                                                                        

│Äèëåé Òèàçèì ÑÐ [Äèëòèàçåì]        │ÁÌÊÊ [C08DB01]                │êàïñóëû çàìåäëåííîãî          │Amoun Pharmaceutical          │005550,    

                                                                 │âûñâîáîæäåíèÿ 90, 120 ìã      │Industries Co, Apic (Åãèïåò)  │06.12.94   

                                                                                                                                        

│Äèëæèíà [Äèëòèàçåì]                │ÁÌÊÊ [C08DB01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kopran Ltd (Èíäèÿ)            │005138,    

                                                                 │30, 60 ìã                                                   │15.07.94   

                                                                                                                                        

│Äèëçåì [Äèëòèàçåì]                 │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã; òàáëåòêè      │Torrent Exports Ltd (Èíäèÿ)   │003702,    

                                                                 │ïðîëîíãèðîâàííîãî äåéñòâèÿ 90 │                              │15.02.94   

                                                                 │ìã                                                                     

                                                                                                                                        

│Äèëêàðäèÿ [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Unique Pharmaceutical         │003724,    

                                                                                               │Laboratories (Èíäèÿ)          │24.02.94   

                                                                                                                                        

│Äèëêàðäèÿ-ðåòàðä [Äèëòèàçåì]       │ÁÌÊÊ [C08DB01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Unique Pharmaceu-tical        │005196,    

                                                                 │90 ìã                         │Laboratories (Èíäèÿ)          │01.08.94   

                                                                                                                                       

│Äèëêîðàí 80 [Ïåíòàýðèòðèòèëà       │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè ðåòàðä 80 ìã         │Inex Hemofarm (Þãîñëàâèÿ)     │01156,     

│òåòðàíèòðàò]                       │[C01DA05]                                                                                 │24.04.85   

                                                                                                                                        

│Äèëòèàçåì Ëàííàõåð [Äèëòèàçåì]     │ÁÌÊÊ [C08DB01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lannacher Heilmittel Gmbh     │009082,    

                                                                 │ðåòàðä 90, 180 ìã             │(Àâñòðèÿ)                     │20.01.97   

                                                                                                                                        

│Äèëòèàçåì [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │êàïñóëû ðåòàðä 90, 120, 180 ìã│Euderma Spa (Èòàëèÿ)          │007214,    

                                                                                                                             │18.06.96   

                                                                                                                                        

│Äèëòèàçåì [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60, 90 ìã            │Pliva Sa (Õîðâàòèÿ)           │006334,    

                                                                                                                             │31.07.95   

                                                                                                                                         

│Äèëòèàçåì [Äèëòèàçåì]              │ÁÌÊÊ [C08DB01]                │êàïñóëû ïðîëîíãèðîâàííîãî     │Searle division of Monsanto   │010352,    

                                                                 │äåéñòâèÿ 90, 120, 180 ìã      │S.a. (Ôðàíöèÿ)                │23.07.98   

                                                                                                                                        

│Äèëòèàçåì Ãåêñàë ðåòàðä [Äèëòèàçåì]│ÁÌÊÊ [C08DB01]                │òàáëåòêè 90 ìã                │Hexal Ag (Ãåðìàíèÿ)           │009063,    

                                                                                                                             │08.01.97   

                                                                                                                                        

│Äèëòèàçåì Íèêîìåä [Äèëòèàçåì]      │ÁÌÊÊ [C08DB01]                │êàïñóëû äåïî 120, 180, 240 ìã │Nycomed Pharma As (Íîðâåãèÿ)  │007919,    

                                                                                                                             │31.10.96   

                                                                                                                                        

│Äèëòèàçåìà ãèäðîõëîðèä [Äèëòèàçåì] │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Norton Healthcare Ltd         │003241,    

                                                                                               │(Âåëèêîáðèòàíèÿ)              │18.08.93   

                                                                                                                                        

│Äèëòèàçåì-Ðàòèîôàðì [Äèëòèàçåì]    │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã                │Ratiopharm Gmbh (Ãåðìàíèÿ)    │008593,    

                                                                                                                             │12.08.98   

                                                                                                                                        

│Äèëòèàçåì-Òåâà [Äèëòèàçåì]         │ÁÌÊÊ [C08DB01]                │òàáëåòêè 30, 60 ìã            │Teva Pharmaceutical           │005112,    

                                                                                               │Industries Ltd (Èçðàèëü)      │11.07.94   

                                                                                                                                       

│Äèëòèçåì ÑÐ [Äèëòèàçåì]            │ÁÌÊÊ [C08DB01]                │òàáëåòêè 90 ìã                │Mustafa Nevzat Ilac Sanayi As │003848,    

                                                                                               │(Òóðöèÿ)                      │12.04.94   

                                                                                                                                        

│Äèëòèçåì ÑÐ [Äèëòèàçåì]            │ÁÌÊÊ [C08DB01]                │òàáëåòêè 120 ìã               │Mustafa Nevzat Ilac Sanayi As │003478,    

                                                                                               │(Òóðöèÿ)                      │01.11.93   

                                                                                                                                        

│Äèëüðåí [Äèëòèàçåì]                │ÁÌÊÊ [C08DB01]                │êàïñóëû ïðîëîíãèðîâàííîãî     │Laboratoires Clin-Midy,       │002809,    

                                                                 │äåéñòâèÿ 300 ìã               │Sanofi (Ôðàíöèÿ)              │13.01.93   

                                                                                                                                        

│Äèëüöåì [Äèëòèàçåì]                │ÁÌÊÊ [C08DB01]                │òàáëåòêè 60 ìã; òàáëåòêè      │Parke-Davis Gmbh/Godecke Ag   │010188,    

                                                                 │ðåòàðä 90 ìã;                 │(Ãåðìàíèÿ)                    │29.04.98   

                                                                 │ëèîôèëèç.ïîðîøîê äëÿ èíúåêöèé │                                         

                                                                 │(ôëàêîíû) 25 ìã /â êîìïëåêòå                                           

                                                                 │ñ ðàñòâîðèòåëåì (àìïóëû) 5 ìë/│                                         

                                                                                                                                        

│Äèìåäðîë [Äèôåíãèäðàìèí]           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 50 ìã                │Natur Produkt (Ôðàíöèÿ)       │009262,    

                                   │áëîêàòîð [R06AA02]                                                                        │19.02.97   

                                                                                                                                        

│Äèìåäðîë [Äèôåíãèäðàìèí]           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 50 ìã                │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009177,    

                                   │áëîêàòîð [R06AA02]                                          │çàâîä ÀÎ (Ýñòîíèÿ)            │20.10.97   

                                                                                                                                        

│Äèìåäðîë 1% äëÿ èíúåêöèé           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Òàëëèííñêèé ôàðìàöåâòè÷åñêèé  │009230,    

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]            │1% - 1 ìë                     │çàâîä ÀÎ (Ýñòîíèÿ)            │10.12.97   

                                                                                                                                        

│Äèìåäðîëà ðàñòâîð äëÿ èíúåêöèé 1%  │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Çäîðîâüå íàðîäó - õàðüêîâñêîå │70/421/37, 

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]            │1% - 1 ìë                     │ãîñôàðì ïðåäïðèÿòèå (Óêðàèíà) │21.05.98   

                                                                                                                                        

│Äèìåäðîëà ðàñòâîð äëÿ èíúåêöèé 1%  │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/421/37, 

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]            │1% - 1 ìë                                                   │15.09.98   

                                                                                                                                        

│Äèìåäðîëà òàáëåòêè 0.05 ã          │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 50 ìã                │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/421/39, 

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]                                                                        │26.01.98   

                                                                                                                                        

│Äèìåäðîëà òàáëåòêè 0.05 ã          │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 50 ìã                │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │70/421/39, 

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]                                                                        │17.12.97   

                                                                                                                                        

│Äèìåäðîëà òàáëåòêè 0.1 ã           │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 100 ìã               │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │70/421/39, 

│[Äèôåíãèäðàìèí]                    │áëîêàòîð [R06AA02]                                                                        │26.01.98   

                                                                                                                                        

│Äèìåêñèä [Äèìåòèë ñóëüôîêñèä]      │ïðîòèâîâîñïàëèòåëüíîå         │æèäêîñòü (ôëàêîí-êàïåëüíèöû)  │Ôàðìàê ÀÎ (Óêðàèíà)           │75/244/9,  

                                   │ñðåäñòâî äëÿ ìåñòíîãî         │25 ìë                                                       │15.07.97   

                                   │ïðèìåíåíèÿ [M02AX03]                                                                                 

                                                                                                                                        

│Äèìåêñèä [Äèìåòèë ñóëüôîêñèä]      │ïðîòèâîâîñïàëèòåëüíîå         │æèäêîñòü äëÿ íàðóæíîãî        │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │75/244/9,  

                                   │ñðåäñòâî äëÿ ìåñòíîãî         │ïðèìåíåíèÿ (ôëàêîíû) 100 ìë                                 │05.01.98   

                                   │ïðèìåíåíèÿ [M02AX03]                                                                                 

                                                                                                                                        

│Äèíàáàê [Äèðèòðîìèöèí]             │àíòèáèîòèê, ìàêðîëèä [J01FA]  │òàáëåòêè 250 ìã               │Eli Lilly (ÑØÀ)               │005907,    

                                                                                                                             │04.04.95   

                                                                                                                                        

│Äèîâàí [Âàëüñàðòàí]                │àíãèîòåíçèíà II ðåöåïòîðîâ    │êàïñóëû 80, 160 ìã            │Ciba-Geigy Ag (Øâåéöàðèÿ)     │009703,    

                                   │àíòàãîíèñò [C09CA03]                                                                      │26.08.97   

                                                                                                                                         

│Äèï Ðèëèô [Èáóïðîôåí]              │ÍÏÂÑ [M02AA13]                │ãåëü (òóáû) 50 ã              │Mentholatum Company Ltd       │007600,    

                                                                                               │(Âåëèêîáðèòàíèÿ)              │21.06.96   

                                                                                                                                        

│Äèï Õèò {ìåòèëíèêîòèíàò 4%,        │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü (òóáû) 15, 35, 67, 100   │Mentholatum Company Ltd       │003913,    

│ìåòèëñàëèöèëàò 2.5%, ýòèëñàëèöèëàò │[M02AC]                       │ã; àýðîçîëü                   │(Âåëèêîáðèòàíèÿ)              │16.05.94   

│12%, ãèäðîêñèýòèëñàëèöèëàò 13% -                                                                                                        

│ìàçü; ìåòèëíèêîòèíàò 1.6%,                                                                                                              

│îêñèýòèëñàëèöèëàò 5%,                                                                                                                   

│ìåòèëñàëèöèëàò 1%, ýòèëñàëèöèëàò                                                                                                        

│5% - àýðîçîëü}                                                                                                                          

                                                                                                                                        

│Äèïèäîëîð [Ïèðèòðàìèä]             │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │006575,    

                                   │ñðåäñòâî [N02AC03]            │15 ìã - 2 ìë                                                │28.09.95   

                                                                                                                                        

│Äèïèðèäàìîë [Äèïèðèäàìîë]          │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Belupo (Õîðâàòèÿ)             │005738,    

                                   │[B01AC07]                     │75 ìã                                                       │13.02.95   

                                                                                                                                        

│Äèïðèâàí [Ïðîïîôîë]                │íàðêîçíîå íåèíãàëÿöèîííîå     │ýìóëüñèÿ äëÿ âíóòðèâåííîãî    │Ici (Âåëèêîáðèòàíèÿ)          │002890,    

                                   │ñðåäñòâî [N01AX10]            │ââåäåíèÿ âîäíàÿ èçîòîíè÷åñêàÿ │                              │03.03.93   

                                                                 │(àìïóëû) 10 ìã/ìë - 20 ìë                                              

                                                                                                                                        

│Äèïðèâàí [Ïðîïîôîë]                │íàðêîçíîå íåèíãàëÿöèîííîå     │ýìóëüñèÿ äëÿ âíóòðèâåííîãî    │Zeneca Pharma Pt (Èíäîíåçèÿ)  │006194,    

                                   │ñðåäñòâî [N01AX10]            │ââåäåíèÿ (àìïóëû) 10 ìã/ìë                                  │16.06.95   

                                                                                                                                        

│Äèïðîãåíò {áåòàìåòàçîíà            │ãëþêîêîðòèêîñòåðîèä           │ìàçü (òóáû) 15, 30 ã; êðåì    │Schering-Plough (Áåëüãèÿ)     │007826,    

│äèïðîïèîíàò 0.64 ìã, ãåíòàìèöèí 1  │+ïðîòèâîìèêðîáíîå ñðåäñòâî    │(òóáû) 15, 30 ã                                             │18.09.96   

│ìã - 1 ã}                          │[D07CC01]                                                                                            

                                                                                                                                        

│Äèïðîëåí [Áåòàìåòàçîí]             │ãëþêîêîðòèêîñòåðîèä äëÿ       │êðåì (òóáû) 0.05% - 15, 30 ã; │Schering-Plough (Áåëüãèÿ)     │009864,    

                                   │ìåñòíîãî ïðèìåíåíèÿ [D07AC01] │ìàçü (òóáû) 0.05% - 15, 30 ã                                │25.11.97   

                                                                                                                                        

│Äèïðîìàë [Âàëüïðîåâàÿ êèñëîòà]     │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Rzeszowskie            │005543,    

                                   │[N03AG01]                     │200 ìã                        │Pharmaceutical Works (Ïîëüøà) │05.12.94   

                                                                                                                                       

│Äèïðîñàëèê {áåòàìåòàçîíà           │ïðîòèâîâîñïàëèòåëüíîå         │ìàçü (òóáû) 30 ã; ëîñüîí      │Schering-Plough (Áåëüãèÿ)     │009121,    

│äèïðîïèîíàò 0.5 ìã, ñàëèöèëîâàÿ    │ñðåäñòâî äëÿ ìåñòíîãî         │(ôëàêîíû) 30 ìë                                             │05.02.97   

│êèñëîòà 30 ìã - 1 ã; áåòàìåòàçîíà  │ïðèìåíåíèÿ [D07XC01]                                                                                 

│äèïðîïèîíàò 0.5 ìã, ñàëèöèëîâàÿ                                                                                                         

│êèñëîòà 20 ìã - 1 ìë}                                                                                                                   

                                                                                                                                        

│Äèïðîñïàí [Áåòàìåòàçîí]            │ãëþêîêîðòèêîñòåðîèä [H02AB01] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Schering-Plough (Áåëüãèÿ)     │009285,    

                                                                 │2 ìã/5 ìã - 1 ìë                                            │04.03.97   

                                                                                                                                        

│Äèñîëü ðàñòâîð äëÿ èíúåêöèé        │ðåãèäðàòèðóþùåå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Íåñâèæñêèé çàâîä              │72/590/2,  

│{íàòðèÿ àöåòàò 2 ã, íàòðèÿ õëîðèä  │[B05BB]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë  │ìåäïðåïàðàòîâ (Áåëàðóñü)      │26.01.98   

│6 ã - 1 ë}                                                                                                                              

                                                                                                                                        

│Äèñîëü ðàñòâîð äëÿ èíúåêöèé        │ðåãèäðàòèðóþùåå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (ôëàêîíû │Êîíîòîïìÿñî ÀÎ (Óêðàèíà)      │72/590/2,  

│{íàòðèÿ àöåòàò 2 ã, íàòðèÿ õëîðèä  │[B05BB]                       │äëÿ êðîâåçàìåíèòåëåé) 400 ìë                                │15.07.98   

│6 ã - 1 ë}                                                                                                                              

                                                                                                                                        

│Äèñòðèë-ëèìîí {2,                  │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè äëÿ ðàññàñûâàíèÿ     │Dina International (Èíäèÿ)    │010453,    

│4-äèõëîðáåíçèëîâûé ñïèðò 1.2 ìã,   │[R02AA20]                                                                                 │07.09.98   

│àìèëìåòàêðåçîë 0.6 ìã}                                                                                                                  

                                                                                                                                        

│Äèñòðèë-îðàíæ {äèõëîðáåíçèëîâûé    │àíòèñåïòè÷åñêîå ñðåäñòâî      │òàáëåòêè äëÿ ðàññàñûâàíèÿ     │Dina International (Èíäèÿ)    │010452,    

│ñïèðò 1.2 ìã, àìèëìåòàêðåçîë 0.6   │[R02AA20]                                                                                 │07.09.98   

│ìã}                                                                                                                                     

                                                                                                                                        

│Äèñóëüôèðàì [Äèñóëüôèðàì]          │ñðåäñòâî ëå÷åíèÿ àëêîãîëèçìà  │òàáëåòêè äëÿ èìïëàíòàöèé 100  │Polfa, Warsaw Pharmaceutical  │007637,    

                                   │[V03AA01]                     │ìã                            │Works Sa (Ïîëüøà)             │10.07.96   

                                                                                                                                        

│Äèñôëàòèë [Äèìåòèêîí â êîìáèíàöèè  │âåòðîãîííîå ñðåäñòâî [A02DA]  │êàïëè (ôëàêîíû ñ äîçàòîðîì)   │Solco Basel Ag (Øâåéöàðèÿ)    │009447,    

│ñ äâóîêèñüþ êðåìíèÿ]                                             │40 ìã/ìë - 30 ìë                                            │14.05.97   

                                                                                                                                        

│Äèòàìèí [Äèãèäðîýðãîòàìèí]         │àëüôà-àäðåíîáëîêàòîð [N02CA01]│òàáëåòêè 2.5 ìã; ðàñòâîð äëÿ  │Lek D.D. (Ñëîâåíèÿ)           │008540,    

                                                                 │èíúåêöèé (àìïóëû) 1 ìã/ìë;                                  │12.05.98   

                                                                 │ðàñòâîð äëÿ ïðèåìà âíóòðü                                              

                                                                 │(ôëàêîíû) 2 ìã/ìë - 30 ìë                                              

                                                                                                                                        

│Äèòåê {ôåíîòåðîë 0.05 ìã,          │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │àýðîçîëü äîçèðîâàííûé 200 äîç │Boehringer Ingelheim          │008030,    

│êðîìîãëèêàò äèíàòðèÿ 1 ìã - 1 äîçà}│[R03AK03]                     │- 10 ìë                       │International Gmbh (Ãåðìàíèÿ) │25.02.97   

                                                                                                                                        

│Äèòèëèí - À ëèîôèëèçèðîâàííûé äëÿ  │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ëèîôèëèç.ïîðîøîê äëÿ          │Êèåâìåäïðåïàðàò ÀÎ (Óêðàèíà)  │009165,    

│èíúåêöèé [Ñóêñàìåòîíèÿ õëîðèä]     │[M03AB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │08.07.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 0.1, 0.2 ã │                                         

                                                                                                                                        

│Äèòèëèíà ðàñòâîð äëÿ èíúåêöèé 2%   │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áèîëåê - àðåíäíîå ïðåäïðèÿòèå │75/1032/8, 

│[Ñóêñàìåòîíèÿ éîäèä]               │[M03AB01]                     │2% - 5, 10 ìë                 │ïî ïðîèçâîäñòâó               │21.05.98   

                                                                                               │èììóíîáèîëîãè÷åñêèõ è                    

                                                                                               │ëåêàðñòâåííûõ ïðåïàðàòîâ                 

                                                                                               │(Óêðàèíà)                                

                                                                                                                                        

│Äèòèëèíà ðàñòâîð äëÿ èíúåêöèé 2%   │ìèîðåëàêñèðóþùåå ñðåäñòâî     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │75/1032/8, 

│[Ñóêñàìåòîíèÿ éîäèä]               │[M03AB01]                     │2% - 5 ìë                                                   │09.04.98   

                                                                                                                                        

│Äèòðàò [Èçîñîðáèä äèíèòðàò]        │âàçîäèëàòèðóþùåå ñðåäñòâî     │òàáëåòêè 5, 10 ìã; êàïñóëû    │Panacea Biotec Ltd (Èíäèÿ)    │003890,    

                                   │[C01DA08]                     │äëèòåëüíîãî âûñâîáîæäåíèÿ 20, │                              │28.04.94   

                                                                 │40 ìã                                                                  

                                                                                                                                        

│Äèóðñàí {àìèëîðèä 5 ìã,            │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │òàáëåòêè 5 ìã/50 ìã           │Tad Pharmazeutisches Werk     │006272,    

│ãèäðîõëîðîòèàçèä 50 ìã}            │ñðåäñòâî [C03EA01]                                          │Gmbh (Ãåðìàíèÿ)               │12.07.95   

                                                                                                                                        

│Äèóðñàí ìèòå {àìèëîðèä 2.5 ìã,     │äèóðåòè÷åñêîå êîìáèíèðîâàííîå │òàáëåòêè 2.5 ìã/25 ìã         │Tad Pharmazeu-tisches Werk    │006271,    

│ãèäðîõëîðîòèàçèä 25 ìã}            │ñðåäñòâî [C03EA01]                                          │Gmbh (Ãåðìàíèÿ)               │12.07.95   

                                                                                                                                        

│Äèóñåìèä [Ôóðîñåìèä]               │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 40 ìã                │Arab Pharmaceutical           │003576,    

                                   │[C03CA01]                                                   │Manufacturing Co Ltd          │09.12.93   

                                                                                               │(Èîðäàíèÿ)                               

                                                                                                                                        

│Äèóñåìèä [Ôóðîñåìèä]               │äèóðåòè÷åñêîå ñðåäñòâî        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arab Pharmaceutical           │003668,    

                                   │[C03CA01]                     │20 ìã - 2 ìë                  │Manufacturing Co Ltd          │03.02.94   

                                                                                               │(Èîðäàíèÿ)                                

                                                                                                                                        

│Äèôåí [Äèêëîôåíàê]                 │ÍÏÂÑ [M01AB05]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sol Pharmaceuticals Ltd       │005389,    

                                                                 │2.5%; òàáëåòêè 50 ìã          │(Èíäèÿ)                       │10.10.94   

                                                                                                                                        

│Äèôåíèíà òàáëåòêè 0.117 ã          │ïðîòèâîñóäîðîæíîå ñðåäñòâî    │òàáëåòêè 117 ìã               │Ëóãàíñêèé ÕÔÇ ÎÀÎ (Óêðàèíà)   │74/331/63, 

│[Ôåíèòîèí]                         │[N03AB02]                                                                                 │05.01.98   

                                                                                                                                        

│Äèôèçàë [Äèêëîôåíàê]               │ÍÏÂÑ [M01AB05]                │òàáëåòêè 50 ìã                │Kopran Ltd (Èíäèÿ)            │005513,    

                                                                                                                             │21.11.94   

                                                                                                                                        

│Äèôèçàë-ÑÐ [Äèêëîôåíàê]            │ÍÏÂÑ [M01AB05]                │òàáëåòêè äëèòåëüíîãî          │Kopran Ltd (Èíäèÿ)            │005513,    

                                                                 │âûñâîáîæäåíèÿ 100 ìã                                        │21.11.94   

                                                                                                                                        

│Äèôëþêàí [Ôëóêîíàçîë]              │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êàïñóëû 50, 100, 150, 200 ìã; │Pfizer (Ôðàíöèÿ)              │007469,    

                                   │[J02AC01]                     │ðàñòâîð äëÿ âíóòðèâåííîãî                                   │24.04.96   

                                                                 │ââåäåíèÿ (ôëàêîíû) 2 ìã/ìë -                                            

                                                                 │50, 100, 200 ìë                                                        

                                                                                                                                       

│Äèôëþêàí [Ôëóêîíàçîë]              │ïðîòèâîãðèáêîâîå ñðåäñòâî     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pfizer (Ôðàíöèÿ)              │007808,    

                                   │[J02AC01]                     │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                │11.09.96   

                                                                 │50 ìã|5 ìë, 200 ìã|5 ìë                                                

                                                                                                                                        

│Äèôëþêàí [Ôëóêîíàçîë]              │ïðîòèâîãðèáêîâîå ñðåäñòâî     │êàïñóëû 50 ìã; ðàñòâîð äëÿ    │Pfizer Pt (Èíäîíåçèÿ)         │006169,    

                                   │[J02AC01]                     │âíóòðèâåííîãî ââåäåíèÿ                                      │13.06.95   

                                                                 │(ôëàêîíû) 2 ìã/ìë                                                      

                                                                                                                                        

│Äèôóðåêñ [Ôóðîñåìèä]               │äèóðåòè÷åñêîå ñðåäñòâî        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Menon Pharma (Èíäèÿ)          │005146,    

                                   │[C03CA01]                     │10 ìã/ìë                                                    │19.07.94   

                                                                                                                                        

│Äèôóðåêñ [Ôóðîñåìèä]               │äèóðåòè÷åñêîå ñðåäñòâî        │òàáëåòêè 40 ìã                │Menon Pharma (Èíäèÿ)          │005528,    

                                   │[C03CA01]                                                                                 │28.11.94   

                                                                                                                                        

│Äèôôóìàë 24 [Òåîôèëëèí]            │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè 100, 200 ìã          │Malesci Instituto             │005172,    

                                   │[R03DA04]                                                   │Pharmabiologico (Èòàëèÿ)      │25.07.94   

                                                                                                                                        

│Äèôôóìàë 24 [Òåîôèëëèí]            │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │òàáëåòêè 350 ìã               │Malesci Instituto             │009373,    

                                   │[R03DA04]                                                   │Pharmabiologico (Èòàëèÿ)      │14.04.97   

                                                                                                                                        

│Äèöåòåë [Ïèíàâåðèÿ áðîìèä]         │ì-õîëèíîáëîêàòîð [A03AX04]    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Solvay Pharma (Ôðàíöèÿ)       │009320,    

                                                                │50, 100 ìã                                                  │19.03.97   

                                                                                                                                        

│Äèöèíîí [Ýòàìçèëàò]                │ãåìîñòàòè÷åñêîå ñðåäñòâî      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lek D.D. (Ñëîâåíèÿ)           │006596,    

                                   │[B02BX01]                     │250 ìã - 2 ìë; òàáëåòêè 250 ìã│                              │27.11.95   

                                                                                                                                        

│Äèýòîíà ìàçü 5%                    │äåðìàòîïðîòåêòîðíîå ñðåäñòâî  │ìàçü (òóáû) 5% - 20, 30 ã;    │Olainfarm Îëàéíñêèé ÕÔÇ ÀΠ   │009244,    

                                   │[D02AX]                       │ìàçü (ôëàêîíû) 5% - 20, 30 ã  │(Ëàòâèÿ)                      │19.12.97   

                                                                                                                                        

│Äëÿíîñ [Êñèëîìåòàçîëèí]            │àëüôà-àäðåíîñòèìóëÿòîð        │ðàñòâîð íàçàëüíûé (ôëàêîíû)   │Ciba-Geigy Hindustan Ltd      │007778,    

                                   │[R01AA07]                     │0.05%, 0.1% - 10 ìë           │(Èíäèÿ)                       │29.08.96   

                                                                                                                                        

│ÄÍÑ Êîíòèíóñ [Äèãèäðîêîäåèí]       │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │òàáëåòêè 60, 90, 120 ìã       │Mundipharma Gmbh (Àâñòðèÿ)    │005732,    

                                   │ñðåäñòâî [N02AA08]                                                                        │10.02.95   

                                                                                                                                        

│Äîáóòàìèí Ãåêñàë [Äîáóòàìèí]       │áåòà-àäðåíîñòèìóëÿòîð         │ëèîôèëèç.ïîðîøîê äëÿ          │Hexal Pharma Gmbh (Ãåðìàíèÿ)  │006084,    

                                   │[C01CA07]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │23.05.95   

                                                                │ðàñòâîðà (ôëàêîíû) 530 ìã                                              

                                                                                                                                        

│Äîáóòàìèí Ãèóëèíè [Äîáóòàìèí]      │áåòà-àäðåíîñòèìóëÿòîð         │ëèîôèëèç.ïîðîøîê äëÿ          │Giulini Pharma Gmbh (Ãåðìàíèÿ)│007389,    

                                   │[C01CA07]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │02.04.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã                                              

                                                                                                                                        

│Äîáóòàìèí Íèêîìåä [Äîáóòàìèí]      │áåòà-àäðåíîñòèìóëÿòîð         │ëèîôèëèç.ïîðîøîê äëÿ          │Nycomed Austria Gmbh (Àâñòðèÿ)│009077,    

                                   │[C01CA07]                     │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │15.01.97   

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã;                                             

                                                                 │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ                                           

                                                                 │èíôóçèîííîãî ðàñòâîðà                                                  

                                                                 │(àìïóëû) 12.5 ìã/ìë - 20 ìë                                            

                                                                                                                                        

│Äîáóòðåêñ [Äîáóòàìèí]              │áåòà-àäðåíîñòèìóëÿòîð         │ëèîôèëèç.ïîðîøîê äëÿ          │Eli Lilly (Ãåðìàíèÿ)          │007658,    

                                   │[C01CA07]                     │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │22.07.96   

                                                                 │ðàñòâîðà (ôëàêîíû) 250 ìã                                               

                                                                                                                                        

│Äîâèöèí [Äîêñèöèêëèí]              │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │ICN Galenika (Þãîñëàâèÿ)      │009723,    

                                   │[J01AA02]                                                                                 │15.09.97   

                                                                                                                                       

│Äîäåêñ [Öèàíîêîáàëàìèí]            │âèòàìèí [B03BA01]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Deva Holding As (Òóðöèÿ)      │007575,    

                                                                 │1000 ìêã/ìë                                                 │05.06.96   

                                                                                                                                        

│Äîêñàë [Äîêñèöèêëèí]               │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Cts Chemical Industries Ltd   │007955,    

                                   │[J01AA02]                                                   │(Èçðàèëü)                     │15.11.96   

                                                                                                                                        

│Äîêñåïèí [Äîêñåïèí]                │àíòèäåïðåññàíò [N06AA12]      │êàïñóëû 10 ìã, 25 ìã          │Polfa, Krakowskie             │008288,    

                                                                                               │Pharmaceutical Works (Ïîëüøà) │04.06.97   

                                                                                                                                        

│Äîêñèáåíå [Äîêñèöèêëèí]            │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Ludwig Merckle Gmbh (Àâñòðèÿ) │006410,    

                                   │[J01AA02]                                                                                 │15.08.95   

                                                                                                                                         

│Äîêñèáåíå Ì [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100 ìã               │Ludwig Merckle Gmbh (Àâñòðèÿ) │006567,    

                                   │[J01AA02]                                                                                 │28.09.95   

                                                                                                                                        

│Äîêñèäàð 100 [Äîêñèöèêëèí]         │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Dar Al Dava (Èîðäàíèÿ)        │003356,    

                                   │[J01AA02]                                                                                 │21.09.93   

                                                                                                                                        

│Äîêñèëàí [Äîêñèöèêëèí]             │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100, 200 ìã          │Lannacher Heilmittel Gmbh     │009071,    

                                   │[J01AA02]                                                   │(Àâñòðèÿ)                     │13.01.97   

                                                                                                                                        

│Äîêñèëåê [Êàëüöèÿ äîáåçèëàò]       │àíãèîïðîòåêòîðíîå ñðåäñòâî    │êàïñóëû 500 ìã                │Lek D.D. (Ñëîâåíèÿ)           │008142,    

                                   │[C05BX01]                                                                                 │27.01.97   

                                                                                                                                        

│Äîêñèóì [Êàëüöèÿ äîáåçèëàò]        │àíãèîïðîòåêòîðíîå ñðåäñòâî    │êàïñóëû 500 ìã                │Hemofarm D.D. (Þãîñëàâèÿ)     │003801,    

                                   │[C05BX01]                                                                                 │29.03.94   

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Belupo (Õîðâàòèÿ)             │007598,    

                                   │[J01AA02]                                                                                 │21.06.96   

                                                                                                                                       

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Chinoin (Âåíãðèÿ)             │005877,    

                                   │[J01AA02]                                                                                 │30.03.95   

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Creat Laboratoires (Ôðàíöèÿ)  │009051,    

                                   │[J01AA02]                                                                                 │25.12.96   

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 50 ìã                 │Norton Healthcare Ltd         │003242,    

                                   │[J01AA02]                                                   │(Âåëèêîáðèòàíèÿ)              │18.08.93   

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Norton Healthcare Ltd         │003518,    

                                   │[J01AA02]                                                   │(Âåëèêîáðèòàíèÿ)              │25.11.93   

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã; ðàñòâîð äëÿ   │Polfa, Tarchomin              │008521,    

                                   │[J01AA02]                     │èíúåêöèé (ôëàêîíû) 100 ìã - 5 │Pharmaceutical Works Sa       │02.03.98   

                                                                 │ìë                            │(Ïîëüøà)                                 

                                                                                                                                        

│Äîêñèöèêëèí [Äîêñèöèêëèí]          │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100, 200 ìã; ïîðîøîê │Sanavita Gesundcheitsmittel & │006753,    

                                   │[J01AA02]                     │äëÿ ïðèãîòîâëåíèÿ             │Co Kg (Ãåðìàíèÿ)              │27.10.95   

                                                                 │èíúåêöèîííîãî ðàñòâîðà                                                 

                                                                 │(ôëàêîíû) 100, 200 ìã                                                  

                                                                                                                                        

│Äîêñèöèêëèí 100 Ñòàäà              │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100 ìã               │Stada Arzneimittel Ag         │007902,    

│ìåæäóíàðîäíûé òàá [Äîêñèöèêëèí]    │[J01AA02]                                                   │(Ãåðìàíèÿ)                    │17.10.96   

                                                                                                                                        

│Äîêñèöèêëèí 200 Ñòàäà              │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 200 ìã               │Stada Arzneimittel Ag         │007901,    

│ìåæäóíàðîäíûé òàá [Äîêñèöèêëèí]    │[J01AA02]                                                   │(Ãåðìàíèÿ)                    │17.10.96   

                                                                                                                                        

│Äîêñèöèêëèí Íèêîìåä [Äîêñèöèêëèí]  │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100 ìã               │Nycomed Dak As (Äàíèÿ)        │005875,    

                                   │[J01AA02]                                                                                 │30.03.95   

                                                                                                                                        

│Äîêñèöèêëèíà ãèäðîõëîðèä 0.1 ã â   │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Áåëìåäïðåïàðàòû ÀÎ (Áåëàðóñü) │79/1239/4, 

│êàïñóëàõ [Äîêñèöèêëèí]             │[J01AA02]                                                                                 │15.09.98   

                                                                                                                                        

│Äîêñèöèêëèíà ãèêëàò [Äîêñèöèêëèí]  │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 50, 100 ìã; òàáëåòêè  │Rugby (ÑØÀ)                   │005746,    

                                   │[J01AA02]                     │100 ìã                                                      │14.02.95   

                                                                                                                                        

│Äîêñèöèêëèí-Ðèâî [Äîêñèöèêëèí]     │àíòèáèîòèê, òåòðàöèêëèí       │òàáëåòêè 100 ìã               │Rivopharm Sa (Øâåéöàðèÿ)      │007727,    

                                  │[J01AA02]                                                                                 │14.08.96   

                                                                                                                                        

│Äîêñîëåì [Äîêñîðóáèöèí]            │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lemery (Ìåêñèêà)              │002832,    

                                   │[L01DB01]                     │èíúåêöèîííîãî ðàñòâîðà                                      │10.02.93   

                                                                 │(ôëàêîíû) 10, 50 ìã                                                    

                                                                                                                                        

│Äîêñîðóáèöèí [Äîêñîðóáèöèí]        │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Rusan Pharma (Èíäèÿ)          │006443,    

                                   │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │29.08.95   

                                                                 │ðàñòâîðà (ôëàêîíû) 10 ìã /â                                            

                                                                 │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                             

                                                                                                                                        

│Äîêñîðóáèöèí-Òåâà [Äîêñîðóáèöèí]   │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │007959,    

                                   │[L01DB01]                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │18.11.96   

                                                                 │ðàñòâîðà 10, 50 ìã                                                     

                                                                                                                                        

│Äîêñîðóáèöèí-Ýáåâå [Äîêñîðóáèöèí]  │ïðîòèâîîïóõîëåâîå ñðåäñòâî    │êîíöåíòðàò äëÿ èíôóçèé        │Ebewe Arzneimittel Gmbh       │009964,    

                                   │[L01DB01]                     │(àìïóëû) 10 ìã/5 ìë, 50 ìã/25 │(Àâñòðèÿ)                     │23.01.98   

                                                                 │ìë; êîíöåíòðàò äëÿ èíôóçèé                                             

                                                                 │(ôëàêîíû) 10 ìã/5 ìë, 50                                               

                                                                 │ìã/25 ìë                                                               

                                                                                                                                        

│Äîêñò [Äîêñèöèêëèí]                │àíòèáèîòèê, òåòðàöèêëèí       │êàïñóëû 100 ìã                │Dolphin Laboratories Ltd      │007052,    

                                   │[J01AA02]                                                   │(Èíäèÿ)                       │06.02.96   

                                                                                                                                        

│Äîêòîð Ìîì {áàçèëèêà ñâÿùåííîãî    │îòõàðêèâàþùåå ñðåäñòâî        │ñèðîï ðàñòèòåëüíûé (ôëàêîíû)  │Unique Pharmaceutical         │003640,    

│ýêñòðàêò 0.1 ã, ñîëîäêè ãîëîé      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Laboratories (Èíäèÿ)          │25.01.94   

│ýêñòðàêò 60 ìã, êóðêóìû êîðíåâèùà  │[R05CA10]                                                                                            

│ýêñòðàêò 50 ìã, èìáèðÿ êîðíåâèùà                                                                                                        

│ýêñòðàêò 10 ìã, àäõàòîäû âàñèêà                                                                                                         

│ýêñòðàêò - 60 ìã, àëîý ýêñòðàêò 50 │                                                                                                     

│ìã, ìåíòîë 6 ìã, äåâÿñèëà êîðíåâèù │                                                                                                     

│è êîðíÿ ýêñòðàêò 20 ìã, ïåðöà                                                                                                            

│êóáåáû ýêñòðàêò 10 ìã, òåðìèíàëèè                                                                                                       

│áåëåðèêè ýêñòðàêò 20 ìã, àëîý                                                                                                           

│áàðáàäîññêîãî ýêñòðàêò 50 ìã - 10                                                                                                       

│ìë}                                                                                                                                     

                                                                                                                                        

│Äîêòîð Ìîì {ìåíòîë 3.06 ã, êàìôîðà │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │ìàçü                          │Unique Pharmaceutical         │003915,    

│5.25 ã, òèìîë 0.1 ã, òåðïåíòèíîâîå │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │Laboratories (Èíäèÿ)          │17.05.94   

│ìàñëî 5.57 ìë, ýâêàëèïòîâîå ìàñëî  │[R05X]                                                                                               

│1.49 ìë, ìóñêàòíîå ìàñëî 0.54 ìë}                                                                                                       

                                                                                                                                        

│Äîêòîð Òàéñ - ëåäåíöû ñ ýêñòðàêòîì │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè                      │Naturwaren Ohg (Ãåðìàíèÿ)     │005491,    

│øàëôåÿ è âèòàìèíîì Ñ {øàëôåÿ       │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                                               │14.11.94   

│ýêñòðàêò 50 ìã, øàëôåÿ ìàñëî 6 ìã, │[R02AA20]                                                                                            

│àñêîðáèíîâàÿ êèñëîòà 20 ìã}                                                                                                             

                                                                                                                                        

│Äîêòîð Òàéññ - ëåäåíöû ñ           │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè                      │Naturwaren, Dr.P.Theiss       │005557,    

│ýêñòðàêòîì ýõèíàöåè {ýõèíàöåè      │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ                                 │(Ãåðìàíèÿ)                    │08.12.94   

│ëèñòüåâ ýêñòðàêò 50 ìã, ìåíòîë}    │[R02AA05]                                                                                           

                                                                                                                                        

│Äîêòîð Òàéññ ðåâìà êðåì {øâåäñêàÿ  │ìåñòíîðàçäðàæàþùåå ñðåäñòâî   │êðåì (òóáû) 30, 70 ã          │Naturwaren Ohg, Dr.P.Theiss   │009877,    

│ãîðå÷ü 6%, êàïñàèöèí 0.095%}       │[M02AB]                                                     │(Ãåðìàíèÿ)                    │03.12.97   

                                                                                                                                        

│Äîëàê [Êåòîðîëàê]                  │ÍÏÂÑ [M01AB15]                │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Cadila Laboratories Ltd       │003396,    

                                                                 │èíúåêöèé (àìïóëû) 15, 30 ìã/ìë│(Èíäèÿ)                       │25.11.93   

                                                                                                                                        

│Äîëãèò êðåì [Èáóïðîôåí]            │ÍÏÂÑ [M02AA13]                │êðåì (òóáû) 5% - 20, 50, 100 ã│Dolorgiet (Ãåðìàíèÿ)          │007201,    

                                                                                                                             │28.05.96   

                                                                                                                                        

│Äîëî [Ïàðàöåòàìîë]                 │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Micro Labs Ltd (Èíäèÿ)        │005680,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                                                  │23.01.95   

                                   │[N02BE01]                                                                                            

                                                                                                                                        

│Äîëîáåíå {äèìåòèëñóëüôîêñèä 150    │àíòèêîàãóëÿíò ïðÿìîé äëÿ      │ãåëü (òóáû) 50, 100 ã         │Merckle Gmbh (Àâñòðèÿ)        │009277,    

│ìã, ãåïàðèí 500 ÌÅ, äåêñïàíòåíîë   │ìåñòíîãî ïðèìåíåíèÿ [C05BA53] │                                                            │27.02.97   

│25 ìã - 1 ã}                                                                                                                            

                                                                                                                                        

│Äîëîáèä [Äèôëóíèçàë]               │ÍÏÂÑ [N02BA11]                │òàáëåòêè 250, 500 ìã          │Merck Sharp & Dohme (ÑØÀ)     │002587,    

                                                                                                                             │03.08.92   

                                                                                                                                        

│Äîëîìîë [Ïàðàöåòàìîë]              │àíàëüãåòè÷åñêîå               │òàáëåòêè 500 ìã               │Al-Hikma Pharmaceuticals      │002598,    

                                   │íåíàðêîòè÷åñêîå ñðåäñòâî                                    │(Èîðäàíèÿ)                    │27.08.92   

                                   │[N02BE01]                                                                                            

                                                                                                                                        

│Äîëòàðä [Ìîðôèí]                   │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå │òàáëåòêè äåïî 10, 30, 60, 100 │Nycomed Dak (Äàíèÿ)           │007980,    

                                   │ñðåäñòâî [N02AA01]            │ìã                                                          │26.11.96   

                                                                                                                                        

│Äîìåíàí [Îçàãðåë]                  │àíòèàãðåãàíòíîå ñðåäñòâî      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Kissei Pharmaceutical Co Ltd  │007011,    

                                   │[B01AC]                       │100, 200 ìã                   │(ßïîíèÿ)                      │25.01.96   

                                                                                                                                        

│Äîíà [Ãëþêîçàìèí]                  │ðåãåíåðàöèè ñòèìóëÿòîð        │ïîðîøîê (ñàøå) 1500 ìã        │Rottapharm (Èòàëèÿ)           │007081,    

                                   │[M01AX05]                                                                                 │13.02.96   

                                                                                                                                        

│Äîíàëãèí [Íèôëóìîâàÿ êèñëîòà]      │ÍÏÂÑ [M01AX02]                │êàïñóëû 250 ìã                │Gedeon Richter (Âåíãðèÿ)      │006654,    

                                                                                                                             │29.02.96   

                                                                                                                                        

│Äîíîðìèë [Äîêñèëàìèí]              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Upsa Laboratoires, a division │008683,    

                                   │áëîêàòîð [R06AA09]            │15 ìã; òàáëåòêè øèïó÷èå 15 ìã │of Bristol-Myers Squibb       │12.10.98   

                                                                                               │(Ôðàíöèÿ)                                

                                                                                                                                        

│Äîïàìèí ÀÂÄ [Äîïàìèí]              │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Arzneimittelwerk Dresden Gmbh │008117,    

                                   │äîôàìèí-ñòèìóëÿòîð [C01CA04]  │èíôóçèîííîãî ðàñòâîðà         │(Ãåðìàíèÿ)                    │13.01.97   

                                                                 │(àìïóëû) 50 ìã - 5 ìë                                                  

                                                                                                                                        

│Äîïàìèí Äæóëèíè 50 [Äîïàìèí]       │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Giulini Pharma Gmbh (Ãåðìàíèÿ)│006777,    

                                   │äîôàìèí-ñòèìóëÿòîð [C01CA04]  │âíóòðèâåííîãî ðàñòâîðà                                      │01.11.95   

                                                                 │(àìïóëû) 50 ìã - 5 ìë                                                  

                                                                                                                                        

│Äîïàìèíà ãèäðîõëîðèä [Äîïàìèí]     │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Warszawskie            │005952,    

                                   │äîôàìèí-ñòèìóëÿòîð [C01CA04]  │1%, 4%                        │Pharmaceutical Works (Ïîëüøà) │12.04.95   

                                                                                                                                        

│Äîïàíîë [Ìåòèëäîïà]                │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè 250 ìã               │Polfa, Grodziskie             │003927,    

                                   │öåíòðàëüíûé [C02AB02]                                       │Pharmaceutical Works (Ïîëüøà) │20.05.94   

                                                                                                                                        

│Äîïàð 275 {ëåâîäîïà 250 ìã,        │äîôàìèí-ñòèìóëÿòîð+           │òàáëåòêè                      │Panacea Biotec Ltd (Èíäèÿ)    │003902,    

│êàðáèäîïà 25 ìã}                   │äåêàðáîêñèëàçû ïåðèôåðè÷åñêîé │                                                            │10.05.94   

                                   │èíãèáèòîð [N04BA02]                                                                                  

                                                                                                                                        

│Äîïåãèò [Ìåòèëäîïà]                │àëüôà2-àäðåíîñòèìóëÿòîð       │òàáëåòêè 250 ìã               │Egis (Âåíãðèÿ)                │2029,      

                                   │öåíòðàëüíûé [C02AB02]                                                                     │03.05.84,  

                                                                                                                             │13.07.95   

                                                                                                                                        

│Äîïìèí [Äîïàìèí]                   │êàðäèîòîíè÷åñêîå ñðåäñòâî,    │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Orion Pharmaceutica           │00705,     

                                   │äîôàìèí-ñòèìóëÿòîð [C01CA04]  │èíôóçèîííîãî ðàñòâîðà 40 ìã/ìë│(Ôèíëÿíäèÿ)                   │23.08.79,  

                                                                                                                             │09.03.93   

                                                                                                                                        

│Äîïïåëüãåðö Âèòàëîòîíèê {æåíüøåíÿ  │àäàïòîãåííîå ñðåäñòâî         │ðàñòâîð äëÿ ïðèåìà âíóòðü     │Queisser Pharma Gmbh & Co     │010401,    

│êîðíÿ ýêñòðàêò 50 ìã, õìåëÿ        │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │(ôëàêîíû) 20, 250, 500, 750,  │(Ãåðìàíèÿ)                    │13.08.98   

│ýêñòðàêò 100 ìã, áîÿðûøíèêà        │[A13A]                        │1000 ìë                                                                

│ëèñòüåâ è öâåòêîâ ýêñòðàêò 100 ìã, │                                                                                                     

│âàëåðèàíû ýêñòðàêò 200 ìã, ìåëèññû │                                                                                                     

│ëèñòüåâ ýêñòðàêò 50 ìã - 100 ìë}                                                                                                        

                                                                                                                                        

│Äîïïåëüãåðö Âèòàìèí Å ôîðòå        │âèòàìèí [A11HA03]             │êàïñóëû                       │Queisser Pharma Gmbh          │007583,    

│[Âèòàìèí Å]                                                                                    │(Ãåðìàíèÿ)                    │14.06.96   

                                                                                                                                        

│Äîïïåëüãåðö æåíüøåíü àêòèâ         │àäàïòîãåííîå ñðåäñòâî         │ðàñòâîð äëÿ ïðèåìà âíóòðü     │Queisser Pharma Gmbh & Co     │010220,    

│{æåíüøåíÿ êîðíÿ ýêñòðàêò 3243 ìã,  │ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ   │(ôëàêîíû) 20, 250, 500 ìë     │(Ãåðìàíèÿ)                    │26.05.98   

│íèêîòèíàìèä 54 ìã, ïèðèäîêñèí 6.49 │[A11AB]                                                                                              

│ìã, êîôåèí 22 ìã}                                                                                                                       

                                                                                                                                        

│Äîïïåëüãåðö Ìåëèññà {ìåëèññû òðàâà │êàðäèîòîíè÷åñêîå ñðåäñòâî     │êàïëè (ôëàêîíû) 15, 50, 100,  │Queisser Pharma Gmbh & Co     │009131,    

│2 ã, äÿãèëÿ êîðåíü 0.5 ã, êîðèöû   │[C01AX]                       │250, 500 ìë                   │(Ãåðìàíèÿ)                    │10.02.97   

│êîðà 0.25 ã, îðåõ ìóñêàòíûé 0.3 ã, │                                                                                                      

│ãâîçäèêà 0.3 ã, ïîìåðàíöà êîðà 1                                                                                                        

│ã, öèòðóñîâûõ ïëîäîâ êîæóðà 1.5 ã, │                                                                                                    

│ýòàíîë 59.6 ã, âîäà 28.9 ã}                                                                                                             

                                                                                                                                        

│Äîðìèêóì [Ìèäàçîëàì]               │ñíîòâîðíîå ñðåäñòâî [N05CD08] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Egis (Âåíãðèÿ)                │002781,    

                                                                 │7.5, 15 ìã; ðàñòâîð äëÿ                                     │29.12.92   

                                                                 │èíúåêöèé (àìïóëû) 5 ìã/1 ìë,                                           

                                                                 │15 ìã/3 ìë                                                             

                                                                                                                                        

│Äîðìèêóì [Ìèäàçîëàì]               │ñíîòâîðíîå ñðåäñòâî [N05CD08] │òàáëåòêè 15 ìã; ðàñòâîð äëÿ   │F.Hoffmann La Roche Ltd       │006833,    

                                                                 │èíúåêöèé (àìïóëû) 5 ìã/1 ìë,  │(Øâåéöàðèÿ)                   │15.11.95   

                                                                 │15 ìã/3 ìë                                                             

                                                                                                                                        

│Äîñòèíåêñ [Êàáåðãîëèí]             │äîôàìèí-ñòèìóëÿòîð [G02CB03]  │òàáëåòêè 0.5 ìã               │Pharmacia&Upjohn (Èòàëèÿ)     │009400,    

                                                                                                                             │21.04.97   

                                                                                                                                        

│Äðàïîëåí {áåíçàëêîíèÿ õëîðèä       │àíòèñåïòè÷åñêîå ñðåäñòâî      │êðåì (òóáû)                   │Wellcome Foundation Ltd       │005503,    

│0.01%, ñåòðèìèä 0.2%, ëàíîëèí 2%,  │[D08AJ]                                                     │(Âåëèêîáðèòàíèÿ)              │16.11.94   

│öåòèëîâûé ñïèðò 5%}                                                                                                                     

                                                                                                                                        

│Äðèëë áîëü â ãîðëå {õëîðãåêñèäèí   │àíòèñåïòè÷åñêîå ñðåäñòâî      │ñïðåé (ôëàêîíû) 55 ìë         │Pierre Fabre (Ôðàíöèÿ)        │007834,    

│50 ìã, òåòðàêàèí 15 ìã, ýòàíîë 95% │[R02AA20]                                                                                 │20.09.96   

│7 ìë - 100 ìë}                                                                                                                          

                                                                                                                                       

│Äðèëë áîëü â ãîðëå {õëîðãåêñèäèíà  │àíòèñåïòè÷åñêîå ñðåäñòâî      │ïàñòèëêè; ïàñòèëêè áåç        │Pierre Fabre (Ôðàíöèÿ)        │006346,    

│äèãëþêîíàò 3 ìã, òåòðàêàèíà        │[R02AA20]                     │ñàõàðà; ïàñòèëêè ñ ðîçîâûì                                  │04.08.95   

│õëîðãèäðàò 0.2 ìã, àñêîðáèíîâàÿ                                  │ìåäîì                                                                  

│êèñëîòà 52.5 ìã}                                                                                                                        

                                                                                                                                        

│Äðèëë îòõàðêèâàþùèé [Êàðáîöèñòåèí] │ìóêîëèòè÷åñêîå ñðåäñòâî       │ñèðîï (ôëàêîíû) 5% - 150 ìë;  │Pierre Fabre (Ôðàíöèÿ)        │007833,    

                                   │[R05CB03]                     │òàáëåòêè æåâàòåëüíûå 750 ìã                                 │20.09.96   

                                                                                                                                        

│Äðèïòàí [Îêñèáóòèíèí]              │ñïàçìîëèòè÷åñêîå ñðåäñòâî     │òàáëåòêè 5 ìã                 │Laboratoires Debat, Affiliate │009119,    

                                   │[G04BD04]                                                   │of Laboratoires Fournier      │04.02.97   

                                                                                               │(Ôðàíöèÿ)                                

                                                                                                                                        

│Äðîïåðèäîë [Äðîïåðèäîë]            │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé          │Gedeon Richter (Âåíãðèÿ)      │2039,      

                                   │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │(ôëàêîíû) 25 ìã - 10 ìë                                     │01.07.70,  

                                   │[N01AX01]                                                                                 │26.04.84,  

                                                                                                                            │06.03.95   

                                                                                                                                        

│Äðîïåðèäîëà ðàñòâîð äëÿ èíúåêöèé   │àíòèïñèõîòè÷åñêîå             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Grindex (Ëàòâèÿ)              │81/1234/7, 

│0.25% [Äðîïåðèäîë]                 │(íåéðîëåïòè÷åñêîå) ñðåäñòâî   │0.25% - 2, 5 ìë                                             │04.04.96   

                                   │[N01AX01]                                                                                            

                                                                                                                                        

│Äóëüêîëàêñ [Áèñàêîäèë]             │ñëàáèòåëüíîå ñðåäñòâî         │ñâå÷è 10 ìã                   │Boehringer Ingelheim          │003464,    

                                   │[A06AB02]                                                   │International Gmbh (Ãåðìàíèÿ) │28.10.93   

                                                                                                                                        

│Äóëüêîëàêñ [Áèñàêîäèë]             │ñëàáèòåëüíîå ñðåäñòâî         │ñâå÷è 10 ìã                   │Boehringer Ingelheim Italy    │009505,    

                                   │[A06AB02]                                                   │Spa (Èòàëèÿ)                  │04.06.97   

                                                                                                                                        

│Äóëüêîëàêñ [Áèñàêîäèë]             │ñëàáèòåëüíîå ñðåäñòâî         │äðàæå 5 ìã                    │Boehringer Ingelheim France,  │008534,    

                                   │[A06AB02]                                                   │a division of Boehringer      │22.04.98   

                                                                                               │Ingelheim International Gmbh             

                                                                                               │(Ôðàíöèÿ)                                 

                                                                                                                                        

│Äóîêàïòîí {àöåòèëñàëèöèëîâàÿ       │àíàëüãåòè÷åñêîå               │òàáëåòêè 300 ìã/300 ìã        │Mag.Dr.T.Strallhofer          │005525,    

│êèñëîòà 300 ìã, ïàðàöåòàìîë 300 ìã}│íåíàðêîòè÷åñêîå ñðåäñòâî                                    │Arzneimittelwerk Gmbh         │25.11.94   

                                   │[N02BA51]                                                  │(Àâñòðèÿ)                                

                                                                                                                                        

│Äóîðàí [Ðàíèòèäèí]                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 150, 300 ìã          │Panacea Biotec Ltd (Èíäèÿ)    │005419,    

                                   │áëîêàòîð [A02BA02]                                                                        │24.10.94   

                                                                                                                                        

│Äóî-Ñåïòîë [Êî-òðèìîêñàçîë]        │ïðîòèâîìèêðîáíîå              │òàáëåòêè 120, 480 ìã          │ICN Polfa Rzeszov Sa (Ïîëüøà) │008530,    

                                   │êîìáèíèðîâàííîå ñðåäñòâî                                                                  │09.04.98   

                                   │[J01EE01]                                                                                            

                                                                                                                                        

│Äóðàöåô [Öåôàäðîêñèë]              │àíòèáèîòèê, öåôàëîñïîðèí      │êàïñóëû 250, 500 ìã; ïîðîøîê  │Bristol-Myers Squibb (Èòàëèÿ) │009274,    

                                   │[J01DA09]                     │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │26.02.97   

                                                                 │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                           

                                                                 │ìë, 250 ìã|5 ìë - 60 ìë /â                                              

                                                                 │êîìïëåêòå ñ äîçàòîðîì/;                                                

                                                                 │òàáëåòêè äèñïåðãèðóåìûå 1 ã                                            

                                                                                                                                        

│Äóðîôèëèí [Òåîôèëëèí]              │áðîíõîäèëàòèðóþùåå ñðåäñòâî   │êàïñóëû ðåòàðä 125, 250 ìã    │Zdravle (ÑÔÐÞ)                │002041,    

                                   │[R03DA04]                                                                                 │12.03.91   

                                                                                                                                        

│Äóýëëèí {ëåâîäîïà 100 ìã,          │äîôàìèí-ñòèìóëÿòîð+           │òàáëåòêè 10 ìã/100 ìã, 25     │Egis Pharmaceutical Works Sa  │009901,    

│êàðáèäîïà 10 ìã; ëåâîäîïà 100 ìã,  │äåêàðáîêñèëàçû ïåðèôåðè÷åñêîé │ìã/100 ìã, 25 ìã/250 ìã       │(Âåíãðèÿ)                     │17.12.97   

│êàðáèäîïà 25 ìã; ëåâîäîïà 250 ìã,  │èíãèáèòîð [N04BA02]                                                                                  

│êàðáèäîïà 25 ìã}                                                                                                                        

                                                                                                                                        

│Äýéëåðò [Òåðôåíàäèí]               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ    │òàáëåòêè 60 ìã                │Micro Labs Ltd (Èíäèÿ)        │005623,    

                                   │áëîêàòîð [R06AX12]                                                                        │05.01.95   

                                                                                                                                        

│Ä-ýïèôðèí [Äèïèâåôðèí]             │ïðîòèâîãëàóêîìíîå ñðåäñòâî    │êàïëè ãëàçíûå 0.1%            │Krka (Ñëîâåíèÿ)               │005052,    

                                   │[S01EA02]                                                                                 │29.06.94   

                                                                                                                                        

│Äþíåêñàí À {ëèäîêàèí 2 ã,          │àíòèñåïòè÷åñêîå ñðåäñòâî      │ãåëü (òóáû)                   │Kreussler Pharma (Ãåðìàíèÿ)   │005422,    

│áåíçàëêîíèÿ õëîðèä 0.1 ã}          │[D08AJ]                                                                                   │25.10.94   

                                                                                                                                        

│Äþôàëàê [Ëàêòóëîçà]                │ñëàáèòåëüíîå ñðåäñòâî         │ñèðîï (ôëàêîíû) 200, 500,     │Solvay Duphar B.V.            │009298,    

                                   │[A06AD11]                     │1000 ìë                       │(Íèäåðëàíäû)                  │13.03.97   

                                                                                                                                        

│Äþôàñòîí [Äèäðîãåñòåðîí]           │ïðîãåñòàãåí [G03DB01]         │òàáëåòêè 10 ìã                │Solvay Duphar B.V.            │008352,    

                                                                                               │(Íèäåðëàíäû)                  │04.11.97   

└───────────────────────────────────┴──────────────────────────────┴──────────────────────────────┴──────────────────────────────┴────────────┘

 

×àñòü II, ãëàâà 1, ðàçäåë  2 (ïðîäîëæåíèå îò Å äî Ï)

 

×àñòü II, ãëàâà 1, ðàçäåë  2 (îêîí÷àíèå îò Ð äî ß)

 

×àñòü II, ãëàâà 1, ðàçäåëû 3-5, ãëàâû 2-5

 

Ïðèëîæåíèÿ 1-4

 

 



Âñå íîðìàòèâíî-ïðàâîâûå àêòû ïî ìåäèöèíå // Çäðàâîîõðàíåíèå, çäîðîâüå, çàáîëåâàíèÿ, ëå÷åíèå, ëåêàðñòâà, äîêòîðà, áîëüíèöû //

Ðåéòèíã@Mail.ru ßíäåêñ öèòèðîâàíèÿ

Copyright © Ìåäèöèíñêèé èíôîðìàöèîííûé ðåñóðñ www.hippocratic.ru, 2012 - 2024